Text

Semiannual Radioactive Effluent Release Rept for Clinton Power Station for Jan-June 1989
	ML20246H565
Person / Time
Site:	Clinton
Issue date:	06/30/1989
From:	Holtzscher D; ILLINOIS POWER CO.
To:	; NRC OFFICE OF INFORMATION RESOURCES MANAGEMENT (IRM)
References
	U-601515, NUDOCS 8909010299
	Download: ML20246H565 (201)
	v • d • e

& ,

.- U 601515 L30-89 (08 -28 )-LP S

1 pg-

1A.120

. CLIN'IDN POWER STATION. P.O. BOX 678. CLiflTON. ILLINOIS 61727 0678. TELEPilONE (217) 935-6881 H

August 28, 1989 i

' Docket No. 50-461 U.S.-Nuclear Regulatery Commission Attention: Document Control Desk Washington, D.C. 20555

Subject:

Clinton Power Station Semiannual Radioactive Effluent Release Renort

Dear Sir:

Attached is the Semiannual Radioactive Effluent Release Report for Clinton Power Station (CPS) for the period of January 1,1989 - June 30, 1989. This submittal is provided in accordance with the requirements of section 6.9.1.7 of the CPS Technical Specifications.

If you have any questions, please contact me.

Sincerely yours,

% ~d/

p, L. Holtzscher Acting M4 nager -

Licensing and Safety SFB/krm Attachment ec: NRC Clinton Licensing Project Manager NRC Resident Office Regional Administrator, Region III, USNRC Illinois Department of Nuclear Safety

%N I \

~ 8909010299 890630 t PDR ADOCK 05000462 W R PNV

l, I

I. CLINTON POWER STATION I l SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT I JANUARY 1,1989 - JUNE 30,1989 I

I I ~

I !

I '

" 4 l lSjl)Til[MQf

,, i i,,a k i:! h

m. J6 ll-g t N

s e e n nE Y - l w i ~_ - d= E E E E . m d) C i g _

L *

Et=~ R W F -

l RADIOLOGICAL Pfl07BCTIDst .

DEPAftT3sENT g

[.

1

p I

I TABLE OF CONTENTS l

i I SECTION

1. Summary . . . . . . . . . . . . . . . . . . . . .

PAGE 6

I

2. Introduction. . . . . . . . . . . . . . . . . . . 8

3. Supplemental Information. . . . . . . . . . . . . 18

4. Effluent and Waste Disposal Data. . . . . . . . . 25

5. Meteorological Data and Dispersion Estimates. . . 37

6. Dose Measurements and Assessments . . . . . . . . 51

7. Changes to the Offsite Dose Calculation Manual and the Solid Waste Process Control Program . . . . . . . . . . . . . . . . . . . . . 63

8. Limiting Condition for Operation Reports. . . . . 74

9. Major Changes to Radioactive Waste Treatment Systems . . . . . . . . . . . . . . . . . . . . . 82

10. New Locations for Dose Calculation and/or Environmental Monitoring. . . . . . . . . . . . . 84 I

I I

Y -

l LIST OF TABLES PAGE Airborne Effluents - Summation of All I Table 1:

Releases . . . . . . . . . . . . . . . . . . 26 Table 2: Airborne Effluents . . . . . . . . . . . . . 27 Table 3: Waterborne Effluents - Summation of All Releases . . . . . . . . . . . . . . . . . . 29 Table 4: Waterborne Effluents . . . . . . . . . . . . 30 Table 5: Solid Waste and Irradiated Fuel Shipments. . 33 Table 6: Estimated Total Errors Associated with Effluent Measurements. . . . . . . . . . . . 35 {

Table 7: Effluent Data Not Available for Previous -

Semiannual Report. . . . . . . . . . . . . . 36 Table 8: Meteorological Data Availability . . . . . . 39 Table 9: Classification of Atmospheric Stability. . . 43 Table 10: Joint Wind Frequency Distribution by Stability Class, I . . . . . . . . . . . . . .

Table 11: Maximum Off-Site Doses and Dose 44 Commitments to Members of the Public . . . . 52 '

Table 12: Calculated Doses to Members of the Public During Use of the Road in'the Southeast Sector within the CPS Site Boundary. . . . . 56 Table 13: Calculated Doses to Members of the Public '

During Use of the Agricultural Acreage in I the South-Southwest Sector within the CPS Site Boundary. . . . . . . . . . . . . . . . 57 I Table 14: Calculated Doses to Members of the Public During Use of Clinton Lake in the Northwest '

Sector within the CPS Site Boundary. . . . . 58 i

Table 15: Calculated Doses to Members of the Public l

During Use of the Department of Conservation Recreation Area in the East-l Southeast Sector within the CPS Site Boundary . . . . . . . . . . . . . . . . . . 59 I

I

I PAGE I Table 16: Calculated Doses for the Residence in the Southwest Sector within the CPS Site Boundary . . . . . . . . . . . . . . . . . . 60 Table 17: Calculated Doses for the Residence in the West-Southwest Sector within the CPS Site Boundary . . . . . . . . . . . . . . . . . . 61 Table 18: Calculated Doses for the Residence in the South-Southeast Sector within the CPS Site .

Boundary . . . . . . . . . . . . . . . . . . 62 I I

I I

l I

I

.I l

l I

I

i

. I l LIST OF FIGURES f

j PAGE Figure 1: CPS Airborne Effluent Release Points. . . . . 10 Figure 2: CPS Waterborne Effluents Release Pathway. . . 11 Figure 3: Effluent Exposure Pathways. . . . . . . . . . 16 Figure 4: Clinton Power Station Monthly Liquid l Radwaste Discharge Total.

I' Figure 5: CPS Wind Rose: 10-meter.

31 40 1

l Figure 6: CPS Wind Rose: 60-meter. . . . . . . . . . . 41 Figure 7: Clinton Power Station Atmospheric Stability Class Prevalences. . . . . . . . . . . . . . 42 l Figure 8: Areas Within the CPS Site Boundary Open to Members of the Public. . . . . . . . . . . 55 l

l I {

I

)

l e

lI I i 4

I -

l

l LIST OF ATTACHMENTS l ATTACHMENT A: ODCM Revision 5, Affected Pages ATTACHMENT B: Solidification Vendor Procedure / Document Approval Cover Sheet I

I I

i ul cp .-M 1

I

SUMMARY

1 g .

.I i

g I

I I

I I 6

SUMMARY

The Semiannual Radioactive Effluent Release Report is a -

I detailed listing of all radioactive releases (both gaseous and liquid) from the Clinton Power Station (CPS) and the resulting radiation doses for the period from January 1 through June 30, 1989. This report includes a detailed meteorological section which provides the weather history of the area during the time of the releases. This information is used to calculate the dose to the public. This report also includes a summary of the amounts of radioactive material contained in solid waste that is packaged and shipped for offsite disposal at federally approved burial I facilities. In addition, this report serves as a medium for notifying the US Nuclear Regulatory Commission (NRC) staff of changes to CPS's Offsite Dose Calculation Manual (CDCM) and Solid Waste Process Control Program (PCP), and exceptions to the CPS effluent monitoring program which must be reported per Technical Specifications 3.3.7.11 and 3.3.7.12.

The NRC requires that nuclear power stations be designed, constructed, and operated in such a way that the amount of I radioactive material in effluent releases to unrestricted areas is kept As Low As Beasonably Achievable (ALARA). To assure these criteria are met, the NRC has established limits governing the release of radioactivity in effluents.

The maximum radiation dose delivered to the public living in the vicinity of CPS, due to radioactivity released from the station, is negligible. The radiation dose to the public is calculated for each release using the concentration of radioactive material and the weather conditions at the time of the release. These doses were only a small fraction of the limit for the most potentially exposed member of the public.

I lI .

!I I

I l I )

I I

SECTION 2 i.

l l_'

, INTRODUCTION' I

I l

)

I I

I I 8 :

- _ . _ _ _ _ _ _ _ _ _ _ _ _ _ . . .a

INTRODUCTION Clinton Power Station is located in Harp Township, DeWitt {

County approximately six miles east of the city of Clinton in east-central Illinois. Clinton Power Station consists of a 985 MWe gross electrical power output boiling water reactor. The reactor and generating units were supplied by General Electric, Sargent and Lundy Engineers served as architect-engineer, and Baldwin Associates was the constructor.

I construction of CPS began in the mid 1970's. Fuel load began in September of 1986 with initial criticality achieved on February 27, 1987. Commercial operation commenced in j

April 1987 and the reactor reached 100% power for the first time on September 15, 1987.

Airborne effluents are released from CPS via two gaseous I

effluent release points to the environment: the Common Station Heating, Ventilation, and Air Conditioning (HVAC) f Stack and the Standby Gas Treatment System (SGTS) Stack (see I Figure 1). Each release point is continuously monitored and a program of periodic sampling and analysis is conducted as specified in the plant Technical Specifications. Liquid 1

{

effluents from CPS are released in batch mode and are sampled and analyzed prior to release. Liquid effluents, variable from 10-60 GPM or 50-300 GPM, combine with Plant Service Water flow (minimum of approximately 5000 GPM) and Plant Circulating Water flow (0-567,000 GPM) in the Seal Well prior to entering the 3.4 mile discharge flume to Lake Clinton (see Figure 2).

I .

I I

9

.. _-_-__-___-___a

l;l- CPS AIRBORNE EFFLUENT RELEASE POINTS Figure 1

!I I 1--

ROOF EL 875'0'

__ / ;

MACHb5 SHOP.ULDING l.

170'F > 206'0* p j NNN CONTROL ROOM -

SGTS VENT A3R TOP CONTAINMENT CONC.EL 917'r 8 :

CowTROL ar = nana I

- ,. ROOF EL 547'0'

}

~ ~

/* / 7) f 7) i I

! COW 1RIN M fT l

/ / ROOF EL 790'0'(H.P.)

I , /t 3 l EL

f ROOF EL 788'O'(LP.)

l o.a. oEN. . .C .uu. g ~ ,E m u T.

(AT EL 719'0")

_ _ _ . u- -- ._.V I l GASEOUS EFFLUENT RFLEASE POINT CHARACTERISTICS I HVAC EXHAUST STACK SGTS EXHAUST STACK RELEASE POINT HEIGHT (m) 61 61 .

BUIL' DING HOGHT(m) 58 58 RELEASE POINT GEOMETRY DUCT PIPE RELEASE POINT ARFJL (m*) 11.15 0.15 RELEASE POINT DIAMETER (m) 3.77* 0.44 ANNUAL AVERAGE FLOW RATE (fr 8/ min) 237,000 4000 VERTICAL EXIT YELOCITY(m/sec) 10.02 12.49 10 I

.IL

'g CPS WATERBORNE EFFLUENTS RELEASE PATHWAY Figure 2 -

I

.l \ \ ._

PLANT SERVICE WATER RW BLDG.

l \

wPTO2s.000 GAuCNSIBATQC I

, (AT LEAST 5000 GPM) g.

7 LIQUID RADWASTE DISCHARGE LINE

_ oo-eo oR 50-300 GPl4 I h RADIATION MONITOR I ALARMNRP SETPonfr CALCUUED BASED ON EACH BATCH ISCTOPIC ANALYSIS AND DunON FLOW

>4 ISOLATION VALVE '

I TERMINES RELEASE ON HIGH RADIKDON.

HGH RELEASE FLOW RATE.OR Low

@ COMPOSITE SAMPLER COLLECTS APPROXIMATELY 20 ml

.)

I EVERY60 MINUTES FROM THE OtSCHARGE FLUME FOR MONTHLY ANALYSIS

)

I SEALWELL e LAKE .

NT CIRCULATING CLINTON WATER l (0-567,000 GPM) DISCHARGE FLUME 3.4 MILES l

I I I I _

l Reaulatorv Limits The NRC requires nuclear power plants to be designed, -

I constructed and operated in such a way that the radioactivity in effluent releases to unrestricted areas is kept AIARA. To assure these criteria are met, each license t

{

authorizing nuclear reactor operation includes Radiological I Effluent Technical Specifications (RETS) governing the release of radioactive effluents (Code of Federal Regulations, Title 10, Part 50, Appendix I). The RETS I designate the limits for release of effluents, as well as the limits for doses to the general public from the release of radioactive liquids and gases. Keeping releases within I these operating limits demonstrates that the ALARA principle is being met.

I The dose to a member of the general public from radioactive material in liquid effluents released to unrestricted areas is limited to:

Less than or equal to 3 mrem per year to the total body.

-and-Less than or equal to 10 mrem per year to any organ.

The dose to air due to release of noble gases in gaseous effluents is limited to:

Less than or equal to 10 mrad per year for gamma radiation.

-and-I Less than or equal to'20 mrad per year for beta radiation.

The dose to a member of the general public from iodine-131, tritium and all particulate radionuclides with a half-life greater than eight days in gaseous effluents is limited to:

I -

Less than or equal to 15 mrem per year to any organ. ~

3 These ALARA limits are a fraction of the dose limits 3 established by the Environmental Protection Agency (EPA).

In its Environmental Dose Standard of 40CFR190, the EPA I

established dose limits in the vicinity of a nuclear power plant. These dose limits are:

I 12

i 1

1 Less than or equal to 25 mrem per year to the j total body. -

Less than or equal to 75 mrem per year to the thyroid.

-and-Less than or equal to 25 mrem per year to any other organ.

See Section 3 for more information on regulatory limits.

Processina and Monitorina Effluents are strictly controlled at CPS to ensure I radioactivity released to the environment is minimal and does not exceed release limits. Effluent controls include the operation of radiation monitoring systems in the plant I and offsite environmental sampling and analysis programs.

In-plant radiation monitoring systems are used to provide a continuous indication of radioactivity and are also used to collect particulate and radioiodine samples. These samples are analyzed in a laboratory to identify the specific concentration of radionuclides being released. Sampling and analysis provide a more sensitive and precise method of I determining effluent composition to complement the information provided by real-time monitoring instruments.

Beyond the plant itself, a radiological environmental monitoring program is maintained in accordance with Federal Regulations. The basic purpose of the program is to assess the radiological impact on the environment due to the operation of the Clinton Power Station. Implicit in this purpose is the regulatory requirement to trend and assess radiation exposure rates and radioactivity concentrations that may contribute to human radiation exposure. The program consists of two phases, preoperational and operational. During the preoperational phase of the I program, the baseline for the local radiation environment was established. The operational phase of the program includes the objective of making confirmatory measurements I to verify that the in-plant controls for the release of radioactive material are functioning as designed.

Assessment of the operational impact of CPS on the environment is based on data collected since the reactor I started.

j I

4 13 l

l I

Exoosure Pathways Radiological exposure pathways are the means by which people -

may become exposed to radioactivity released from nuclear I. facilities. The major pathways of concern are those which could cause the highest calculated radiation dose. These pathways are determined from the type and amount of I radioactivity released, the environmental transport mechanism and use of the environment. The environmental transport mechanism includes the meteorological I characteristics of the area which will be defined by wind speed and wind direction at the time of the release. This information is used to evaluate how the radionuclides will be distributed in the area. The most important factor in evaluating the exposure pathway is the use of the environment by the people living around CPS. Factors such as location of homes in the area, use of cattle for milk and I meat, and the growing of gardens for vegetable consumption are very important considerations in evaluating exposure pathways. Figure 3 illustrates the various effluent I

exposure pathways considered.

The radioactive gaseous effluent exposure pathways include I direct radiation, deposition on plants and soil, and inhalation by animals and humans. The radioactive liquid effluent exposure pathways include drinking water, fish consumption and direct exposure from the lake.

I Dose Assessment I Whole body radiation involves the exposure of all organs in the. human body to ionizing radiation. Most background radiation exposures consist of whole body exposure although specific organs can receive radiation exposure from distinct I radionuclides. These radionuclides enter the body by inhalation and ingestion and seek different crgans depending on the nuclide. For example, radioactive iodine selectively concentrates in the thyroid, radioactive cesium collects in muscle and liver tissue, and radioactive strontium in mineralized bone.

The total dose to organs from a given radionuclides also depends on the amount of activity in the organ and the I amount of time that the radionuclides remains in the body.

Some radionuclides remain for very short periods of time due to their rapid radioactive decay and/or elimination rate from the body, while others may remain longer.

The radiation dose to people in the area surrounding CPS is calculated for each release using the concentrations of radioactive material and the weather conditions present at the time of the release. The dose is calculated in all sixteen geographical sectors surrounding CPS and takes into account tha location cf the nearest residents, vegetable 14 I . - - _ .

I

~

gardens producing broad leaf vegetables, and milk and meat animals in all sectors. The calculated dose also uses the l

concept of a " maximum exposed individual" and " standard -

l 3 man", and the maximum use factors for the environment, such 5 as how much milk a person drinks and how much. air a person breathes in a year.

See Tables 11-18 of Section 6 for more detailed information on dose to the public.

I l

l I

I <

I l

I I

.I .

I I

15

R

_ E WN OO

PI 'oE m N T *eK S

_ OT TS N

A s[ . PuL A

Y I

E I

L 5B C

_ o

@w@

i -

u O

_ .u oE eL uP 3 uO SE

_ y ES NE P

Y B

RS

_ E OA BE RE L kN E===

R E

4I AR

(*4a H

P S

_ O M

T E E A R L P

Y u O B

_ o E

O P

E P

MD T

u L

2

_ S E P M

L

- S

[=

A E

_ L

=y E

R s

)

T N

E

=/

SA M LE AM M S I

K, N L

_ AI M

(

_ ~

Gaseous Effluents

.3 Gaseous effluent radioactivity released from CPS'is g classified into two categories, 1) noble gas, and 2) iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than eight days.

Noble gases, such as xenon and krypton, are biologically and chemically nonreactive; these radionuclides cause external radiation exposure. Iodine-131, iodine-133, tritium and radionuclides in particulate form with half-lives greater I' than eight days are the major contributors to internal dose.

See Tables 1, 2, 6 and 7 of Section 4 for more detailed l information on gaseous effluents.

Licuid Effluents Radioactivity in liquid effluents consists of radioactive fission and activation products, tritium and entrained noble i gases.

]

See Tables 3, 4, 6 and 7 and Figure 4 of Section 4 for more .

detailed information on liquid effluents. I Solid Waste Shionents In order to reduce the radiation exposure to personnel and maintain the ALARA concept, the NRC and the Department of Transportation (DOT) have established limits on the types of radioactive waste and the amount of radioactivity that may be packaged and shipped offsite for burial or disposal. To 1 ensure that CPS is complying with these regulations, the !

I types of waste and the radioactivity present are reported to the NRC.

See Table 5 of Section 4 for more detailed information on I solid waste shipments.

I I l I

I 17

- - - - - - - _ _ _ _ _ _ _ _ _ _ _ _ . - - - - - - - - _ _ _ _ _ - . _ _ _ _ .J

I

I crzo >

SUPPLEMENTAL-INFORMATION I-g.

I I

I 18 I

I. REGULATORY LIMITS A. Gaseous Effluents

1. In accordance with Title 10 of the Code of Federal Regulations, Part 20, the maximum permissible concentrations for gaseous effluents shall not exceed the values given in 10CFR20, Appendix B, Table II, Column 1.

I To ensure these concentrations are not exceeded, dose rates due to radioactive materials released in gaseous effluents from I 'the site to areas at and beyond the site boundary shall be limited to the following:

a. Noble gases -

I Less than or equal to 500 mrem / year to the total body.

I -

Less than or equal to 3000 mrem / year to the skin.

b. Iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than eight days:

Less than or equal to 1500 mrem / year to any organ.

I 2. In accordance with Title 10 of the Code of Federal Regulations, Part 50, Appendix I, air

'E dose due to noble gases released in gaseous B effluents to areas at and beyond the site boundary shall be limited to the following:

a. Less than or equal to 5 mrad for gamma )

radiation and less than or equal to 10 mrad for beta radiation during any calendar quarter.

b. Less than or equal to 10 mrad for gamma radiation and less than or equal to 20 l mrad for beta' radiation during any ~

calendar year.

3. In accordance with 10CFR50, Appendix I, dose l to a member of the public (from !

iodine-131, iodine-133, tritium and all i radionuclides in particulate form with half-11 19

'l lives greater than eight days) in gaseous a effluents released to areas at and beyond the site boundary shall be limited to the -

following:

a. Less than or equal to 7.5 mrem to any organ, during any calendar quarter.

b. Less than or equal to 15 mrem to any organ, during any calendar year.

B. Liquid Effluents

-g 1. The concentration of radioactive material 3 released in liquid effluents to unrestricted areas shall be limited to the concentrations specified in Title 10 of the Code of Federal I Regulations, Part 20, Appendix B, Table II, Column 2, for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited to 2.0E-04 microcuries per milliliter total activity.

2. The dose or dose commitment to a member of the public from radioactive materials in liquid effluents released to unrestricted l

I areas shall be limited to:

l a. Less than or equal to 1.5 arem to the l

total body and less than or equal to 5 mrem to any organ during any calendar quarter.

l l

b. Less than or equal to 3 mrem to the total body and less than or equal to 10 I mrem to any organ during any calendar year.

II. MAXIMUM PERMISSIBLE CONCENTRATION A. Gaseous

1. The maximum permissible concentrations (MPC) for gaseous effluents are specified in Title '

10 of the Code of Federal Regulations, Part I 20, Appendix B, Table II, Column 1. However, the MPC's of 10CFR20 are not utilized directly for limiting gaseous effluents. CPS

]

i Technical Specifications establish I requirements to limit the release rate of '

effluents such that discharges of gaseous I

20 I >

I I

l l

1

.E radioactive material will not result in the {

E- dose rates, to a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA either within or outside -

I; the SITE BOUNDARY, higher than those which would occur if average annual concentrations exceeded MPC limits. The maximum permissible dose rates for gaseous releases are:

I a. Technical Specification 3.11.2.1.a (Dose rate at and beyond the site boundary from gaseous effluents in the form of

-I noble gases).

I Less than or equal to 500 mrem / year to the total body.

Less than or equal to 3000 i mrem / year to.the skin.

b. Technical Specification 3.11.2.1.b (Dose rate at and beyond the site boundary from gaseous effluents in the form of iodine-131, iodine-133, tritium and all I radionuclides in particulate form with half-lives greater than eight days).

Less than or equal to 1500 mrem / year to any organ.

B. Liquids )

1. The maximum permissible concentrations (MPC) for liquids are those listed in 10CFR20, Appendix B, Table II, Column 2, with the most restrictive MPC (whether soluble or insoluble) being used in all cases. For dissolved and entrained noble gases the MPC I of 2.0E-04 microcuries per milliliter is applied. This MPC is based on the Xe-135 MPC in air (submersion dose) converted to an )

equivalent concentration in water as I- discussed in the International Commission on 1 l

Radiological Protection (ICRP), Publication 2.

III. AVERAGE ENERGY -

I The CPS Technical Specifications limit the dose equivalent rates due to the release of fission and activation gases to less than or equal to 500 mrem per 4 j

year to the total body and less than or equal to 3000 mrem per year to the skin. Therefore, the average beta and gamma energies (E) for gaseous efflue.nts as lI 21 c___ _ _ _ _ _ - _ _ _ _ _ _ _ _ _ _ ._ __ .Y

I I described in Regulatory Guide 1.21, " Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and -

I Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants", is not applicable.

IV. MEASUREMENT AND APPROXIMATIONS OF TOTAL RADIOACTIVITY A. Fission and Activation Gases

1. Gas samples are routinely collected monthly and as required by CPS Technical Specification Table 4.11.2-1 and counted on a high purity germanium detector (HPGu) for principal gamma emitters. The HVAC and SGTS release points are continuously monitored, and the average release flow rates for each release point are used to calculate the total activity released in a given time period.

I 2. Tritium is collected by passing a known volume of the sample stream through a gas washer containing a known quantity of I demineralized water. The collected samples are distilled and analyzed by liquid scintillation. The tritium released was calculated for each release point from the measured tritium concentration, the volume of sample, the tritium collection efficiency, and the stack exhaust flow rates.

B. Iodines Iodine is continuously collected on a charcoal I. cartridge filter via an isokinetic sampling assembly on each release point. Filters are normally exchanged once per week and analyzed on I an HPGe system. The daily average flow rates for each release point are averaged for the duration of the sampling period and these results along with isotopic concentrations are used to determine total activity released during the time period in question.

I C. Particulate I Particulate are continuously collected on a filter paper via an isokinetic sampling assembly on each release point. Filters are normally exchanged once per week and analyzed on an HPGe l system. Flow rates and total activity are determined in the same manner as for iodines.

I 22

)

D. Waterborne Effluents Each tank of liquid radwaste is sampled and analyzed for principal gamma emitters prior to

.I release. Each sample tank is recirculated for a sufficient amount of time prior to sampling to ensure that a I representative semple is obtained.

Samples are analyzed on an HPGe system and release permits are generated based on the values obtained from the isotopic analysis and the most recent values for tritium, gross alpha, iron-55, strontium-89 and strontium-90. An aliquot based on release volume is saved and added to composite I containers. The conce.ntrations of composited isotopes and the volumes of the releases associated with there composites establish the proportional relationships that are then utilized for calculating the total activity released for these isotopes.

V. BATCH RELEASES A. Liquid 1st Otr 89 2nd Otr 89

1. Number of batch I releases: 0 11 !

2. Total time period for batch roleases: N/A 9.69E+02 min.

I 3. Maximum time period for l

batch release: N/A 1.04E+02 min.

I 4. Average time period for batch release: N/A 8.81E+01 min.

5. Minimum time

. I-period for batch release: N/A 5.90E+01 min.

6. Average stream I flow during periods of release: N/A 7.74E+04 1pm

7. Total waste l I' volume: N/A 9.85E+05 liters g 8. Total dilution l

3 volume: N/A 7.50E+07 liters I

lI I

B. Gaseous 1st Otr 89 2nd Otr 89

1. Number of -

g batch releases: 0 0 3 2. Total time period for I

I 3.

batch relea=es:

Maximum time period for N/A N/A batch release: N/A N/A I 4. Average time period for batch release: N/A N/A 3 5. Minimum time E period for batch release: N/A N/A VI. ABNORMAL RELEASES There have been no abnormal releases of radioactive material to the environment during this reporting period.

{

I I

I 1 l

I '

I I 1 I .

l l

i I

I - - - - - - - - - - - - - -

r-___---_--------_. -

I tl l SocTzo. .

'I EFFLUENT AND WASTE DISPOSAL DATA E

iI I

I '

lI E

I

,I l>

1 l

l I ,

I

'6 I 25 I u

I I TABLE 1 I SENIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT AIRBORNE itFFLUENTS - SUNNATION OF ALL RELEASES Data Parfod: January 1, 1989 - June 30, 1989 Nuclide Catecorv Unit First Ouarter Second Ouarter k A. Fission & Activation Gases I1.TotalRelease l Ci <2.24E+03 <1.97E+03 l

2. Average Release Rate for Period uCi/sec <2.88E+02 <2.S1E+02 I3. Percent of Applicable Limit <7.24E-02

% <3.35E-02 B. Iodine-131

1. Total Releasel Ci 23.46E-05 <6.19E-05 23,81E-06 <4.75E-04 l'2.AverageRelease Rate for Period uCi/sec 24.45E-06 <7.96E-06 24.85E-07 <6.04E-05 )

3. Percent of Applicable Limit % 23.95E-C6 <7.06E-06 24.30E-07 <5.35E-05 C. Particulate

1. Particulate Released l with Half-lives >B I Days

2. Average Release Ci 27.31E-04 <8.32E-04 21.08E-04 <6.18E-04*

uCi/sec Rate for Period 19.40E-05 <1.07E-04 21.37E-05 <7.86E-05*

3. Percent of I I.

Applicable Limit % 23.2BE-06 <2.27E-05 24.11E-06 <1.69E-05*

4. Gross Alpha Activity Released Ci 21.52E-06 <2.99E-05 <2.12E-05 D. Tritium

1. Total Releasel Ci ll.36E-02 <1.44E+00 <4.95E+00 I2.AverageRelease Rate for Period uCi/sec 11.75E-03 <1.85E-01 <6.30E-01 Percent of l3. Applicable Limit % 21.07E-07 <1.14E-05 <3.85E-05 1 Notation: The first value presented (2) includes only activity positively detected at the 95% confidence level (CL). The second I value (<) includes detected activity plus the Minimum Detectable Activity (MDA) values of any samples in which activity was not detected at the 95% CL.

Reported values include Sr-89 and Sr-90 values based on first quarter 1989 sample analyses and second quarter 1989 ventilation exhaust rates.

26

l TABLE F

~

l

' SEMIANNUALRADIOACTIVEEFFLUENTRELEpEREPORT AIRBORNE EFFLUENTS (Curies)

Data Period: January 1, 1989 - June 30, 1989 Nuclide First Ouarter Second Ouarter A. Gases l i Kr-85 Kr-85m Kr-87

<1.84E+03

<6.27E+00

<1.48E+01

<1.77E+03

<6.04E+00

<1.90E+01 l l Kr-88 <2.32E+01 <2.13E+01

.5 Xe-133 <1.82E+01 <1.76E+01 Xe-135 <5.67E+00 <5.52E+00 Xe-135m <7.96E+01 <3.67E+01 lI Xe-138 <2.43E+02 <7.83E+01 Others:

Ar-41 <1.27E+01 <1.29E+01 Total <2.24E+03 <1.97E+03 B. Iodines I-131 23.46E-05 <6.19E-05 23.81E-06 <4.75E-04 l .I-132 <2.06E-04 <5.15E-05 l I-133 22.18E-05 <6.79E-05 <5.60E-04 l I-134 <3.12E-04 <3.08E-04 l I-135 <2.32E-04 <1.30E-03 Total 25.64E-05 <8.80E-04 23.81E-06 <2.69E-03 l

- IC. Particulate with Half-lives >8 Days Sr-89 <7.09E-06 <7.40E-06*

Sr-90 <2.07E-06 <2.16E-06*

Cs-134 <3.20E-05 <2.31E-05 Cs-137 <3.18E-05 <3.12E-05 Ba-140 <1.23E-04 <8.78E-05 I

l 32 Notation: The first value presented (2) includes only activity 3 positively detected at the 95% confidence level. The second value (<)

includes detected activity plus the MDA values of any samples in which l activity was not detected at the 95% confidence level.

1

Reported values are estimated based on first quarter 1989 composite analyses and second quarter 1989 ventilation exhaust rates.

27

l I

TABLE 2 (Cont'd) l SEMIANNUALRADIOACTIVEEFFLUENTRELEg8EREPORT AIRBORNE EFFLUENTS (Curies)

Data Period: January 1, 1989 - June 30, 1989 Nuclide First Ouarter Second Ouarter Others:

Cr-51 5.87E-04 8.11E-06 I Mn-54 Co-58 Fe-59 27.00E-05 22.93E-05

<1.18E-04

<6.74E-05

<7.90E-05 21.97E-05 <5.71E-05

<3.54E-05

<6.64E-05 Co-60 24.42E-05 <1.38E-04 27.97E-05 <1.08E-04 Zn-65 <7.53E-05 <7.74E-05 Ce-141 <3.11E-05 <2=54E-05 Ce-144 <1.27E-04 <9.64E-05 Total 27.31E-04 <8.32E-04 21.08E-04 <6.18E-04 I

I I

I -

I '

2 Notation: The first value presented (2) includes only activity i

I positively detected at the 95% confidence level. The second value includes detected activity plus the MDA values of any samples in which

(<)

activity was not detected at the 95% confidence level.

28

TABLE 3 I SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT WATERBORNE EFFLUENTS - SUMMATION OF ALL RELEASES Data Period: January 1, 1989 - June 30, 1989 Nuclide Catecorv Unit First Ouarter Second Ouarter l A. Fission & Activation l Products

1. Total Release 3 Ci 24.47E-03* <2.39E-03*

2. Average Diluted

).-'3. Concentration Percent of uCi/m3 25.96E-08* <3.19E-08*

Applicable Limit % 21.44E-01* <5.35E-01*

I B.1.Tritium Total Release 3 Ci 3.68E-01

2. Average Diluted I Concentration uCi/ml f 4.91E-06

, I 3. Percent of L Applicable Limit % 1.64E-01

, C. Dissolved and Entrained Gasgs l 1. Total Release Ci <1.66E-02 l 2. Average Diluted Concentration uCi/ml

<2.21E-07

3. Percent of Applicable Limit % <1.11E-01 >

D. Gross Alpha I Radioactivity Released Ci 2.28E-05 E . Volume of Waste gal. 2.60E+05 I Released liters 9.85E+05 F. Volume of Dilution gal. 1.98E+07 Water Used liters 7.50E+07 l

- 1 3 Notation: The first value presented (2) includes only activity I positively detected at the 95% confidence level. The second value (<)

includes detected activity plus the MDA values of any samples in which activity was not detected at the 95% CL.

Reported values include Fe-55, Sr-89, and Sr-90 values based on fourth quarter 1988 sample analyses and second quarter 1989 discharge volumes.

29 1

I TABLE 4 I SEMIANNUALRADIOACTIVEEFFLUE!!TRELEAgEREPORT WATERBORNE EFFLUENTS (Curies)

Data Period: January 1, 1989 - June 30, 1989 -

Nuclide First Ouarter Second Ouarter A. Tritium 3.68E-01

0. Fission & Acti-vation Products I Mn-54 Co-58 Co-60 21.41E-03 12.18E-04 22.72E-03

<2.45E-04 Fe-55 9.85E-05*

Fe-59 <2.25E-04 Zn-65 <2.26E-04 Sr-89 I Sr-90 Mo-99 Ag-110m

<9.85E-06*

<4.85E-06*

<5.51E-04 2.38E-05 I Sb-124 I-131 I-133

<9.09E-05

<5.10E-05

<7.23E-05 I-135 I Cs-134 Cs-137

<1.71E-04

<7.36E-05

<7.48E-05 Ba-140 I La-140 Ce-141 Ce-144

<2.44E-04

<4.42E-05

<5.27E-05

<2.51E-04 Total 24.47E-03 <2.39E-03 C. Dissolved and Entrained Gases Kr-85

<1.47E-02 Kr-85m I Kr-87 Kr-88

<4.55E-05

<1.61E-04

<1.55E-04 Xe-133 <1.11E-04 I Xe-133m Xe-135 Xe-135m

<3.81E-04

<4.41E-05

<3.74E-04 i fe-138

' <6.75E-04 Total <1.66E-02 '

4 Notation: The first value presented (1) includes only activity positively detected at the 95% confidence level. The second value (<)

i includes detected activity plus the MDA values of any samples in which I

activity was not detected at the 95% CL.

fe Reported values are estimated based on fourth quarter 1988 sample analyses and second quarter 1989 discharge volumes.

I 30

I I .

,I I

FIGURE 4 l

l CLINTON POWER STATION MONTHLY LIQUID RADWASTE DISCHARGE TOTAL g Data Period: January 1,1989 - June 30,1989 l 150,000 140422 130,000 -

t19780[

E 110,000 -

I -

90,000 -

~

I 3 70,000 -

50,000 -

I 30,000 -

I -

10,000 -

0 0 0 i i i i i i JAN FEB MAR APR MAY JUN 1989 I

31

SOLID WASTE NR) IRRADIATED FUEL SHIPMENTS During this reporting period there were twenty-one (21) radioactive waste shipments and no irradiated fuel shipments from CPS as reported in Table 5. All waste shipped in this reporting period was classified as Class A. In addition, CPS Technical Specifications, section 6.9.1.7 requires reporting of the following information for solid waste

-shipped offsite during the report period.

1. ' Container volume: 7.50 cubic feet, 92 cubic feet *,

1173 cubic feet *, 178.9 cubic feet,.and 183.2 cubic feet.

2. Total curie quantity: 671 curies as determined by dose-to-curie methodology and sample concentration methodology estimates.

3. Principal radionuclides: See Table 5, A.2 for listing of measured radionuclides. ,

4. ' Source of waste and processing employed: Spent resins, filter sludges and evaporator concentrates solidified in bitumen or cement. Compacted and non-compacted dry active waste.

5. Type of container: LSA, Type A and strong tight package.

6. Solidification agent or absorbent: Bitumen and cement (no absorbents used).

These are containers containing non-compressed dry active waste shipped to a waste processor not to a burial site.

32

. - - - - _ . . _ , - = . . - -

TABLE 5 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT SOLID WASTE AND IRRADIATED FUEL SHIPMENTS Data Period: January 1, 1989 - June 30, 1989 A.

SOLID WASTE SHIPPED OFFSITE FOR BURIAL OR DISPOSAL (Not irradiated fuel) 6-month Est. Total

1. Tyne of Waste Unit Period Error. %

Spent resins, filter m 3

a. 1.84E+02 sludges, evaporator- Ci 6.69E+02 25.0 bottoms, etc.

b. Dry compressible m3 7.32E+02 waste, contaminated Ci 1.56E+00 25.0 equip, etc.

c. Irradiated components m 3 0.00E0 control rods, etc. Ci 0.00E0 0.0

d. Other (describe) m3 0.00E0 Ci 0.00E0 0.0

2. Estimate of major nuclide composition (by type of waste)

(Curies)

a. Fe-55 70.754% 4.85E+02 Co-60 13.590% 9.32E+01 Mn-54 11.321% 7.76E+01 Fe-59 1.347% 9.24E+00 Other 0.582% 3.99E+00

b. Fe-55 72.170% 1.13E+00 Mn-54 12.050% 1.88E-01 Co-60 8.232% 1.28E-01 Cr-51 2.409% 3.76E-02 Co-58 2.293% 3.58E-02 Other 2.847% 4.44E-02 l

l c. None N/A N/A

d. None N/A N/A l

1 1

33 i

_-.--_---_x--

TABLE 5 (Cont'd) .

SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT SOLID WASTE AND IRRADIATED FUEL SEIPMENTS Data Period: January 1, 1989 - June 30, 1989

3. Solid Waste Disposal Ntmher of Shinments Mode of Transportation Destination 19 Truck Richland, WA 2 Truck Barnwell, SC ^

{

B. IRRADIATED FUEL SHIPMENTS (Disposition)

Number of Shionents Mode of Transportation Destination l None N/A N/A '

C. TECHNICAL SPECIFICATIONS CLASSIFICATION REQUIREMENTS -

N/A I

i 1

l l

l I

34 1 1

TABLE 6 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT ESTIMATED TOTAL ERRORS ASSOCIATED WITH EFFLUENT MEASUREMENTS Data Period: January 1, 1989 - June 30, 1989 Measurement Averaae % Ertgr Larcest % Error

1. Airborne Effluents

a. Activation & Fission Gases Xe-135 i20.4 124.8

b. Iodine-131 I31.1 146.9

c. Particulate Na-24 124.9 125.5 Cr-51 126.5 132.9 Mn-54 30.5 138.2 Tc-99m 24.5 125.9

d. Gross Alpha 24.8 34.6

e. Tritium 120.8 i21.0

f. Beta Emitters Sr-89 21.7 125.0 Sr-90 115.8 25.0

2. Waterborne Effluents

a. Activation & Fission Products Cr-51 i20.4 133.8 Kn-54 112.6 117.2 Co-58 il5.2 120.1 Co-60 il2.4 116.7

b. Tritium i 1.1 i 1.2 ;

1

. c. Gross Alpha 135.5 148.3 .

d. Beta Emitters Sr-89 i 2.3 i 6.1 Sr-90 1 3.8 114.7 Fe-55 1 6.2 112.6 1

35

TABLE 7 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT EFFLUENT DATA NOT AVAILABLE FOR PREVIOUS SEMIANNUAL REPORT Data Period: October 1, 1988 - December 31, 1988 Nuclide Category Unit Fourth Quarter 1988 A. Airborne Effluents

1. Sr-89 Ci 5.81E-05

2. Sr-90 Ci 18.44E-07 <8.46E-07 B. Liquid Effluents

1. Sr-89 Ci <8.41E-07

2. Sr-90 Ci <8.41E-07

3. Fe-55 Ci 8.41E-06 Notation: The first value presented (1) includes only activity positively detected at the 95% confidence level.

The second value (<) includes detected activity plus the MDA values of any samples in which activity was not detected at the 95% CL.

36

I I- .EcTIe. ,

g:

METEOROLOGICAL DATA AND DISPERSION ESTIMATES I.

I I

I 4 I l I :

I J I 37 I ;

METEOROLOGY AND DISPERSION DATA The meteorological monitoring program began at the Clinton Power Station site on April 13, 1972. The meteorological system consists of a tower 199 feet high with two levels of instrumentation, at the 10-meter and 60-meter levels. Wind directions and speeds at the 10-meter and 60-meter levels are measured by a combined cup and vane sensor. The temperature at these levels is sensed by an aspirated dual temperature sensor. One-half of the dual sensor at each elevation is.used for ambient temperature while the other half is used to provide a differential temperature between the 10- and 60-meter levels. Dew-point is measured at the 10-meter level with an aspirated dew-point sensor.

Precipitation.is measured at ground level by a tipping bucket rain gauge.

Meteorological monitoring instruments have been placed on the Clinton Power Station microwave tower at the 10-meter level to act as a backup to the existing meteorological tower.

Clinton Power Station meteorological data is transmitted to the Main Control Room via a dedicated telephone line. There the signals are received and converted to a 4 to 20 milliamp signal and fed individually to a microprocessor and chart recorders. The microprocessor is part of the Clinton Power Station Radiation Monitoring System. Meteorological data is available via the microprocessor in the Main Control Room, Technical Support Center and Radiation Protection office.

Dispersion modeling for effluents for normal operation of Clinton Power Station is a straight-line, sector-averaged Gaussian plutt model designed to estimate average relative concentration at various receptor points. The model was developed in accordance with routine release analysis procedures specified in Regulatory Guide 1.111. For joint frequency input data, periods of calm are distributed in accordance with a directional distribution. For hourly input data, periods of calm are assigned the previous hour's wind direction. Periods of calm are assigned a wind speed value of half the specified instrument threshold value. See l Tables 8-10 and Figures 5-7 for more detailed information on i

meteorology and dispersion data. '

38

I TMM 8 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT -

METEOROLOGICAL DATA AVAILABILITY I Data Period: January 1, 1989 - June 30, 1989 I Parameter Percent of Valid Hours Durina Period

1. Wind Speed

a. 10-meter Sensor 95%

b. 60-meter Sensor I 2. Wind Direction 95%

I a. 10-meter Sensor

b. 60-meter Sensor 95%

95%

3. Temperature

a. 10-meter 95%

b. 60-meter I c. Temperature Difference (10m-60m) 95%

94%

4. Percent of hours for which valid 94.3%

I 10-meter Wind Speed, Wind Direction,

& Delta Temperature were available

5. Percent of hours for which valid 94.3% '

I. 60-meter Wind Speed, Wind Direction,

& Delta Temperature were available I

l I !

I I

I 39 I

I FIGURE 5 I CPS VIND ROSE: 10-METER Data Period: January 1, 1989 - June 30, 1989 I- N NNW NNE 6.0% 6.3%

I .

~

NW 6.9%

NE 7.2%

l.

I I WNW 7.4%

g

=

w ENE 5.1%

I 2_

i 5.9% IE A UNE EEUUNIE 4.6%

I gg '

=

k WSW = '

ESE-5.0% ,

3.5%

SW SE 5.7% ....

6.5%

SSW SSE 7.9% g 6.0% ,

6*2%

WIND SPEED KEY I

~

>24 MPH E 19-24 MPH E 13-18 MPH I 8-12 MPH 4-7 MPH I-3 MPH

)

I 40

. _ - _ _-_____ __-_--_...__--__..- --- _ A

lI j, _ FIGURE 6 CPS WIND ROSE: 60-METER Data Period: January 1, 1989 - June 30, 1989 -

l N

NNW NNE 6.4%. 8.1%

I '

NW NE r,, 7.6% 5.8%

3 I WNW 5.6%

ENE

^

4.9%

I '

, E . ,

g 4.7% II83 Eh I ! 3III E N3 3.8%

5 I .,

WSW I 5.I% ;.. ESE 3.8%

SW SE I 6.7% 4.9%

B I

~

SSW SSE -

10.3% g 6.1%

9.7%

WIND SPEED KEY ;

"->24 MPH !

E 19-24 MPH I = 13-18 MPH 8-12 MPH 4-7 MPH I-3 MPH 41

~

t s 3 sn% ba% %

6 e5 t%

a b a%

Un4 U2 t6s l

/3 4 5 1

2 b0a2 S29 t6 S 4 y/

lyrs es Us l

n/ / t/ y/ l y/ s s Ss r es l eru s r e ou tr r r t r au e S a u mH r o t o l yu u o l t

yu o ro mo t e

E e eH h H h H eH eH r0 d 0 g5 g8 d 4 t6r M C t9 x3 o7 i 2

4 io 2 l

7 x8 N E1 M1 lS2 S8 M3 E1 0 1

E L

A9 MMM 9]G t a

n o

V89 i

t N E1 Re /, \ b u

O Pnu i

r t

I s T J i

D

_ AS - y T S S Ay c

n

_ 7 ERCu La r n

a

/ -

' e u

q e

r R E YJ U vF G W T:

d n

I

_ F OI d o P Lire i

I '

W BP -

' t n

N O AaTt

/

i J

o TSD a n

_ N o I

LIC d e

CR s

a E B

_ H P

_ S O

M T

A ."

I TABLE 9 .

I SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT CLASSIFICATION OF ATMOSPHERIC STABILITY I Stability Pasquill Defining C1 ossification Categories conditions Extremely unstable A -0.900<aTS-0.019 Moderately unstable , B -0.019<aTS-0.017 I NrutralSlightly unstable C -0.017<aTS-0.015 D -0.015<aTS-0.005 Slightly stable E -0.005<aTS-0.015 F 0.015<aTS-0.040 I Moderately stable Extremely stable G 0.040<aTS-0.900 Invalid ATS-0.900 or AT>0.900 AT = temperature difference in Celsius degrees per meter I

I I

I -

l I l I

I 43 I ;

I TABLE 10, Page 1 of 7 i I SEMIANNUAL RADI0 ACTIVE EFFLUENT RELEASE REPORT JOINT WIND FREQUENCY O!STRIBUTION BY STABILITY CLASS Data Period: January 1, 1989 June 30, 1989

~

i STABILITY CLASS A

)

VIND SPEED (MPN) AT 10 METER LEVEL DIRECTION 1-3 47 8-12 13-18 19 24 >24 TOTAL N 5.00E 00 2.00E 01 2.50E 01 1.70E 01 1.00E 00 0.00E 01 6.80E 01 I NNE NE EUE 1.10E 01 1.40E 01 1.00E 01 1.90E 01 2.30E 01 2.20E 01 3.30E 01 2.90E 01 3.60E 01 9.00E 00 7.00E 00 1.00E 01 5.00E 00 0.00E-01 0.00E 01 0.00E 01 1.00E 00 0.00E-01 7.70E 01 7.40E 01 7.80E 01 E 6.00E 00 3.40E 01 3.10E 01 2.00E 00 0.00E 01 0.00E 01 7.30E 01 ESE 7.00E 00 2.40E 01 2.70E 01 2.00E 00 0.00E 01 0.00E 01 6.00E 01 SE 1.30E 01 4.00E 01 4.70E 01 3.00E 00 0.00E 01 0.00E 01 1.03E 02 I

SSE 1.40E 01 3.20E 01 2.30E 01 3.00E 00 0.00E-01 0.00E 01 7.20E 01 ;

S 7.00E 00 2.00E 01 4.10E 01 2.00E 01 2.00E 00 0.00E 01 9.00E 01 SSW 8.00E 00 1.90E 01 4.30E 01 4.10E 01 2.00E 00 0.00E 01 1.13E 02 SW 7.00E 00 1.80E 01 4.50E 01 2.80E 01 3.00E 03 0.00E 01 1.01E 02 I WSW W

WKW 4.00E 00 3.00E 00 8.00E 00 1.00E 01 1.50E 01 1.20E 01 4.50E 01 3.50E 01 3.20E 01 1.00E 01 2.60E 01 4.60E 01 1.20E 01 9.00E 00 1.70E'01 0.00E 01 1.00E 00 8.10E 01 8.90E 01 0.00E 01 1.15E 02 I WW NWW TOTAL 1.70E 01 6.00E 00 1.40E 02 3.40E 01 2.20E 01 3.64E 02 3.80E 01 2.70E 01 5.57E 02 3.10E 01 1.80E 01 2.73E 02 4.00E 00 0.00E-01 5.50E 01 0.00E-01 0,00E 01 2.00E 00 1.24E 02 7.30E 01 1.39E 03 PER100$ OF CALM (HOURS): 2.400E 01 WIND SPEED (MPH) AT 60 METER LEVEL DIRECTION 1-3 47 8 12 13-18 19 24 >24 TOTAL N 3.00E 00 2.20E 01 1.90E 01 1.60E 01 2.00E 00 0.00E 01 6.20E 01 I NNE NE ENE 7.00E 00 9.00E 00 0.00E 01 1.40E 01 1.10E 01 1.00E 01 4.80E 01 1.90E 01 2.50E 01 3.60E 01 1.70E 01 1.90E 01 5.00E 00 5.00E 00 1.40E 01 3.00E 00 1.00E 00 0.00E 01 1.13E 02 6.20E 01 6.80E 01 I

E 3.00E 00 7.00E 00 2.70E 01 2.50E 01 2.00E 00 1.00E 00 6.50E 01 ESE 6.00E 00 1.50E 01 2.10E 01 1.90E 01 3.00E 00 0.00E 01 6.40E 01 SE 5.0DE 00 2.30E 01 3.50E 01 1.20E 01 0.00E 01 0.00E 01 7.50E 01 SSE 5.00E 00 2.90E 01 1.40E 01 2.30E 01 3.00E 00 2.00E 00 7.60E 01 I

l S 6.00E 00 2.20E 01 3.70E 01 3.90E 01 8.00E 00 9.00E 00 1.21E 02 SSW 3.00E 00 1.70E 01 4.50E 01 2.20E 01 2.10E 01 1.2TE 01 1.20E 02 l SW 3.00E 00 2.30E 01 2.70E 01 4.60E 01 1.50E 01 5.00E 00 1.19E 02 l VSW 2.00E 00 1.30E 01 2.70E 01 2.90E 01 1.00E 01 2.00E 00 8.30E 01 5 W 1.00E 00 1.40E 01 2.10E 01 2.30E 01 6.00E 00 1.10E 01 7.60E 01 WNW 3.00E 00 1.40E 01 2.30E 01 4.80E 01 2.10E 01 1.00E 00 1.10E 02 WW 7.00E 00 1.60E 01 2.40E 01 3.10E 01 2.50E 01 1.00E 00 1.04E 02 I- NWW 8.00E 00 3.30E 01 2.80E 01 2.30E 01 3.00E 00 0.00E 01 9.50F 01 TOTAL 7.10E 01 2.83E 02 4.40E C2 4.28E 02 1.43E 02 4.80E 01 1.41E 03 PER100$ OF CALM (HOURS): 2.000E 00 44 I -

_ _ _ _ _ _ _ _ _ _ _ . _ _ _ . . _ . ~ . _ . . . _ , . _ . _ -

I TABLE 10, Page 2 of 7 I SEM! ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT JOINT WIND FREQUENCY DISTRIBUTION BY STABILITY CLASS Data Period: January 1, 1989 - June 30, 1989 ~

l STABILITY CLASS B WIND SPEED (MPH) AT 10 METER LEVEL DIRECTION 13 47 8 12 13-18 19 24 >24 TOTA L N 1.00E 00 2.00E 00 1.00E 01 1.00E 01 0.00E 01 0.00E 01 2.30E 01 NNE 0.00E-01 1.00E 00 6.00E 00 9.00E 00 5.00E 00 1.00E 00 2.20E 01 l 5 NE 0.00E 01 4.00E 00 0.00E-01 2.00E 00 2.00F 00 0.00E 01 8.00E 00 l' 0.00E 01 ENE 6.00E 00 4.00E 00 1.00E 00 0.00E 01 0.00E 01 1.10E 01

. E 1.00E 00 6.00E 00 1.00E 00 0.00E 01 0.00E 01 0.00E 01 8.00E 00 ESE 1.00E 00 7.00E 00 0.00E 01 0.00E 01 0.00E 01 0.00E 01 8.00E 00 SE 0.00E-01 1.00E 00 3.00E 00 0.00E-01 0.00E 01 0.00E 01 4.00E 00 SSE 0.00E-01 0.00E 01 2.00E 00 2.00E 00 0.00E 01 0.00E 01 4.00E 00 S 0.00E 0) 4.00E 00 2.00E 00 3.00E 00 1.00E 00 0.00E 01 1.00E 01 SSW 1.00E 00 2.00E 00 3.00E 00 1.00E 00 1,00E 00 1.00E 00 9.00E 00 SW 0.00E-01 0.00E-01 4.00E 00 0.00E 01 0.00E 01 0.00E 01 4.00E 00 I WSW W

WW 0.00E 01 0.00E 01 2.00E 00 1.00E 00 1.00E 00 0.00E-01 2.00E 00 2.00E 00 2.00E 00 0.00E 01 4.00E 00 8.00E 00 4.00E 00 1.00E 00 0.00E 01 0.00E 01 0.00E-01 0.00E-01 7.00E 00 8.00E 00 1.20E 01 I NW NWW TOTAL 0.00E 01 0.00E 01 6.00E 00 1.00E 00 3.00E 00 3.90E 01 9.?0E 00 5.00E 00 5.50E 01 3.00E 00 1.10E 01 5.40E 01 0.00E 01 0.00E 01 1.40E 01 0.00E 01 0.00E 01 2.00E 00 1.30E 01 1.90E 01 1.70E 02 PER100S OF CALM (HOURS): 2.000E 00 VIND SPEED (MPH) AT 60 METER LEVEL DIRECTION 1-3 47 8-12 13-18 19 24 >24 TOTAL M 1.00E 00 3.00E 00 1.00E 00 6.00E 00 0.00E-01 0.00E-01 1.10E 01 I NNE NE ENE 0.00E 01 0.00E 01 0.00E-01 1.00E 00 1.00E 00 0.00E-01 9.00E 00 0.00E 01 4.00E 00 2.40E 01 0.00E 01 3.00E 00 8.00E 00 3.00E 00 2.00E 00 6.00E 00 3.00E 00 0.00E 01 4.80E 01 7.00E 00 9.00E 00 0.00E 01 0.00E 01 7.00E 00 I

E 4.00E 00 0.00E 01 0.00E 01 1.10E 01 ESE 1.00E 00 1.00E 00 2.00E 00 2.00E 00 0.00E 01 0.00E-01 6.00E 00 SE 0.00E 01 2.00E 00 1.00E 00 0.00E 01 0.00E 01 0.00E 01 3.00E 00 SSE 0.00E 01 0.00E 01 2.00E 00 3.00E 00 1.00E 00 0.00E 01 6.00E 00 S 0.00E 01 0.00E 01 5.00E 00 0.00E 01 1.00E 00 2.00E 00 8.00E 00 SSW 0.00E-01 2.00E 00 3.00E 00 2.00E 00 2.00E 00 3.00E 00 1.20E 01 SW 0.00E-01 1.00E 00 2.00E 00 2.00E 00 0.00E-01 0.00E-01 5.00E 00 I WSW W

WW 0.00E-01 0.00E-01 0.00E 01 0.00E-01 0.00E 01 0.00E 01 1.00E 00 0.00E 01 1.00E 00 1.00E 00 1.00E 00 1.00E 01 1.00E 00 1.00E 00 2.00E 00 2.00E 00 1.00E 00 0.00E 01 5.00E 00 3.00E 00 1.30E 01 I

NW 0.00E 01 1.00E 00 1.00E 00 9.00E 00 0.00E-01 0.00E 01 1.10E 01 WNW 0.00E 01 3.00E 00 3.00E 00 6.00E 00 2.00E 00 0.00E 01 1.50E 01 TOTAL 2.00E 00 1.50E 01 4.20E 01 7.30E 01 2.30E 01 1.70E 01 1.72E 02 PERIOOS OF CALM (HOURS): 0.00E-01 I 45 I -

TABLE 10, Pepe 3 of 7 f

SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT JOINT WIND FREQUENCY DISTRIBUTION BY STABILITY CLASS Data Period: January 1,1989 - JLne 30,1989 STA8f t!TY CLASS C WIND SPEED (MPN) AT 10 METER LEVEL DIRECTf0N 1-3 4-7 8 12 13-18 19 24 >24 TOTAL N 1.00E 00 2.00E 00 5.00E 00 6.00E 00 0.00E-01 0.00E 01 1.40E 01 NNE 1.00E 00 6.00E 00 5.00E 00 1.30E 01 3.00E 00 3.00E 00 3.10E 01 NE 4.00E 00 5.00E 00 7.00E 00 4.00E 00 3.00E 00 5.00E 00 2.80E 01 ENE 0.00E-01 5.00E 00 5.00E 00 0.00E-01 0.00E-01 0.00E-01 1.00E 01 E 1.00E 00 2.00E 00 2.00E 00 0.00E-01 0.00E 01 0.'00E 01 5.00E 00 ESE 0.00E-01 4.00E 00 1.00F. 00 0.00E 01 0.00E-01 0.00E 01 5.00E 00 SE 1.00E 00 2.00E 00 6.00E 00 0.00E 01 0.00E 01 0.00E 01 9.00E 00 SSE 0.00E-01 2.00E 00 7.00E 00 3.00E 00 0.00E 01 0.00E-01 1.20E 01 S 0.00E-01 2.00E 00 4.00E 00 2.00E 00 0.00E 01 0.00E 01 8.00E 00 S$W 0.00E-01 1.00E 00 2.00E 00 1.00E 00 0.00E 01 0.00E 01 4.00E 00 SW 0.00E 01 1.00E 00 4.00E 00 1.00E 00 0.00E 01 0.00E 01 6.00E 00 I WSW W

WNW 1.00E 00 0.00E-01 1.00E 00 0.00E-01 0.00E 01 0.00E 01 4.00E 00 1.00E 00 4.00E 00 3.00E 00 2.00E 00 3.00E 00 1.00E 00 2.00E 00 5.00E 00 1.30E 01 9.00E 00 1.00E 01 2.00E 00 1.00E 00 1.80E 01 I NW NNW TOTAL 2.00E 00 0.00E 01 1.20E 01 1.00E 00 2.00E 00 3.50E 01 7.00E 00 1.50E 01 7.90E 01 1.10E 01 1.30E 01 6.90E 01 2.00E 00 0.00E 01 1.40E 01 0.00E 01 0.00E-01 1.60E 01 2.30E 01 3.00E 01 2.25E 02 PERIODS OF CALM (HOURS): 0.000E 01 WIWD SPEED (MPH) AT 60 METER LEVEL DIRECTION 1-3 47 8 12 13 18 19 24 >24 TOTAL N 0.00E-01 0.00E O' 3.00E 00 4.00E 00 5.00E 00 0.00E 01 1.20F 01 I NNE 0.00E 01 3.00E 00 1.10E 01 1.80E 01 4.00E 00 4.00E 00 4.00E 01

. NE 0.00E 01 4.00E 00 2.00E 00 4.00E 00 4.00F 00 1.20E 01 2.60E 01 ENE 0.00E-01 0.00E 01 8.00E 00 4.00E 00 1.00E 00 0.00E-01 1.30E 01 I E ESE SE 0.00E*01 1.00E 00 0.00E 01 0.00E 01 1.00E 00 2.00E 00 3.00E 00 3.00E 00 4.00E 00 1.00E 00 0.00E 01 3.00E 00 0.00E 01 1.00E 00 0.00E 01 0.00E 01 0.00E 01 0.00E 01 4.00E 00 6.00E 00 9.00E 00 SSE 0.00E 01 0.00E*01 3.00E 00 4.00E 00 4.00E 00 1.00E 00 1.20E 01 5 0.00E 01 0.00E-01 2.00E 00 8.00E 00 0.00E-01 2.00E 00 1.20E 01 SSW 0.00E-01 1.00E 00 2.00E 00 2.00E 00 2.00E 00 0.00E-01 7.00E 00 SW 0.00E 01 1.00E 00 1.00E 00 6.00E 00 0.00E 01 0.00E 01 8.00E 00 WCW 0.00E-01 0.00E*01 .0.00E-01 3.00E 00 1.00E 00 4.00E 00 8.00E 00 W 0.00E 01 0.00E 01 1.00E 00 1.00E 00 2.00E 00 5.00E 00 9.00E 00 WWW 0.00E 01 0.00E 01 2.00E 00 5.00E 00 2.00E 00 2.00E 00 1.10E 01 I NW NRW TOTAL 0.00E 01 1.00E 00 2.00E 00 1.00E 00 1.00E 00 1.40E 01 3.00E 00 6.00E 00 5.40E 01 1.00E 01 1.30E 01 8.60E 01 5.00E 00 5.00E 00 3.60E 01 2.00E 00 0.00E 01 3.20E 01 2.10E 01 2.60E 01 2.24E 02 PERIOOS OF CALM (HOURS): 1.000E 00 46 I _ _ -

~- . . . - _ . , . -

TABLE 10, Page 4 of 7 I SEMIANNUAL RAD 10 ACTIVE EFFLUENT RELEASE REPORT JOINT WIND FREQUENCY DISTRIBUTION BY STABILITY CLASS

~

Data Period: January 1,1989 - Jurw 30,1989 STABILITY CLASS D

'dfND SPEED (MPH) AT 10 METER LEVEL

.I 13 47 DIRECTION 8 12 13-18 19-24 >24 TOTAL N 6.00E 00 3.20E 01 3.70E 01 2.20E 01 0.00E 01 0.00E-01 I

9.70E 01 NNE 6.00E 00 1.10E 01 1.90E 01 1.90E 01 5.00E 00 0.00E 01 6.00E 01 NE 1.10E 01 1.50E 01 2.90f 01 1.00E 01 1.00E 00 9.00E 00 7.50E 01 ENE 8.00E 00 2.60E 01 9.00E 00 0.00E-01 0.00E-01 0.00E 01 4.30E 01 g' E 9.00E 00 1.30E 01 2.00E 00 0.00E 01 0.00E-01 0.00E 01 2.40E 01 1

E ESE 5.00E 00 1.30E 01 0.00E-01 0.00E-01 0.00E 01 0.00E 01 1.80E 01 SE 3.00E 00 1.90E 01 1.90E 01 5.00E 00 0.00E 01 0.00E 01 4.60E 01 I 2.00E 00 1.90E 01 2.70E 01 7.00E 00 SSE 0.00E-01 0.00E-01 5.50E 01 S 1.00E 00 1.10E 01 4.20E 01 1.30E 01 1.00E 00 0.00E 01 6.80E 01 SSW 4.00E 00 8.00E 00 2.20E 01 2.40E 01 2.00E 00 1.00E 00 6.10E 01 SW 2.00E 00 4.00E 00 1.90E 01 5.00E 00 0.00E 01 0.00E 01 3.00E 01 WSW 2.00E 00 6.00E 00 1.00E 01 1.10E 01 Co00E-01 2.00E 00 3.10E 01 W 2.00E 00 6.00E 00 1.70E 01 1.80E 01 4.00E 00 4.00E 00 5.10E 01 WNW 5.00E 00 1.20E 01 2.50E 01 2.60E 01 1.00F. 01 2.00E 00 8.00E 01 I WW NNW TOTAL 1.00E 00 4.00E 00 7.10E 01 1.10E 01 2.30E 01 2.29E 02 2.80E 01 2.6DE 01 3.31E 02 1.90E 01 2.10E 01 2.00E 02 2.00E 00 0.00E-01 2.50E 01 0.00E 01 0.00E-01 1.80E 01 6.10E 01 7.40E 01 8.74E 02 PERIODS OF CALM (HOURS): 4.000E 00 l VfWD SPEED (MPH) AT 60 METER LEVEL DIRECTION 13 47 8-12 13 18 19-24 >24 TOTAL N 1.00E 00 1.20E 01 2.50E 01 4.80E 01 1.60E 01 0.00E 01 1.02E 02 NNE 0.00E-01 4.00E 00 1.90E 01 3.20E 01 5.00E 00 5.00E 00 6.50E 01 NE 0.00E 01 6.00E 00 1.00E 01 2.40E 01 2.00E 01 1.40E 01 7.40E 01 ENE 0.00E 01 2.00E 00 2.30E 01 4.00E 00 0.00E 01 0.00E 01 2.90E 01 E 2.00E 00 5.00E 00 1.20E 01 5.00E 00 0.00E-01 0.00E 01 2.40E 01 ESE 0.00E 01 3.00E 00 9.00E 00 1.00E 00 0.00E 01 0.00E 01 1.30E 01 SE 1.00E 00 8.00E 00 1.90E 01 9.00E 00 4,00E 00 1.00E 00 4.20E 01 SSE 0.00E 01 1.00E 00 9.00E 00 3.20E 01 1.80E 01 3.00E 00 6.30E 01

$ 1.00E 00 2.00E 00 1.90E 01 4.10E 01 1.50E 01 5.00E 00 8.30E 01 SSV 1.00E 00 4.00E 00 7.00E 00 3.80E 01 2.30E 01 1.10E 01 8.40E 01 SW 1.00E 00 1.00E 00 7.00E 00 1.50E 01 4.00E 00 1.00E 00 2.90E 01 l WSW 0.00E 01 2.00E 00 7.00E 00 1.50E 01 3.00E 00 1.00E 00 2.80E 01 ,

W 1.00E 00 1.00E 00 4.00E 00 1.70E 01 7.00E 00 6.00E 00 3.60E 01 WNW 0.00E 01 3.00E 00 9.00E 00 1.70E 01 2.00E 00 9.00E 00 4.00E 01 I WW NWW TOTAL 3.00E 00 3.00E 00 1.40E 01 4.00E 00 5.00F 00 6.30E 01 2.80E 01 2.90E 01 2.36E 02 3.70E 01 1.80E 01 3.53E 02 2.00E 01 9.00E 00 1.46E 02 7.00E 00 0.00E-01 6.30E 01 9.90E 01 6.40E 01 8.75E 02 PERIODS OF CALM (HOURS): 3.000E 00 l

I TABLE 10, Pepe 5 of 7 l

SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT E

J0!NT WIND FREQUENCY DISTRIBUTION BY STABILITY CLASS Data Period: January 1, 1989 June 30, 1989 STABILITY CLASS E 1

WIND SPEED (MPH) AT 10 METER LEVEL l

I DIRECTION 1-3 9.00E 00 4-7 8 12 13-18 19-24 >24 TOTAL i N 2.20E 01 1.50E 01 2.00E 00 0.00E 01 1.00E 00 4.90E 01 l

.lE NNE NE 1.20E 01 1.10E 01 2.10E 01 3.1DE 01 9.00E 01 1.80E 01 1.00E 00 1.00E 00 0.00E-01 0.00E 01 0.00E 01 0.00E 01 4.30E 01 6.10E 01 ENE 7.00E 00 2.30E 01 3.00E 00 0.00E 01 0.00E 01 0.00E-01 3.30E 01 E 1.00E 01 2.00E 01 2.00E 00 0.00E 01 0.00E 01 0.00E-01 3.20E 01 ESE 8.00E 00 1.50E 01 2.00E 00 0.00E 01 0.00E-01 0.00E 01 2.50E 01 SE 8.00E 00 3.90E 01 6.00E 00 1.00E 00 0.00E 01 0.00E 01 5.40E 01

$$E 5.00E 00 3.20E 01 1.30E 01 0.00E 01 0.00E-01 0.00E 01 5.00E 01 S 4.00E 00 3.40E 01 6.80E 01 1.20E 01 0.00E 01 0.00E-01 1 ME 02 SSW 4.00E 00 2.20E 01 4.40E 01 2.30E 01 1.00E 00 0.00E 01 9.40E 01 SW 5.00E 00 7.00E 00 2.80E 01 1.00E 01 0.00E-01 0.00E 01 5.00E 01 I WSW W

WNW 2.00E 00 4.00E 00 2.00E 00 1.00E 01 1.70E 01 2.70E 01 2.90E 01 2.80E 01 2.00E 01 8.00E 00 9.00E 00 3.00E 00 0.00E 01 0.00E 01 0.00E 01 0.00E-01 0.00E 01 0.00E-01 4.90E 01 5.80E 01 5.20E 01 I NW NNW TOTAL 4.00E 00 3.00E 00 9.80E 01 1.80E 01 1.30E 01 3.51E 02 8.00E 00 1.30E 01 3.06E 02 0.00E-01 1.00E 00 7.10E 01 0.00E 01 0.00E-01 1.00E 00 0.00E 01 0.00E 01 1.00E 00 3.00E 01 3.00E 01 8.28E 02 PERIDOS OF CALM (HOURS): 1.300E 01 VIND SPEED (MPM) AT 60 METER LEV Q DIPECTf0N 1-3 47 8-12 13 18 19 24 >24 TOTAL N 0.00E 01 7.00E 00 1.80E 01 8.00E 00 1.00E 00 1.00E 00 3.50E 01 I NNE NE ENE 2.00E 00 0.00E-01 2.00E 00 5.00E 00 5.00E 00 4.00E 00 1.10E 01 9.00E 00 2.20E 01 1.80E 01 1.80E 01 1.10E 01 1.30E 01 1.00E 01 3.00E 00 0.00E 01 1.00E 00 0.00E 01 4.90E 01 4.30E 01 4.20E 01

]

E 2.00E 00 5.00E 00 1.90E 01' 1.20E 01 0.00E-01 0.00E-01 3.80E 01 l ESE 1.00E 00 3.00E 00 1.50E 01 3.00E 00 1.00E 00 0.00E 01 2.30E 01 SE 1.00E 00 5.00E 00 1.90E 01 5.00E 00 0.00E 01 1.00E 00 3.10E 01

$$E 0.00E 01 2.00E 00 1.10E 01 3.00E 01 8.00E 00 0.00E-01 5.10E 01 S 0.00E-01 4.00E 00 2.10E 01 5.30E 01 3.00E 01 0.00E-01 1.08E 02 SSW 1.00E 00 3.00E 00 2.00E 01 4.90E 01 4.60E 01 1.50E 01 1.34E 02 SW 0.00E 01 2.00E 00 1.30E 01 3.20E 01 2.10E 01 2.00E 00 7.00E 01 I VSW W

WWW 0.00E 01 0.00E 01 0.00E 01 2.00E 00 4.00E 00 5.00E 00 5.00E 00 9.00E 00 1.40E 01 2.80E 01 2.40E 01 1.60E 01 9.00E 00 1.20E 01 4.00E 00 0.00E 01 0.00E 01 0.00E 01 4.40E 01 4.90E 01 3.90E 01 I 0.00E 01 NW 1.60E 01 2.00E 01 1.50E 01 2.00E 00 0.00E 01 5.30E 01 WW 1.00E 00 3.00E 00 2.00E 01 8.00E 00 0.00E 01 0.00E-01 3.20E 01 TOTAL 1.00E 01 7.50E 01 2.46E 02 3.30E 02 1.60E 02 2.00E 01 8.41E 02 PERIOOS OF CALM (HOURS): 0.000E -01 I 48 I

I o

H TABLE 10, Page 6 of 7 I SEMIANNUAL RAD 10 ACTIVE EFFLUENT RELEASE REPORT JOINT WIND FREQUENCY DISTRIBUTION BY STABILITY CLASS Data Period: Januarv 1,1989 - June 30,1989 I STABILITY CLASS F WIND SPEED (MPH) AT 10 METER LEVE'.

DIRECTION 13 4-7 B-12 13 1B 19 24 >?4 TOTAL M 7.00E 00 7.00E 00 1.00E 00 0.00E 01 0.00E 01 0.00E 01 1.50E 01 NNE 8.00E 00 5.00E 00 2.00E 00 0.00E-01 0.00E 01 1.00E 00 1.60E 01 NE 6.00E 00 2.80E 01 6.00E 00 0.00E-01 0.00E-01 0.00E 01 4.00E 01 ENE 7.00E 00 1.10E 01 2.00E 00 0.00E 01 0.00E 01 0.00E-01 2.00E 01 I E ESE SE 1.20E 01 1.10E 01 1.10E 01 1.60E 01 6.00E 00 1.50E 01 1.00E 00 0.00E 01 1.00E 00 0.00E-01 0.00E 01 0.00E 01 0.00E 01 0.00E 01 0.00E 01 0.00E 01 0.00E 01 0.00E-01 2.90E 01 1.70E 01 2.70E 01 I

SEE 7.00E 00 2.50E 01 4.00E 00 0.00E 01 0.00E-01 0.00E-01 3.60E 01 S 7.00E 00 2.20E 01 2.00E 00 0.DJE 01 0.00E 01 0.00E-01 3.10E 01 SSW 4.00E 00 1.70E 01 1.10E 01 0.00E-01 0.00E 01 0.00E 01 3.20E 01 SW 9.00E 00 1.10E 01 9. DOE 00 0.00E 01 0.00E 01 0.00E 01 2.90E 01 I WSW W

6.00E 00 8.00E 00 6.00E 00 7.00E 00 8.00E 00 2.00E 00 3.00E 00 0.00E 01 0.00E 01 0.00E 01 0.00E-01 0.00E 01 0.00E 01 1.50E 01 1.90E 01 WWW 1.00E 01 1.00E 00 0,00E 01- 0.00E 01 0.00E 01 1.70E 01 I NW NNW TOTAL 9.00E 00 5.00E 00 1.2.3E 02 1.00E 01 4.0DE 00 2.02E 02 1.00E 00 2.00E 00 4.80E 01 0.00E 01 0,00E 01 0.00E 01 0.00E 01 0.00E-01 0.00E 01 0.00E 01 0.00E-01 1.00E 00 2.00E 01 1.10E 01 3.74E 02 PERIOOS OF CALM (HOURS): 3.0D0E 00 VIND SPEED (MW ) At 60 MEffR LEVEL I DIRECTION 1-3 47 8-12 13 18 19-24 >24 TOTA L N 1.00E 00 6.00E 00 3.00E 00 3.00E 00 0.00E 01 0.00E 01 1.30E 01 I NNE NE ENE 0.00E-01 0.00E 01 0.00E-01 1.00E 00 3.00E 00 5.00E 00 2.00E 00 4.00E 00 1.00E 01 7.00E 00 1.20E 01 1.40E 01 1.00f 00 2.00E 00 4.00E 00 1.00E 00 0.00E 01 0.00E-01 1.20E 01 2.10E 01 3.30E 01 E 3.00E 00 5.00E 00 5.00E 00 1.00E 00 0.00E 01 0.00E 01 1.40E 01 I- ESE 3.00E 00 8.00E 00 1.10E 01 4.00E 00 0.00E-01 0.00E 01 2.60E 01 SE 6.00E 00 1.30E 01 6.00E 00 2.00E 00 0.00E 01 0.00E 01 2.70E 01 2.00E 00 6.00E 00 4.0JE 00 9.00E 00 I

SSE 3.00E 00 0.00E 01 2.40E 01 S 5.00E 00 4.00E 00 1.00E 01 3.30E 01 0.00E 01 0.00E 01 5.20E 01 SSW 1.00E 00 3.00E 00 1.10E 01 2.20E 01 2.00E 00 0.00E-01 3.90E 01 SW 0.00E-01 3.00E 00 9.00E 00 1.80E 01 1.00E 00 0.00E 01 3.10E 01 I WSW W

WWW 2.00E 00 1.00E 00 1.00E 00 2.00E 00 4.00E 00 1.00E 00 9.00E 00 4.00F 00 3.00E 00 5.00E 00 3.00E 00 2.00E 00 0.00E 01 1.00E 00 0.00E 01 0.003-01 1.80E 01

?.30E 01 0.00E-01 0.00E 01 7.00E 00 I NW NWW TOTAL 0.00E 01 1.00E 00 2.60E 01 5.00E 00 5.00E 00 7.40E 01 9.00E 00 1.00E 01 1.10E 02 3.00E 00 5.00E 00 1.43E 02 0.00E 01 0.00E 91 1.40E 01 0.00E 01

,0.00E-01 1.00E 00 1.70E 01 2.10E 01 3.6BE 02 PERIODS OF CALM (HOURSJ: 9.000E 00 I

49 lI L_-_---_-- _ - - _ _ _ _ _ _ - - - _ - - - _ - - - -- --

1 lI TABLE 10, Page 7 of 7 l

SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT RINT WlND FREQUENCY 0!STRIBUTION BY STABILITY CLASS l Date Period: January 1, 1989 - June 30, 1989 STABitfTY CLASS C VIND SPEED (MPH) AT 10 METER LEVEL DIRECTION 13 47 8-12 13-18 19-24 >?4 TOTAL N 6.00E DD 0.00E 01 0.00E-01 0.00E 01 0.00E 01 te.00E 01 6.00E 00 NNE 8.00E 00 2.00E 00 C.00E 01 0.00E 01 0.00E 01 0.00E 01 1.00E 01 1 I NE ENE E

6.00E 00 9.00E 00 4.00E 00 1.00E 00 6.00E 00 1.10E 01 1.00E 00 0.00E-01 1.00E 00 0.00E 01 0.00E 01 0.00E-01 0.00E-01 0.00E 01 0.00E-01 0.00E-01 . 8.00E 00 0.00E-01 1.50E 01 0.00E 01 1.60E 01 I ESE SE

$$E 5.00E 00 1.30E 01 7.00E 00 7.00E 00 9.00E 00 1.10E 01 0.00E 01 0.00E-01 0.00E 01 0.00E 01 0.00E 01 0.00E 01 0.00E 01 0.00E 01 0.00E 01 0.00E-01 0.00E 01 0.00E-01 1.20E 01 2.20E 01 1.80E 01 S 6.00E 00 4.00E 00 0.00E-01 0.00E 01 0.00E 01 0.00E 01 1.00E Q1 SSW 3.00E DO 7.00E 00 1.00E 00 0.00E-01 0.00E 01 0.00E 01 1.10E 01 SW 5.00E 00 6.00E 00 1.00E 00 0.00E-01 0.00E-01 0.00E-01 1.20E 01 USW 5.00E 00 2.00E 00 0.00E 01 0.00E 01 0.00E 01 0.00E 01 7.00E 00 l W 5.00E 00 4.00E 00 0.00E 01 0.00E-01 0.00E-01 0.00E 01 9.00E 00

" 9.00E 00 WWW 0.00E 01 0.00E 01 0.00E-01 0.00E 01 0.00E 01 9.00E 00 NW 6.005 00 3.00E 00 4.00E 00 0.00E 01 0.00E 01 0.00E 01 1.30E 01 l NNW 6.00E 00 2.00E 00 0.00E-01 0.00E-01 0.00E-01 0.00E 01 8.00E 00 TOTAL 1.03E 02 7.50E 01 8.00E 00 0.00E 01 0.00E 01 0.00E-01 1.86E 02 PERIODS OF CALM (HOURS): 3.000E 00 I HOURS OF GOOD DATA: 4.097E 03 = 94.3% OF TCTAL HOURS VfND SPtED (MPH) AT 60 METER LEVEL DIRECTION 1-3 4-7 8-12 13-18 19-24 >24 TOTAL N 0.00E-01 4.00E 00 0.00E 01 2.00E 00 0.00E 01 0.00E 01 6.00E 00 I- NWE 0.00E 01 4.00E 00 0.00E-01 0.00E-01 0.00E 01 0.00E-01 4.00E 00 NE 3.00E 00 1.00E 00 1.00E 00 1.00E 00 0.00E 01 0.00E-01 6.00E 00 ENE 1.00E 00 3.00E 00 1.00E 00 0.00E 01 1.00E 00 0.00E 01 6.00E 00 E 2.00E 00 6.00E 00 2.00E 00 3.00E 00 0.00E 01 0.00E 01 1.30E 01 l ESE 3.00E 00 4.00E 00 6.00E 00 4.00E 00 0.00E 01 0.00E-01 1.70E 01 SE 2.00E 00 6.00E 00 3.00E 00 3.00E 00 0.00E 01 0.00E 01 1.40E 01 SSE 0.00E 01 6.00E 00 1.00E 00 9.00E 00 0.00E 01 0.00E 01 1.60E 01 S 0.00E 01 2.00E 00 4.00E 00 8.00E 00 0.00E 01 0.00E 01 1.40E 01 l SSW 0.00E 01 3.00E 00 1.30E 01 8.00E 00 1.00E 00 0.00E-01 2.50E 01 !

l SW 1.00E 00 0.00E-01 5.00E 00 7.00E 00 0.00E 01 0.00E 01 1.30E 01 l l = WSW 4.00E 00 4.00E 00 1.40E 01 1.00E 00 1.00E 00 I 0.00E 01 2.40E 01 l W 2.00E 00 1.00E 00 2.00E 00 1.00E 00 0.00E 01 0.00E 01 6.00E 00 g WNW 0.00E 01 6.00E 00 2.00E 00 0.00E-01 0.00E 01 0.00E 01 8.00E 00 g NW 2.00E 00 1.00E 00 4.00E 00 0.00E 01 0.00E-01 0.00E 01 7.00E 00 NNW ?.00E 00 1.00E 00 2.00E 00 4.00E 00 0.00E 01 0.00E 01 9.00E 00 TOTAL 2.20E 01 5.20E 01 6.00E 01 5.10E 01 3.00E 00 0.00E 01 1.88E 02 l PERIO)S OF CALM (HOURS): 1.000E 00 HOURS OF G300 DATA: 4.097E 03 = 94.3% OF TOTAL HOURS

, 50

-I - _

l

I g- . mon .

I DOSE MEASUREMENTS AND ASSESSMENTS I

I I

-I I

I I

I 51

_ _ _ _ _ _ _ - - - - - - - _ _ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - ~ ~ ~ ~ ~ ~ '

ll TABLE 11 IE ssMIAwwUAL mADICACTIrz rFFLUrmT manzAsz aspOaT l 3 MAZIMUM* OFF-SITE DOSES AND DOSE COMMITMENTS TO MEMBERS OF TEE PUBLIC Data Period: January 1, 1989 - June 30, 1989 DOSE **

Source 1st Qtr 2nd Qtr

- - 1 IA. Waterborne Effluents (mrem): Oraan 0.00 7.31E-03 2

Total Body 0.00 6.42E-04

, 3 4 l B. Airborne Effluents

1. Iodines and Particulate: Orcan 7.95E-04 3.42E-04 l

I (mrem)

Total Body 3.69E-04 5

2.95E-04 5

2. Noble Gases: Gamma 0.00 0.00 (mrad)

Beta 0.00 0.00 l

6 6 C. Direct Radiation N/A N/A (mrem)

I i THERE ARE NO OTHER URANIUM FUEL CYCLE FACILITIES WITHIN 8 KM OF CPS

" Maximum" means the largest fraction of the corresponding Appendix I Iooc dose design objective.

l l

The numbered footnotes on the following page briefly explain how each j maximum dose was calculated, including the organ and predominant l

I 000 pathway (s).

Includes dose from estimated Fe-55 activities during fourth quarter l

I 1988 composite analyses.

I 1 l

l 52 l I

~

i

_________________d

I l

i i

Footnotes for Table 11 i 1. Dose to the adult GI-LLI tract by the fish pathway.

I Calculated using methodology cor.tained in the CPS Offsite Dose Calculation Manual (ODCM).

2. Dose to the adult Total Body by the fish pathway.

Calculated using methodology contained in the CPS Offsite Dose Calculation Manual (ODCM).

. 3. Dose to the adult thyroid via the inhalation, l3 vegetation, and ground-plane pathways. Calculated at

'E 0.9 miles North using methodology contained in the CPS ODCM.

4. Dose to the adult skin via the ground-plane pathway.

Calculated at 0.9 miles North using methodology contained in the CPS ODCM.

5. Dose to the adult Total Body via the inhalation, vegetation, and ground-plane pathways. Calculated at I 0.9 miles North using methodology contained in the CPS ODCM.

6. In accordance with CPS Technical Specification 6.9.1.7, dose caused by direct radiation from CPS for this reporting period will be reported in the July thro::qh December 1989 Semiannual Radioactive Effluent Release Report.

.I I

I I -

I '

I I

53

i lI DOSES TO MEMBERS OF TFE PUBLIC WITHIN THE SITE BOUNDARY I CPS Technical Specification 6.9.1.7 requires that the Semiannual Radioactive Effluent Release Report include an assessment of the radiation doses from radioactive liquids and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY. The meteorological conditions concurrent with the time of release of radioactive materials in gaseous effluents shall be used for determining the gaseous pathway doses. Within the CPS site I. boundary there are seven areas which are open to members of the public as identified by CPS ODCM Table 3.4-3 (see Figure 8):

A road at 0.3 miles in the SE sector Agricultural acreage at 0.9 miles in the SSW I

sector A portion of Clinton Lake at 0.2 miles in the im sector I -

The Department of Conservation Recreation Area at 0.8 miles in the ESE sector A residence at 0.8 miles in the SW sector I A residence at 1.5 miles in the WSW sector A residence at 1.7 miles in the SSE sector At all of the above locations the plume, inhalation and I. ground-plane exposure pathways are used for dose calculations. No other exposure pathways were identified by the 1988 Annual Land Use Census (as of the time of this l report the 1989 Annual Land Use Census had not been completed). All dose calculations were performed using the methodology contained in the CPS ODCM.

I I

I I .

I .

I I

54 I - -

I FIGURE 8 I AREAS WITHIN THE CPS SITE BOUNDARY OPEN TO MEMBERS OF THE PUBLIC .

a=-2 s-I l 1 CLINTON

, s esf I 47g. -

~w u.... WAPELLA a ( MAROA , ..., , . .. . .... .., ......

3 r ...............m....-

y e

, c ..... u . . m . .. ,o , .. ....

I . . , ., e

,, m . .. . .. . ... ....

u...

I

... .. m .. .. ,,,. .. . .. ..,....

a !s s-

! h ':,@

B W t a @'

d :. b d

! 4 ,

c.p.s.

I :

4>

]

I sAcoN ca.

PIATT CO.

WELDONgR g, . (

l 9CISCO :

a 7

I . (,a y cn Co.

.N FARMER I A DELAN TO '

CHAMPAIGN . 74 55 I

I I. TABLE 12

-g SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT 3 CALCULATED DOSES TO MEMBERS OF TER PUBLIC DURING USE OF THE ROAD IN THE SOUTHEAST SECTOR WITHIN THE CPS SI!3 BOUNDARY Data Period: January 1, 1389 - June 30, 1989 Exposure Pathway Orcans Dose (nrem),

plurae* total body 0.00 skin 0.00 ground plane

total body 5.17E-05 I

skin 6.08E-05 inhalation; four highest organ doses:

teen lung 1.94E-06 child lung 1.57E-06 adult lung 1.33E-06 infant lung 1.00E-06 Doses via these pathways are not dependent upon age-group.

I I

I ~

I I

56 I

l. .

1 1

1 E TABLE 13 l I SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT CALCULATED DOSES TO MEMBERS OF THE PUBLIC DURING USE OF THE AGRICULTURAL ACREAGE l

" IN THE SOUTH-SOUTHWEST SECTOR WITHIN l THE CPS SITE BOUNDARY Data Period: January 1, 1989 - June 30, 1989 ExDosure Pathway Orcans Dose imrem)

I plume

total body skin 0.00 0.00 ground plane

I total body skin 2.21E-05 2.59E-05 inhalation; four highest organ doses:

teen lung 1.22E-06 child lung 9.89E-07 I adult lung infant lung 8.39E-07 6.31E-07 I

Doses via these pathways are not dependent upon age-group.

I g- . 1 I

I .

1 I l I

57 I

l' l

I TABLE 14 I SEMIANNUAL RADI0 ACTIVE EFFLUENT RELEASE REPORT CALCULATED DOSES TO MEMBERS OF THE PUBLIC DURING USE OF CLINTON LAKE IN THE NORTHWEST SECTOR WITHIN THE CPS "I

l SITE BOUNDARY Data Period: January 1, 1989 - June 30, 1989 I. Exposure Pathway Oraans Dose (nren)

I plume

total body skin 0.00 0.00 ,

ground plane

total body I skin 1.26E-04 1.48E-04 inhalation; four highest organ doses:

toen lung 4.65E-06 child lung 3.77E-06 adult lung 3.18E-06

'I infant lung 2.41E-06

Doses via these pathways are not dependent upon age-group.

lI I ,i I

I .

I I

I 58 I __

I TABLE 15 I SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT CALCULATED DOSES TO MEMBERS OF THE PUBLIC DURING USE OF THE DEPARTMENT OF CONSERVATION RECREATION AREA IN THE EAST-SOUTHEAST SECTOR WITHIN THE CPS SITE BOUNDARY Data Period: January 1, 1989 - June 30, 1989 ErDosure Pathway Orcans Dose (mrem) plume

I total body skin 0.00 0.00 ground plane

total body I skin 7.64E-05 8.99E-05 inhalation; four hignest organ doses:

teen lung 8.83E-07 child lung 7.16E-07 I adult lung infant lung 6.05E-07 4.58E-07 I *- Doses via these pathways are not dependent upon age-group. .

I I

I I -

I I

I 59 I

TABLE 16 I GEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT CALCULATED DOSES FOR THE RESIDENCE IN THE SOUTEWEST SECTOR WITHIN THE CPS SITE BOUNDARY Data Period: January 1, 1989 - June 30, 2989 Exoosure Pathway Orcrans Dose (mrem) plume

total body 0.00 skin 0.00 ground plane

total body 2.53E-04 skin 2.98E-04 inhalation; four highest organ doses:

teen lung 1.51E-05 I- child lung 1.22E-05 adult lung 1.03E-05 I infant lung 7.78E-06

Doses via these pathways are not dependent upon age-group.

I I

I I -

I 60 I - _

TABLE 17 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT CALCULATED DOSES FOR TEE RESIDENCE IN THE WEST-8OUTHWEST SECTOR WITHIN THE CPS SITE BOUNDARY Data Period: January 1, 1989 - June 30, 1989 ErDosure Pathway Orcans Dose (mren) plume

total body 0.00 skin 0.00 ground plane

total body 6.49E-05 skin 7.64E-05 inhalation; four highest organ doses:

teen lung 4.44E-06 child lung 3.59E-06 adult lung- 3.05E-06 infant lung 2.29E-06

Doses via these pathways are not dependent upon age-group.

I 61 1 -

TABLE 18 SENIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT CALCULATED DOSES FOR THE RESIDENCE IN THE SOUTE-SOUTREAST SECTOR WITEIN THE CPS SITE BOUNDARY Data Period: January 1, 1989 - June 30, 1989 Ernosure Pathway Orcans Dose (Erem).

plume

total body 0.00 skin 0.00 ground plane

total body 9.93E-05 skin 1.17E-04 inhalation; four highest organ doses:

teen lung 3.25E-06 child lung 2.63E-06 adult lung 2.24E-06 infant lung 1.68E-06 Doses via these pathways are not dependent upon age-group.

)

62 l

-7

-I,4 5

SECTION 7' CHANGES TO-THE OFF8ITE DOSE CALCULATION NANUAL-AND'THE--SOLID WASTE PROCESS CONTROL PROGRAM 63 I i

_______. _ _ ._. ___._____ _ 1

1 i

CHANGES TO THE OFFSITE DOSE CALCULATION MANUAL ,

-1 In accordance with CPS Technical Specification 6.14.2, changes to the CPS ODCM shall be reported in the Semiannual Radioactive Effluent Release Report. Revision 5 to the CPS ODCM was approved by the CPS Facility Review Group on February 7, 1989. Attachment A contains copies of the changed pages and the documentation of required reviews. A summary of revision is provided on pages 65-72.

i e.

64

_ _ _ - . _ _ _ _ _ _ - _ - _ - - - - - - - _ _ - _ - - - _ - - - - - - - _ - - - _ - - _ - _ _ _ _ _ - _ - - - _ - - - ---------------------------------__---a

SUMMARY

OF REVISION 22dit

-1 Changed page numbers for Sections 2.5 and 2.6.

iv Deleted' reference to Table 2.6-1,. revise ~ titles for Tables 3.5-13 and'3.5-16.

v Revised titles for Tables 3.5-17 through 3.5-31.

vi Added new Figure 2.5-3.

vii Revised List of Effective pages.

2-1 Deleted reference to FSAR, replaced with USAR in paragraph 2.1.

3 Correction in Section 2.3.1.1 referencing CPS RETS Table 4.11.1 to Table 4.11.1-1.

2-6 Replaced Figure 2.1-1 due to illegible map.

2-9 Revised the definition for the quantity F1 , the near' field average dilution factor.

2-11 Revised Table 2.4-1 Aij factors for P-32 due to the latest NRC recommended value for the bioaccumulation factor for phosphorus, and Sr-91.

2-12 Revised Table 2.4-1 Aij factors for Te-125m.

2-13 Revised Table 2.4-1 Aij factors for Ba-135.

2-14 Changed the bioaccumulation factor (BFi) for freshwater fish for phosphorus due to the latest NRC recommendation.

2-15 Revised Table 2.4-3 DFi factors for Sr-91.

2-16 Revised Table 2.4-3 DFi factors for Te-127m, Te-129m, and I-133.

2-17 Revised Table 2.4-3 DFi factors for Ba-139, 2-18 Revised Figure 2.5-1 to reflect actual plant nomenclature.

2-20 Add new Figure 2.5-3 SOLID RADWASTE SYSTEM SIMPLIFIED FLOW DIAGRAM. Rev. 2 verbage becomes page 2-21.

65

SUMMARY

OF REVISION (Cont'd)

~

Pace 2-21 Rev. 2 page 2-20 verbage becomes new page. Rev. 2 page 2-21 containing Table 2.6-1 deleted.

2-22 Removed this page since Table 2.6-1 was deleted in '

Rev. 2.

3-5 Placed the symbol which indicatos rate (.) over the Qim instead of (X/Q)m, deleted reference to "j" for summation, and corrected definition of Mi by changing mrem to mrad.

3-9 Revised Table 3.4-2 Pij factors for Cu-64 and Br-

85. ,

f 3-10 Revised Table 3.4-2 Pij factors for Y-91m.

3-14 Included the units in the definition for the quantities (X/Q)m and (r/q)m. ,

l 3-16 Corrected the units in the definition for the quantity gim which should be uCi instead of Ci.

3-19 Added the definition for Ys.

3-20 Corrected definition for lambda (w), by changing half-time to half-life.

3-28 Changed the units f r Skin Dose Factor (Li) to mrem /yr per uCi/m 3 3-30 Replaced Figure 3.1-1 due to illegible map.

I 3-32 Revised Table 3.5-1 (DFAi)a factors for P-32 to l agree with RG 1.109. l 3-33 Revised Table 3.5-1 (DFAi)a factors for Zr-95, Te- 1 127, ano I-133 to agree with RG 1.109.

3-34 Revised Table 3.5-1 (DFAi)a factors for Cs-137 ar.d Ba-139 to agree with RG 1.109.

3-35 Revised Table 3.5-2 (DFAi)a factors for Cr-51 to agree with RG 1.109.

3-39 Revised Table 3.5-3 (DFA1)a factors for Nb-95 to agree with RG 1.109, 3-40 Revised Table 3.5-3 (DFAi)a factors for La-142 and Nd-147 to agree with RG 1.109.

66

j

SUMMARY

OF REVISION (Cont'd)

Pace l l

3-41 Revised Table 3.5-4 (DFA1)a factors for Zn-69 to agree with RG 1.109.

3-43 Revised Table 3.5-4 (DFA1)a factors for Ba-140 and Ce-144 to agree with RG 1.109.

3-44 Correct element number for Co-60.

1 3-45 Revised Table 3.5-5 DFGi skin factor for Te-131 to agree with RG 1.109.

3-49 Revised Table 3.5-7 (DFLi)a factors for P-32 to agree with RG 1.,109.

3-50 Revised Table 3.5-7 (DFLi)a factors for Y-91m and Te-127 to agree with RG 1.109.

3-53 Revised Table 3.5-8 (DFLi)a factors for Zr-95 to agree with RG 1.109.

3-56 Revised Table 3.5-9 (DFL1)a factors for Y-93 to agree with RG 1.109.

3-61 Changed Table 3.5-13 to read Inhalation Pathway Factors following the convention used in NUREG-0133.

3-62 Changed Table 3.5-13 to read Inhalation Pathway Factors following the convention used in NUREG-0133. Corrected values for Ru-103.

3-63 Changed Table 3.5-13 to read Inhalation Pathway Factors following the convention used in NUREG-0133. Corrected values for I-134 and Ba-141.

3-64 Changed Table 3.5-14 to read Inhalation Pathway Factors following the convention used in NUREG-0133. Corrected values for Br-84 and Rb-89.

3-65 Changed Table 3.5-14 to read Inhalation Pathway Factors following the convention used in NUREG-0133.

3-66 Cnanged Table 3.5-14 to read Inhalation Pathway Factors following the convention used in NUREG-0133.

67

SUMMARY

OF REVISION (Cont'd)

Page 3-67 Changed Table 3.5-15 to read Inhalation Pathway.

Factors following the convention used in NUREG-0133. Corrected values for Rb-86 and Sr-89.

3-68 Changed Table 3.5-15 to read Inhalation Pathway Factors following the convention used in NUREG-0133. Corrected values for Te-127 and I-130.

3-69 Cham,, ed Table 3.5-15 to read Inhalation Pathway Factrer following the convention used in NUREG-0133.

3-70 Changed Table 3.5-16 to read Inhalation Pathway Factors following the convention used in NUREG-0133.

3-71 Changed Table 3.5-16 to read Inhalation Pathway Factors following the convention used in NUREG-0133. Corrected values for Tc-101.

3-72 Changed Table 3.5-16 to read Inhalation Pathway Factors following the convention used in NUREG-0133.

3-73 Changed Table 3.5-17 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for C-14, Zn-65 and Sr-91.

3-74 Changed Table 3.5-17 to read Cow Milk Pathway Factors following the convention used in NUREG-0133.. Revised values for Zr-97, Nb-95, Tc-101, Ru-103, Te-127 and Te-129.

3-75 Changed Table 3.5-17 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Cs-138, Ba-139 and Ba-

- 140. Clarified units for table as noted by "*".

3-76 Changed Table 3.5-18 to read Cow Milk Pathway Factors following the convention used in NUREG- -

0133. Revised values for C-14, Zn-65 and Sr-90.

3-77 Changed Table 3.5-18 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Nb-95, Tc-99m, Tc-101, Te-127, Te-129 and I-131.

68

SUMMARY

OF REVISION (Conted) f.ASA 3-78 Changed Table 3'.5-18 to read Cow Milk Pathway.

Factors-following the convention used in NUREG-0133. Revised values for-Cs-138, Ba-139) Ba-140,-

'La-140,.and Co-141. Clarified-units for table as noted by:"*".

3-79 Changed Table:3.5-19 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for C-14 and Fe-59.

3-80 Changed Table 3.5-19 to read Cow Milk Pathway Factors following'the' convention used'in NUREG-0133. Revised values for Nb-95, Tc-101, Te-127, Te-129 and Te-131. .

3-81 Changed Table 3.5-19 to' read Cow Milk Pathway Factors.following the convention used in NUREG-

'0133. Revised values for Cs-138, Ba-139, Ba-140 and.Ce-141. Clarified units for table as noted by 3 . Changed Table 3.5-20 to' read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for C-14. -

3-83 Changed Table'3.5-20 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. . Revised values for Y-91m, Zr-97, Nb-95, Tc-101, Te-127 and Te-129.

3-84 Changed Table 3.5-20 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Cs-138 and Ba-139.

Clarified units for table as noted by "*".

3-85 Changed Table 3.5-21 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values for C-14, P-32, and Ni-63.

1'.

L 3-86 Changed Table 3.5-21 to read Goat Milk Pathway -

Factors following the convention used in NUREG-0133. Revised values for Nb-95, Tc-101, Ru-105, Te-127 and Te-129.

69

SUMMARY

OF REVISION (Cont'd)

EASA 3-87 Changed Table 3.5-21 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Cs-134, Cs-138, Ba-139 and Pr-144. Clarified units for table as noted by 3-88 Changed Table 3.5-22 to read Goat Milk Pathway Factors following the convention used in NUREG-

'0133. Revised values for C-14 and Zn-65.

3-89 Changed Table 3.5-22 to read Goat Milk Pathway Factors following the convention used in NUREG-0133.. Revised values for Nb-95, Tc-101, Te-127, Te-129, and I-132.

3-90 Changed Table 3.5-22 to read Goat Milk Pathway Factors following the conve.: tion used in NUREG-0133. Revised values for Cs-138, Ba-139, La-140 and Ce-141. Clarified units for table as noted by -

3-91 Changed Table 3.5-23 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revicea values for C-14 and Fe-55.

3-92 Changed Table 3.5-23 to read Goat Milk Pathway Factors following the convention used in NUREG- ,

0133. Revised values for Nb-95, Tc-101, Ru-105, Te-127 and Te-129.

3-93 Changed Table 3.5-23 to read Goat Milk Pathway Factors following the convention usc' in NUREG-0133. Revised values for Cs-138, Ba-139 and Ce-141. Clarified units for table as noted by "*".

3-94 Changed Taale 3.5-24 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values for C-14.

l 3-95 Changed Table 3.5-24 to read Goat Milk Pathway -

Factors following the convention used in NUREG-0133. Revised values for Nb-95, Tc-101, Te-127, Te-129, To-131m and I-132.

l

)

70 s

1

SUMMARY

OF REVISION (Cont'd)

Pace 3-96 Changed Table 3.5-24 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Cs-137, Cs-138, Ba-139 and Nd-147. Clarified units for table as noted by 3-97 Changed Table 3.5-25 to read Meat Pathway Factors following the convention used in NUREG-0133.

Revised values for C-14, Zn-65 and Zn-69.

3-98 Changed Table 3.5-25 to read Meat Pathway Factors following the convention used in NUREG-0133.

Revised values for Nb-95, Ru-105, Te-127, Te-131m, Te-131 and I-133.

3-99 Changed Table 3.5-25 to read Meat Pathway Factors following the convention used in NUREG-0133.

Revised values for I-135, Cs-138, Ba-139, La-140, Ce-141 and W-187. Clarified units for table as noted by "*".

3-100 Changed Table 3.5-26 to read Meat Pathway Factors following the convention used in NUREG-0133.

Revised values for C-14, Ni-65 and Zn-65.

3-101 Changed Table 3.5-26 to read Meat Pathway Factors following the convention used in NUREG-0133.

Revised values for Zr-95, Nb-95, Te-127 and I-133.

3-102 Changed Table 3.5-26 to read Meat Pathway Factors following the convention used in NUREG-0133.

Revised values for Cs-138. Clarified units for table as noted by "*".

3-103 Changed Table 3.5-27 to read Meat Pathway Factors following the convention used in NUREG-0133.

Revised values for C-14 and Zn-65. ,

l 3-104 Changed Table 3.5-27 to read Meat Pathway Factors l following the convention used in NUREG-0133. -

Revised values for Y-92, Nb-95, Te-127 and I-133.

f 3-105 Changed Table 3.5-27 to read Meat Pathway Factors following the convention used in NUREG-0133.

Revised values for Cs-138 and Pr-143. Clarified units for table as noted by "*".

}

71 j

SUMMARY

OF REVISION (Cont'd)

Page 3-106 Changed Table 3.5-28 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for Na-24, Cr-51, Cu-64, Br-83, Br-84 and Rb-88.

3-107 Changed Table 3.5-28 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for Nb-95, Tc-101, Te-127 and Te-129.

3-108 Changed Table 3.5-28 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for I-135, Cs-138, La-140, Ce-141 and Nd-147. Clarified units for table as noted by "*".

3-109 Changed Table 3.5-29 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for Zn-69, Br-83 and Br-84.

3-110 Changed Table 3.5-29 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for Nb-95, Tc-101 and Te-129.

3-111 Changed Table 3.5-29 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for Cs-138. Clarified units for table as noted by "*".

3-112 Changed Table 3.5-30 to read Vegetation Pathway "

Factors following the convention used in NUREG-0133. Revised values for Br-83, Br-84 and Sr-90.

3-113 Changed Table 3.5-30 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for Nb-95, Tc-101, Te-127 and Te-129.

3-114 Changed Table 3.5-30 to read Vegetation Pathway -l Factors following the convention used in NUREG- t 0133. Revised values for I-135, Cs-138, Ce-141 f and W-187. Clarified units for table as noted by l

3-115 Changed Table 3.5-31 to read Ground Plane Pathway )

Factors following the convention used in NUREG- )

0133. Revised value for Nb-95, Cs-134 and Cs-138.

72 4

_- - - _ . _ J

CHANGES TO THE SOLID WASTE PROCESS CONTROL PROGRAM

-l In accordance with CPS Technical Specification 6.13.2, changes to the Solid Waste Process Control Program (PCP) shall be reported in the Semiannual Radioactive Effluent Release Report. At Clinton Power Station the PCP consists of two documents:

CPS No. 1888.00, PROCESS CONTROL PROGRAM, which establishes process control requirements and methods.

Westinghouse Radiological Services Process Control Program STD-PCP-03-003.

In January, Westinghouse Radiological Services replaced U.S.

Ecology Nuclear as the solidification vendor at Clinton Power Station. Westinghouse Radiological Services utilizes a Mobile Dewatering / Cement Solidification Process. On January 6, 1989 CPS approved the Westinghouse Radiological Services Process Control Program STD-PCP-03-003, Revision 3 for use on site. Because STD-PCP-03-003 Revision 2 is the revision which was approved in the process topical by the NRC, changes which occurred in Revision 3 are summarized below as a matter of protocol. No changes were made to CPS No. 1888.00, PROCESS CONTROL PROGRAM during this reporting period. ,

Revised Section Summarv of Chances Appendix Revised STD-R-05-006, Class A Stable, Class B and Class C waste formulations using Portland Type I cement.

STD-R-05-006 Corrected typographical error Page 3 and incorrect sample size.

STD-R-05-006 Added footnote to define EC-3, Pages 4 and 5 a proprietary additive and renumbered following footnotes.

Westinghouse Radiological Services certifies that none of -

the changes made reduce the overall conformance of the solidified waste product to existing criteria for solid f waste.

73 j

SECTION 8 LIMITING CONDITION FOR OPERATION REPORTS 1

1 24

. LIMITING CONDITION FOR OPERATIOW REPORTS

,In accordance with CPS Technical Specifications 3.3.7.11 and 3.3.7.12 inoperable' radioactive liquid and gaseous affluent monitoring instrumentation channels. remaining in an

-inoperable condition for greater than 30 days shall be reported in the Semiannual Radioactive Effluent Release Report. During this reporting period.four inoperability conditions occurred which require reporting. The following is a description of these conditions:

1. LCO Event: 88-10-16 Information:-

Operability Requirement: Table 3.3.7.11-1.3.b Date Entered: 10/19/88 at 0305 Date Restored: 6/24/89 at 0250 Time Period: 248 days, 0.7 hours8.101852e-5 days 0.00194 hours 1.157407e-5 weeks 2.6635e-6 months Explanation: The cause of this Limiting Condition for Operation was presented in the Illinois Power Company Clinton Power Station Semiannual Radioactive Effluent Release Report for the period July 1, 1988, through December 31, 1980.

On February 23, 1989 work commenced on MWR D05337 to install temporary modification 88-100 which installed vent / test fittings at 'the flow-transmitter to allow propar instrument line venting sad to recalibrates the flow transmitter to a range of 0-50,000 GPM.

Flow data from OUIX-PR052 (Plant-Service Water Flow Monitor) was observed from February 28, 1989 until May 23, 1989. An engineering evaluation of the data revealed-that modification 88-100 did not provide the results that had been anticipated. It was. determined that the flow monitor square rooter -

was not designed to function accurately at flows of less than 8000 gpm. Temporary modification 88-100 was removed on May 25, 1989 and following required surveillance, OUIX-PR052 was returned to operation on June 24, 1989.

75 i

2. LCO Event: 89-02-01 Information:

Operability Requirement: Table 3.3.7.11-1.1.a Date Entered: 2/1/89 at 1115 Date Restored: 5/20/89 at 0627 Time Period: 107 days, 19.2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months Explanation: On February 1, 1989, Radiation Protection personnel monitoring the Area Radiation / Process Radiation (AR/PR) System Central Control Terminal (CCT) noted that the Liquid Radwaste Discharge Process Radiation Monitor (PRM), ORIX-

- PR040, had entered into a TRANSMIT CRC ERROR (communication error between the AR/PR CCT and ORIX-PR040). Maintenance Request (MR)

D2056 was initiated to troubleshoot and repair the cause of the failure. Maintenance Work Request (MWR) D2056 was subsequently initiated and assigned as a Priority 3 (CPS has priorities 1-4 with 1 being the highest) and scheduled to start on April 19, 1989.

On April 19, 1989, a DIP connector was replaced on communication cables in ORIX-PR040 and a channel -

functional test was started. The channel functional test was satisfactorily completed on April 26, 1989, however, during monitor restoration a 1 inch swagelock fitting on the monitor sample bowl was found to be galled.

On April 27, 1989, the galled fitting was repaired and monitor calibration commenced. On April 28, 1989 the monitor detector failed calibration sensitivity requirements. The detector was changed and it also failed -

calibration sensitivity requirements.

76 a

On May 3, 1989, Nuclear Station Engineering Department (NSED) personnel assistance was requested -

to help determine the reason for the inability of detectors _to pass calibration sensitivity requirements. Engineering personnel determined that high background radiation levels in the area of the monitor in conjunction with low activity calibration, sources could be affecting detector response during calibration, It was also discovered that the coupling compound in the sodium iodide detectors had dried out. On May 12, 1989, the detector was rebuilt and new coupling compound was applied. On May 17, 1989, calibration uas completed satisfactorily and on May 20, 1989, the monitor was returned to

service.

Between April 19, 1989 when work was commenced on ORIX-PR040 and May 20, 1989 when the monitor was returned to service, a total of 12 days passed with no work being performed due to a shortage of manpower, higher priorities, or a weekend with no work performed.

77

- a

3. LCO Event: 89-03-45 Information: ~

Operability Requirement: Table 3.3.7-11-1.2.c -

Date Entered: 3/31/89 at 1323 Date Restored: 5/11/89 at 2230 Time Period: 41 days, 9.1 hours1.157407e-5 days 2.777778e-4 hours 1.653439e-6 weeks 3.805e-7 months Explanation: On March 8, 1989, Fuel Pool Heat Exchanger Service Water Process Radiation Monitor (PRM) 1RIX-PR004 entered a hign alarm condition.

Liquid samples were taken on the affected process stream with no radioactivity detected.

Maintenance Request (MR) D06509 was initiated to troubleshoot and repair the cause of the high alarm.

Per CPS Technical Specification 3.3.7.11, Fuel Pool Heat Exchanger Service Water PRMs are only needed during releases via this pathway.

As of March 8, 1989, the Fuel Pool Heat Exchangers were not in service, therefore an LCO Event was not declared until March 31, 1989 when flow was established in the Fuel Pool Heat Exchangers.

On March 31, 1989, when the LCO event was entered, the redundant Fuel Pool Heat Exchanger Service Water PRM, 1RIX-PR005, was out of service due to a failed detector as reported on Maintenance Request C46104 initiated September 19, 1988.

Me.intenance Work Request D06509 on 1RIX-PR004 was assigned a priority of 3 and scheduled for work to commence on April 27, 1989. On April 27, 1989 1RIX-PR004 monitor history data was reviewed to see if any monitor spikes into high alarm had occurred within the past 24 days (24 days is the maximum -

history maintained by AR/PR system equipment). No indication of monitor spikes occurred. Attempts were made to induce spiking in the monitor by mechanically agitating internal circuit boards. No spikes occurred. At this time 1RIX-PR004 was left in service to observe monitor behavior.

78

1 On May 11, 1989 Radiation.

Protection personnel satisfactorily performed source check -

surveillance on 1RIX-PR004 and the monitor was declared operable at 2230 hours0.0258 days 0.619 hours 0.00369 weeks 8.48515e-4 months . MWR D06509 was subsequently closed out on June 2, 1989. As of this date no further spiking had occurred on the monitor.

The redundant Fuel Pool Heat Exchanger Service Water PRM (1RIX-PR005) was declared operable on June 1, 1989 following replacement-of its detector and successful completion of monitor calibration.

This effort under MWR C46104 began on May 24, 1989.

1RIX-PR004 and 1RIX-PR005 were not returned to service with 30 days of March 31, 1989 due to the manpower restrictions as a result of the ongoing plant refueling outage at that time. Resources are used on a priority basis particularly'on items required by CPS Technical Specifications and operating conditions that if not worked would restrict a plant mode change. The

. provisions of CPS Technical Specification 3.04 are not applicable to 1RIX-PR004 and 1RIX-PR005, thus their inoperability l would-not prevent a plant mode change.

i I

i i

l I

79 I I

j

- _ _ _ = _ _ _ - _ _ - _ _ _ _ _ - - . _-__ _ .-_

r i 4 .- LCO' Event: 89-04-07 Information:

Operability Requirement: Table 3.3.7-11-1.2.b -

'Date Entered: 4/11/89 at 0017 Date Restored: 16/30/89 at 0005 Time' Period: 79 days,'23.8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months Explanation: On April 11, 1989, while performing

' daily channel checks per CPS No.

9911.24,- AR/PR SHIFTLY/ DAILY SURVEILLANCE'on the Division 1 Shutdown Service Water Effluent Process Radiation Monitor (PRM) 1RIX-PR038 it.was noted that-monitor history was erratic with hourly averkges in the alarm status. Chemistry sample. data indicated no activity present in this process stream.' Maintenance Request D04094 was initiated to.

troubleshoot-and repair the cause of failure. Maintenance Work Request (MWR) D04094 was

subsequently initiated as1a' .

priority 3 with a scheduled-start date of June 16, 1989.

On June'7,-1989, the Division II Shutdc a Service Water Effluent PRM 1RIX-PRc39. pump seized.

Maintenance Request D06343 was initiated to troubleshoot and repair the cause of failure.- - MWR D06343 was subsequently initiated as a priority 3 with a scheduled start date of June 20, 1989.

On June 15, 1989 components on 1RIX-PR038 were' agitated to see if a monitor spike would result.- A spike resulted when the component boards of the detector to

_. . microprocessor interfaca box were agitated. The interface box boards were subsequently reseated and no further spikes occurred when the -

boards were agitated.

80

On June 19, 1989 following three days of normal operation with no spiking or other abnormalities, the -

monitor was declared operational following the satisfactory completion of required surveillance.

On June 20, 1989 troubleshooting on 1RIX-PR039 indicated that the pump and pump motor required replacement. On June 27, 1989 the pump and motor on 1RIX-PR039 were replaced. On June 30, 1989 following two days of observation with no noted discrepancies, the monitor was declared operational following the satisfactory completion of requined surveillance.

81

___ )

SECTION 9 MAJOR CHiUMES TO RADIOACTIVE WASTE TREATMENT SYSTEMS I

i 1

82 l

) i MAJOR CHANJES TO RADIOACTIVE WASTE TREATMENT SYSTEMS In accordance with CPS Technical' Specification 6.15, licensee-initiated major changes to the liquid, gaseous or solid radioactive waste treatasnt systems shall be reported in the Semiannual Radioactive Effluent Release Report. No major changes to the Waste Treatment Systems were reviewed and approved during this reporting period.

83

O ,. .

.SECTION:10 NEW LOCATIONS FOR DOSE CALCULATION AND/OR ENVIRONMENTAL NONITORING

)

')

I 1-

[

84

NEW LOCATIONS FOR DOSE CALCULATION AND/OR ENVIRONMENTAL MONITORING -

In accordance with CPS Technical Specification 6.9.1.7, new locations for dose calculations and/or environmental monitoring identified by the Annual Land Use Census shall be reported in the Semiannual' Radioactive Effluent Release Report. As of June 30, 1989, the 1989 Land Use Census had not begun. Results of the 1989 Land Use Census will be provided in the Semiannual Radioactive Effluent Release Report to be submitted after January 1, 1990.

4 i

85 j

ATTACEMENT A ODCM Revision 5, Affected Pages

}

SAFETY EVALUATION FORM Document Evaluated: Ance ca ecdae. w rA m .+,et,rna r, v - at m , v LES Log i: 69- 0024 w . - h /e3

References:

ra u .tr.,o<.c. r ci- t 5 a 4..a 6 3/y. ., 6,,J sN.,.i 3

Peg C m,h, uoq esores ois-3 ogM %.r pman L. w~y, tv.ure_t. 4 e Joh J 9f6fts uocec /e t-tsst.. Rach. chk Ng .TM%

r.m : D i c. < d4e.

t 1(OTE: Each block (including the lines provided for a written response following the YES/NO questions) must be completed.

Describe the basic document or system and the changea being made.

Include the interface / impact on other systems.

Ynn 5 + A cecra m. ,n. b bt ,,, crenener. b on NRC leilu dak-l % IW %

~ ;. t 4% . -s A n .... i % .., , - !,<. w .,,,., . ,1 %L., /C !!..- r h .~ e < l. IL, che N s~

wa nw h.A in R e , .- c. 5 hend unen e v c c,. w . e ,,,.cl wnc 4L- obc M .

, v v TL, c,_ w no monch no env. mu

. e shs o' s e result of +be. neenes J cacn c ve s .

TL o<.oeud el'. u s can Le Co .J l- + L. Las v.*,. S L -u

- > LO I._,

.i n Jfu<l.J.

BLOCK A - 10CFR50.59 APPLICABILITY Answer the question corresponding..to .the . type cf change being

, made (i.e., question "a" for modifications; question "b" for l procedures; question "c" for tests; and q'uestion "d" for experiments). Mark all other questions N/A". For any question (s) not marked "N/A", provide an explanation for your answer. .

YES NO / N/A a. Is this a change to the facility as

} described in the FSAR?

) YES / NO N/A b. Is this a new procedure or a change to a procedure as described in the FSAR?

YES NO /N/A c. Is this a tese not described in the FSAR? '-

YES NO / N/A d. Is this an experiment not described in the FSAR?

SAFETY EVALUATION F0 lim (Con't)

BLOCK A - 10CFR50.59 APPLICABILITY (Con't)

Explain the reason for the YES/NO Answer:

TLe FsAR d e not addrm Yke. nMM hotoe ve c %tt e4', c, ucleon; o[Me Ts ie . w cele rev A +o en en le_ ole >+; ens n de m ccenedacre tlhk ne-obce. Tb ObcM 4 net noc4 of & FS AR. , ~

NOTE: If any of the questions in Block A is checked YES, then g

10CFR50.59 applies to the change or activity, and it will 3 . he reported to the NRC in the annual report,.

BLOCK B - RADWASTE TREATMENT SYSTEMS .

YES /NO The proposed activity involves a modification to l ' he Radiological Waste Treatment Systems described in Chapter 11 of the FSAR.

Because: TL.s. r eon c L,ecy a , . n ,-+ c< n a l.+ c. m,xtJ,c a .on b R .,

ha o,e+ hNn+ Suc h a cMen R-c 9+=% ._ _ __

I

.~. ._

J If the above . statement.was answered-YES,. complete -CNP-1,09 --

I Attachment 3, " Safety Evaluation for Changes to Radioactive Waste Tregtment System"

\

BLOCK C - TECH. SPEC. / LICENSE IMPACT l 3 YES /NO The proposed activity -involver a change to-any l 5 part of the Operating License, including the j

. Technical. Specification.and Appendiv B. l I .

Because: TL. ncy m u c chb n de,c e nt i m d A da,nndenkt con olinnw !

uAL A CPS tea bcs ' '

o n4 coc m ehree,s s

on aOowed ,a.&& aise.e- Usuft c m occa r.r e . cxe Thk %c_. Litt In h we#.i '

in4cnet +bt c,copeud clanen gen gn.+,i4ed' O RC. r.'c e en h . "

l BLOCK D - UNREVIEWED SAFETY QUESTION

' Implementation or performance of the proposed activity will:

YES /NO a. Increase the probability of occurrence of an accident previously evaluated in the FSAR.

I YES ATO b. Increase the consequences of an accident previously evaluated in the FSAR.

l I Page 2 of fy

_ cs?H __ _ _ _ - _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ - _ _ - -

SAFETY EVALUATION FORM (Con't)

BLOCK D - UNREVIEWED SAFETY QUESTION (Con't) -

YES / NO c. Create the possibility of an accident of a different type than any already evaluated in the FSAR.

YES_' NO d. Increase the probability of a malfunction of equipment important to safety previously evaluated in the FSAR.

YES v NO e. Increase the consequences of a malfunction of

" equipment :Important to safety previously evaluation in *he FSAR.

YES #NO f. Create the possibl.!ity of a ma,1 function of equipment important.to safety different-than previously evaluated in the FSAR.

YES /NO g. Reduce the margin of safety as defined in the -

basis for any technical specification. ,

Provide the written bases for your answers to the YES/NO questions. Include discussions of the system / procedural functions and the effect of the change on these functions, operatin releases,g characteristics, hazards analyses, radioactive

_ and.. interfacing. sys temsw 4#se,<addicionaLcpagestif necessary)

LN,h 5 4n 4Ti obcM rs h tne 0 cohme%.) 4 adeleess -and corred severo!

b s cr*Do nt tPS lOJohr . et en

tio K! h A h kr Ob(0. .PS P re ti t$ lyn R dO Ao c ho*ny me thod oo rn mene re or accomploo'ns used -bn demons +rof +)le cvdinIoca re oI ,$ n. n c+s a sM,'e n oesenis'onr on b ornoml r>ol>lIc ond u -

,kr. P e\P er &O MC h v? Pebne (we f C, G( C O /~r f toh( h) d SCrf oo of f f N coeno cchcl in 4k- re u is n'i.3 can o n s oeu- toosisd ucX b b r3 Oc cmcen ned h a a urn nts en tukich ;+ is 6ad 1 $elodda NRC

'J

~

Rec u bte n/ G,ude 1, ? O9 u

o '

t If any statement in this block was answered YES, the action

{ described in the evaluated document involves an Unreviewed Safety J Question.

Page 3 of [

.I SAFETY EVALUATION FORM (Con't) .

I Check the applicable boxes:

BLOCK E -

SUMMARY

'I [ ( The evaluated document does not involve a change to the Technical Specifications, Operating License, or an Unreviewed Safety Question. Proceed with implementation.

P] The evaluated document involves a change to the Technical

Specification or the Operating License. NRC approval is required before implementation.

[ ] The evaluated document involves Unreviewed Safety Question. NRC approval is required before implementation.

,e Mrs

'E ORIGINATOR Omees A Coaec (0 P.fldn i/,c /6$

E Print Name Signature /Date \

DEPT. HEAD .Dae;d. U /Yl((Gr b/

Print Name v v 0//ch Signature /Date E ED I /- w w CE _ L 1 / 3[&Y' Print Name Signature /Date Peter E. Walberg AO g [

MANAGER L&S Print Na$

h PL4 .[m yf f

j [!5 h Signature /.Date ~

FRG bssdI h 8e0kr0=s=

Print Name h$vY' ~ =2/0/17

~

Signatufe/Date 7 NRAG dA o 5 Pr2.nt ame o2.gnature/Date I {

I 4

I I

I amo a < '

l lI

' Safety Evaluation M

Prorrancatic Review Checklist

%S lo 8: Oh-'OO?d. -

Document reviewed: d'"N$lTE. M56 <~AL.Cdr K77'DM l'IM %L J_e_J/. 6 NOII: Questions should be answered based on the as received form, not after cocoent resolution.

Y's No N/A i _ _ 1. Has the document or activity evaluated been properly identified?

1 _ _ 2. Does the description adequately tell what's being done or changed?

y _ _ 3.

I 4_

4 Is block A properly filled out, .is it consistent with KRC interpretations, and is there adequate justification?

Does block E give an adequate reason if checked NO, based on TSAR system definition w or equivalent authority?

I g _ _ 5. If NO, does block C give an adequate justification why the Tech Specs, including environmental lech Specs and Operating License do not need to be changed?

_ _ 1 6. If YES, does block C provide a reference to either the Proposed Tech Spec Change Iy__ 7.

Package number or the Proposed License Change number?

Does block D give the reasons for the YES/NO items checked? Are they valid reasons that would stand up independently under audit? Is the full scope of the description covered?

I y _ _ B. Have specific sections of the TSAR, Technical Specifications, and other documents used in answering the questions on the fort: been referenced?

g ,3 _ _ 9. Kave the above TSAR & Technical Specification references been properly interpreted, g and do th;e other references appear appropriate?

4 _ 10 Have applicable codes, standards, and regulations been considered?

$ 11. Are the supporting analyses (if required) attached?

Eave the supporting analyses been properly documented and do they cover the I _ __ $ 12._

approriste scope?

$ _ ,,,,,,, 13. Have required reviews been performed?

I -g y ____14 15.

Ts the NSED Technical Review Checklirt attached?

The correct response is, checked in Eleck E.

_ _ $ 16*. Have all other areas, if required, been addressed? (list, if any)

Problens identified (if any)

_ hk WEIuiume W

I Corrective Action I d I .

I & %w sla)n

< oae uS Revgeq

[ , - . -

p,,fy{}~'

I l 1

l I. 10CFR50.59 Evaluation YES W TT NO

?

l I Radwaste System Safety Evaluation (IE-80)

[] $d ;

{

, REVIEW OF SAFETY. EVALUATION BY OTHERS LOG #: 5436 TITLE: ooc.t/s al5 -l/06 YES NO N/A

,pF [] [] 1. Document and Safety Evaluation read.and understood.

[] [] W 2. Objective statements correctly reference to FSAR/ Tech Spec.

l p [] [] 3. Objective statements appropriate to scope of change.

I [] [] 'p& 4. Critical technical data validated to design base documents.

I [] [] PF 5. FSAR/ Tech Spec / Design Base data consistent with document reviewed.

6.

I [] []

% Cor.ar.nts , if any, resolved with originator.

COM12NTS : /N rag _ _

~

I Prepared by: g n.g ,h k d'b Date: 1.'2h8 Cl l Supervisor: /2 9 bM/ Date: /' 2 3' b Director: Date: [!2$b I

I I " '"*

!I I Revision 5' Summary Page i Changed page numbers for Sections 2.5 and 2.6.

f iv Delete reference to Table 2.6-1, revise titles for Tables 3.5-13 through 3.5-16.

v Revise titles for Tables 3.5-17 through 3.5-31.

vi Add a new Figure 2.5-3.

.I vii q Revise List of Effective pages.

2-1 Deleted reference to FSAR, replaced with USAR in paragraph 2.1.

2-3 Correction in Section 2.3.1.1 referencing CPS RETS Table 4.11.1 to Table 4.11.1-1. ,

2-6 Replaced Figure 2.1-1 due to map being 111egible.

2-9 Revised the definition for the quantity Fy , the near field average dilution factor I 2-11 Revised Table 2.4-1 Aij factors for the P-32 due to the latest NRC recommended value for the bioaccumulation factor for phosphorus, and Sr-91 2-12 Revised Tdble.2.4-1 Aij factors for Te-125m.

2-13 Revised Table 2.4-1 Aij factors for Ba-139.

2-14 Changed the Moaccumulation factor (BFi) for freshwater fi'sh for phospho Ns due to the latest NRC recommendation.

2-15 Re. vised Table 2.4-3 DUi factors for Sr-91.

I 2-16 Revised Table 2.4-3 DFi factors for Te-127m, Te-129m, and I-133.

2-17 Revised Table 2.4-3 DFi factors for Ba-139.

2-18 Revised Figure 2.5-1 to reflect actual plant nomenclature.

2-20 Add new Figure ?,.5-3 SOLID RADWASTE SYSTEM SIMPLIFIED FLOW .

DIAGRCf. Rev. 2 verbage becomes page 2-21.

I 2-21 Rev. 2 page 2-20 verbage becomes new page.

containing Table 2.6-1 deleted.

Rev. 2 page 2-21 2-22 Removed this page since Table 2.6-1 was deleted in Rev. 2.

3-5 Placed the symbol which indic'ates rate (.) over the Qim instead of (X/Q)m, deleted reference to "j" for summation, and corrected definition of Mi by changing mrem to mrad.

CLINTON-I 1 Rev. 5-2/89 I _

CPS-ODG4 Revision 5 Summary l

l Page 3-9 Revised Table 3.4-2 Pij factors for Cu-64 and Br-85.

3-10 Revised Table 3.4-2 Pij factors for Y-91m.

I '3-14 Included the units in the definition for the quantities (X/Q)m and (x/q)m.

3-16 Corrected the units in the definition for the quantity qim which should be uCi instead of C1.

t 3-19

Added the definition for Ys.

3-20 Corrected definition for lambda w, by changing half-time to half-life.

'l 3 28 Changed the units for Skin Dose Factor (Li) to mrem /yr per uCi/m3 3-30 Replaced Figure 3.1-1 due to map being illegible.

3-32 I Revised Table 3.5-1 (DFAi)a factors for P-32 to agree with RG 1.109.

3-33 Revised Table 3.5-1 (DFAi)a factors for Zr-95, Te-127, and l I-133 to agree with RG 1.109.

3-34 Revised Table 3.5-1 (DFA1)a factors for Cs-137 and Ba-139 to agree with RG 1.109.

3-35 Revised Table 3.5-2 (DFA1)a factors for Cr-51 to agree with RG 1.109.

3-39 Revised Table. 3.5-3 (DFAiia facters for Nb 95 to agree with RG 1.109.

3-40 Revised Table 3.5-3 (DFAL)a factors for La,-142 and Nd-147 to agree with RG 1.109.

3-41 Revised Table 3.5-4 (DFAi)a factors for Zn-69 to agree with RG 1.109.

3-43 Revised Table 3.5-4 (DFAi)a factors for Ba-140 and Ce-144 to -

agree with RG 1.109.

l 3-44 Correct element number for Co-60.

3-45 Revised Table 3.5-5 DFGi skin factor for Te-131 to agree with RG 1.109.,

3-49 Revised Table 3.5-7 (DFLi)a factors for P-32 to agree with RG 1.109.

CLINTON-I 2 Rev. 5-2/89

CPS-0DCM Revision 5 Summarv l

Page 3-50 Revised Table 3.5-7 (DFLi)a factors for Y-91m and Te-127 to agree with RG 1.109. 1 3-53 Revised Table 3.5-8 (DFLi)a factors for Zr-95 to agree with RG 1.109. 1 3-56 Revised Table 3.5-9 (DFLi)a factors for Y-93 to agree with RG 1.109.

I 3-61 , Changed Table 3.5-13 to read Inhalation Pathway Factors j

- following the convention used in NUPIG-0133. i 3-62 Changed Table 3.5-13 to read Inhalation Pathway Factors. _

following the convention used in NUREG-0133. Corrected values l for Ru-103.

I 3-63 Changed Table 3.5-13 to read Inhalation Pathway Factors i

l following the convention used in NUREG-0133. Corrected values {q I for I-134 and Ba-141. i l

3-64 Changed Table 3.5-14 to read Inhalation Pathway Factors )

I following the convention used in NUREG-0133.

for Br-84 and Rb-89.

Corrected values l

3-65 I Changed Table 3.5-14 to read Inhalation Pathway Factors following'the convention used in NUREG-0133.

j 3-66 Changed Table 3.5-14 to read Inhalation Pathway Factors I following the convention used in NUaEG-0133.

3-67 Changed Table 3.5-15 to read Inhalation Pathway Factors I following the convention used in NUREG-0133. Corrected for Rb-86 and Sr-89.

values i l

3-68 I Changed Table 3.5-15 to read Inhalation Pathway Factors folicwing the convention used in NUREG-0133. Corrected for Te -127 and I-130.

values l 3-69 Changed Table 3.5-15 to read Inhalation Itathway Factors following the convention used in NUREG-0133. l I 3-70 Changed Table 3.5-16 to read Inhalation Pathway Factors following the. convention used in NUREG-0133. .!

l 3-71 I Changed Table 3.5-16 to read Inhalation Pathway Factors following the convention used in NUREG-0133.

for Tc-101.

Corrected values l 3-72 Changed Table 3.5-16 to read Inhalation Pathway Factors following the convention used in NUREG-0133.

4 CLINTON-I 3 Rev. 5-2/89 I .

, CPS-0DCM I

, l Revision 5 Summary i

Page

.j 3-73 Changed Table 3.5-17 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for C-14, 2n-65 and Sr-91.

I 3-74 Changed Table 3.5-17 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Zr-97, Nb-95,,Tc-101, Ru-103, Te-127 and Te-129.

3-75 : Citanged Table 3.5-17 to read Cow Milk Pathway Factors following

, the convention used in NUREG-0133. Revised values for Cs-138,

+ Ba-139 and Ba-140. Clarified units for table as noted by "*".

3-76 Changed Table 3.5-18 to read Cow Milk Pathway Factors f.ollowing the convention used in NUREG-0133. Revised values for C-14, Zn-65 and Sr-90. ,

3-77 Changed Table 3.5-18 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for 100-95, I. Tc-99m, Tc-101, Te-127, Te-129 and I-131.

3-78 Changed Table 3.5-18 to read Cow Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Cs-138, Ba-139, Ba-140, La-140 and Ce-141. Clarified units for table as noted by "*".

3-79 Changed Table 3.5-19 to read Cow Milk Pathway Factors following i the convention used in NUREG-0133. Revised values for C-14 and Fe-59. {

3-80 changed Tcdle 3.5-19 to rend Cow Milk Pathway Factors following j I t'.4a convention used in NUEEG-0133.

Tc 101, Te-127, Te-129 and Te-131.

Revised values for Nb-95, ~

3-81 Changed TaLJe 3.5-19 to read Cow Milk Pathway Factors follcwing the conventien used in NUREG-0133. Fevised values for Cs-138, Ba-139, Ba-140 and Ce-141. Clarified units for table. as noted by ',"".

3-82 ChanSed Table 3.5-20 to read Cow Milk Pathvay Factors following the convention used in NUREG+0133. Revised values for C-14.

3-83 Changed Table 3.5-20 to read Cow Milk Pathway Factors following -

the convention used in NUREG-0133. Revised values for Y-91m, Zr-97, Nb-95, Tc-101, Te-127 and Te-129.

l 3-84 Changed Table 3.5-20 to read Cow Milk Pathway Factors following j I

the convention used in NUREG-0133. Revised values for Cs-138 j and Ba-139. Clarified units for table as noted by "*".

I CLINTON-I 4 Rev. 5-2/89

CPS-0DCM I Revision 5 Summary Page 3-85 Changed Table 3.5-21 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values for C-14, P-32 and Ni-63.

3-86 Changed Table 3.5-21 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Nb-95, Tc-101, Ru-105, Te-127 and Te-129.

3-87 : Changed Table 3.5-21 to read Goat Milk Pathway Factors

following the convention used in NUREG-0133. Revised values

~

for Cs-134, Cs-138, Ba-139 and Pr-144. Clarified units for table as noted by "*".

l l

3-88 Changed Table 3.5-22 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values I. for C-14 and Zn-65.

l 3-89 Chang,ed Table 3.5-22 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Kevised values for Nb-95, Tc-101, Te-127, Te-129, and I-132.

3-90 Changed Table 3.5-22 to, read Goat Milk Pathway Factors l following the convention used in NUREG-0133. Revised values for Cs-138, Ba-139, La-140 and Ce-141. Clarified units for l 3-91 table as noted by "*".

Changed Table 3.5-23 to read Goat Milk Fathway Factors I following the convention used in NUREG-0133. Revised values for C-14 and Fe-55.

3-92 Changed Table 3.5-23 to read Goat Milk Pathway Factors I following the convention used in NUREG-0133. Revised values for Ub-95, Te -101, Ru-105, Te-127 and Te-129.

i l

l 3-93 Changsd Table 3.5-23 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Cs-138, Ba-139 and Cc-141. Clarified units for table as noted by "*".

3-94 Changed Table 3.5-24 to read Goat Milk Pathway Factors following the convention used in NUREG-0133.

1 I for C-14.

Revised values 3-95 Changed Table 3.5-24 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values l

for Nb-95, Tc-101, Te-127, Te-129, Te-131m and I-132.

I CLINTON-1 5 Rev. 5-2/89 I . _

CPS-0DCM Revision 5 Summary 3-96 Changed Table 3.5-24 to read Goat Milk Pathway Factors following the convention used in NUREG-0133. Revised values for Cs-137, Cs-138, Ba-139 and Nd-147. Clarified units for table as noted by "*".

I 3-97 Changed Table 3.5-25 to read Meat Pathway Factors following the convention used in NUREG-0133. Revised values for C-14, Zn-65 and Zn-69.

3-98 ; Changed Table 3.5-25 to read Meat Pathway Factors following the I ~ convention used in NUREG-0133. Revised values for Nb-95, Ru-105, Te-127, Te-131m, Te-131 and I-133.

3-99 Changed Table 3.5-25 to read Meat Pathway Factors following the I convention used'in NUREG-0133. Revised values for I-135, Cs-138, Ba-139, La-140, Ce-141 and W-187. Clarified units for ,

table as noted by "*".

3-100 Changed Table 3.5-26 to read Meat Pathway Factors following the convention used in NUREG-0133. Revised values for C-14, Ni-65 and Zn-65.

3-101 Changed. Table 3.5-26 to read Meat Pathway Factors following the convention used in NUREG-0133. Revised values for Zr-95, Nb-95, Te-127 and I-133.

3-102 Changed Table 345-26 to read Meat Pathway Factors following the I convention used in NMEG-0133. Revised values for Cs-138.

Clarified units for tab 7.e as noted by "*%

3-103 I Changed Table 3.5-27 to read Meat Pathway Factors following the convention used in NUREG-0133.

2n-65.

Revi. sed values for C-14 and 3-104 Changed Table 3.5-27 to read Meat Pathway Factors fcilewing the ccnvention used in NUREG-0133. Revised values for Y-92, Nb-95, Te-127 and I-133.

3-105 Changed ' Table 3.5-27 to read Meat Pathway Factors following de convention used in NUREG-0133. Revised values for Cs-138 and Pr-143. Clarified units for table as noted by "*".

3-106 Changed Table 3.5-28 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for Na-24, Cr-51, Cu-64, Br-83, Br-84 and Rb-88.

3-107 Changed Table 3.5-28 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values

, for Nb'95, Tc-101, Te-127 and Te-129.

l CLINTON-I 6 Rev. 5-2/89 I .

CPS-0DCM I Revision 5 Sunmary Page 3-108 Changed Table 3.5-28 to read Vegetation Pathway Factors l following the convention used in NUREG-0133. Revised values for I-135, Cs-138, La-140, Ce-141 and Nd-147. Clarified units for table as noted by "*".

3-109 Changed Table 3.5-29 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for 2n-69, Br-83 and Br-84.

3-110 Changed Table 3.5-29 to read Vegetation Pathway Factors

+

following the convention used in NUREG-0133. Revised values I for Nb-95, Tc-101 and Te-129.

3-111 Changed Table 3.5-29 to read Vegetation Pathway Factors I following the convention used in NUREG-0133. Revised values for Cs-138. Clarified units for table as noted by "*".

3-112 I Changed Table 3.5-30 to read Vegetation Pathway Factors following the convention used in NUREG-0133.

for Br-83, Br-84 and Sr-90.

Revised values 3-113 Changed Table 3.5-30 to read Vegetation Pathway Factors following the convention used in NUREG-0133. Revised values for Nb-95, Tc-101, Te-127 and Te-129.

3-114 Changed Table 3.5-30 to read Vegetation Pathway Factors I following the convention used in NUREC-0133. Revised values I for 7.-135, C N 3S, Cc-1t? and W 187. Clarified units for table

,as not 'a y " * * ' ,

3 115 Changed Tchle 3.5-31 to read Ground Plane Pathway Factors I" following the convention use/ in NUF.UG-0133. Revised values for Nb -95, Cs-134 and Cs-138.

I i

I I I

\

CLINTON-I 7 Rev. 5-2/89 I ,

CPS-0DCM I ILLINOIS POWER COMPANY CLINTON PCWER STATION UNIT 1 0FFSITE DOSE CALCULATION MANUAL Docket No. 50-461 1

I I

l l

I CLINTON-I Rev.5-2/89 1

CPS-0DCM Illinois Power Company Clinton Power Station

~

OFFSITE DOSE CALCULATION MANUAL Table of Contents Section Title Page

. l . ,0 PREFACE l-1 I

l 2 . 'O LIQUID EFFLUENTS 2-1 2.1 Introduction 2-1 2.2 Liquid Radwaste Discharge Process Radiation 2-1

Monitoring (PRM) System '

2.2.1 Method of Representative Sampling 2-1 2.3 10CFR20 Release Rate Limits 2-1 2.3.1 Liquid Radwaste Discharge PRM 2-2 Setpoints 2.3.2 Plant Service Water Effluent 2-7 l PRM Setpoints 2.3.3 Shutdown Service Water (SX) Effluent 2-8 !

PRM Setpoints I 2.3.4 Fuel Pool Heat Exchanger Service 2-8

{

l Water Effluent PRM Setpoints I 2.4 10CFR50, Appendix I Release Rate Limits 2-9

]

4 2.5 Compliance With CPS RETS 3.11.1.3/3.11.1.4 2-21 1

1 2.6 Doses From Other Significant Liquid Effluent Pathways 2-21 3.0 GASEOUS EFFLUENTS 3-1 3.1 Introduction 3-1 3.2 Gaseous Effluent Release Point Monitoring 3-2 3.2.1 HVAC Stack Process Radiation ~3-2 Monitoring (PRM) System CLINTON-I i Rev.5-2/89

- CPS-ODCM Tables '

Table Title Page -

2.4-1 Adult Ingestion Dose Commitment Factors-A 2-11 13 2.4-2 Bioaccumulation Factors-BF g 2-14 2.4-3 Adult Ingestion Dose Factors-DF ,2-15 f

3.4-1 Dose Factors For Noble Gases and Daughters 3-8 3.4-2 Inhalation Pathway Dose Rate Factors (CHILD)-P g 3-9 3.4-3 Annual Doses in Unrestricted Areas 3-12 3.5-1 3-32 Inhalation Dose Factors For Infant-(DFAg)a 3.5-2 3-35 Inhalation Dose Factors For Child-(DFA1 )a 3.5-3 Inhalation Dose Factors For Teen-(DFA1 ), 3-38 3.5-4 Inhalation Dose Factors For Adulr-(DFAg ), 3-41 3.5-5 Ground Plane Dose Factors DFG 1 3-44 3.5-6 Ingesticta Dose Facters Fe lufanc-(DFLg ) , 3-46 j 3.5-7 Inge.stion Dose Factors For Child--(DFLg ), 3-49 3.5-8 Ingestion Dose Factore For Tecn-(DFLg ), 3-52 3.5-9 Ingestion Dose Factors For Adult-(DFL1 )a 3-55 3.5-10 Input Parameters For Calculating RC 3-58 3

3.5-11 InputParametersForCalculatingRyg3 3-59' 3.5-12 InputParametersForCalculatingR{g3 3-60 3.5-13 I Inhalation Pathway Factors - R,13 (INFANT) 3-61 3.5-14 Inhalation Pathway Factors - R,I t) (CHILD) 3-64 3.5-15 I Inhalation Pathway Factors - R g3 (TEEN) 3-67 3.5-16 InhalationPathwayFactors-Rh3(ADULT) 3-70 f

I l

l I

CLINTON-I iv Rev.5-2/89 l l

t

- _ - _ - - - - - _ _ - - - - - - - - - - - - b

CPS-0DCM I Tables I Table Title Page .

3.5-17 Cow Milk Pathway Factors - R (INFANT) 3-73 3.5-18 Cow Milk Pathway Factors - R,C (CHILD) 3-76 3.5-19 Cow Milk Pathway Factors - R C 3-79 3 (TEEN) 3.5-20 Cow Milk Pathway Factors - R (ADULT) 3-82 3.5-21 Goat Milk Pathway Factors - R (INFANT) 3-85 3.5-22 Goat Milk Pathway Factors - R,C (CHILD) 3-88 3.5-23 Goat Milk Pathway Factors - R C (TEEN) ' 3I91 3.5-24 Goat Milk Pathway Factors - R (ADULT) 3-94

3.5-25 MeatPathwayFactors-Rft) (CHILD) 3-97 3.5-26 D Meat Pathway Factors - R,Ig3 (TEEN) 3-100 l 3.5-27 3.5-28 Meat Pathway Factors - R g3 (ADULT) 3-103 Vegetation ?athway Factors - R (CHILD) 3-106 3.5-29 VegetationPghwayFactors-Rh3(TEEN) 3-109 3,,5-30 3-112 VegetationPathwayFactors-R[g3(ADULT) 3.5.31 GroundPlanePathwayFactors-Rf 3-115 5.0-1 Radiological Environmental Monitoring Program Sampling and Collection Frequencies 5-3 7.2-1 Annual Average Mixed-Mode X/Q 7-6 7.2-2 Annual Average Mixed-Mode D/Q 7-10 7 .2-3 Wind Speed and Wind Direction Classification 7-14 I 7.2-4 Gaseous Effluent Release Point Characteristics 7-15 7.2-5 Site Boundary Dispersion and Deposition Parameters 7-16 1

l CLINTON-I v Rev.5-2/89

( . - _ _ _ - - _ _ _ _ _ _ _ - - - - . . - _ - - - - - - - _ _

CPS-ODCM Figures l I Figure Title Page l 2.1-1 Unrestricted Area Boundary For Liquid Effluents 2-6 2.5-1 Liquid Radwaste Treatment System 2-18 2.5-2 Shutdown and Fuel Pool Heat Exchanger Service I 2.5-3 :

Water Effluent Monitors Solid Radwaste System Simplified Flow Diagram 2-19 2-20

!l 3.1-1 CPS Site Boundary For Gaseous Effluents 3-30 3.3-1 Main Condenser Off-Gas Treatment System 3-31 ,

!g 5.0-1 REMP Locations Within 1.5 Miles of CPS 1

5-13 5.0-2 REMP Locations Within 6 Miles of CPS 5-14 1

5.0-3 REMP Locations Within 50 Miles of CPS 5-15 I

l I

l lI ,

I -

I l CLINTON-I vi Rev.5-2/89 I

CPS-ODCM ll; I Lict of Effective Pages !

Pat,e Revision Page Revision Page Revision Page Revision .i I L 11 111 5

1 2

3-16 3-17 3-18 5

1 3-65 3-66 5

5 4-1 5-1 1

2 j

1 3-67 5 5-2 2 I iv vi v

5

~5 5

3-19 3-20 3-21 5

5 1

3-68 3-69 3-70 5

5 5

5-3 5-4 5-5 1

1 1

)

vii .5 3-22 1 3-71 5 5-6 2 ll. 1-1 . 1 3-25 1 3-72 5 5-7 1 2-1 5 3-24 1 3-73 5 5-8 2 {

2-2 L. 4 3-25 2 3-74 5 5-9 3 I 2-3 2-4 2-5 5

4 4

3-26 3-27 3-28 1

2 3-75 3-76 5

5 5-10 5-11 2

1 1

5 3-77 5 5-12 Z j 2-6 5 3-29 2 3-78 5 5-13 3 j 2-7 3 3-30 5 3-79 5 5-14 3 -

2-8 2 3-31 2 3-80 5 -

5-15 2 j 2-9 3-32 I 2-10 2-11 5

1 5

3-33 3-34 5

5 5

3-81 3-82 3-83 5

5 5

6-1 7-1 7-2 2

2 1

{

1 l

2-12 5 3-35 5 3-84 5 7-3 I

1 2-13 5 3-36 1 3-85 5 7-4 1 2-14 5 3-37 1 3-86 5 7-5 1 2-15 5 3-38 1 3-87 5 7-6 2 I 2-16 3-39 ,

5 5 3-88 5 7-7 2 2-17 5 3-40 5 3-89 5 7-8 2 2-18 5 3-41' 5 3-90 5 7-9 2 2-19 2 3-42 3-91 I 2-20 2-21 5

5 3-43 3-44 1

5 5

3-92 3-93 5

5 5

7-10 7-11 7-12 2

2 2

{

)

'1 2 3-45 5 3-94 5 7-13 I 3-2 3-3 3-4 1

2 3-46 3-47 1

1 3-95 3-96 S

5 7-14 7-15 2

1 2

i 2 3-48 1 3-97 5 7-16 4 I 3-5 3-6 3-7 5

2 1

3-49 3-50 3-51 5

5 1

3-98 3-99 3-100 5

5 5

7-17 7-18 7-19 2

1 1

3-8 3-52 3-101 I

1 1 5 7-20 1 3-9 5 3-53 5 3-102 5 7-21 2 1 3-10 5 3-54 1 3-103 5 7-22 1 3-11 2 3-55 1 3-104 7-23 I

5 1 3-12 4 3-56 5 3-105 5 7-24 1 .1 3-13 2 3-57 1 3-106 5 7-25 1 l 3-14 5 3-58 1 3-107 5 7-26 2 !

t l

I 3-15 1 3-59 3-60 3-61 1

1 5

3-108 3-109 3-110 5

5 5

7-27 7-28 7-29 1

1 1 l 3-62 5 3-111 5 7-30 1 l 3-63 5 3-112 5 7-31 1 3-64 3-113 5 5 3-114 5 3-115 5 l

CLINTON-I vii Rev.5-2/89

_ __-_-___-_______-_-A

I ord-uncM 2.0 IQUID EFFLUENTS 2.1 1.troduction

^

Liquid radwaste effluent released from CPS will meet 10CFR20 f I concentration limits at the point of discharge to the unrestricted area shown in Figure 2.1-1. This design and operation objective I

l will be achieved at all times. Actual discharges of liquid radwaste effluent will occur on a batch basis and the average concentration at the point of discharge will normally be only a small percentage of the allowed limits. Reference Clinton USAR IE Section 11.5 for a description of radiation monitoring, sampling g and effluent contror systems.

Cutpulative quarterly dose contributions due to radioactive effluents released to the unrestricted area will be determined once every 31 days using NUREG-0133 and Regulatory Guide 1.109 methodology and parameters. ~~

2.2 Liquid Radwaste Discharge Process Radiation Monitoring (PRM) System This monitoring subsystem measures liquid radwaste effluent radioactivity prior to the effluent joining plant service water and circulating water dilution streams. A high radioactivity signal l from this gamma scintillation detector automatically terminates the liquid radwaste effluent release. The liquid radwaste effluent {

flow, variable from 10-60 GPM or 50-300 GPM, c.ombines with Plant I Service Water flow (minimum flow approximately 5000 GPM during plant shutdown-pariods depending on system loads) and Plant Circulating Water flow (0-567,000 GPM) in the Seal Well prior to entering the 3.4 mile discharge flume to Lake Clinton (see Figure I 2.5-1).

2.2.1 Method of Representative Sampling To obtain a representative sample of the liquid radwaste tank to be discharged, the tank is isolated from all inputs and I recircula'ted a minimum of two tank volumes at which time a sample is obtained for isotopic analysis.

2 .3 10CFR20 Release ~ Rate Limits I '1he requirements pertaining to discharge of liquid radwast!

I' effluent to the unrestricted area are specified in CPS RE*tS 3.11.1.1: j i

CLINTON-I 2-1 Rev.5-2/89

I The available dilution water flow (F) should be constant for a given release, and the liquid radwaste tank discharge flow (f) and I. monitor setpoint (c) are set to meet the condition of equation (1) for a given effluent concentration (Cup The method by which this is accomplished is illustrated itt he)c. tions 2.3.1.1 through ~

2.3.1.5.

2.3.1.1 The isotopic concentration for a liquid radwaste tank to be

, a discharged is obtained from the sum of the measured I concentration * "S determin*d b7 the analyses required in CFs 1

RETS Table 4.11.1-1:

l

[Cf = jCg+ IC+IC a +C s +CFe, T pCi/ml (2) where gC g = The sum of concentrations Cg of each measured gamma emitter g (including I-131) ,

observed by gamma spectroscopy of the waste sample, I EC uCi/ml.

= The sum of concentrations C of alpha emitters -(a) in liquid radwaste as measufed in the most current QUARTEPLY composite discharge tank sample,yCi/ml.

IC ss = The sum of concentrations C of Sr-89/Sr-90 in liquid radvacte as observedsin the most current QUARTERLY composite discharge tank sample,yCi/ml.

C T = The measured concentration of H-3 in liquid radwaste I .

as detetuined from analysis of the most current QUARTERLY composite discharge tank sample,yCi/ml.

I C Fe = The measured concentration of Fe-55 in liquid radwaste as observed in the most current QUARTERLY composite discharge tank sample,yCi/ml.

I I

I -

I CLINTON-I 2-3 Rev.5-2/89 I

S E E .E 0 N

Y O

E DIO WWW 3 0

OO N.O USLt T P . P O P Y DILD S sis L E

D E YIN I tTt

' E H RW O O - oAo T A

A N TA TC N E # MTNI M D UT I

R 7E W NN L LIS L t Y A 1 T

O EUDN L I ILGl t x E E N 0 R D t If S O Y YI T R A E "c NH o WDE.U L O OP !

P D T N C I

T EAI F M

D D MDt PA D U R I

$"H HY OETF E E E U E e TR

'ER$ N N P N S N O T I

S S #'s WA DC K

AtT HN .O E WSWEW I E

G E E R

k'tE EUI ANP S AH E LC L TAE COI N O .E E.

L T E ININ T

EI N IT RTNT E LS U$ ADB n ROY I ESAP.UOEOPO Q

SL UE L

[ HU TLDIOLSL PSNCHIP H.L t

LAOo Rf t N CEDLEEtE Y ER Ht f ETEC

[ ISCL N CUS S

T N

j UQ A EER ILTR RHT ATSRAPDP ONAEA CfC SR A P

M PUA PTEV ALKE A

L mE U L

F

)

P Y

T HNNOA A 1

E TRD U EDRNRN CN TAUCWLN - ALACH 2

L DC DI

.I L 3

.O O

NRE L f LATW 4

CL E S

8 F (

E E C

N D ,I E

0 I t U S E Y Q - H R mL A

I D)5 0 N 4 UE j . 0T R Y W

0O !

O H ft t(

K A

m 1F -

1Y

.R ,

L 2A #.s ?

D N 4 k ' 3 men rU uO gB 1 i I E

M U

L

. F

[

1 y

W

. E T

O N

A E H i

E 0

l fA g ,

m FARA (

t i

j ,

/

fr~ o D / t

.E T i sN y

W C

H I O i R J MT S E

R N

Q I

y U

$ p M E T

O N

/ i a

M 2

4 E

T E O T M N O i

f M

n*tsZdOZ N N 0 wINN0W

_M

Gn-uvun 2.4 10CFR50, Appendix I Release Rate Limits CPS RETS 3.11.1.2 requires that the cumulative dose i contributions to an individual from radioactive material in -I l liquid effluents released to the unrestricted area be determined at least once per 31 days.

limits are:

The applicable dose 1

I and i 1.5 mrem / calendar quarter - TOTAL BODY 1 5.0 mrem / calendar quarter - ANY ORGAN

< 3 mrem / calendar year - TOTAL BODY I-

, 1 10 mrem / calendar year - ANY ORGAN

( The dose contribution to the maximum exposed individual from '

all radionuclides identified in liquid effluents released to the unrestricted area i., calculated as follows:

I g (

m Dj= .g A 13 7.Ey aty C 11 F , mrem (8) where D = The cumulative calendar quarter or yearly dose to I 3 any organ j from liquid effluent for the total release period, mrem l Ac t = The length of the ith release time period over which C iy and F y are averaged for liquid releases, hours I = Liquid Radwaste Tank Volume / Liquid Radwaste Discharge Flow Rate C gy = The average concentration of nuclide i in undiliited liquid effluent during release period at y for any liquid release, pCi/ml I Fy = The near field average dilution factor for C during any liquid effluent release, dimensiobless.

Defined as the ratio of the average undiluted liquid radwaste flow during the release, to the product of the average flow from the discharge structure (during the reporting period, i.e., quarter or year) to the unrestricted receiving water and Z I = Average Undiluted Liquid Waste Flow (9)

(Average Discharge Structure Flow) Z Z = The applicable dilution factor for Lake Clinton, dimensionless

= 1.0 CLINTON-I 2-9 Rev.5-2/89 I _ _ _

CPS-ODCM I

TABLE 2.4-1 ADULT INGESTION DOSE COMMITMENT FACTORS - A g (mres/hr per pCi/ml) l ISOTOPE BONE LIVER T. BODY THYROID KIDNEY LUNG CI-LLI I

H-3 NO DATA 2.26E-01 2.26E-01 2.26E-01 2.26E-01 2.26E-01 2.26E-01 C-14 3.12E+04* 6.24E@3 6.24E+03 6.24E+03 6.24E+03 6.24E+03 6.24E+03

! NA-24 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4.06EM2 4.06E+02

~

l" P-32 1.39E+06 8.62E+04 5.36E+04 NO DATA NO DATA NO DATA 1.56E+05 CR-51 NO DATA NO DATA 1.27EMO 7.60E-01 2.80E-01 1.68E+00 3.20E+02 HN-54 NO DATA 4.37E+03 8.34E+02 NO DATA 1.30E+03 NO DATA 1.34E+04

~

MN-56 NO DATA 1.10E+02 1.95E+01 NO DATA 1.40EM2 NO DATA 3.51E+03 FE-55 6.57E+02 4.54E+02 1.06E+02 NO DATA NO DATA 2.53E+02 2.63E@2 FE-59 1.04E+03 2.44E+03 9.34E+02 NO DATA NO DATA 6.81E+02 8.13E@3 CO-58 NO DATA 8.90E+01 2.00EM 2 NO DATA NO DATA NO DATA 1.80E+03 I. Co-60 NO DATA 2.56E+02 5.64E+02 NO DATA NO DATA NO DATA 4.80E43 NI-63 3.11E+04 2.15E+03 1.04E+03 NO DATA NO EATA NO DATA 4.49E+02 I NI-65 1.26EM 2 4.64E+01 7.48E+00 NO DATA NO DATA NO DATA 4.16E+02 CU-64 NO DATA 9.97E+00 4.67E4 0 NO DATA 2.51EMI NO DATA 8.4SE@2 ZN-65 2.31EM4 7.36E+04 3.33EM4 NO DATA 4.92E+04 NO DATA 4.64E+04 I ZN-69 ER-83 BR-84 4.92E+01 NO DATA NO DATA 9.42E+01 NO DATA NO DATA 6.55EMO 4.03E+01 5.23E401 NO DATA NO DATA NO DATA 6.12EMI NO DATA NO DATA NO DATA NO DATA NO DATA 1.41E+01 5.81EM I 4.10E-04 I BR-85 NO DATA NO DATA 2.15E+00 NO DATA NO DATA NO DATA LT E-15**

RB-86 NO DATA 1.01E45 4.70EM4 NO DATA NO DATA NO DATA 1.99E+04 RB-88 NO DATA 2.89E+02 1.53E+02 NO DATA NO DATA NO DATA 4.00E-09 I RB-89 SR-89 SR-90 NO DATA 2.21E+04 5.43E+05 1.92E+02 NO DATA NO DATA 1.35E+02 6.34E+02 1.33E+05 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 1.11E-11 3.54E+03 1.57E+04 I SR-91 4.06E+02 NO DATA 1.64E+01 NO DATA NO DATA NO DATA 1.94E+03 SR-92 1.54EM 2 NO DATA 6.67E+00 NO DATA NO DATA NO DATA 3.05E+03 Y-90 5.75E-01 NO DATA 1.54E-02 NO DATA NO DATA NO DATA 6.10E+03 CLINTON-I 2-11 Rev.5-2/89 I .

CPS-ODCM TABLE 2.4-1 (continued)

ADULT INGESTION DOSE COMMITMENT FACTORS - Aq (mrem /hr per UCi/ml)

ISOTOPE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI lI Y-91m 5.43E-03 NO DATA 2.10E-04 NO DATA NO DATA NO DATA 1.60E-02 Y-91 8.42E400 NO DATA 2.25E-01 NO DATA NO DATA NO DATA 4.64E+03 Y-92 5.05E-02 NO DATA 1.48E-03 NO DATA NO DATA NO DATA 8.84E+02 i

I Y-93 ZR-95 ZR-97 1.60E-01 2.40E-01 1.32E-02 NO DATA 7.69E-02 2.67E-03 4.42E-03 5.20E-02 1.22E-03 NO DATA NO DATA NO DATA NO DATA 1.21E-01 4.04E-03 NO DATA NO DATA NO DATA 5.08E+03 2.44E+02 8.28E+02 NB-95 4.46E+02 2.48E+02 1.33E+02 NO DATA 2.45E+02 NO DATA 1.51E+06 M0499 NO DATA 1.03E+02 1.96E+01 NO DATA 2.33E+02 NO DATA 2.39E402 TC-99m 8.86E-03 2.50E-02 3.19E-01 NO DATA 3.80E-01 1.23E-02 1.48E+01 TC-101 9.11E-03 1.31E-02 1.29E-01 NO DATA 2.36E-01 6.70E-03 3.94E-14 RU-103 4.42EMO NO DATA 1.90E+00 NO DATA 1.69E%1 NO DATA 5.16E+02 RU-105 3.f8E-01 NO DATA 1.45E-01 NO DATA 4.76E+00 NO DATA 2.25E+02 I RU-106 6.57E+01 NO DATA 8.32E+00 NO DATA 1.27EM 2 NO DATA 4.25E+03 AG-110m NO DATA NO DATA Nu DATA NO DATA NO DATA NO DATA NO DATA TE-125m 2.57E+03 9.RE+02 3.43E+02 7.70E+02 1.04E+04 NO DATA 1.02EM 4 I TE-127m TE-127 TE-129m 6.47E+03 1.05EM 2 1.10E+04 2.31E+03 3.77E+01 4.10E+03 7.69E402 2.28E+01 1.74E+03 1.65E+03 7.79E+01 3.78E+03 2.63EM 4 4.28E+02 4.59E+04 NO DATA NO DATA NO DATA 2.17EM4 8.30E+03 5.54E+04 I TE-129 3.00E+01 1.13E401 ..?1E+00 1 30E+01 1.26E+02 NO DATA 2.26E+01 TE-131m 1.65E+03 8.09E+02 6.14E+02 . 28E403 8.19E+03 NO DATA 8.03EM4 TE-131 1.88E+01 *7.87E+00 5.95E+00 1.55EM I 8.25E% 1 NO DATA 2.67E+00 I TE-132 I-130 I-131 2.41E+03 2.71E+01 1.49EM 2 1.56E+03 7.99E+01 2.13E+02 1.46E+03 3.15E401 1.22E+02 1.72E+03 6.78E+03 6.99E+04 1.50E+04 1.25EM2 3.66E+02 NO DATA NO DATA NO DATA 7.37E+04 6.88EMI 5.63E+01

~

I I-132 7.28E+00 1.95E+01 6.81E+00 6.81E+02 3.10E+01 NO DATA 3.66E+00 1-133 5.09E+01 8.85E+01 2 70E401 1.30E+04 1.54E+02 NO DATA 7.96EMI I-134 3.80E+00 1.03E+01 3.69E+00 1.79E+02 1.64E+01 NO DATA 9.00E-03 CLINTON-I 2-12 Rev.5-2/89 I

CPS-0DCN TABLE 2.4-1 (continued)

ADULT INGESTION DOSE COMMITMENTgFACTORS - A .

(mrem /hr per pCi/ml)

ISOTOPE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI 1.59E+01 4.16E+01 II-135 CS-134 2.97E405 7.07E445 1.53E+01 5.78E405 2.74E403 NO DATA 6.67E+01 2.29E+05 NO DATA 7.60E44 4.70E+01 1.24E+04 CS-136 3.11E+04 1.23E+05 8.84E+04 NO DATA 6.84E+04 9.37E+03 1.40E+04 CS-137 . 3.81E405 5.21E+05 3.41E+05 NO DATA 1.77E+0! 5.88E404 1.01E+04 C5-138 k 2.64E+02 5.21E402 -2. 58E+02 NO DATA 3.83E402 3.78E401 2.22E-03 BA-139 9.29E-01 6.60E-04 2.72E-02 NO DATA 6.1SE-04 3.75E-04 1.65E+00 1.94E+02 2.44E-01 1.27E401 8.29E-02 IBA-140 BA-141 4.50E-01 3.40E-04 1.52E-02 NO DATA NO DATA 3.16E-04 1.4CE-01 1.93E-04 4.00E+02 ,

2.12E-10 BA-142 2.04E-01 2.09E-04 1.28E-02 NO DATA 1.77E-04 1.18E-04 2.89E-19 I LA-140 1.49E-01 7.53E-02 1.99E-02 NO DATA NO DATA NO DATA 5.53E443 LA-142 7.65E-03 3.48E-03 8.66E-04 NO DATA NO DATA NO DATA 2.54E+01 CE-141 2.24E-02 1.51E-02 1.72E-03 NO DATA 7.03E-03 NO DATA 5.78E+01 CE-143 3.94E-03 2.92E+00 3.23E-04 NO DATA 1.28E-03 NO DATA 1.09E+02 I'CE-144 1.17E+00 4 88E-01

. 6.26E-02 NO DATA 2.89E-01 NO DATA 3.94E+02 PR-143 5.50E-01 2. 20E--01 2.72E-02 NO DATA 1.27E-01 NO DATA 2.41E+03 I PR-144 F.80E-03 7.47E-04 9.14E-05 NO DATA 4.21E-04 NO DATA 2.59E-10 3.76E-01 4.34E-01 2.60E-02 NO DATA 2.54E-01 NO DATA 2.08E403 I ND-147 W-187 2.95E+02 2.47E442 8.63E+01 NO DATA NO DATA NO DATA 8.09E444 NP-239 2.84E-02 2.80E-03 1.54E-03 NO DATA 8.72E-t3 NO DATA 5. 74E402 I

I

;.12 x 10 4

- Less than 10-15 CLINTON-I 2-13 Rev.5-2/89 I

CPS-ODCM.

l TABLE 2.4-2 BI0 ACCUMULATION FACTORS -BF (pCi/kg per pCi/ liter) i ~

I FRESHWATER I- ELEMENT FISH H 9.0E-01 I -

C NA P

4.6E+03 1.0E+02

3.0E+03 I

CR 2.0E+02 MN 4.0E+02 FE 1.0E+02 CO I NI CU 5.0E+01 1.0E+02 5.0E+01 ZN 2.0E+03 I BR RB SR 4.2E+02 2.0E+03 3.0E+01 I Y ZR NB 2.5E+01 3.3E+00 3.0E+04 I MO TC RU 1.0E+01 1.5E+01 l.0E+01 Rh 1.0E+01 I -

TE 1

CS 4.0E+02 1.5E+01 2.0E+03 I BA LA CE 4.0E+00 2.5E+01 1.0E+00 PR I ND W

2.5E+01 2.5E+01 l.2E+03 EP 1.0E+01 I -

lI I !

L CLINTON-I 2-14 Rev.5-2/89 lI

CPS-0DCM TABLE 2.4-3 ADULT INGESTION DOSE FACTORS -DF.

1 (mrem /pCi ingested) -

I NUCLIDE BONE LIVER T. BODY THYROID RIDNEY LUNG GI-LLI I H-3 C-14 NA-24 NO DATA 1.05E-07 2.84E-06* 5.68E-07 1.70E-06 1.70E-06 1.05E-07 5.68E-07 1.05E-07 5.68E-07 1.05E-07 5.68E-07 1.05E-07 5.68E-07 1.05E-07 5.68E-07 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 I P-32 g 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA NO DATA 2.17E-05 I CR-51 MF-54 NO DATA NO DATA NO DATA 4.57E-06 2.66E-09 8.72E-07 1.59E-09 NO DATA 5.86E-10 1.36E-06 3.53E-09 NO DATA 6.69E-07 1.40E-05 I MN-56 FE-55 FE-59 NO DATA 2.75E-06 4.34E-06 1.15E-07 1.90E-06 2.04E-08 s.43E-07 NO DATA NO DATA 1.46E-07 NO DATA NO DATA 1.06E-06 3.67E-06 1.09E-06 1.02E-05 3.91E-06 NO DATA NO DATA 2.85E-06 3.40E-05 I -

CO-58 NO DATA 7.45E-07 1.67E-06 NO DATA NO DATA NO DATA 1.51E-05 CO-60 2.14E-06 4.72E-06 I HI-63 NO DATA 1.30E-04 9.01E-06 4.36E-06 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 4.02E-05 1.88E-06 NI-65 5.28E-07 6.86E-08 3.13E-08 NO DATA NO DATA NO DATA 1.74E-06 CU-64 NO DATA 8.33E-08 3.91E-08 NO DATA 2.10E-07 NO DATA 7.10E-06 ZN-65 4.84E-06 1.54E-05 6.96E-06 NO DATA 1.03E-05 NO DATA 9.70E-06 I ZN-69 1.03E-08 1.97E-08 1.37E-09 NO DATA 1.28E-08 NO DATA 2.96E-09 I BR-83 ER-84 NO DATA NO DATA NO DATA NO DATA 4.02E-08 5.21E-08 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 5.79E-08 4.09E-13 BR-85 NO DATA NO DATA 2.14E-09 NO DATA NO DATA NO DATA LT E-24** l RB-86 NO DATA 2.11E-05 9.83E-06 NO DATA NO DATA NO DATA 4.16E-06 RB-88 NO DATA 6.05E-08 3.21E-08 NO DATA NO DATA NO DATA 8.36E-19 I RS-89 NO DATA 4.01E-08 2.82E-08 NO DATA NO DATA NO DATA 2.33E-21 SR-89 3.08E-04 NO DATA 8.84E-06 NO DATA NO DATA NO DATA 4.94E-05 SR-90 7.58E-03 1.86E-03 ]

NO DATA NO DATA NO DATA NO DATA 2.19E-04 j SR-91 5.67E-06 NO DATA 2.29E-07 NO DATA NO DATA NO DATA 2.70E-05 SR-92 2.15E-06 NO DATA 9.30E-08 NO DATA NO DATA NO DATA 4.26E-05 Y-90 9.62E-09 NO DATA 2.58E-10 NO DATA NO DATA NO DATA 1.02E-04 I i i

CLINTON-I 2-15 Rev.5-2/89 I _o

CPS-0DCM I l TABLE 2.4-3 (continued)

ADULT INGESTION DOSE FACTORS - DF.

1 (mrem /pCi ingested) l I NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I

{

i Y-91m 9.09E-11 NO DATA 3.52E-12 NO DATA NO DATA NO DATA 2.67E-10 j Y-91 1.41E-07 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 {

Y-92 8.45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 )

I Y-93 ' 2.68E-09 NO DATA 7.40E-11 NO DATA NO DATA NO DATA 8.50E-05

\

j ZR-95 g 3.04E-08 9.75E-09 6.60E-09 NO DATA 1.53E-08 NO DATA 3.09E-05 1 IR-97 1.68E-09 3.39E-10 1.55E-10 LO DATA 5.12E-10 NO DATA 1.05E-04 NB-95 6.22E-09 3.46E-09 1.86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 MO-99 NO DATA 4.31E-06 8.20E-07 NO DATA 9.76E-06 NO DATA 9.99E-06 .

TC-99m 2.47E-10 6.98E-10 8.89E-09 NO DATA 1.06E-08 3.42E-10 4.13E-07 i TC-101 2.54E-10 3.66E-10 3.59E-09 NO DATA 6.59E-09 1.87E-10 1.10E-21 RU-103 1.85E-07 NO DATA 7.97E-08 NO DATA 7.06E-07 NO DATA 2.16E-05 RU-105 1.54E-08 NO DATA 6.08E-09 NO DATA 1.99E-07 NO DATA 9.42E-06 I RU-106 AG-110m TE-125m 2.75E-06 1.60E-07 2.68E-06

.NO DATA 1.48E-07 9.71E-07 3.48E-07 8.79E-08 3.59E-07 NO DATA NO DATA 8.06E-07 5.31E-06 2.91E-07 1.09E-05 NO DATA NO DATA NO DATA 1.78E-04 6.04E-05 1.07E-05 l

{

I TE-127m 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2. 75 E-05 NO DATA 2.27E-05 TE-127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 NO DATA 8.68E-06 TE-129m 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 NO DATA 5.79E-05 l

I TE-129 TE-131m TE-131 3.14E-08 1.73E-06 1.97E-08 1.18E-08 8.46E-07 8.23E-09 7.65E-09 7.05E-07 6.22E-09 2.41E-08 1.34E-06 1.62E-08 1.32E-07 8.57E-06 8.63E-08 NO DATA NO DATA NO DATA 2.37E-08 8.40E-05 2.79E-09 I TE-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 NO DATA 7.71E-05 I-130 7tS6E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 NO DATA 1.92E-06 I-131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 NO DATA 1.57E-06 I-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 NO DATA 1.02E-07 I-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 NO DATA 2.22E-06 8-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 NO DATA 2.51E-10 {

I '

I CLINTON-1 2-16 Rev.5-2/89 I

CPS-0DCM TABI.E 2.4-3 (continued) l ADULT INGESTION DOSE FACTORS - DF.1 (mrem /pCi ingested) -

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I-135 4.43E-07 s.16E-06 4.28E-07 7.65E-05 1.86E-06 NO DATA 1.31E-06 CS-134 6.22E-05 .48E-04 1.21E-04 NO DATA 4.79E-05 1.59E-05 2.59E-06 CS-136 6.51E-06 :. 57E-05 1.85E-05 NO DATA 1.43E-05 1.96E-06 2.92E-06 i

CS-137 7.97E-05 1.09E-04 7.14E-05 NO DATA 3.70E-05 1.23E-05 2.11E-06 CS-138 ' 5.52E-08 1.09E-07 5.40E-08 NO DATA 8.01E-08 7.91E-09 4.65E-13 l

BA-139 9.70E-08 6.91E-11 2.84E-09 NO DATA 6.46E-11 3.92E-11 1.72E-07

)

l 1 BA-140 !

2.03E-05 2.55E-08 1.33E-06 NO DATA 8.67E-09 1.46E-08 4.18E-05 , l BA-141 4.71E-08 3.56E-11 1.59E-09 NO DATA 3.31E-11 2.02E-11 2.22E-17 BA-142 2.13E-08 2.19E-11 1.34E-09 NO DATA 1.85E-11 1.24E-11 3.00E-26 I IA-140 2.50E-09 1.26E-09 3.33E-10 NO DATA NO DATA NO DATA 9.25E-05 LA-142 1.28E-10 5.82E-11 1.45E-11 NO DATA NO DATA NO DATA 4.25E-07 CE-141 9.36E-09 6.33E-09 7.18E-10 NO DATA 2.94E-09 NO DATA 2.42E-05 I CE-143 1.65E-09 1.22E-06 1.35E-10 NO DATA 5.37E-10 NO DATA 4.56E-05 CE-144 4.88E-07 2.04E-07 2.62E-08 NO DATA 1.21E-07 NO DATA 1.65E-04 PR-143 9.20E-09 3.69E-09 4.56E-10 l

NO DATA 2.13E-09 NO DATA 4.03E-05 PR-144 3.01E-11 1.25E-11 1.53E-12 NO DATA 7.05E-12 NO DATA 4.33E-18 ND-147 6.29E-09 7.27E-09 4.35E-10 NO DATA 4.25E-09 NO DATA 3.49E-05 l W-187 1.03E-07 8.61E-08 3.01E-08 NO DATA NO DATA NO DATA 2.82E-05 NP-239 1.19E-09 1.17E-10 6.45E-11 NO DATA 3.65E-10 NO DATA 2.40E-05 l

0 2.84 'A 10-06 B ** Less than 10-24 g .

I I

CLINTON-I 2-17 Rev.5-2/89 1

1

\ urs-uvun FIGURE 2.5-1 LIQUID RADWASTE TREATMENT SYSTEM I "

g~_)' x , O x, I r I : -

I .

-coi f v

+-

-x

'x n

c et.

~-

cy cy owcosec ,$ $hoc.

.n ,

y- % o wcosso %L k!bi"^'

r "

y -

e b MM owcases -J k-I

., ,--r I.

x ca1.aa, ow1.,3 owroir owroi.

1 1 _pw r s3A ly Xt-l * , ,,o 3, *cnoe e 'ow c.,,ts zwar swee y q .)$

_ ~ .

Cettecf6 " gg , g =q O To 4 ' bic+er CM f.m.lc. ling n..$c e %be

I

Monitors required by CPS TECHNICAL SPECIFICATIONS O1S Floor Drain OWZO1P Chem. Ust. 2WF04T Floor Drain OWE 02TA,B, and C Vaste Evcporator Evap. Tank Pump Evaporator Tank Samp. Tk Pumps TOIS Floor Drain OWE 01FA,B, and C OWZOIT Chem. Waste OWE 01TA and B Excess Evaporator Waste Filters Evaporator Tank Water Tanks

'ZOIS Chemical 0VE01DA,B, and C IWF04P Fir. Drn. OWE 01PA and B Excess ,

Taste Evaporator Waste Demins Evap. Tank Pump Water Tank Pumps T04T Floor Drain OWE 02TA,B, and C 2WF04P Fir. Drn. IPR 036 Sc vice

porator Tank Waste Sample Tks. Evap. Tank Pump Water PR>l I OPR040 Liquid RW Discharge PRM CLINTON-1 2-18 Rev.5-2/89 I

e *3 ee

' mt e ta pO t k a

g J i

r t 4 i nt s

oftiC 6 J s n r d O '

eO to n t fv pr m e 0' e S V9 %

5 -

_M

' N 8

I

' t M

e v

t i

M Y C

8 0i e S

S M O' 8@f w MA ER M TG SA YI SD 3

. M5

_ EW TO y 2 SL 5

_ AF e W

_ 7

_ r DD u AE g RI iF DI

. MF IL LP OM SI S

_M e

_M t

r a

_ o t t

t a a t

s pf 9 '

$' e

_ n e,n s s a v

r g I ps ea n ra ce /p $vm t S A

i s e M o

$, t P' t r il lA WINat C

_M m

_ M e

_ e t

_ e.

_ a n. 0'

.M a

_ r f

_ e a '

_ l

c.e n

C '

l % oD

_ a c en8v WO t t "

otHi34.a I MiMO % @:< . (J INNyQ

.M

CPS-0DCM I i

2.5 Compliance With CPS RETS 3.11.1.3/3.11.1.4 I I The projected doses due to releases of liquid radwaste l

f l

effluents will be calculated using equation (8). If the sum I of the accumulated dose to date for the month and the projected dose for the remainder of the month exceeds CPS RETS 3.11.1.3 limits, then the liquid radwaste treatment 1

J l

system shall be used. This is to ensure compliance with the !

OPERABILITY requirement of CPS RETS 3.11.1.3, Figure 2.5-1 shows the appropriate portions of the liquid radwaste a treatment system which will be used.

3 The use of temporary liquid radwaste hold-up tanks may occur at CPS.

To comply with CPS RETS 3.11.1.4,.the amount of liquid radwaste stored in such tanks shall be limited to 10 curies, excluding tritium and dissolved or entrained noble ga'ses. In I lieu of the 10 curie limit, the methodology presented in Appendix B of NUREG-0133 (BWR-RATAFR code) will be used to I

establish the curie limit.

I 2.6 Doses From Other Significant Liquid Effluent Pathways

]

1 I Section 2.4 of the CPS-0DCM describes demonstrating compliance with CPS RETS 3.11.1.2 based upon the aquatic food

- and potable water exposure pathways only. Other exposure

)'

pathways, namely shoreline deposits and irrigated foods, may arise at Clinton Power Station and will be included in the '

section-2.4 dose contribution if they are likely to provide a

~

i significant contribution to the total dose. A pathway is considered significant if a conservative evaluation yields an additional dose increment equal to or more than 10 percent of the total from all other existing pathways. Methods for-calculating doses from other potentially significant liquid effluent pathways are presented in Appendix A to Regulatory Guide 1.109.

When it is determined that other liquid effluent pathways do exist, the Regulatory Guide 1.109 Appendix A equations and parameters will be used in lieu of site-specific data to l determine a pathway's significance.

j e

l l l CLINTON-I 2-21 Rev.5-2/89 l

.crs-vuun i

3.4.1 Dose Rate Due To Noble Gases !

I In order to comply with CPS RETS 3.11.2.l(a),

the dose rate at or beyond the site boundary .

l due to noble gases shall be calculated as follows: j 1

D =EggK [(X7Q),Qg,] (1) e

= total body dose rate at time of release, mrem / year l ,

Ds "Ei (b i+1.lM f)[(X7Q) ,Qg ,] (2)

( =

skin dose rate at time of release, mrem / year The terms in the above equations are defined I 3.4.2 in section 3.4.2.

Dose Rate Due To Radiciodines, Particulate and Tritium I In order to comply with CPS RETS 3.ll.2.l(b), organ dose rates due to I radiciodines (I-131, I-133), particulate with half-lives > 8 days and tritium shall be calculated as follows:

gf3(M),kg, D g =r P (3)

= organ dose rate at time of l release, mrem /yr The terms used in equations (1) through (3) are defined as follows:

K g= The total body dose factor due to I gamma emissions for each identified noble gas radionuclides i, mrem /yr per pCi/m3 i L. =

1 The skin dose factor due to beta emissions for each identified noble gas radionuclides i, mrem /yr per pCi/m3 M.=

1 The air dose factor due to gamma I emissions for each identified noble gas radionuclides i, mrad /yr per pCi/m3 (1.1 mrem / mrad converts air dose to skin dose)

CLINTON-1 3-5 Rev.5-2/89

CPS-0DCM l

TABLE 3.4-2 INHALATION PATHWAY DOSE RATE FACTORS (CHILD) -P (mrem /yr per pCi/m3) il '

l ORGA_N1 BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 1.12E+03* 1.12E+03 1.12E+03 1.12EM 3 1.12E+03 1.12E+03 C-14 3.59E+04, 6.73E%3 6.73E%3 6.73EM 3 6.73E4 3 6. 73E403 6.73E+03 NA-24 1.61E+04' 1.61EM 4 1.61E+04 1.61EM4 1.61E+04 1.61E44 1.61E404 P-32 2.60E+06 1.14E45 9.88E+04 NO DATA NO DATA NO DATA 4.22EM4 CR-51 NO DATA NO DATA 1.54E+02 8.55E+01 2.43+01 1.70EM 4 1.08E+03 HN-54 NO DATA 4.29E-04 9.51E+03 NO DATA 1.00EM 4 1.58EM6 l 2.2,9E+04 MN-56 NO DATA 1.66E+00 3.12E-01 NO DATA 1.67E+00 1.31EM4 1.23E+05 FE-55 4.74E+04 2.52E44 7.77E+03 NO DATA NO DATA 1.11 EMS 2.87E+03 FE-59 2.07E+04 3.34E404 1.67E+04 NO DATA NO DATA 1.27E%5 7.07E404 I CO-58 C0-60 NI-63 NO DATA NO DATA 8.21E405 1.77E+03 1.31E+04 4.63E+04 3.16E+03 2.26E+04 2.80E+04 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 1.11E+06 7.07E+06 2.75E+05 3.44E+04 9.62E+04 6.33E+03 NI-65 2.99E+00 2.'96E-01 1.64E-01 NO DATA NO DATA 8.18E403 8.40E44 Cti-64 NO DATA 1.99EM O 1.07E+00 NO DATA 6.03EM O 9.58E%3 3.67E+04 ZN-65 4.26E404 1.13E+05 7.03E+04 NO DATA 7.14EM 4 9.95E+05 1.63E+04 I ZN-69 BR-83 BR-84 6.70E-02 NO DATA NO DATA 9.66E-02 NO DATA NO DATA 8.92E-03 4.74E+02 5.48E442 NO DATA NO DATA NO DATA 5.85E-02 NO DATA NO DATA 1.42E+03 NO DATA NO DATA 1.02E%4 LT 3.70E-15**

LT 3.70E-15 I BR-85 NO DATA NC DATA 2.53E+01 NO DATA NO DATA NO DATA LT 3.70E-15 RB-86 NO DATA 1.98E+05 1.14E+05 NO DATA NO DATA NO DATA 7.99E+03 RB-88 NO DATA 5.62E+02 3.66E+02 NO DATA NO DATA NO DATA 1.72E+01 I RB-89 SR-89 SR-90 NO DATA 5.99EM5 1.01E%8 3.45E+02 NO DATA NO DATA 2.90EM2 1.72E+04 6.49E+06 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 2.16E+06 1.48EM7 1.89E+00 1.67E+05 3.43E+05 t

SR-91 1.21E+02 NO DATA 4.59E+00 NO DATA NO DATA 5.33E+04 1.74E+05 SR-92 1.31E+01 NO DATA 5.25E-01 NO DATA NO DATA 2.40E+04 2.42E+05 Y-90 4.11E+03 NO DATA 1.11E+02 NO DATA NO DATA 2.62E+05 2.68 EMS CLINTON-I 3-9 Rev.5-2/89 I

CPS-0DCM TABLE 3.4-2 (cont'd)

INHALATION PATHWAY DOSE RATE FACTORS (CHILD) - P.. I (mrem /yr per pCi/m3) 13 -

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI, ISOTOPE ,

Y-91m 5.07E-01 NO DATA 1.84E-02 NO DATA NO DATA 2.81E+03 1.72+03 Y-91 9.14E+05 NO DATA 2.44E+04 NO DATA NO DATA 2.63+06 1.84E+05 Y-92 2.04E+01 NO DATA 5.81E-01 NO DATA NO DATA 2.39E404 2.39E+05 Y-93 k 1.87E+02 NO DATA 5.11E+00 NO DATA NO DATA 7.44E404 3.89E+05 ZR-95 1.90 EMS 4.18E+04 3.70E+04 NO DATA 5.96E+04 2.23E%6 6.11E+04 ZR-97 1.88E402 2.72E+01 1.60E+01 NO DATA 3.89E+01 1.13E+05 3.51 EMS '

I NB-95 MO-99 2.35E+04 NO DATA 9.18EM3 1.72E+02 6.55E+03 4.26E+01 NO DATA NO DATA 8.62EM 3 3.92E+02 6.14E+05 3.70E404 1.35E405 1.27E+05 TC-99m 1.78E-03 3.48E-03 5.77E-02 NO DATA 5.07E-02 9.51E+02 4.81E+03 TC-101 8.10E-05 8.51E-05 1.08E-03 NO DATA 1.45E-03 I RU-103 RU-105 2.79E+03 1.53E+00 NO DATA NO DATA 1.07E+03 5.55E-01 NO DATA NO DATA 7.03E+03 1.34E+0D 5.82E+02 6.62E+05 1.59E+04 1.63E401 4.48E+04 9.95E+04 RU-106 1.36E+35 NO, DATA 1.69E+04 NO DATA 1.84E+05 1.43E+07 4.29E+05 AG-110m 1.69E+04 1.14E+04' 9.14EM3 NO DATA 2.12E404 5.48E+06 1.00E+05 TE-125m 6.73E+03 2.33E+03 9.14E+02 1.92EM3 NO DATA 4.77E+05 3.38E+04 TE-127m 2.49E%4 8.56E403 3.03E+03 6.07EM3 6.36EM4 I TE-127 TE-129m 2.77E+00 1.92E+04 9.51E-01 6.85E403 6.11E-01 3.04E+03 1.96E400 6.33E+03 7.07E+00 5.03E+04 1.48EM 6 1.00E+04 1.76E+06 7.14E+04 5.62E+04 1.82E+05 I TE-129 TE-131m 9.77E-02 1.34E+02 3.50E-02 5.92E+01 2.38E-02 7.14E-02 2.57E-01 2.93E+03 2.55E+04 5.07E+01 9.77E+01 4.00E+02 2.06E+05 3.08E+05 TE-131 2.17E-02 8.44E-03 6.59E-03 1.70E-03 5.88E-02 2.05E+03 1.33E+03 i

TE-132 4.81EM 2 I

I I-130 I-131 8.18E+03 4.81E+04 2.72E402 1.64E+04 4.81E+04 2.63E+02 8.44E+03 2.73E+04 3.18EM 2 1.85E+06 1.62E+07 1.77E+03 2.45E+04 7.88E+04 3.77E+05 NO DATA NO DATA 1.38E%5 5.11E+03 2.84E+03 l

I-132 2.12E+03 4.07E403 1.88E443 1.94EM5 6.2SEM3 NO DATA 3.20E403 l I-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 NO DATA 5.48E+03 I-134 1.17E+03 2.16E+03 9.95E+02 5.07E%4 3.30E+03 NO DATA 9.55E+02 l

CLINTON-I 3-10 Rev.5-2/89 l

X -

CPS-0DCM i

N The beta air dose factor for each

. E- i= identified noble gas radionuclides E 1, mrad / year per pCi/m3 (N l

,j values are listed in Tableg 3.4-1). 1' (XTQ), = The highest calculated annual average relative concentration from mixed-mode release points l for areas at or beyond the site boundary for long-term (>500 hrs /yr) releases, sec/m3

(x/q)* = The relative concentration from I

mixed-mode release points for areas at or beyond the site boundary for short-term (<500 hrs /yr not to exceed 150 Eri/qtr) releases, sec/m3 ,

Q*-

t The average release of noble gas radionuclides i for long-term releases from mixed-mode release points, pC1. Releases shall be I cumulative over the calendar quarter or year, as appropriate.

qt,= The average release of noble gas radionuclides i for short-term releases from mixed-mode release points, pCi. Releases shall be l cumulative over the calendar quarter or year, as appropriate.

I 3.17 x 10-8 -

The inverse of the number of seconds in a year.

I _

I -

I CLINTON-I 3-14 Rev.5-2/89 1

- ----_ - - - - - )

)

CPS-0DCM {

n r

j

]

l qim = The releases of radionuclides i i (I-131, 1-133, tritium and i particulate) for short-term -)

(< 500 hrs /yr not to exceed 150 l -

hrs /qtr) releases from mixed-mode release points, pCi. Releases l

shall be cumulative over the I

calendar quarter or year, as l appropriate.

7 (b~fQ)* = The relative deposition from

~

mixed-mode release points for I areas at or beyond the site boundary for long-term

(> 500 hrs /yr) releases, m_3" I

(d/q)* = The relative deposition from mixed-mode release points for areas at or beyond the site boundary for short-term

(< 500 hrs /yr not to e hrs /qtr) releases, m-peed 150 l W,= The dispersion parameter for estimating the dose to an individual at a controlling I location for long-term mixed-mode releases.

I =

(XTQ) , sec/m3, for the inha19 tion pathway I

= , f r the food and (L7Q)m, m f ground plane pathways I w, = The dispersion parameter for estimating the dose to an individual at a controlling location for short-term l mixed-mode releases.

=

(x/ , sec/m3, for the inh Stion pathway ,

=

(d/q),, m- for the food and l ground plane pathways I

l CLINTON-I 3-16 Rev.5-2/89 I

uea-vuun I DFGt '= The ground plane dose conversion factor for radionuclides i,

.I- mrem / hour per pCi/m2 Values for DFG t were obtained from Table E-6 -

I of Regulatory Guide 1.109 and are presented in Table 3.5-5 of this Manual.

A t= The decay constant for

~

radionuclides 1, sec l ,

t- The exposure time, sec

=

6.31E+08 see (20 years) 3.5.2.1.3 Calculation of The Grass-Cow / Goat-Milk I C Pathway Factor, R Raij = K 9F(U,p) pm(r) (DFLt)a (9)

At+A y ff -A U ps + II~fpfs )e ih e i f, Y Y

. P s ,

m2-mrem /yr per pCi/sec K' = A units conversion constant, 10 6 l pCi/uci Qp = The cow / goat feed consumption i rate, kg(wet)/ day U

ap

=

The receptor's milk consumption rate for age group (a),

liters / year Y =

The agricultural productivity by I P unit area of pasture feed grass, kg/m2 I Y 8

=

The agricultural productivity by unit area of stored feed, kg/m2 I F

=

The stable element transfer coefficients, days / liter r= Fraction of deposited activity ,

retained on feed grass, lL i

i dimensionless CLINTON-I 3-19 Rev.5-2/89 I - -

$ CPS 0DCM- !

s (DFLg )a = The organ ingestion dose factor-for radionuclides i and the receptor.in age group (a), i mrem /pC1. Values for (DFLg ), - !

were obtained from Tables E-ll 3 through E-14 of. Regulatory Guide l 1.109 and are presented in Table !

3.5-6 through 3.5-9 of this Manual. l q

. t = The decay constant for radionuclides i, sec-1 k x" = The decay constant for removal of )

l activity on leaf and plant._g surfaces by weathering, sec j

j I = 5.73 x 10-7 sec (corresponding to a 14-day half-life)

, f

'g tg = The transport time from pasture E to animal, to milk, to receptor, ;

sec l t g = The transport time from pasture to harvest, to animal, to -

receptor, see f = Fraction of the year that the l P cow / goat is on pasture, dimensionless f

s = Fraction of the cow / goat feed l that is pasture grass while the cow / goat is on pasture, dimensionless The input pargmeters for calculating R are listed in Table 3.5-10.,g3 ,.

Tritium !

The concentration of tritium in milk is based on its airborne concentration rather than the deposition. -

k=K'K"F,Qp,p(DFL),

U g [0.75(0.5/H)],

mrem /yr per pCi/m 3 (10)

CLINTON-I 3-20 Rev.5-2/89 I

l l I

CPS-0DCM l l

I 3.7.2 Skin Dose Rate Setpoint To ensure compliance with the CPS RETS j 3.11.2.la skin dose rate limit, PRM '

set 7oints shall be calculated using the

.I methodology presented in section 3.7.1 and by substituting the following equation for equation (19):

3000 F j Ci/sec Q)=3 , (21)

(X/Q)3rt(L t +1.lMg ).tt) 4 where 1

Qgd = The maximum acceptable release ,

rate of all noble gases in ;

release path j , pCi/sec l F 3= Total dose rate allocation factor

. assigned to release path j (varying

l between 0.0 and 1.0), dimensionless I 3000= Skin dose rate limit specified in CPS RETS 3.ll.2.la, mrem / year (X/Q)3 = The highest relative concentration of release path j at the site boundary I =

(XTQ) ,or (x/q) , depending on I duration of release, sec/m3 (reference section 3.5.1)

L g= The skin dose factor due to gamma I emissions for each identified noble gas radionuclides i, mrem /yr per yCi/m3, as listed in Table 3.4-1 of this Manual.

1.1 = An air dose to skin dose equivalent conversion factor, mrem / mrad M t= The air dose factor due to gamma emissions for each identified

' l noble gas radionuclides i, mrad /yr per yCi/m3, as listed in Table 3.4-1 of this Manual f.= The fraction defined by equation 1

f3 (18)

LI l CLINTON-I 3-28 Rev.5-2/89

,1 j

! t ; t C,*

M M nR T

F S n. .

S E E . E 0 Y E N O WWW 3 6

O DI O O .O USLIT P P Y M O E

D E

DI YIN ERW O H

LD S I

O.0AO

.PNS 5

1 I L

E T

A A T E C .NW TATC NI INTH M t

NN DUT L L SlL f X

Y AR Tn)1 T EO E

EUDN L LOIL E

I IH Y O

R D Se ITS O O f Y R WDE.U B M A E D T N C N Ele n H Nt t

t T M FL eat OEtF*E o

D SND O

P P

A Ue HY O U n L e TR f

RS E

N N E P E N S S 0 i I

'E AIT WSWEW I

E8 SEIACA(SANP S WA.DC R X ANTA H N E.OC E O HO E.EE E

R EE EUI E LOIT LRTN NN T T TWT SlIlL M MSI N PR ROY USA ADD o ESAP.UOE i HU TLDIOLS PSNDINNH.UE O O L RN j

)/ g t

L LAOOI

.f / N CEDL IE TEC CR SCL EE EWEl C ACUSA fH T

/M Q

/

f 1 e,

A EER I

RHT RAPDP LTRSR ONAEAWPU RTEV ALKE AL M S ATSETR EDRNRH OU LDCDI NREl CLE .

T HNNO AA CN $

N )

P TAUCWL N ARAL 0H

. . I 1. O . A T. W E Y T

1 S 3 4 6 U (

M L F

E C

N F E E 0 t

S f E n M S U

n 0

A D

O 4 tu E / Y

. O D

S M1 1 3

A G

R W

f t

T I

K A

L O

e F h

_ Mr u

g R Y i N

g g

fli fft f

E O "M UP L U 4

I Y

a 3

E T

A FE -W 0 TC LF i

Eh f

i D ER A

l l

_ MF N ot C /

ti -.

U UC R OS A /

_ O .

llOff

_ B C

_ S j g

_ I E l ' o T A M I L

P,' s

/g~-

t v

.S ,

w n

S O I P

I Z

M C ,

r Q

k j n

.M 1

E

/m/ -

_ T e 0

/

f f

M -

"- Y '

2 4

E M T O

N t

f 0

N M

n&syoZ3H qyO MD4*L'y*W 1 1

(

M M e li! 1 IIl\ll ,l E

CPS-0DCM Table 3.5-1 INHALATION DOSE FACTORS FOR INFANT - (DFA t )a .

(mrem per pCi inhaled)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 C-14 1.89E-05* 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 !

NA-24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 P-32 1.45E-03 8.03E-05 5.53E-05 NO DATA NO DATA N0' DATA 1.15E-05 CR-51 NO DATA NO DATA 6.39E-08 4.11E-08 9.45E-09 9.17E-06 2.55E-07 MN-54 NO DATA 1.81E-05 3.56E-06 NO DATA 3.56E-06 7.14E-04 5.04E-06 MN-56 NO DATA 1.10E-09 1.58E-10 NO DATA 7.86E-10 8.95E-06 5.12E-05 FE-55 1.41E-05 8.39E-06 2.38E-06 NO DATA NO DATA 6.21E-05 7.82E-07 FE-59 9.69E-06 1.68E-05 6.77E-06 NO DATA NO DATA 7.25E-04 1.77E-05 I CO-58 CO-60 NI-63 NO DATA NO DATA 2.42E-04 8.71E-07 5.73E-06

.1.46E-05 1.30E-06 8.41E-06 8.29E-06 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 5.55E-04 3.22E-03 1.49E-04 7.95E-06 2.28E-05 1.73E-06 NI-65 1.71E-09 2,03E-10 8.79E-11 NO DATA NO DATA 5.80E-06 3.58E-05 CU-64 NO DATA 1.34E-09 5.53E-10 NO DATA 2.84E-09 6.64E-06 1.07E-05 ZN-65 1.38E-05 4.47E-05 2.22E-05 NO DATA '2.32E-05 4.62E-04 3.67E-05 3.85E-11 I ZN-69 BR-83 BR-84 NO DATA NO DATA 6.91E-11 NO DATA NO DATA 5.13E-12 2.72E-07 2.86E-07 NO DATA NO DATA NO DATA 2.87E-11 NO DATA NO DATA 1.05E-06 NO DATA NO DATA 9.44E-06 LT E-24**

LT E-24 I BR-85 NO DATA NO DATA 1.46E-08 NO DATA NO DATA NO DATA LT E-24 RB-86 NO DATA 1.36E-04 6.30E-05 NO DATA NO DATA NO DATA 2.17E-06 I RB-88 NO DATA 3.98E-07 2.05E-07 NO DATA NO DATA NO DATA 2.42E-07

' 3 RB-89 NO DATA 2.29E-07 1.47E-07 NO DATA NO DATA NO DATA 4.87E-08 E SR-89 2.84E-04 NO DATA 8.15E-06 NO DATA NO DATA 1.45E-03 4.57E-05

~

l SR-90 2.92E-02 NO DATA 1.85E-03 NO DATA NO DATA 8.03E-03 9.36E-05 I SR-91 6.83E-08 NO DATA 2.47E-09 NO DATA NO DATA 3.76E-05 5.24E-05 SR-92 7.50E-09 NO DAT4 2.79E-10 NO DATA NO DATA 1.70E-05 1.00E-04 Y-90 2.35E-06 NODdA 6.30E-08 NO DATA NO DATA 1.92E-04 7.43E-05 l

I CLINTON-I 3-32 Rev.5-2/89

CPS-0DCM I Table 3.5-1 (continued)

INHALATION DOSE FACTORS FOR INFANT - (DFA g )a (mrem per pCi inhaled)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Y-91m 2.91E-10 NO DATA 9.90E-12 NO DATA NO DATA 1.99E-06 1.68E-06 i Y-91 4.20E-04 NO DATA 1.12E-05 NO DATA NO DATA 1.75E-03 5.02E-05

( Y-92 1.17E-08 NO DATA 3.29E-10 NO DATA NO DATA 1.75E-05 9.04E-05

\ :

Y-93 1.07E-07 NO DATA 2.91E-09 NO DATA NO DATA 5.46E-05 1.19E-04

. ZR-95 8.24E-05 1.99E-05 1.45E-05 NO DATA 2.22E-05 1.25E-03 1.55E-05 ZR-97 1.07E-07 1.83E-08 8.36E-09 NO DATA 1.85E-08 7.88E-05 1.00E-04 NB-95 1.12E-05 4.59E-06 2.70E-06 NO DATA 3.37E-06 3.42E-04 9.05E-06 MO-99 NO DATA 1.18E-07 2.31E-08 NO DATA 1.89E-07 9.63E-05 3.48E-05 TC-99m 9.98E-13 2.06E-12 2.66E-11 NO DATA 2.22E-11 5.79E-07 1.45E-06 L

TC-101 4.65E-14 5.88E-14 5.80E-13 NO DATA 6.99E-13 4.17E-07 6.03E-07 RU-103 1.44E-06 NO DATA 4'.85E-07 NO DATA 3.03E-06 3.94E-04 1.15E-05 RU-105 8.74E-10 NO DATA 2.93E-10 NO DATA 6.42E-10 1.12E-05 3.46E-05 RU-106 6.20E-05 NO DATA 7.77E-06 NO DATA 7.61E-05 8.26E-03 1.17E-04 AG-110m 7.13E-06 5.16E-06 3.57E-06 NO DATA 7.80E-06 2.62E-03 2.36E-05 TE-125m 3.40E-06 1.4?E-06 4.70E-07 1.16E-06 NO DATA 3.19E-04 9.22E-06 TE-127s 1.19E-05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05 l TE-127 1.59E-09 6.81E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E-05 TE-129m 1.01E-05 4.35E-06 1.59E-06 3.91E-06 2.27E-05 1.20E-03 4.93E-05 TE-129 5.63E-11 2.48E-11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 TE-131m 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 1.42E-04 8.51~ e5 TE-131 1.24E-11 5.87E-12 3.57E-12 1.13E-11 2.85E-11 1.47E-06 5.87E-06 TE-132 2.66E-07 1.69E-07 i

I I-130 I-131 4.54E-06 2.71E-05 9.91E-06 3.17E-05 1.26E-07 3.98E-06 1.40E-05 1.99E-07 1.14E-03 1.06E-02 7.39E-07 1.09E-05 3.70E-05 2.43E-04 NO DATA NO DATA 3.15E-05 1.42E-06 7.56E-07 I I -132 I-133 1.21E-06 9.46E-06 2.53 E-06 1.37E-05 8.99E-07 4.00E-06 1.21E-04 2.82E-06 NO DATA 1.36E-06 2.54E-03 1.60E-05 NO DATA 1.54E-06 I-134 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 NO DATA 9.21E-07 I CLINTON-I 3-33 Rev.5-2/89

CPS-0DCM k

i I

Table 3.5-1 (continued)

I INHALATION DOSE FACTORS FOR INFANT - (DFAt )a .

l (mrem per pCi inhaled) i

)

NUCLIDE BONE LIVER T. BODY I

THYROID KIDNEY LUNG GI-LLI l i

1-135 2.76E-06 5.43E-06 1.98E-06 4.97E-04 6.05E-06 NO DATA 1.31E-06 )

CS-134 2.83E-04 5.02E-04 5.32E-05 NO DATA 1.36E-04 5.69E-05 9.53E-07 !

CS-136 3.45E-05 9.61E-05 3.78E-05 NO DATA 4.03E-05 8.40E-06 1.02E-06 g CS-137 k 3.92E-04 4.37E-04 3.25E-05 NO DATA 1.23E-04 5.09E-05 9.53E-07 E CS-138 3.61E-07 5.58E-07 2.84E-07 NO DATA 2.93E-07 4.67E-08 6.26F-07 BA-139 1.06E-09 7.03E-13 3.07E-11 NO DATA 4.23E-13 4.25E-06 3.64E-05 I BA-140 4.00E-05 4.00E-08 2.07E-06 NO DATA 9.59E-09 1.14E-03 2.74E-05 l BA-141 1.12E-10 7.70E-14 3.55E-12 NO DATA 4.64E-14 2.12E-06 3.39E-06 BA-142 2.84E-11 2.36E-14 1.40E-12 NO DATA 1.36E-14 1.11E-06 4.95E-07 LA-140 3.61E-07 1.43E-07 3.68E-08 NO DATA NO DATA 1.20E '.A 6.06E-05 l LA-142 7.36E-10 2.69E-10 6.46E-11 NO DATA NO DATA 5.87E-06 4.25E-05 CE-141 1.98E-05 1.19E-05 1.42E-06 NO DATA 3.75E-06 3.69E-04 1.54E-05 I CE-143 2.09E-07 4 38E-07 1.58E-08 NO DATA 4.03E-08 8.30E-05 3.55E-05 CE-144 2.28E-03 8.65E-04 1.26E-04 NO DATA 3.84E-04 7.03E-03 1.06E-04 PR-143 1.00E-05 3.74E-06 4.99E-07 NO DATA 1.41E-06 3.09E-04 2.66E-05 PR-144 3.42E-11 1.32E-11 1.72E-12 NO DATA 4.80E-12 1.15E-06 3.06E-06 ND-147 5.67E-06 5.81E-06 3.57E-07 NO DATA 2.25E-06 2.30E-04 2.23E-05 W-187 9.26E-09 6.44E-09 2.23E-09 NO DATA NO DATA 2.83E-05 2.54E-05 I NP-239 2.65E-07 2.37E-08 1.34E-08 NO DATA 4.73E-08 4.25E-05 1.78E-05 I

1.89 X 10-05

- Lers than 10-24 I

I CLINTON-I 3-34 Rev.5-2/89 I

CPS-0DCM I Table 3.5-2 INHALATION DOSE FACTORS FOR CHILD - (DFA g )a (mrem per pCi inhaled)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 C-14 9.70E-06* 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 NA-24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 P-32 k 7.04E-04 3.09E-05 2.67E-05 NO DATA NO DATA NO DATA 1.14E-05 CR-51 NO DATA NO DATA 4.17E-08 2.31E-08 6.57E-09 4.59E-06 2.93E-07 MN-54 NO DATA 1.16E-05 2.57E-06 NO DATA 2.71E-06 4.26E-04 6.19E-06 MN-56 NO DATA 4.48E-10 8.43E-11 NO DATA 4.52E-10 3.55E-06 3.33E-05 FE-55 1.28E-05 6.80E-06 2.10E-06 NO DATA NO DATA 3.00E-05 7.75E-07 I FE-59 5.59E-06 9.04E-06 4.51E-06 NO DATA NO DATA 3.43E-04 1.91E-05 CO-58 NO DATA 4.79E-07 8.55E-07 NO DATA NO DATA 2.99E-04 9.29E-06 CO-60 NO DATA 3.55E-06 6.12E-06 NO DATA NO DATA 1.91E-03 2.60E-05 NI-63 2.22E-04 1.25E-05 7.56E-06 NO DATA NO DATA 7.43E-05 1.71E-06 NI-65 8.08E-10 7.99E-11 4.44E-11 NO DATA NO DATA 2.21E-06 2.27E-05 CU-64 NO DATA 5.39E-10 2.90E-10 NO DATA 1.63E-09 2.59E-06 9.92E-06 1.15E-05 I ZN-65 3.06E-05 1.90E-05 NO DATA 1.93E-05 2.69E-04 4.41E-06 ZN-69 1.815-11 2.61E-11 2.41E-12 NO DATA 1.58E-11 3.84E-07 2.75E-06 BR-83 NO DATA NO DATA 1.28E-07 NO DATA NO DATA NO DATA LT E-24**

BR ,84 NO DATA NO DATA 1.48E-07 NO DATA NO DATA NO DATA LT E-24 BR-85 NO NO DATA 6.84E-09 NO DATA NO DATA NO DATA LT E-24 RB-86 NO DATA 5.36E-05 3.09E-05 NO DATA NO DATA NO DATA 2.16E-06 RB-88 I NO DATA 1.52E-07 9.90E-08 NO DATA NO DATA NO DATA 4.66E-09 RB-89 NO DATA 9.33E-08 7.83E-08 NO DATA NO DATA NO DATA 5.11E-10 SR-89 1.62E-04 NU DATA 4.66E-06 NO DATA NO DATA 5.83E-04 4.52E-05 SR-90 2.73E-02 NO DATA 1.74E-03 NO DATA NO DATA 3.99E-03 9.28E-05 I CLINTON-I 3-35 Rev.5-2/89 I -

CPS-0DCM Table 3.5-3 (continued)

INHALATION DOSE FACTORS FOR TEEN - (DFA g )a ,

(mrem per pCi inhaled)

- NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI yi u

SR-91 1.10E-08 NO DATA 4.39E-10 NO DATA NO DATA 7.59E-06 3.24E-05 SR-92 1.19E-09 NO DATA 5.08E-11 NO DATA NO DATA 3.43E-06 2.49E-05 Y-90 3. 73E~0'7 NO DATA 1.00E-08 NO DATA NO DATA 3.66E-05 6.99E-05 3 Y-91m b 4.63E-11 NO DATA 1.77E-12 NO DATA NO DATA 4.00E-07 3.77E-09 L3 Y-91 8.26E-05 NO DATA 2.21E-06 NO DATA

NO DATA 3.67E-04 5.11E-05 Y-92 1.84E-09 NO DATA 5.36E-11 NO DATA NO DATA 3.35E-06 2.06E-05

'I Y-93 1.69E-08 NO DATA 4.65E-10 NO DATA NO DATA 1.04E-05 7.24E-05 ZR-95 1.82E-05 5.73E-06 3.94E-06 NO DATA 8.42E-06 3.36E-04 1.86E-05 ZR-97 1.72E-08 3.40E-09 1.57E-09 NO DATA 5.15E-09 1.62E-05 7.88E-05 E NB-95 2.32E-06 1.29E-06 7.08E-07 NO DATA 1.25E-06 9.39E-05 1.21E-05

'E MO-99 NO DATA 2.11E-08 '4.03E-09 NO DATA 5.14E-08 1.92E-05 3.36E-05 TC-99m 1.73E-13 4.83E-13 6.24E-12 NO DATA 7.20E-12 1.44E-07 7.66E-07 TC-101 7.40E-15~ 1.05E-14 1.03E-13 NO DATA 1.90E-13 8.34E-08 1.09E-16 RU-103 2.63E-07 NO DATA 1,12E-07 NO DATA 9.29E-07 9.79E-05 1.36E-05 RU-105 1.40E-10 NO DATA 5.42E-11 NO DATA 1.76E-10 2.27E-06 1.13E-05 RU-106 1.23E-05 NO DATA 1.55E-06 NO DATA 2.38E-05 2.01E-03 1.20E-04 AG1-10m 1.73E-06 1.64E-06 9.99E-07 NO "ATA 3.13E-06 8.44E-04 3.41E-05 TE -125m 6.10E-07 2.80E-07 8.34E-08 1.75E-07 NO DATA 6.70E-05 9.38E-06 I TE-127m 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05 TE-127 2.51E-10 1.14E-10 5.52E-11 1.77E-10 9.10E-10 1.40E-06 1.01E-05

, TE-129m 1.74E-06 8.23E-07 2.81E-07 5.72E-07 6.49E-06 2.47E-04 5.06E-05 TE-129 8.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-11 4.12E-07 2.02E-07 I' TE-131n 1.23E-08 7.51E-09 5.03E-09 9.06E-09 5.49E-08 2.97E-05 7.76E-05 -

TE-131 1.97E-12 1.04E-12 6.30E-13 1.55E-12 7.72E-12 2.92E-07 1.89E-09 I CLINTON-1 3-39 Rev.5-2/89 I I )

CPS-ODCM Table 3.5-3 (continued) i INHALATION DOSE FACTORS FOR TEEN - (DFAg )g (mrem per pCi inhaled)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE-132 4.50E-08 3.63E-08 2.74E-08 3.07E-08 2.44E-07 5.61E-05 5.79E-05 I-130 7.80E-07 2.24E-06 8.96E-07 1.86E-04 3.44E-06 NO DATA 1.14E-06 I-131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 NO DATA 8.11E-07 i

I-132 k L99E-07 5.47E-07 1.97E-07 1.89E-05 8.65E-07 NO DATA 1.59E-07 I I-133 I-134 1.52E-06 1.11E-07 2.56E-06 2.90E-07 7.78E-07 1.05E-07 3.65E-04 4.94E-06 4.49E-06 4.58E-07 NO DATA NO DATA 1.29E-06 2.55E-09 I-135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1.86E-06 NO DATA 8.69E-07 CS-134 6.28E-05 1.41E-04 6.86E-05 NO DATA 4.69E-05 1.83E-63 '.22E-06 i I CS-136 6.44E-06 2.42E-05 1.71E-05 NO DATA 1.38E-05 2.22E-06 1.36E-06 )

i CS-137 8.38E-05 1.06E-04 3.89E-05 NO DATA 3.80E-05 1.51E-05 1.06E-06 CS-138 5.82E-08 1.07E-07 5.58E-08 NO DATA 8.28E-08 9.84E-09 3.38E-11 BA-139 1.67E-10 {

1.18E-13 4.87E '.2 NO DATA 1.11E-13 8.08E-07 8.06E-07 '

BA-140 6.84E-06 6.38E-09 4.40E-07 NO DATA 2.85E-09 2.54E-04 2.86E-05 BA-141 1.78E-11 1.32E-14 5.93E-13 NO DATA 1.23E-14 4.11E-07 9.33E-14 BA-142 4.62E-12 4.63E-15 2.84E-13 NO DATA 3.92E-15 2.39E-07 5.99E-20 LA-140 5.99E-08 2.95E-08 7.82E-09 NO DATA NO DATA 2.68E-05 6.09E-05 LA-142 1.20E-10 5.31E-11 1.32E-11 NO DATA NO DATA 1.27E-06 1.50E-06 CE-141 3.55E-06 2.37E-06 2.71E-07 NO DATA 1.11E-06 7.67E-05 1.58E-05 CE-143 3.32E-08 2.42E-08 2.70E-09 NO DATA 1.08E-08 1.63E-05 3.19E-05 CE-144 6.11E-04 2.53E-04 3.28E-05 NO DATA 1.51E-04 1.67E-03 1.08E-04 PR-143 1.67E-06 6.64E-07 8.28E-08 NO DATA 3.86E-07 6.04E-05 2.67E-05 PR-144 5.37E-12 2.20E-12 2.72E-13 NO DATA 1.26E-12 2.19E-07 2.94E-14 ND-147 9.83E-07 1.07E-06 6.41E-08 NO DATA 6.28E-07 4.65E-05 2.28E-05 W-187 1.50E-09 1.22E-09 4.29E-10 NO DATA NO DATA 5.92E-06 2.21E-05 .

NP-239 4.23E-08 3.99E-09 2.21E-09 NO DATA 1.25E-08 8.11E-06 1.65E-05

3.52 X 10.06 O* Less than 10-24 CLINTON-I 3-40 Rev.5-2/89 I i

U1'b-UDUM Table 3.5-4 INHA1.ATION DOSE FACTORS FOR ADULT - (DFA g ),

l (mrem per pCi inhaled)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 C-14 2.27E-06* 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 1.28E-06 I NA-24 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 P-32 I, 1.65E-04 9.64E-06 6.26E-06 NO DATA NO DATA NO DATA 1.08E-05 CR-51 NO DATA NO DATA 1.25E-08 7.44E-09 2.85E-09 1.80E-06 4.15E-07 MN-54 NO DATA 4.95E-06 7.87E-07 NO DATA 1.23E-06 1.75E-04 9.67E-06 HN-56 NO DATA 1.55E-10 2.29E-11 NO DATA 1.63E-10 1.18E-06 2.53E-06 -

FE-55 3.07Ee06 2.12E-06 4.93E-07 NO DATA NO DATA 9.01E-06 7.54E-07 FE-59 1.47E-06 3.47E-06 1.32E-06 NO DATA NO DATA 1.27E-04 2.35E-05 Co-58 NO DATA 1.98E-07 2.59E-07 NO DATA NO DATA 1.16E-04 1.33E-05 CO-60 NO DATA 1.44E-06 1.85E-06 NO DATA NO DATA 7.46E-04 3.56E-05 NI-63 5.40E-05 3.93E-06 1.81E-06 NO DATA NO DATA 2.23E-05 1.67E-06 I NI-65 CU-64 1.92E-10 NO DATA 2.62E-11 1.83E-10 1.14E-11 7.69E-11 NO DATA NO DATA 7.00E-07 1.54E-06 NO DATA 5.78E-10 8.48E-07 6.12E-06 ZN-65 4.05E-06 1.29E-05 5.82E-06 NO DATA 8.62E-06 1.08E-04 6.68E-06 ZN-69 4.23E-12 8.14E-12 5.65E-13 NO DATA 5.27E-12 1.15E-07 2.04E-09 BR-83 NO DATA NO DATA 3.01E-08 NO DATA NO DATA NO DATA 2.90E-08 BR-84 NO DATA NO DATA 3.91E-08 NO DATA NO DATA NO DATA 2.05E-13 I BR-85 RB-86 NO DATA NO DATA NO DATA 1.69E-05 1.60E-09 7.37E-06 NO DATA NO DATA NO DATA NO DATA LT E-24**

NO DATA NO DATA 2.08E-06 RB-88 NO DATA 4.84E-08 2.41E-08 NO DATA NO DATA NO DATA 4.18E-19 NO DATA 3.20E-08 2.12E-08 NO DATA NO DATA NO DATA 1.16E-21 I.RB-89 SR-89 SR-90 3.80E-05 1.24E-02 NO DATA NO DATA 1.09E-06 7.62E-04 NO DATA NO DATA NO DATA 1.75E-04 1.20E-03 4.37E-05 NO DATA 9.02E-05 1

I CLINTON-I 3-41 Fev.5-2/89 .

l i

_ _ _ - _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ - _- _ - A

CPS-ODCM Table 3.5-4 (continued)

INHALATION DOSE FACTORS FOR ADULT .(DFAg ),

(mrem per pCi inhaled) ~l' NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I-132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.48E-07 NO DATA 5.08E-08 I-133 1.08E-06 1.85E-06 5.65E-07 2.69E-04 3.23E-06 NO DATA 1.11E-06 I-134 8.05E-08 2.1GE-07 7.69E-08 3.73E-06 3.44E-07 NO DATA 1.26E-10 I-135 i 3.35E-07 '8.73E-07 3.21E-07 5.60E-05 1.39E-06 NO DATA 6.56E-07 CS-134 4.66E-05 1.06E-04 9.10E-05 NO DATA 3.59E-05 1.22E-05 1.30E-06 CS-136 4.88E-06 1.83E-05 1.38E-05 NO DATA 1.07E-05 1.50E-06 1.46E-06

)

i CS-137 5.98E-05 7.76E-05 5.35E-05 NO DATA 2.78E-05 9.40E-06 1.05E-06 i CS-138 4.14E-08 7.76E-08 4.05E-08 NO DATA 6.00E-08 6.07E-09 2.33E-13 !

BA-139 1.17E-10 8.32E-14 3.42E-12 NO DATA 7.78E-14 4.70E-07 1.12E-07 BA-140 4.88E-06 6.13E-09 3.21E-07 NO DATA 2.09E-09 1.59E-04 2.73E-05 BA-141 1.25E-11 9.41E-15 4.20E-13 NO DATA 8.75E-15 2.42E-07 1.45E-17 BA-142 3.29E-12 3.38E-15 2.07E-13 NO DATA 2.86E-15 1.49E-07 1.96E-26 l 1

LA-140 4.30E-08 -2.17E-08 5.73E-09 NO DATA NO DATA 1.70E-05 5.73E-05 LA-142 8.54E-11 3.88E-11 9.65E-12 NO DATA NO DATA 7.91E-07 2.64E-07 l CE-141 2.49E-06 1.69E-06 1.91E-07 NO DATA 7.83E-07 4.52E-05 1.50E-05 2

CE-143 2.33E-08 1.72E-08 1.91E-09 .NO DATA 7.60E-09 9.97E-06 2.83E-05 CE-144 4.29E-04 1.79E-04 2.30E-05 NO DATA 1.06E-04 9.72E-04 1.02E-04 PR ,143 1.17E-06 4.69E-07 5.80E-08 NO DATA 2.70E-07 3.51E-05 2.50E-05 PR-144 3.76E-12 1.56E-12 1.91E-13 NO DATA 8.81E-13 1.27E-07 2.69E-18 ND-147 6.59E-07 7.62E-07 4.56E-08 NO DATA 4.45E-07 2.76E-05 2.16E-05 W-187 1.06E-09 8.85E-10 3.10E-10 NO DATA NO DATA 3.63E-06 1.94E-05 NP-239 2.87E-08 2.82E-09 1.55E-09 NO DATA 8.75E-09 4.70E-06 1.49E-05

2.27 X 10-06

- Less than 10~20 CLINTON-I 3-43 Rev.5-2/89

CPS-0DCM TABLE 3.5-5 GROUND PLANE DOSE FACTORS - DFG 1 .

(mrem /hr per pCi/m2)

ELEMENT TOTAL BODY SKIN H-3 0.0 0.0 I C-14 NA-24 P-32 0.0 2.50E-08*

0.0 0.0 2.90E-08 0.0 CR-51 I

%. 2.20E-10 2.60E-10 MN-54 5.80E-09 6.80E-09 MN-56 1.10E-08 1.30E-08 FE-55 0.0 0.0 '

I FE-59 CO-58 Co-60 8.00E-09 7.00E-09 9.40E-09 8.20E-09 1.70E-08 2.00E-08 I NI-63 hl-65 CU-64 0.0 3.70E-09 1.50E-09 0.0 4.30E-09 1.70E-09' ZN-65 I ZN-69 BR-63 4.00E-09 0.0 6.40E-ll 4.60E-09 0.0 9.30E-ll BR-84 1.20E-08 1.40E-08 l

I BR-85 RB-36 RS-86 0.0 6.30E-10 0.0 7.20E-10 3.50E-09 4.00E-67

I RB-89 SR-89 SR-91 1.50E-08 5.60E-13 7.10E-09 1.80E-08 6.50E-13 8.30E-09 SR-92 9.00E-09 1.00E-08 Y-90 2.20E-12 2.60E-12 Y-91m 3.80E-09 4.40E-09 Y-91 2.40E-ll 2.70E-ll l

I Y-92 Y-93 1.60E-09 5.70E-10 1.90E-09 7.80E-10 ZR-95 5.00E-09 5.80E-09 I

E ZR-97 5.50E-09 6.40E-09 IN NS-95 3.10E-09 6.00E-09 i MO-99 1.90E-09 2.20E-09

) TC-99m 9.60E-10 1.10E-09 l . TC-101 2.70E-09 3.00E-09 -

RU-103 3.60E-09 4.20E-09 RU-105 4.50E-09 5.10E-09 RU-106 1.50E-09 1.80E-09 AG-110m 1.80E-08 2.10E-08 lI l CLINTON-I 3-44 Rev.5-2/89 I

CPS-UDCM I Table 3.5-5 (Continued)

GROUND PLANE DOSE FACTORS - DFGg

~

(mrem /hr per pCi/m2) s -

ELEMENT TOTAL BODY SKIN TE-125m 1

I TE-127m TE-127 3.50E-11 1.10E-12 1.00E-11 4.80E-ll 1.30E-12 1.10E-11 TE-129m 7.70E-10 9.00E-10 TE-129 -

7.10E-10 8.40E-10 TE-131m 8.40E-09 9.90E-09 TE-131t c 2.20E-09 2.60E-06

, TE-132 1.70E-09 2.00E-09 l-130 1.40E-06 1.70E-06 I-131 2.80E-09 3.40E-09 I I-132 I-133 1-134 1.70E-08 3.70E-09 1.60E-08 2.00E-08 4.50E-09 1.90E-08 I-135 1.20E-08 1.40E-08 l

l CS-134 1.20E-08 1.40E-08 CS-136 1.50E-08 1.70E-08 i

CS-137 4.20E-09 4.90E-09 CS-138 2.10E-08 2.40E-08 BA-139 2.40E-09 2.70E-09

, BA-140 2.10E-09 2.40E-09 i

E SA-141 4.30E-09 4.90E-09 E BA-142 7.90E-09 9.00E-09 LA-140 1.50E-08 1.70E-08 LA-142 1.50E-08 1.80E-08 CE-141 5.50E-10 6.20E-10 CE-143 2.20E-09 2.50E-09 CE-144 3.20E-10 3.70E-10 PR-143 0.0 0.0 I'FR-144 2.00E-lO 2.30E-10 ND-147 1.00E-09 1.20E-09 I W-187 NP-239 3.10E-09 9.50E-10 3.60E-09 1.10E-09 l

l l

I

2.50 X 10-08 l

l l CLINTON-I 3-45 Rev.5-2/89 l3 iE - --- -- -_ - -----

C1'S -U DCM TABLE 3.5-7 INGESTION DOSE FACTORS FOR CHILD - (DFL;)a (mrem per pCi ingested)

I N'CLIDE U BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 C-14 1.21E-05* 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06

' 2.42E-06 NA -24 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 l P-32 ( 8.25E-04 3.86E-05 3.18E-05 NO DATA NO DATA NO DATA 2.28E-05 CR-51 NO DATA NO DATA 8.90E-09 4.94E-09 1.35E-09

' 9.02E-09 4.72E-07 MN-54 NO DATA 1.07E-05 2.85E-06 NO DATA 3.00E-06 NO DATA 8.48E-06 MN-56 NO DATA 3.34E-07 7.54E-08 NO DATA 4.04E-07 NO DATA 4.84E~05 -

FE-55 1.15E-05 6.10E-06 1.89E-06 ND DATA NO DATA 3.45E-06 1.13E-06 FE-59 1.65E-05 2.67E-05 1.33E-05 NO DATA NO DATA 7.74E-06 2.78E-05 L CO-58 NO DATA 1.80E-06 5.51E-06 NO DATA NO DATA NO DATA 1.05E-05 CO-60 NO DATA 5.29E-06 1.56E-05 NO DATA NO DATA NO DATA 2.93E-05 NI-63 5.38E-04 2.88E-05 1.83E-05 NO DATA NO DATA NO DATA 1.94E-06

! NI-65 2.22E-06 2.09E-07 1.22E-07 NO DATA NO DATA NO DATA 2.56E-05 CU-64 NO DATA 2.45E-07 1.48E-07 NO DATA 5.92E-07 NO DATA 1.15E-05 ZN-65 1.37E-05 3.65E-05 2.27E-05 NO DATA 2.30E-05 NO DATA 6.41E-06 ZN-69 4.38E-08 I BR-83 BR-84 NO DATA NO DATA 6.33E-08 NO DATA NO DATA 5.85E-09 1.71E-07 1.98E-07 NO DATA NO DATA NO DATA 3.84E-08 NO DATA NO DATA NO DATA NO DATA NO DATA 3.99E-06 LT E-24**

LT E-24 I BR-85 RB-86 NO DATA NO DATA 9.12E-09 NO DATA NO DATA NO DATA LT E-24 NO DATA 6.70E-05 4.12E-05 NO DATA NO DATA NO DATA 4.31E-06 RB-88 NO DATA 1.90E-07 1.32E-07 NO DATA NO DATA NO DATA 9.32E-09

,g RB-89 NO DATA 1.17E-07 1.04E-07 NO DATA NO DATA NO DATA 1.02E-09 l_g SR-89 1.32E-03 NO DATA 3.77E-05 NO DATA NO DATA NO DATA 5.11E-05 -

SR-90 1.70E-02 NO DATA 4.31E-03 NO DATA NO DATA NO DATA 2.29E-04 SR-51 2.40E-05 NO DATA 9.06E-07 NO DATA NO DATA NO DATA 5.30E-05 SR-92 9.03E-06 NO DATA 3.62E-07 NO DATA NO DATA NO DATA 1.71E-04 Y-90 4.11E-08 NO DATA 1.10E-09 NO DATA NO DATA NO DATA 1.17E-04 j ls" CLINTON-1 3-49 Rev.5-2/89 l

CPS-0DCM l

TABLE 3.5-7 (continued)

INGESTION DOSE FACTORS FOR CHILD - (DFL f )a (mrem per pCi ingested) gCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Y-91m 3.82E-10 NO DATA 1.39E-11 NO DATA NO DATA NO DATA 7.48E-07 Y-91 , 6.02E-in NO DATA 1.61E-08 NO DATA NO DATA NO DATA 8.02E-05 Y-92 3.60E-G NO DATA 1.03E-10 NO DATA NO DATA NO DATA 1.04E-04

(

1 Y-93 1.14E-08 NO DATA 3.13E-10 NO DATA NO DATA NO DATA 1.70E-04 ZR-35 1.16E-07 2.55E-08 2.27E-08 NO DATA 3.65E-08 NO DATA '2.66E-05 ZR-97 6.99E-09 1.01E-09 5.96E-10 NO DATA 1.45E-09 NO DATA 1.53E-04 i

NB-95 2.25E-08 8.76E-09 6.26t-09 NO DATA 8.23E-09 NO DATA 1.62E-05 HO-99 NO DATA 1.33E-05 3.29E-06 NO DATA 2.84E-05 NO DATA 1.10E-05 TC-99m 9.23E-10 1.81E-09 3.00E-08 NO DATA 2.63E-08 9.19E-10 1.03E-06 l

l TC-101 1.07E-09 1.12E-09 1.42E-08 NO DATA 1.91E-08 5.92E-10 3.56E-09 RU-103 7.31E-07 NO DATA 2.81E-07 NO DATA 1.84E-06 NO DATA 1.F9E-05 RU-105 6.45E-08 NO DATA 2.34E-08 NO DATA 5.67E-07 NO DATA 4.2]E-05 RU-106 i 1.17E-05 l

I AG-110m TE-125m 5.39E-07 1.14E-05 NO DATA 3.64E-07 3.09E-06 1.46E-06 2.91E-07 1.52E-06 NO DATA NO DATA 3.20E-06 1.58E-05 6.78E-07 NO DATA NO DATA NO DATA NO DATA 1.82E-04 4.33E-05 1.10E-05 l

TE 127m 2.89E-05 7.78E-06 3.43E-06 6.91E-06 8.24E-05 NO DATA 2.34E-05 !

TE-127 4.71E-07 1.27E-07 1.01E-07 3.26E-07 1.34E-06 NO DATA 1.84E-05 {

TE-129m 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 NO DATA 5.94E-05 {

TE-129 1.34E-07 3.74E-08 3.18E-08 I TE-131m TE-131 7.20E-06 8.3GE-08 2.49E-06 2.53E-08 2.65E-06 2.47E-08 9.56E-08 5.12E-06 6.35E-08 3.92E-07 2.41E-05 2.51E-07 NO DATA NO DATA NO DATA 8.34E-06 1.01E-04 4.36E-07 I TE-132 1.01E-05 2.92E-06 4.47E-06 5.40E-06 6.51E-06 4.15E-05 NO DATA 4.50E-05

~

l I-130 5.90E-06 3.04E-06 6.50E-04 8.82E-06 NO DATA 2.76E-06 I-131 1.72E-05 1.73E-05 9.83E-06 5.72E-03 2.84E-05 NO DATA 1.54E-06 I-132 8.00E-07 I I-133 I-134 5.92E-06 4.19E-07 1.47E-06 7.32E-06 7.78E-07 6.76E-07 2.77E-06 3.58E-07 6.82E-05 1.36E-03 1.79E-05 2.25E-06 1.22E-05 1.19E-06 NO DATA LO DATA NO DATA 1.73E-06 2.95E-06 5.16E-07 i

I CLINTON-I 3-50 Rev.5-2/89

CPS-0DCM

(

I ;

TABLE 3.5-8 (continued) (

INGESTION DOSE FACTORS FOR TEEN - (DFL g ),

(mrem per pCi ii.,ested) .i I

l i

NUCLIDE BONE LIVER T. BODY THTROID l

KIDNEY LUNG GI-LLI Y-91m 1.29E-10 NO DATA 4.93E-12 NO DATA NO DATA NO DATA 6.09E-09 Y-91 2.01E-07 NO DATA 5.39E-09 !

NO DATA NO DATA NO DATA 8.24E-05 T-92 1.21E-09 NO DATA 3.50E-11 l NO DATA NO DATA NO DATA 3.32E-05 T-93 ( 3.83E-09 NO DATA 1.05E-10 NO DATA NO DATA NO DATA 1.17E-04 ZR-95 4.12E-08 1.30E-08 8.94E-09 NO DATA 1.91E-08 NO DATA 3.00E-05 ZR-97 2.37E-09 4.69E-10 2.16E-10 NO DATA 7.11E-10 NO DATA 1.27E-04 I NE-95 MO-99 8.22E-09 NO DATA 4.56E-09 6.03E-06 2.51E-09 NO DATA 4.42E-09 NO DATA 1.95E-05 1.15E-06 NO DATA 1.38E-05 NO DATA 1.08E-05 TC-99m 3.32E-10 9.26E-10 1.20E-08 NO DATA 1.38E-08 5.14E-10 6.08E-07 TC-101 3.60E-10 5.12E-10 5.03E-09 I RU-103 RU-105 2.55E-07 2.18E-08 NO DATA NO DATA' 1.09E-07 8.46E-09 NL .1ATA NO DATA NO DATA 9.260-09 8.99E-07 2.75E-07 3.12E-10 NO DATA NO DATA S.75E-17 2.13E-05 1.76E-05 I RU-106 AG-110m' 3.92E-06 2.05E-07 NO DATA 4.94E-07 NO DATA 7.56E-06 NO DATA 1.88E-04 1.94E-07 1.18E-07 NO DATA 3.70E-07 NO DATA 5.45E-05 TE-125m 3.83E-06 1.38E-06 5.12E-07 1.07E-06 NO DATA NO DATA 1.13E-05 TE-127m 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 NO DATA 2.41E-05 TE-127 1.58E-07 5.60E-08 3.40E-08 1.09E-07 6.40E-07 NO DATA 1.22E-05 TE-129m 1.63E-05 6.05E-06 2.58E-06 5.26E-06 6.82E-05 NO DATA 6.12E-05 I TE-129 4.48E-08 1.67E-08 1.09E-08 3.20E-08 1.88E-07 NO DATA 2.45E-07 TE-131m 2.44E-06 1.17E-06 9.76E-07 1.76E-06 1.22E-05 NO DATA 9.39E-05 TE-131 2.79E-08 1.15E-08 8.72E-09 2.15E-08 1.22E-07 NO DATA 2.29E-09 TE-132 3.49E-06 I I-130 I-131 1.03E-06 5.85E-06 2.21E-06 2.98E-06 8.19E-06 2.08E-06 1.19E-06 4.402-06 2.33E-06 2.43E-04 2.39E-03 2.12E-05 4.59E-06 1.41E-05 NO DATA NO DATA NO DATA 7.00E-05 2.29E-06 1.62E-06 I I -132 I-133 2.79E-07 7.30E-07 2.62E-07 2.46E-05 1.15E-06 NO DATA 3.18E-07 2.01E-06 3.41E-06 1.04E-06 4.76E-04 5.98E-06 NO DATA 2.58E-06 I-134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.10E-07 NO DATA 5.10E-09 I CLINTON-I 3-53 Rev.5-2/89

{

I I

CPS-0DCM I TABLE 3.5-9 (continued)

INGESTION DOSE FACTORS FOR ADULT - (DFL g ),

(arem per pCi ingested)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG CI-LLI Y-91m 9.09E-11 NO DATA 3.52E-12 NO DATA NO DATA NO DATA 2.67E-10 Y-91 1.41E-07 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 Y-92 8.45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 Y-93 ( 2.68E-09 NO DATA 7.40E-11 NO DATA NO DATA NO DATA 8.5 E-05 I ZR-95 ZR-97 3.04E-08 1.6BE-09 9.75E-09 3.39E-10 6.60E-09 1.55E-10 NO DATA NO DATA 1.53E-08 5.12E-10 NO DATA NO DATA 3.09E-05 1.05E-04 NB-95 6.22E-09 3.46E-09 1.86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 MO-99 NO DATA 4.31E-06 8.20E-07 NO DATA 9.76E-06 NO DATA 9.99E-06 TC-99m 2.47E-10 6.98E-10 8.89E-09 1.06E-08 I NO DATA 3.42E-10 4.13E-07 TC-101 2.54E-10 3.66E-10 3.59E-09 NO DATA 6.59E-09 1.87E-10 1.10E-21 I RU-103 RU-105 1.85E-07 1.54E-08 NO DATA NO DATA 7.97E-08 6.08E-09 NO DATA NO DATA 7.06E-07 1.99E-07 NO DATA NO DATA 2.16E-05 9.42E-06 RU-106 2.75E-06 NO DATA 3.48E-07 NO DATA 5.31E-06 NO DATA 1.78E-04 AG-110m 1.60E-07 1.48E-07 8.79E-08 NO DATA 2.91E-07 NO DATA 6.04E-05 TE-125m 2.68E-06 9.71E-07 3.59E-07 8.06E-07 I 1.09E-05 NO DATA 1.07E-05 TE-127m 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 NO DATA 2.27E-05 I TE-127 TE ,129m 1.10E-07 1.15E-05 3.95E-08 4.29E-06 2.38E-08 1.82E-06 8.15E-08 3.95E-06 4.48E-07 4.80E-05 NO DATA NO DATA 8.68E-06 5.79E-05 TE-129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 NO DATA 2.37E-08 TE-131m 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 NO DATA 8.40E-05 TE-131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 I 8.63E-08 NO DATA 2.79E-09 TE-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 NO DATA 7.71E-05 I I-130 I-131 7.56E-07 4.16E-06 2.23E-06 5.95E-06 8.80E-07 3.41E-06 1.89E-04 1.95E-03 3.48E-06 1.02E-05 NO DATA NO DATA 1.92E-06 1.57E-06 I-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 NO DATA 1.02E-07 I-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 NO DATA 2.22E-06 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 I _I-134 NO DATA 2.51E-10 CLINTON-I 3-56 Rev.5-2/89 t

CPS-0DCM TABLE 3.5-13 I I INHALATION PATHWAY FACTORS - R ..(INFANT) a13 (mrem /yr perpCi/m3)

I ORGAN:

ISOTOPE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI g H-3 NO DATA 6.47E402* 6.47E+02* 6.47E+02* 6.47E%2* 6.47EM 2* 6.47E+02*

i 3 C-14 2.65E%4 5.31E+03 5.32EM 3 5.31E403 5.31E+03 5.31E%3 5.31E %3 NA-24 1.06E+04 1.06E404 1.06EM 4 1.06E+04 1.06E+04

, 1.06E+04 1.06E404 P-32 2.03E406 1.12EM5 7.74EM4 NO DATA NO DATA NO DATA l

1.61E+04 CR-51 NO DATA NO DATA 8.95EMI 5.75E+01 1.32E%1 1.28E+04 3.57E+02 MN-54 NO DATA 2.53E+04 4.98E+03 NO DATA 4.98E403 1.00E+06 7.06E+03 ,

MN-56 NO DATA 1.54E+00 2.21E-01 NO DATA 1.10E40 1.25E% 4 7.17E+04 FE-55 1.97E+04 1.17E+04 3.33E+03 NO DATA NO DATA 8.69E404 FE-59 1.09EM3 l 1.36E404 2.35E+04 9.48E403 NO DATA NO DATA 1.02EM6 2.48E+04 l CO-58 NO DATA 1.22E+03 1.82E+03 NO DATA NO DATA 7.77E+05 1.11E+04 Co-60 NO DATA 8.02E403 1.18E+04 NO DATA NO DATA 4.51EM6

' 3.19E+04 NI-63 3.39E+05 2.04E+04 1.16E+04 NO DATA NO DATA 2.09E%5 2.42E+03 {

I NI-65 CU-64 ZN-65 2.39E+00 NO DATA 1.93EM 4 2.84E-01 1.88E+00 6.26E404 1.23E-01 7.74E-01 3.11E+04 NO DATA NO DATA NO DATA 3.98E+00 8.12E+03 9.30E403 5.01E%4 1.50E+04 j

j NO DATA 3.25E+04 6.47E+05 5.14E%4

{

I ZN-69 5.39E-02 9.67E-02 7.18E-03 NO DATA 4.02E-02 1.47E+03 1.32E%4 BR-83 NO DATA j l

NO DATA 3.81E+02 NO DATA NO DATA NO DATA LT1.4E-15** i BR-84 NO DATA NO DATA 4.00E+02 NO DATA NO DATA NO DATA LT1.4E-15 l

I BR-85 RB-86 RB-88 NO DATA NO DATA NO DATA NO DATA 1.90E+05 5.57E+02 2.04E+01 8.82E+04 2.87E402 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA LT1.4E-15 3.04E+03 NO DATA 3.39E402 RB-89 NO DATA 3.21E+02 2.06E+02 NO DATA NO DATA NO DATA 6.82E%1 i SR-89 3.98E+05 NO DATA 1.14E+04 NO DATA NO DATA 2.03E+06 6.40E+04 SR-90 4.09E+07 NO DATA 2.59E406 NO DATA NO DATA 1.12E+07 1.31E+05 I

CLINTON-1 3-61 Rev.5-2/89

CPS-0DCM 4

TABLE 3.5-13 (continued)

INHALATION PATHWAY FACTORS - R 1 (INFANT)

(mrem /yr per pCi/m3)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE SR-91 9.56E+01- NO DATA 3.46E+00 NO DATA NO DATA 5.26E+04 7.34E+04 !

SR-92 1.05E+01 NO DATA 3.91E-01 NO DATA NO DATA 2.38E404 1.40E+05 Y-90 . 3.29E+03 NO DATA 8.82E+01 NO DATA NO DATA 2.69E+05 1.04E+05 Y-91m 4.07E-01 NO DATA 1.39E-02 NO DATA NO DATA 2.79E+03 2.35E+03 Y-91 5.88E+05 NO DATA 1.57E+04 NO DATA NO DATA 2.45E+06 7.03E+04 Y-92 1.64E+01 NO DATA 4.61E-01 WO DATA NO DATA 2.45E+04 1.27E405 ;

~

Y-93 1.50E+02 NO DATA 4.07EMO NO DATA NO DATA 7.64E+04 1.67E+05 '

I ZR-95 ZR-97 1.15E405 1.50E+02 2.79E+04 2.56E+01 2.03E+04 1.17E+01 NO DATA NO DATA 3.11E+04 2.59E+01 1.75E+O6 1.10E+05 2.17E+04 1.40E+05 NE-95 1.57E+04 6.43E+03 3.78E+03 NO DATA 4.72E+03 4.79E+05 1.27E+04 MO-99 NO DATA 1.65E+02 3.23E+01 NO DATA - 2.65E+02 1.35E+05 4.87E+04 TC-99m 1.40E-03 2.88E-03 3.72E-02 NO DATA 3.11E-02 8.11E+02 2.03E+03 I TC-101 6.51E-05 8.23E-05 8.12E-04 NO DATA 9.79E-04 5.84E+02 8.44E402 RU-103 2.02E+03 NO DATA 6.79E+02 NO DATA 4.24E+03 5.52E+05 1.61E404 RU-105 1.22E400 NO DATA 4.10E-01 NO DATA 8.99E-01 1.57E+04 4.84E404 I RU-106 8.68E+04 NO DATA 1.09E+04 NO DATA 1.07E+05 1.16E+07 1.64E405 AG ,110m 9.98E+03 7.22E+03 5.00E+03 NO DATA 1.09E+04 3.67E+06 3.30E+04 1 TE-125m 4.76F+03 1.99E+03 6.58E+02 1.62E+03 NO DATA 4.47E+05 1.29E+04 TE-127'm 1.57E+04 6.90E403 2.07E+03 4.87EM3 3.75E+04 1.31E406 2.73E404 I TE-127 TE-129m 2.23E+00 1.41EM 4 9.53E-01 6.09E+03 4.89E-01 2.23E+03 1.85 E+00 5.47E+03 4.86E400 3.18E404 1.03E%4 1.68EM 6 2.44E+04 6.90E+04

)

l l

TE-129 7.88E-02 3.47E402 1.88E-02 6.75E-02 1.75E-01 3.00EM3 2.63E+04 -

TE-131m 1.07E+02 5.50E+01 3.62E+01 8.93E+01 2.65E+02 1.99E+05 1.19E+05 TE-131 1.74E-02 8.22E-03 5.00E-03 1.58E-02 3.99E-02 2.06E+03 8.22E+03 I TE-132 3.72E+02 2.37E+02 1.76E+02 2.79E+02 1.03EM3 3.40E+05 4.41E404 i I-130 6.36E+03 1.39E+04 5.57EM3 1.60E+06 1.53E+04 NO DATA 1.99E+03 I-131 3.79E+04 4.44E4 4 1.96E+04 1.48E+07 5.18E404 NO DATA 1.06EM3 I CLIN 7?ON-I 3-62 Rev.5-2/89

l' CPS-ODCM l

TABLE 3.5-13 (continued)

I INHALATION PATINAY FACTORS - Raij (INFANT) ,

g (mrem /yr per uCi/m3) l g ORGAN: B_0NE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI g ISOTOPE

)

l l

I-132 1.69E+03 3.54E+03 1.26E403 1.69E+05 3.95E+03 NO DATA 1.90E+03 I-133 1.32E+04 1.92E+04 5.60E+03 3.56E+06 2.24E+04 NO DATA 2.16E+03 1-134 ,' 9.21E+02 1.88E403 6.65E+02 4.45E404 2.09E+03 NO DATA 1.29EM3 l

I-135 3.86E+03 7.60E+03 2.77E+03 6.96EM5 8.47E403 NO DATA 1.83E+03 CS-134 3.96E+05 7.03 EMS 7.45E+04 NO DATA 1. 90E445 7.97E+04 1.33E+03 CS-136 4.83E+04 1.35E+05 5.29E+04 NO DATA 5.64E444 1.18E+04 1.43EM3 3

)

CS-137 5.49E+05 l CS-138 BA-139 5.05E+02 1.48E+00 6.12E+05 7.81E+02 9.84E-04 4.55E+04 3.98E+02 4.30E-02 NO DATA NO DATA NO DATA 1.72E+05 4.10E+02 5.92E-04 7.13EM4 6.54E+01 5.95E+03 1.33E403 8.76EM2 5.10E+04 l

l I BA-140 BA-141 5.60E+04 1.57E-01 5.60E+01 2.90E403 NO DATA 1.34E+01 1.60E+06 3.84E+04 i

1.08E-04 4.97E-03 NO DATA 6.50E-05 2.97E+03 4.75E+03 )

BA-142 3.98E-02 3.30E-05 1.96E-03 NO DATA 1.90E-05 1.55E+03 6.93E+02 LA-140 5.05E+02 2.00E+02 5.15E+01 NO DATA NO DATA 1.68E405 8.48E+04 LA-142 1.03E400 3.77E-01 9.04E-02 NO DATA NO DATA 8.22EM 3 5.95E404 i CE-141 2.77E+04 1.67E+04 1.99EM3 NO DATA 5.25E+03 5.17 EMS 2.16E+04 CE-143 2.93E+02 1.93E+02 2.21E+01 NO DATA 5.64E+01 1.16E+05 4.97E+04 CE-_144 3.19E+06 1.21E+06 1.76E+05 NO DATA 5.38E+05 9.84E+06 1.48E+05 PR-143 1.40E+04 5.24E+03 6.99E+02 NO DATA 1.97E+03 4.33EM5 3.72E404 PR-144 4.79E-02 1. 85E- 02 2.41E-03 NO DATA 6.72E-03 1.61E+03 4.28E+03 ND-147 7.94E+03 8.13EM 3 5.00E+02 NO DATA 3.15E4 3 3.22E+05 3.12E+04 W-187 1.30E401 9.02EM0 3.12E400 NO DATA NO DATA 3.96E+04 3.56E+04 l

NP-239 3. 71E402 3.32E+01 1.88E441 NO DATA 6.62E+01 5.95E+04 2.49E+04 2

6.47 x 10 0* Less than 1.40 x 10-15 I CLINTON-I 3-63 Rev.5-2/89 I

CPS-0DCM

I l TABLE 3.5-14 ;

I INHALATION PATHWAY FACTORS - R ..(CHILD) a t] .

(mrem /yr per pCi/m3)

ORGAN: BONE LIVER LBODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 1.12E403* 1.12E+03 1.12EM3 1.12E+03 1.12E+03 1.12E+03 I C-14 NA-24 :

3.58E+04 1.61E404 6.73E+03 1.61EM4 6.73EM3 1.61E+04 6.73E403 1.61E+04 6.73E403 1.61E+04 6.73E+03 1.61E+04 6.73E+03 1.61E+04 P-32 2.60E406 1.14E+05 9.87EM 4 NO DATA NO DATA NO DATA 4.21E+04 i

CR-51 NO DATA NO DATA 1.54E+02 8.54E+01 2.43E+01 1.70E404 1.08EM3 j MN-54 NO DATA 4.29E+04 9.51EM 3 NO DATA 1.00E+04 1.58E+06 2.29E+04 MN-56 NO DATA 1.66E+00 3.12E-01 NO DATA 1.67EM0 1.31E404 1.23 EMS E FE-55 4.74E+04 2.52E404 7.77E+03 NO DATA NO DATA 1.11E+05 2.87E+03 E FE-59 2.07EM4 3.34E+04 1.67E+04 NO DATA NO DATA 1.27E+06 7.07E+04 CO-58 NO DATA 1.77E+03 3.16E+03 NO DATA NO DATA 1.11E+06 3.44E+04 CO-60 NO DATA 1.31E+04 2.26E+04 NO DATA NO DATA 7.07E+06 9.62E+04 NI-63 8.21E+05 4.63E+04 2.80EM4 NO DATA NO DATA 2.75E+05 G.33E+03 NI-65 2.99EMO 2.96E-01 1.64E-01 NO DATA NO DATA 8.18EM3 8.40E404 l CU-64 NO DATA 1.99E400 1.07E+00 NO DATA 6.03E+00 9.58E+03 3.67E+04 }

ZN-65 4.26E+04 1.13E+05 7.03EM 4 NO DATA 7.14E+04 9.95E+05 1.63E404 {

l ZN-69 6.70E-02 9.66E-02 8.92E-03 NO DATA 5.85E-02 1.42E+03 1.02EM4 BR-83 NO DATA NO DATA 4.74E+02 NO DATA NO DATA NO DATA LT3.70E-15**

BR-84 NO DATA NO DATA 5.48E+02 NO DATA NO DATA NO DA"A LT3.70E-15 BR-85 NO DATA NO DATA 2.53E+01 NO DATA NO DATA NO DATA LT3.70E-15 RB-86 NO DATA 1.98 EMS 1.14E+05 NO DATA NO DATA NO DATA 7.99E+03 I RB-88 NO DATA 5.62E402 3.66E+02 NO DATA NO DATA NO DATA 1.72E401 RB-89 NO DATA 3.45E+02 2.89E402 NO DATA NO DATA NO DATA 1.89E400 .

SR-89 5.99E+05 NO DATA 1.72E+04 NO DATA NO DATA 2.16E+06 1.67E+05 4 SR-90 1.01E+08 NO DATA 6.44EM6 NO DATA NO DATA 1.48E+07 3.43E405 I

l SR-91 1.21EM 2 NO DATA 4.59E+00 NO DATA NO DATA 5.33E+04 1.74E+05 I SR-92 Y-90 1.31E+01 4.11E403 NO DATA NO DATA 5.25E-01 1.11E+02 NO DATA NO DATA NO DATA NO DATA 2.40E+04 2.62E+05 2.42E+05 2.66E+05 I CLINTON-I 3-64 Rev.5-2/89

CPS-0DCM I

TABLE 3.5-14 (continued)

INHALATION PATHWAY FACTORS - R (CHILD) ,

(mrem /yr per pCi/m3)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE 4"

Y-91m 5.07E-01 NO DATA 1.84E-02 NO DATA NO DATA 2.81E+03 1.72E+03 Y-91 9.14E+05 NO DATA 2.44E+04 NO DATA NO DATA 2.63E+06 1.84E+05 Y-92 . 2.04E+01 NO DATA 5.81E-01 NO DATA NO DATA 2.39E+04 2.39E+05

+

Y-93 1.86E+02 NO DATA 5.11E+00 NO DATA NO DATA 7.44EM4 3.89E+05 ZR-95 1.90 EMS 4.18E+04 3.70E+04 NO DATA 5.96E+04 2.23E+06 6.11E+04 ZR-97 1.88EM2 2.72E+01 1.60E+01 I NO DATA 3.89E401 1.13E405 3.51E+05 NB-95 2.35E404 9.18E@3 6.55E+03 NO DATA 8.62E+03 6.14E+05 3.70E+04 I MD-99 TC-99m NO DATA 1.78E-03 1.72E+02 3.48E-03 4.26E+01 5.77E-02 NO DATA NO DATA 3.92E+02 5.07E-02 1.35E+05 9.51E+02 1.27E405 4.81Ee3 TC-101 8.10E-05 8.51E-05 1.08E-03 NO DATA 1.45E-03 5. 84E H)2 1.63E+01 RU-103 2.79E+03 NO DATA 1.07E+03 NO DATA 7.03E+03 6.62E+05 4.48E+04 RU-105 1.53E+00 I NO DATA 5.55E-01 NO DATA 1.34E+00 1.59E44 9.95E+04 RU-106 1.36E+05 NO DATA 1.69EM4 NO DATA 1.84E+05 1.43E+07 4.29EM5 AG-110m 1.69E+04 1.14E+04 9.14E+03 NO DATA 2.12E+04 5.48E+06 1.00EM5 ;

TE-125m 6.73E+03 2.33E+03 9.14E+02 1.92E% 3 NO DATA 4.77E+05 3.38EM4 TE-127m 2.49EM4 8.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 ;

TE-127 2.77E@0 9.51E-01 6.11E-01 1.96E+00 7.07E+00 1.00E+04 5.62E+04 TE-129m 1.92E+04 6.85EM3 3.04E403 6.33E+03 {

5.03E+04 1.76E+06 1.82E+05 l TE-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01 2.93E+03 2.55E+04 I TE-131m TE-131 1.34E+02 2.17E-02 5.92E+01 8.44E-03 5.07E+01 6.59E-03 9.77E+01 1.70E-02 4.00E+02 5.88E-02 2.06E+05 2.05E43 3.08E+05 1.33E+03 l

TE-132 4.81E+02 2.72E+02 2.63E+02 3.17E % 2 1. 77E403 3.77E+05 1.38E+05 I-130 8.18E+03 1.64E+04 8.44E+03 1.85E446 2.45EM4 NO DATA 5.11E403 l I-131 4.81E404 4.81E+04 2.73E+04 1.62E+07 7.88E404 NO DATA 2.84EM3 l 1

I-132 2.12E+03 4.07E+03 1.88E+03 1.94E405 6.25E+03 NO DATA 3.20E+03 I I-133 I-134 1.66E+04 1.17E+03 2.03E+04 2.16E+03 7.70E+03 9.95E402-3.85E% 6 5.07E444 3.38E+04 3.30E403 NO DATA NO DATA 5.48E+03 9.54E+02 CLINTON-I 3-65 Rev.5-2/89 i

CPS-ODCM TABLE 3.5-14 (continued) l INHALATION PATHWAY FACTORS - R (CHILD)

(mrem /yr per pCi/m3)

ORGAN: BONE '

LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE I-135 4.92E403 8.73E+03 4.14E+03 7.92 EMS 1.34E404 NO DATA 4.44E+03 CS-134 6.51E+05 1.01E+06 2.25E+05 NO DATA 3.30E+05 1.21E45 3.85E+03 CS-136 : 6.51E+04 1.71 EMS 1.16E+05 NO DATA 9.55E404 1.45E+04 4.18E@3 l CS-137 9.07E+05 8.25E+05 1.28E+05 NO DATA 2.82EM5 1.04E+05 3.62EM3 CS-138 6.33EM 2 8.40E+02 5.55E+02 NO DATA 6.22E+02 6.81E+01 2.70E+02 BA-139 1.84E400 9.84E-04 5.37E-02 NO DATA 8.62E-04 5.77E+03 5.77E404 BA-140 7.40E% 4 6.48 Eel 4.33E+03 NO DATA 2.11E+01 1.74EM 6 1.02E405 l l BA-141 1.96E-01 1.09E-04 6.36E-03 NO DATA 9.47E-05 2.92E+03 2.75E+02 E BA-142 5.00E-02 3.60E-05 2.79E-03 NO DATA 2.91E-05 1.64E+03 2.74E+00 LA-140 6.44E+02 2.25E+02 7.55E+01 NO DATA NO DATA 1.83E+05 2.26E+05 LA-142 1.30E+00 4.11E-01 1.29E-01 NO DATA NO DATA 8.70E+03 7.59E+04 CE-141 3.92E+04 1.95E+04 2.90E+03 NO DATA 8.55E+03 5.44E+05 5.66E+04 CE-143 3.66E402 1.99EM 2 2.87EMI NO DATA 8.36EMI 1.15E405 1.27E+05 I CE-144 PR-143 6.77EM6 1.85E+04 2.12E+06 5.55E+03 3.61 EMS 9.14E+02 NO DATA NO DATA 1.17E+06 3.00E+03 1.20EM 7 4.33E+05 3.89E+05 9.73E404 PR-144 5.96E-02 1.85E-02 3.00E-03 FO DATA 9.77E-03 1.57E+03 1.97EM2 ND-147 1.08E+04 8.73EM3 6.81E+02 NO DATA 4.81E+03 3.28E+05 8.21E+04 W-187 1.63E+01 9.66E+00 4.33EMO NO DATA NO DATA 4.11E404 9.10E+04 NP-239 4.66E+02 3.34E401 2.35ErO1 NO DATA 9. 73EMI 5.81E+04 6.40E+04 l g

'

1.12 x 10 8 g ** Less than 3.70 x 10-15 ,

I I

CLINTON-I 3-66 Rev.5-2/89

! 1 l CPS-0DCM l

l TABLE 3.5-15 INHALATION PATHWAY FACTORS - R (TEEN)

(mrem /yr per VCi/m3) i ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI

) ISOTOPE H-3 NO DATA 1.27E403* 1.27E+03 1.27E+03 1.27E+03 1.27E403 1.27E+03 l

I C-14 NA-24 ,

2.60E+04 1.38E+04 4.87E+03 1.38E+04 4.87E+03 1.38E+04 4.87E+03 1.38E+04 4.87EM3 1.38E404 4.87E+03 1.38E+04 4.87E+03 1.38E+04 P-32 1.89E+06 1.10E405 7.16E404 NO DATA NO DATA NO DATA 9.28E+04 CR-51 NO DATA NO DATA 1.35E+02 7.50E+01 3.07E+01 2.10E404 3.00E+03 l HN-54 NO DATA 5.11EM4 8.40E+03 NO DATA 1.27E+04 1.98E406 6.68E+04 j MN-56 NO DATA ,1.70E+00 2.52E-01 NO DATA 1. 79EM0 1.52E+04 5.74E+04 l I FE-55 FE-59 3.34E+04 1.59E+04 2.38E+04 3.70E+04 5.54E+03 1.43E+04 NO DATA NO DATA NO DATA NO DATA 1.24E+05 1.53EM6 6.39E+03 1.78E+05 CO-58 NO DATA 2.07E+03 2.78E+03 NO DATA NO DATA 1.34E+06 9.52E+04 CO-60 NO DATA 1.51E+04 1.98E404 NO DATA NO DATA 8.72E+06 2.59E+05 EI-63 5.80E+05 4.34E+04 1.98E404 NO DATA NO DATA 3.07E+05 1.42E+04 NI-65 2.18E+00 2.93E-01 1.27E-01 NO DATA NO DATA 9.36E+03 3.67E+04 I CU-64 ZN-65 NO DATA 3.86E+04 2.03E+00 1.34E405 8.48E-01 6.24E+04 NO DATA NO DATA 6.41E+00 8.64E+04 1.11E404 1.24E+06 6.14E%4 4.66E+04 I l

I ZN-69 4.83E-02 9.20E-02 6.46E-03 NO DATA 6.02E-02 1.58E+03 2.85E+02 BR-83 NO DATA NO DATA 3.44EM 2 NO DATA NO DATA NO DATA LT8E-15**

BR-84 NO DATA NO DATA 4.33E+02 NO DATA NO DATA NO DATA LT8E-15 BR-85 NO DATA NO DATA 1.83E+01 NO DATA NO DATA NO DATA LT8E-15 RB-86 NO DATA 1.90E+05 8.40E+04 NO DATA NO DATA NO DATA 1.77E+04 RB-88 NO DATA 5.46E+02 2.72E+02 NO DATA NO DATA NO DATA 2.92E-05 RB-89 NO DATA 3.52E+02 2.33E+02 NO DATA NO LATA NO DATA 3.38E-07 -

SR-89 4.34E+05 NO DATA 1.25E+04 NO DATA NO DATA 2.42E% 6 3.71E+05 SR-90 1.08E408 NO DATA 6.68E+06 NO DATA NO DATA 1.65E4M 7.65 EMS SR-91 8.80E+01 NO DATA 3.51E+00 NO DATA NO DATA 6.07E+04 2.59E+05 I SR-92 Y-90 9.52E+00 2.98E403 NO DATA NO DATA 4.06E-01 8.00E401 NO DATA NO DATA NO DATA NO DATA 2.74E+04 2.93E%5 1.19E+05 5.59E405 I CLINTON-I 3-67 Rev.5-2/89 l

I

CPS-0DCM I

TABLE 3.5-15 (continued)

INHALATION PATINAY FACTORS - R (TEEN)

(mrem /yr per pCi/m3)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE Y-91m 3.70E-01 NO DATA 1.42E-02 NO DATA NO DATA 3.20E+03 3.02E401 I Y-91 Y-92 6.61E+05

1.47E4CI NO DATA NO DATA 1.77E+04 4.29E-01 NO DATA NO DATA NO DATA NO DATA 2.94E406 2.68E+04 4.09 EMS 1.65E4 0 i

Y-93 1.35E402 NO DATA 3.72E+00 NO DATA NO DATA 8.32E+04 5.79E+05 ZR-95 1.46E+05 4.58E+04 3.15E+04 NO DATA 6.74EM 4 2.69E+06 1.49E445 ZR-97 1.38E+02 2.72E401 1.26E+01 NO DATA 4.12E+01 1.30E405 6.30E+05 I NB-95 1.86EM 4 1.03E+04 5.66E403 NO DATA 1.00EM4 7.51E+05 9.68E+04 MO-99 NO DATA 1.69E+02 3.22E+01 NO DATA 4.11E402 1.54E+05 2.69E+05 TC-99m 1.38E-03 3.86E-03 4.99E-02 NO DATA 5.76E-02 1.15E+03 6.13E+03 TC-101 5.92E-05 8.40E-05 8.24E-04 NO DATA 1.52E-03 6.67E+02 8.72E-07 RU-103 2.10E+03 NO DATA 8.96E+02 NO DATA 7.43E+03 7.83E+05 1.09E+05 RU-105 1.12E+00 NO DATA 4.34E-01 NO DATA 1.41EMO 1.82E+04 9.04E%4 RU-106 9.84E%4 NO DATA 1.24E+04 NO DATA 1.90E+05 1.61E+07 9.60E+05 I AG-110m TE-125m 1.38E+04 4.88E+03 1.31E+04 2.24E403 7.99E+03 6.67E+02 NO DATA 1.40E+03 2.50E+04 NO DATA 6.75E+06 5.36E+05 2.73 EMS 7.50E+04 TE-127m 1.80E+04 8.16E403 2.18E+03 4.38E% 3 6.54E+04 1.66E+06 1.59E+05 TE-127 2.01E+00 9.12E-01 4.42E-01 1.42EMO 7.28E+00 1.12EM4 8.08E+04 TE-129m 1.39E+04 6.58E+03 2.25E+03 4.58E+03 5.19E+04 1.98E+06 4.05E405 TE-129 7.10E-02 3.38E-02 1.76E-02 5.18E-02 2.66E-01 3.30E+03 1.62E+03 TE-131m 9.84E+01 6.01E+01 4.02E+01 7.25E+01 4.39E+02 2.38E+05 6.21E+05 TE-131 1.58E-02 8.32E-03 5.04E-03 1.24E-02 6.18'.-02 2.34E+03 1.51E+01 TE-132 3.60E+02 2.90E+02 2.19E+02 2.46E+02 1.53E+03 4.49E+05 4.63E+05 I-130 6.24EM3 1.78E+04 7.17E+03 1.49E+06 2.75E+04 NO DATA 9.12E+03 1-131 3.54E+04 4.91E+04 2.64EM4 1.46E+07 8.40EM 4 NO DATA 6.49E+03 I-132 1.59E+03 4.38E+03 1.58E+03 1.51EM5 6.92E+03 NO DATA 1.27E+03 I I-133 I-134

1. 22E404 8.88E+02 2.05E+04 2.32EM3 6.22E+03 8.40E+02 2.92E+06 3.95E+04 3.59E+04 3.66E+03 NO DATA NO DATA 1.03E+04 2.04E+01 CLINTON-I 3-68 Rev.5-2/89 lI

CPS-ODCM TABLE 3.5-15 (continued)

INHALATION PATINAY FACTORS - R,1) (TEEN)

. (mrem /yr per pCi/m3)

ORGAN: BONE LIVER T.EODY THYROID KIDNEY LUNG GI-LLI ISOTOPE I-135 3.70E+03 9.44E+03 3.49E+03 6.21E+05 1.49E+04 NO DATA 6.95E+03 I CS-134 CS-136 :

5.02E+05 5.15E+04 1.12E+06 1.94EM5 5.49E+05 1.37E+05 NO DATA NO DATA 3.75E+05 1.10EM5 1.46E+05 1.78E+04 9.76E+03 1.09E+04 l s.

CS-137 6.70E+05 8.48E+05 3.11E+05 NO DATA 3.04E+05 1.21E405 8.48E+03 CS-138 4.66E+02 8.56E+02 4.46E+02 NO DATA 6.62E+02 7.87E+01 2.70E-01 BA-139 1.34E+00 9.44E-04 3.90E-02 NO DATA 8.88E-04 6.46E+03 6.45E+03 BA-140 5.47E+04 6.70E+01 3.52E+03 NO DATA 2.28E+01 2.03E+06 2.29E+05 Q BA-141 1.42E-01 1.06E-04 4.74E-03 NO DATA 9.84E-05 3.29E+03 7.46E-04 E BA-142 3.70E-02 3.70E-05 2.27E-03 NO DATA 3.14E-05 1.91EM3 4.79E-10 LA-140 4.79E+02 2.36E+02 6.26E+01 NO DATA NO DATA 2.14E+05 4.87E+05 LA-142 9.60E-01 4.25E-01 1.06E-01 NO DATA NO DATA 1.02E+04 1.20E+04 CE-141 2.84E+04 1.90EM4 2.17E+03 NO DATA 8.88EM3 6.14E+05 1.26E+05 CE-143 2.66E+02 1.94E+02 2.16E+01 NO DATA 8.64EMI 1.30E+05 2.55E+05 CE-144 4.89E+06 2.02E+06 2.62E+05 NO DATA 1.21E+06 1.34E407 8.64E+05 PR-143 1.34EM4 5.31EM 3 6.62E+02 NO DATA 3.09EM3 4.83E+05 2.14E+05 PR-144 4.30E-02 1.76E-02 2.18E-03 NO DATA 1.01E-02 1.75E+03 2.35E-04 ND-147 7.86E+03 8.56EM3 5.13E+02 N0' DATA 5.02E+03 3.72E+05 1.82E+05 W-187 1.20E+01 9.76E+00 3.43EMO NO DATA NO DATA 4.74E+04 1.77E+05 NP-239 3.38E+02 3.19EMI 1.77EM1 NO DATA 1.00E+02 6.49E+04 1.32E+05

1.27 x 103 I O* Less than 8.00 x 10-15 .

I .

CLINTON-I 3-69 I Rev.5-2/89 I -

CPS-ODCM TABLE 3.5-16 I IIMALATION PATHWAY FACTORS - R ..(ADULT)

I an .

(mrem /yr per pCi/m3)

ORGAN: BONE LIVER

~

T. BODY THYROID KIDNEY LUNG GI-LLI

~

ISOTOPE H-3 NO DATA 1.26E+03* 1.26E+03 1.26EM3 1.26E+03 1.26E+03 1.26E+03 C-14 1.82EM4 3.41E+03 3.41EM3 3.41E403 3.41E+03 3.41E+03 3.41F+03 NA-24 , 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E444 1. 0'.2; r04 i

I P-32 CR-51 MN-54 1.32E406 NO DATA 7.71E+04 NO DATA 5.01E+04 1.00EM2 NO DATA 5.95E+01 NO DATA 2.28E+01 NO DATA 1.44E+04 8.64E+04 3.32E+03 NO DATA 3.96E404 6.30EM3 NO DATA 9.84E+03 1.40E+06 7.74E+04 I MN-56 NO DATA 1.24E+00 1.83E-01 NO DATA 1.30EM0 9.44E+03 2.02E+04 FE-55 2.46E+04 1.70E+04 3.94E+03 NO DATA NO DATA 7.21E+04 6.03E+03

.I FE-59 1.18E+04 2.78E+04 1.06EM4 NO DATA NO DATA 1.02E+06 1.88E405 C0-58 NO DATA 1.58E+03 2.07E+03 NO DATA NO DATA 9.28E+05 1.06E+05 CO-60 NO DATA 1.15E+04 1.48E+04 NO DATA NO DATA 5.97E+06 2.85E+05 NI-63 4.32E+05 3.14E+04 1.45E+04 NO DATA NO DATA 1.78E+05 1.34E+04 NI-65 1.54E+00 2.10E-01 9.12E-02 NO DATA NO DATA 5.60E+03 1.23E+04 CU-64 NO DATA 1.46EMO 6.15E-01 NO DATA 4.62E+00 6.78E+03 4.90E% 4 ZN-65 3.24E+04 1.03E+05 4.66E+04 NO DATA 6. 90E404 8.64E+05 5.34EM4 ZN-69 3.38E-02 6.51E-02 4.52E-03 No DATA 4.22E-02 9.20E+02 1.63E+01 BR-83 NO DATA NO DATA 2.41E+02 NO DATA NO DATA NO DATA 2.32E+02 BR-84 NO DATA NO DATA 3.13EM 2 NO DATA NO DATA NO DATA 1.64E-03 I BR-85 110 DATA NO DATA 1.28EMI NO DATA NO DATA I

NO DATA LT8E-15**

I RB-86 RB-88 NO DATA NO DATA 1.35E+05 3.87E+02 5.90E+04 1.93E+02 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 1.66E+04 3.34E-09 ;

RB-89 NO DATA 2.56E+02 1.70E+02 NO DATA NO DATA NO DATA 9.28E-12 -

SR-89 3.04E+05 NO DATA 8.72E+03 NO DATA NO DATA 1.40E+06 3.50E+05 SR-90 9.92E+07 NO DATA 6.10EM6 NO DATA NO DATA 9.60E+06 7.22E%5 l

l l

SR-91 6.19E401 NO DATA 2.50E+00 NO DATA NO DATA 3.65E+04 1.91E405 !

I SR-92 Y-90 6.74E+00 2.09E+03 NO DATA NO DATA 2.91E-01 5.61E+01 NO DATA NO DATA NO DATA NO DATA 1.65E+04 1.70E+05 4.30E404 5.06 EMS j l

l I CLINTON-I 3-70 Rev.5-2/89

? CPS-0DCM TABLE 3.5-16 (continued)

INHALATION PATHWAY FACTORS - R (ADULT)

(mrem /yr per pCi/m3)

ORGAlu BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOToFE Y- 91m 2.61E-01 NO DATA 1.02E-02 NO DATA NO DATA 1.92E+03 1.33E+00 I Y-91 Y-92 :

4. 62 EMS 1.03E+01 NO DATA NO DATA 1.24E+04 3.02E-01 NO DATA NO DATA NO DATA NO DATA 1.70E+06 1.57E+04 3.85E+05 7.35E404 i

Y-93 9.44E+01 NO DATA 2.61E+00 NO DATA NO DATA 4.85E+04 4.22E+05 ZR-95 1.07E405 3.44E+04 2.33E+04 NO DATA 5.42E+04 1.77E+06 1.50E405 ZR-97 9.68E401 1.96E401 9.04E% 0 NO DATA 2.97E401 7.87E+04 5.23 EMS NB-95 1.41EM4 7.82E+03 4.21EM3 NO DATA 7.74E403 5.05E405 1.04E+05 MO-99 NO DATA 1.21E+02 2.30E+01 NO DATA 2.91E+02 9.12E+04 2.48E+05 TC-99m 1.03E-03 2.91E-03 3.70E-02 NO DATA 4.42E-02 7.64EM2 4.16E+03 TC-101 4.18E-05 6.02E-05 5.90E-04 NO DATA 1.08E-03 3.99E+02 1.09E-11 RU-103 1.53EM 3 NO DATA 6.58E% 2 NO DATA 5.83E+03 5.05E+05 1.10E+05 RU-105 7.90E-01 NO DATA 3.11E-01 NO DATA 1.02EMO 1.10E%4 4.82E%4 RU-106 6.91E%4 NO DATA 8.72E403 NO DATA 1.34E+05 9.36EM 6 9.12E+05 I AG-110m TE-125m 1.08E+04 3.42E+03 1.00E404 1.58E+03 5.94E% 3 4.67E+02 NO DATA 1.05E+03 1.97EM 4 1.24E+04 4.63E+06 3.14E+05 3.02E405 7.06E+04 TE-127m 1.26E+04 5.77E403 1.57EM3 3.29E403 4.58E+04 9.60EM5 1.50EM5 TE-127 1.40E+00 6.42E-01 3.10E-01 1.06E+00 5.10E+00 6.51E+03 5.74E+04 TE-129m 9.76EM3 4.67E+03 1.58E+03 3.44E+03 3. 66E404 1.16E% 6 3.83E+05 TE-129 4.98E-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01 1.94E+03 1.57E+02 TE-131m 6.99E401 4.36E+01 2.90E% 1 5.50E+01 3.09E+02 1.46E+05 5.56E+05 TE-131 1.11E-02 5.95E-03 3.59E-03 9.36E-03 4.37E-02 1.39E+03 1.84E401 TE-132 2.60E+02 2.15E+02 1.62E402 1.90E+02 1.46E403 2.88E+05 5.10E+05 -

I-130 4.58E+03 1.34E+04 5.28E+03 1.14E+06 2.09E+04 NO DATA 7.69E+03 2.52E%4 3.58E+04 2.05E+04 1.19E+07 6.13E% 4 I .1-131 NO DATA 6.28E+03 I-132 1.16E+03 3.26E+03 1.16E%3 1.14E+05 5.18E+03 NO DATA 4.06E+02 I I-133 I-134 8.64EM3 6.44EM 2 1.48E+04 1.73E+03 4.52E% 3 6.15E% 2 2.15E+06 2.98E%4 2.58E+04 2.75E+03 NO DATA NO DATA 8.88E+03 1.01E+00 CLINTON-7 3-71 Rev.5-2/89

1 CPS-0DCM TABLE 3.5-16 (continued)

INHALATION PATHWAY FACTORS - R (ADULT)

^

(mrem /yr per pCi/m3) l ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI j ISOTOPE I-135 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.11E%4 NO DATA 5.25E%3 CS-134 3.73E+05 8.48E+05 7.28E+05 NO DATA 2.87E+05 9.76E+04 1.04E+04 CS-136 3.90E+04 1.46 EMS 1.10 EMS NO DATA 8.56EM4 1.20E%4 1.17E+04

'u CS-137 4.78E+05 6.21E+05 4.28E+05 NO DATA 2.22E+05 7.52E+04 8.40E%3 CS-138 3.31EM2 6.21E+02 3.24E+02 NO DATA 4.80E+02 4.86E+01 1.86E-03 l

BA-139 9.36E-01 6.66E-04 2.74E-02 NO DATA 6.22E-04 3.76E%3 8.96E+02 BA-140 3.90E+04 4. 90EMI 2.57E+03 NO DATA 1.67E+01 1.27E+06 2.18E%5 I BA-141 BA-142 1.00E-01 2.63E-02 7.53E-05 2.70E-05 3.36E-03 1.66E-03 NO DATA NO DATA 7.00E-05 2.29E-05 1.94E+03 1.19E+03 1.16E-07 1.57E-16 LA-140 3.44E+02 1.74E+02 4.58E+01 NO DATA NO DATA 1.36E+05 4.58E+05 LA-142 6.83E-01 3.10E-01 7.12E-02 NO DATA NO DATA 6.33E+03 2.11E%3 CE-141 1.99E+04 1.35E+04 1.53E+03 N0 DATA 6.26E+03 3.62E45 1.20 EMS I CE-143 1.86E+02 1.38E+02 1.53E+01

~

NO DATA 6.08E+01 7.98E+04 2.26E45 I CE-144 PR-143 3.43E+06 9.36E+03 1.43E+06 3.75E%3 1.84E+05 4.64E+02 NO DATA NO DATA 8.48E+05 2.16E+03 7.78E+06 2.81E45 8.16E45 2.00 EMS PR-144 3.01E-02 1.2SE-02 1.53E-03 NO DATA 7.05E-03 1.02E%3 2.15E-08 I ND-147 5,27E+03 6.10EM3 3.65E+02 NO DATA 3.56EM 3 2.21E+05 1.73E+05 W-187 8.48E+00 7.08E+00 2.48E+00 NO DATA NO DATA 2.90E%4 1.55E+05 j NP-239 2.30E+02 2.26E+01 1.24E+01 NO DATA 7.00EMI 3.76E44 1.19E+05 l 3 l

0 1.26 x 10

- Less than 8.00 x10-15 I

il CLINTON-I 3-72 Rev.5-2/89 1

CPS-0DCM I

TABLE 3.5-17 COW MILK PATHWAY FACTORS - R (INFANT)

(m2 mrem /yr per pCi/sec)

I ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 2.38EM3* 2.38E%3* 2.38E403

2.38E+03* 2.38E%3* 2.38E403*

I C-14 NA-24 3.23E+06* 6.89E+05* 6.89E+05* 6.89E405* 6.89E+05* 6.89E+05*

1.55E+07** 1.55E+07 1.55EM7 1.55E+07 1.55E+07 1.55E% 7 6.89E+05*

1.55E407

(

P-32 1.60E+11 9.41E409 6.20E+09 NO DATA NO DATA NO DATA 2.16E+09 CR-51 NO DATA NO DATA 1.61E+05 1.05E+05 2.29E+04 2.04E+05 4.69E+06 MN-54 NO DATA 3.90E+07 8.84E406 NO DATA 8.64E+06 NO DATA 1.43E+07 MN-56 NO DATA 3.12E-02 5.39E-03 NO DATA 2.69E-02 NO DATA 2.84E+00 I FE-55 FE-59 1.35E+08 2.25E+08 8.72E+07 3.92E+08 2.33E+07 1.55E+08 NO DATA NO DATA NO DATA NO DATA 4.26E+07 1.16E+08 1.11E+07 1.87E+C8 CO-58 NO DATA 2.43E+07 6.06E407 NO DATA NO DATA NO DATA 6.05E+07 CO-60 NO DATA 8.82E+07 2.08E408 NO DATA NO DATA NO DATA 2.10E+08 NI-63 3.50E+10 2.16E+09 1.21EM 9 NO DATA NO DATA NO DATA 1.08E+08 NI-65 3.52E+00 3.98E-01 1.81E-01 NO DATA NO DATA NO DATA 3.03E+01 I CU-64 IN-65 NO DATA 5.55E+09 1.84E+05 1.91E+10 8.52E+04 8.78EM9 NO DATA NO DATA 3.11E+05 9.23E+09 NO DATA NO DATA 3.78EM 6 1.61E+10 ZN-69 1.94E-11 3.49E-11 2.60E-12 NO DATA 1.45E-11 NO DATA 2.85E-09 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA KO DATA NO DATA NO DATA NO DATA I RB-86 RB-88 NO DATA NO DATA 2.23E+10 1.88E-44 1.10E+10 1.03E-44 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 5.70E+08 1.83E-44 RB-89 NO DATA 3.43E-52 2.36E-52 NO DATA NO DATA NO DATA 1.17E-52 -

SR-89 1.26E+10 NO DATA 3.61E+08 NO DATA NO DATA NO DATA 2.59E+08 SR-90 1.22E+11 NO DATA 3.10E+10 NO DATA NO DATA NO DATA 1.52E+09 SR-91 2.71E+05 NO DATA 9.76E+03 NO DATA NO DATA NO DATA 3.20E+05 i I SR-92 Y-90 4.68E+00 6.83E+02 NO DATA NO DATA 1.74E-01 1.83E401 NO DATA NO DATA

'NO DATA NO DATA NO DATA NO DATA 5.05E+01 9.43E+05 I CLINTON-1 3-73 Rev.5-2/89 i I I I

CPS-0DCM I TABLE 3.5-17 (continued) j COW MILK PATHWAY FACTORS - R C (INFANT)

(n;2 mrem /yr per y Ci/sec)

I ,

)

1 ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE f

Y-91m 6.09E-19 NO DATA 2.08E-20 NO DATA NO DATA NO DATA 2.03E-15 l Y-91 7.33E+04 NO DATA 1.95E+03 NO DATA NO DATA NO DATA 5.26E+06 l Y-92 ) 5.35E-04 NO DATA 1.50E-05 NO DATA NO DATA NO DATA 1.02E+01 Y-93 2.14E%0 NO DATA 5.83E-02 NO DATA NO DATA NO DATA 1.69E+04 ZR-95 6.82E+03 1.66E+03 1.18E+03 NO DATA 1.79E+03 NO DATA 8. 28 EMS ZR-97 4.03E+00 6.96E-01 3.16E-01 NO DATA 7.01E-01 NO DATA 4.41E% 4 NB-95 5.93 EMS 2.44E+05 1.41E+05 NO DATA 1. 75E-K)5 NO DATA 2.06E% 8 MO-99 NO DATA 2.07E H)8 4.04E+07 NO DATA 3.10E+08 NO DATA 6.83E+07 TC-99m 2.75E+01 5.66EMI 7.29EM 2 NO DATA 6.09E+02 2. 96E-K)1 1.64EM4 TC-101 2.72E-59 3.42E-59 3.39E-58 NO DATA 4.07E-58 1.87E-59 5.81E-57 RU-103 8.67E+03 NO DATA 2.92E+03 NO DATA 1.81E+04 NO DATA 1.06E+05 RU-105 8.00E-03 NO DATA 2.70E-03 NO DATA 5.88E-02 NO DATA 3.18E+00 RU-106 1.91E+05 NO DATA 2.38EM 4 NO DATA 2.26E%5 NO DATA 1.45E+06 AG-110m 3.85E+08 2.81E+08 1.86E+08 NO DATA 4.02E+08 NO DATA 1.46E+10 TE-125m 1.51EM8 5.05E+07 2.04E+07 5.08E+07 NO DATA NO DATA 7.19E+07 TE-127m 4.22E+08 1.40E+08 5.10E+07 1.22EM8 1.04E+09 NO DATA 1.70E+08 TE-127 6.31E+03 2.11EM 3 1.39E+03 5.13E6 3 1.58E+04 NO DATA 1.36ER S TE '129m 5.56EM8 1.91E+08 8.56E+07 2.14EM8 1.39E+09 NO DATA 3.32E+08 TE-129 2.71E-09 9.34E-10 6.33E-10 2.27E-09 6.75E-09 NO DATA 2.17E-07 TE-131m 3.37E+06 1.36E+06 1.12E+06 2.75E+06 9.35E+06 NO DATA 2.29E%7 TE-131 3.48E-32 1.29E-32 9.78E-33 3.11E-32 8.91E.32 NO DATA 1.41E-30 TE-132 2.12E+07 1.05E% 7 9.80E+06 1.55EM 7 6.57E+07 NO DATA 3.89E+07 -

I-130 3.53E+06 7.76E+06 3.12E+06 8.70E+08 8.53E+06 NO DATA 1.66E+06 I-131 2.71EM9 3.19EM9 1.40E+09 1.05E+12 3.73E+09 NO DATA 1.14EM8 I-132 1.43E+00 2.90E+00 1.03E+00 1.36E+02 3.24E+00 NO DATA 2.35E+00 I I-133 I-134 3.63E+07 1.64E-11 5.28E+07 3.36E-11 1.55EM 7 1.20E-11 9.60EM 9 7.86E-10

6. 21 E-K)7 3.76E-11 NO DATA NO DATA 8.93E+06 3.48E-11 I CLINTON-I 3-74 Rev.5-2/89

CPS-0DCM I

TABLE 3.5-17 (continued)

COW MILK PATHWAY FACTORS - R (INFANT)

(m2 mrem /yr perp Ci/sec)

I ORGAN: BONE. LIVER T. BODY THYROID KIDNEY LUNG CI-LLI ISOTOPE I-135 1.13 EMS 2.24 EMS 8.18E+04 2.01E+07 2.50E+05 NO DATA 8.12E+04 CS-134 3.65E+10 6.81E+10 6.88E+09 NO DATA 1.75E+10 7.19E+09 1.85E+08 CS-136 ; 1.97EM9 5.81E+09 2.17E+09 NO DATA 2.31E+09 4.73E+08 8.82EM7 u

CS-137 5.15E+10 6.03E+10 4.27EM9 NO DATA 1.62E+10 6.55EM9 1.89E+08 CS-138 8.06E-23 1.31E-22 6.35E-23 NO DATA 6.53E-23 1.02E-22 2.09E-22 BA--139 4.29E-07 '2.84E-10 1.24E-08 NO DATA 1.71E-10 1.72E-10 2.72E-05 BA-140 2.45E+08 2.45E+05 1.26E+07 NO DATA 5.72E+04 1.50EM5 5.92E+07 BA-141 4.16E-45 2.85E-48 1.31E-46 NO DATA 1.71E-48 1.73E-48 5.08E-44 BA-142 2.32E-79 1.93E-82 1.14E-80 NO DATA 1.11E-82 1.17E-82 9.56E-79 LA-140. 4.05E+01 1.60E+01 4.11E+00 NO DATA NO DATA NO DATA 1.88E+05 LA-142 1.73E-10 6.34E-11 1.52E-11 NO DATA NO DATA NO DATA 1.08E-05 CE-141 4.34E+04 2.65E+04 3.12E+03 I

NO DATA 8.17E@ 3 NO DATA 1.37E+07 CE-143 3.98E+02 2.64E+05 3.01EMI NO DATA 7.69E+01 NO DATA 1.54E+06 I CE-144 PR-143 2.34EM6 1.49E+03 9.56E+05 5.56E+02 1.31E+05 7.37EMI NO DATA NO DATA 3.87E+05 2.07E+02 NO DATA NO DATA 1.34E+08 7.85E+05 PR-144 6.27E-53 2.43E-53 3.16E-54 NO DATA 8.79E-54 NO DATA 1.13E-48 ND-147 8.79E+02 9.03E+02 5.53EMI NO DATA 3.48E+02 NO DATA 5.72E+05 W-187 6.10E+04 4.24E+04 1.46E+04 I

NO DATA NO DATA NO DATA 2.49E+06 NP-239 3.64E+01 3.26E+00 1.84E+00 NO DATA 6.49E+00 NO DATA 9.41E+04

mrem /yr per yCi/m3 00 1.55 x 10 7 I

I CLINTON-I 3-75 Rev.5-2/89

CPS-0DCM I TABLE 3.5-18 C

COW MILK PATHWAY FACTORS - alj R ..(CHILD)

(m mrem /yr per pCi/sec) 2 I !

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I

ISOTOPE H-3 NO DATA 1.57EM3* 1.57EM3* 1.57E+03* 1.57E+03* 1.57E+03* 1.57E+03*

I C-14 NA-24 :

1.65E+06* 3.29E+05* 3.29E+05* 3.29E+05* 3.29E+05* 3.29E+05*

8.93E+06** 8.93E+06 8.93E+06 8.93E+06 8.93Et06 8.93E+06 3.29E+05*

8.93E+06 i.

I P-32 CR-51 7.79E+10 NO DATA 3.64E+09 NO DATA 3.00EM9 1.01E+05 NO DATA 5.63E+04 NO DATA 1.54E+04 NO DATA 1.03E+05 2.15EM9 5.38E+06 i

I HN-54 NO DATA 2.10E+07 5.59E+06 NO DATA 5.88E+06 NO DATA 1.76E+07 MN-56 NO DATA 1.28E-02 2.88E-03 NO DATA 1.54E-02 NO DATA 1.85E+00 I FE-55 FE-59 1.12E+08 1.20E+08 5.94EM 7 1.95E6 8 1.84E+07 9.71E@7 NO DATA NO DATA NO DATA NO DATA 3.36E+07

5. 65E%7 1.10E407 2.03EM8 CO-58 NO DATA 1.21EM 7 3.71E+07 NO DATA NO DATA NO DATA 7.0SE+07 CO-60 NO DATA 4.32E+07 1.27E+08 NO DATA NO DATA NO DATA 2.39E+08 NI-63 2.97E+10 1.59E+09 1.01E+09 NO DATA NO DATA NO DATA 1.07E+08 NI-65 1.65EMO 1.56E-01 9.10E-02 NO DATA NO DATA NO DATA 1.91E+01 I CD-64 ZN-65 NO DATA 4.13E+09 7.40E+04 1.10E+10 4.47E+04 6.83EM9 NO DATA NO DATA 1.79E+05 6.92E+09 NO DATA NO DATA 3.47E+06 1.93E+09

{

ZN-69 9.11E-12 1.32E-11 1.22E-12 NO DATA 7.99E-12 NO DATA 8.30E-10 BR-83 ]'

NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 NO DATA 8.78EM9 5.40Ev09 NO DATA NO DATA NO DATA 5.65EM8 RB-88 NO DATA 7.16E-45 4.98E-45 NO DATA NO DATA NO DATA 3.51E-46 l

RB-89 NO DATA 1.4GE-52 1.25E-52 NO DATA NO DATA NO DATA 1.22E-54 -

SR-89 6.63E+09 NO DATA 1.89E+08 NO DATA NO DATA NO DATA 2.57E% 8 SR-90 1.12E+11 NO DATA 2.84E+10 NO DATA NO DATA NO DATA 1.51E+09 i

r I

I 1

CLINTON-1 3-76 Rev.5-2/89 I -

CPS-0DCM I

TABLE 3.5-18 (continued)

COW MILK PATHWAY FACTORS - R (CHILD)

(m2 mrem /yr per pCi/sec) 'l ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE SR-91 1.30 EMS NO DATA 4.89EM3 NO DATA NO DATA NO DATA 2.86E+05 SR-92 2.20E+00 NO DATA 8.83E-02 NO DATA NO DATA NO DATA 4.17EMI Y-90 : 3. 23E+02 NO DATA 8.65E+00 NO DATA NO DATA NO DATA 9.20E+05 Y-91m 2.88E-19 NO DATA 1.05E-20 NO DATA NO DATA NO DATA 5.63E-16 Y-91 3.90E+04 NO DATA 1.04E+03 NO DATA NO DATA NO DATA 5.20EM6 Y-92 2.53E-04 NO DATA 7.23E-06 NO DATA NO DATA NO DATA 7.30E%0 Y-93 1.01E+00 NO DATA 2.76E-02 NO DATA NO DATA NO DATA 1.50E+04 I ZR-95 ZR-97 3.84E+03 1.92EM O 8.44E+02 2.78E-01 7.51E+02 1.64E-01 NO DATA NO DATA 1.21E+03 3.99E-01 NO DATA NO DATA 8.80E+05 4.21E%4 NS-95 3.18E+05 1.24 EMS 8.84E+04 NO DATA 1.16E+05 NO DATA 2.29E+08 MO-99 NO DATA 8.15E+07 2.02E+07 NO DATA 1.74E+08 NO DATA 6.74E+07 TC-99m 1.32E+01 2.58E+01 4.28E+02 NO DATA 3. 75 E+02 1.31E@l 1.47E+04 TC-101 1.28E-59 1.34E-59 1.70E-58 NO DATA 2.29E-58 7.08E-60 4.26E-59 I RU-103 RU-105 4.29EM 3 3.80E-03 NO DATA NO DATA 1.65E+03 1.38E-03 NO DATA NO DATA 1.08E+04 3.34E-02 NO DATA NO DATA 1.11E+05 2.48E+00 RU-106 9.25EM 4 NO DATA 1.15E+04 NO DATA 1.25E+05 NO DATA 1.44EM6 AG-110m 2.09E+08 1.41EM 8 1.13E+08 NO DATA 2.63E+08 NO DATA 1.68E+10 TE-125m 7.39E+07 2.00E+07 9.85Ee6 2.07EM7 NO DATA NO DATA 7.13EM7 TE-127m 2.08E+08 5.61EM 7 2.47E+07 4.98EM7 5.94E+08 NO DATA 1.69E% 8 I TE-127 TE-129m 2.97E+03 2.71E+08 8.01EM 2 7.58E+07 6.37E+02 4.21E+07 2.06E+03 8.74E+07 8.45E+03 7.97E+08 NO DATA NO DATA 1.16E+05 3.31E+08 TE-129 1.28E-09 3.57E-10 3.04E-10 9.12E-10 3.74E-09 NO DATA 7.96E-08 -

TE-131m 1.60E+06 5.53E+05 5.88E+05 1.14EM 6 5.35E+06 NO DATA 2.24E+07 TE-131 1.64E-32 5.01E-33 4.89E-33 1.26E-32 4.97E-32 NO DATA 8.63E-32 TE-132 1.03E+07 4.56E+06 5.51E+06 6.64E46 4.23E+07 NO DATA 4.59E+07 I I-130 I-131

1. 72E+C6 1.30E+09 3.47E+06 1.31E+09 1.79E+06 7.44E+08 3.82E% 8 4.33E+11 5.19E+06 2.15E+09 NO DATA NO DATA

1. 62E406 1.17E+08 I CLINTON-I 3-77 Rev.5-2/89 l

CPas-UDCM 1 TABLE 3.5-18 (continued)

I C COW MILK PATHWAY FACTORS - R ..(CHILD) at]

I (m2 mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOT0FE i I 132 6.91E-01 1.27EMO 5.84E-01 5.89E+01 1.94E400 NO DATA 1.49E+00 I-133 1.72E407 I I-134 ,

7.92E-12 2.12E407 1.47E-11 8.03E406 6.77E-12 3.94E+09 3.38E-10 3.54EM7 2.25E-11 NO DATA NO DATA 8.56E+06 9.75E-12 I I-135 CS-134 CS-136 5.43EM 4 2.27E+10 1.01EM9 9.77EM4 3.72E+10 4.62E+04 7.85E+09 8.65E+06 NO DATA 1.50 EMS 1.15E+10 NO DATA 4.14E+09 7.44E+04 2.01E+08 2.78E+09 1.80E+09 NO DATA 1.48EM9 2.21E+08 9.76EM7 CS-137 3.23E+10 3.09E+10 4.56EM9 NO DATA 1.01E+10 3.63E+09 1.94E408 CS-138 3.82E-23 5.31E-23 3.37E-23 NO DATA 3.74E-23 4.02E-24 2.45E-23 BA-139 2.01E-07 1.08E-10 5.84E-09 NO DATA 9.39E-11 6.33E-11 1.16E-05 l BA-140 1.18E+08 1.03E+05 6.84E+06 NO DATA 3.37E+04 6.12E+04 5.94E+07 1

BA-141 1.96E-45 1.10E-48 6.38E-47 NO DATA 9.50E-49 6 45E-48 1.12E-45 BA-142 1.10E-79 7.93E-83 6.15E-81 NO DATA 6.41E-83 4.66E-83 1.44E-81 I LA-140 1.94E401 6.78E+00 2.11E+00 NO DATA NO DATA NO DATA 1.89E405 LA-142 8.23E-11 2.62E-11 8.21E-12 NO DATA NO DATA NO DATA 5.20E-06 I. CE-141 4.94E404 1.09E+04 1.62E403 NO DATA 4.78E+03 NO DATA 1.36E+07 CE-143 1.87EM2 1.02E+05 1.47E+01 NO DATA 4.26E+01 NO DATA 1.49E+06 CE-144 1.63E+06 5.10E+05 8.68E+04 NO DATA 2.82E+05 NO DATA 1.33E+08 PR-143 7.19E+02 2.16E402 3.57E+01 NO DATA 1.17E402 NO DATA 7.76E+05 PR-144 2.94E-53 9.10E-54 1.48E-54 NO DATA 4.81E-54 NO DATA 1.96E-50 l

ND-147 4.44EM2 3.59E+02 2.78E+01 NO DATA 1.97E+02 NO DATA 5.69E405 W-187 2.88E+04 1.71E+04 7.66E+03 NO DATA 140 DATA NO DATA 2.40E+06 NP-239 1. 72E401 1.24E+00 8.69E-01 NO DATA 3.58E+00 NO DATA 9.15E+04 .

O mrem /yr per p Ci/m3

- 8.'93.x 106 CLINTON-I 3-78 Rev.5-2/89 I - -

cn,-cecw ;

1 TABLE 3.5-19 COW MILK PATHWAY FACTORS - R 1)( M )

(m mrem /yr per pCi/sec) 2 -

I ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI i)

ISOTOPE '

H-3 NO DATA 9.92E402* 9.92E+02* 9.92E+02* 9.92E+07* 9.92E4 2* 9.92E+02*

C-14 6. 70E+05

1.34E+05* 1.34 EMS

1.34E+05* 1.34r.65* 1.34E+05* 1.34E+05*

I HA-24 I

i' 4.29E% 6** 4.29E+06 4.29EM 6 4.29E+06 4.29E+06 4.29EM 6 4.29E+06 P-32 3.15E+10 1.95EM9 1.22E+09 NO DATA NO DATA NO DATA 2.64EM 9

,CR-51 NO DATA NO DATA 5.00E+04 2.78E404 1.10E+04 7.14E+04 8.41E+06 MN-54 NO DATA 1.40EM 7 2.78E+06 NO DATA 4.19E+06 NO DATA 2.88E+07 <

MN-56 NO DATA 7.32E-03 1.30E-03 NO DATA 9.26E-03 NO DATA 4.82E-01 FE-55 4.46EM 7 3.16E+07 7.38E+06 NO DATA NO DATA 2.01E+07 1.37E+07 FE-59 5.18E+07 1.21E+08 4.67E+07 NO DATA NO DATA 3.81E+07 2.86E+08 '

I CO-58 CO-60 NI-63 NO DATA NO DATA 1.18E+10 7.98E+06 2.78E+07 8.34E+08 1.84E+07 6.26E+07 4.00E+08 NO DATA NO DATA NO~ DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 1.10E+08 3.62E+08 1.33E+08 i NI-65 6.79E-01 8.67E-02 3.95E-02 NO DATA NO DATA NO DATA 4.70E+00 CU-64 NO DATA 4.20E+04 1.97E+04 NO DATA 1.06E+05 NO DATA 3.26E+06 ZN-65 2.11EM9 7.32E+09 3.41EM9 NO DATA 4.68E+09 NO DATA 3.10E409 I ZN-69 3.70E-12 7.06E-12 4.94E-13 NO DATA 4.61E-12 NO DATA 1.30E-11 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA I BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA l I 3R-85 RB-86 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA I

NO DATA 4.74E+09 2.23Ee 9 NO DATA NO DATA NO DATA 7.01E+08 RB-88 NO DATA 3.90E-45 2.08E-45 NO DATA NO DATA NO DATA 3.34E-52

) I RB-89 SR-89 SR-90 NO DATA 2.68E+09 6.62E+10 7.98E-53 NO DATA NO DATA 5.64E-53 7.67E+07 1.64E+10 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 1.22E-61 3.19E+08 1.86E+09

!I I

SR-91 5.27E+04 NO DATA 2.10E+03 NO DATA NO DATA NO DATA 2.39E405 SR-92 9.03E-01 NO DATA 3.85E-02 NO DATA NO DATA NO DATA 2.30E+01 Y-90 1.31E402 NO DATA 3.53E+00 NO DATA NO DATA NO DATA 1.08E+06 i

$LINTON-I 3-79 Rev.5-2/89 j

w.- -.~a.

TABLE 3.5-19 (continued)

COW MILK PATHWAY FACTORS - R (TEEN)

(m2 mrem /yr per pCi/sec) '

l ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE I

Y-91m 1.18E-19 NO DATA 4.49E-21 NO DATA NO DATA Y-91 NO DATA 5.55E-18 1.58E404 NO DATA 4.24E+02 NO DATA NO DATA NO DATA Y-92 6.48EM 6 1.03E-04 NO DATA 2.97E-06 NO DATA NO DATA NO DATA 2.82EMO t

Y-93 4.10E-01 NO DATA 1.12E-02 NO DATA NO DATA

'I ZR-95 ZR-97 1.65EM 3 7.87E-01 5.20E+02 1.56E-01 3.5SEM2 7.17E-02 NO DATA NO DATA 7.64E+02 2.36E-01 NO DATA NO DATA NO DATA 1.25E+04 1.20E+06 4.22E+04 I NB-95 1.41E405 7.81E404 4.30E+04 NO DATA 7.57E+04 NO DATA 3.34E+08 MO-99 NO DATA 4.46E407 8.50E+06 NO DATA 1.02E+08 NO DATA 7.98E+07 TC-99m 5.74EM O 1.60E+01 2.08E+02 NO DATA 2.39E+02 8.89E+00 1.05E+04 I TC-101 RU-103 RU-105 5.22E-60 1.81E+03 1.56E-03 7.42E-60 NO DATA NO DATA 7.29E-59 7.73E+02 6.06E-04 NO DATA NO DATA NO DATA 1.34E-58 6.37E+03 1.97E-02 4.52E-60 NO DATA NO DATA 1.27E-66 1.51E+05 1.26E+00 I RU-106 3. 75E+04 d0 DATA 4.73E403 NO DATA 7.23E+04 NO DATA 1.80E406 AG-110m 9.64E+07 9.12E+07 5.55E+07 NO DATA 1.74E+08 NO DATA 2.56E+10 TE-125m 3.01E+07 1.08E+07 4.02E+06 8.41EM6 NO DATA NO DATA 8.88E+07 I TE-127m TE-127 TE-129m 8.43E407 1.21E+03 1.10E+08 2.99E+07 4.28E+02 4.09E+07 1.00E+07 2.60E+02 1.74E447 2.01E+07 8.33EM 2 3.56E407 3.42EM8 4.89E+03 4.61E+08 NO DATA NO DATA NO DATA 2.10E408 9.33E+04 4.14E+08 I TE-129 5.18E-10 1.93E-10 1.26E-10 3.70E-10 2.17E-09 NO DATA 2.83E-09 TE-131m 6.56E+05 3.15E+05 2.63E+05 4.73E+05 3.28E+06 NO DATA 2.53E+07 TE-131 6.70E-33 2.76E-33 2.09E-33 5.16E-33 2.93E-32 NO DATA 5.50E-34 l

I TE-132 I-130 I-131 4.29E+06 7.33E+05 5.36E+08 2.72E% 6 2.12E+06 7.50E+08 2.56E406 8.47E+05 4.03E408 2.87E+06 1.73E+08 2.19E+11 2.61E+07 3.27E+06 1.29E+09 NO DATA NO DATA NO DATA 8.61E407

1. 63E406 f

1.48E408

I I-132 2.90E-01 7.59E-01 2.72E-01 2.56E+01 1.20E+00 NO DATA 3.31E-01 1-133 7.06E406 1.20E+07 3.65E+06 1.67E+09 2.10E+07 NO DATA 9.06E+06 I-134 .3.34E-12 8.86E-12 3.18E-12 1.48E-10 1.40E-11 NO DATA 1.17E-13

1 l

CLINTON-I 3-80 Rev.5-2/89 I - -- -- - -- -

CPS-0DCM l

TABLE 3.5-19 (continued) l C COW MILK PATHWAY FACTORS - R ..(TEEN) a13 .

l 3 (m2 mrem /yr per pCi/sec) g l ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE l I-135 2.29E+04 5.90E+04 2.19E404 3.80E406 9.32E+04 NO DATA 6.54E+04 CS-134 9.79E+09 2.30E+10 1.07E+10 NO DATA 7.32EM 9 2.80E+09 2.87EM 8 CS-136 : 4.48E+08 1.76E409 1.18E+09 NO DATA 9.59E+08 1.51E+08 1.42E+08 g s.

3 C3-137 1.33E+10 1.77E+10 6.18E+09 NO DATA 6.03EM9 2.34E409 2.52E+08 CS-138 1.58E-23 3.03E-23 1.51E-23 NO DATA 2.23E-23 2.60E-24 1.37E-26 BA-139 8.20E-08 5.77E-11 2.39E-09 NO DATA 5.44E-11 3.98E-11 7.31E-07 BA-140 4.85E+07 5.95EM4 3.13E+06 NO DATA 2.02E+04 4.00E+04 7.49E+07 BA-141 7.98E-46 5.96E-49 2.67E-4 7 NO DATA 5.53E-49 4.08E-49 1.70E-51 BA-142 4.54E-80 4.54E-83 2.80E-81 NO DATA 3.85E-83 3.02E-83 1.40E-91 l LA-140 8.11E+00 3.9,8E+00 1.06E+00 NO DATA NO DATA NO DATA 2.29E+05 l

LA-142 3.42E-11 1.52E-11 3.78E-12 NO DATA NO DATA NO DATA 4.62E-07 E-141 8.88E+03 5.93E+03 6.81E+02 NO DATA 2.79E403 NO DATA 1.70E+07 E

g -

CE-143 7. 64EMI 5.55EM4 6.21E+00 NO DATA 2.49E401 NO DATA 1.67EM6 I CE-144 PR-143 6.61 EMS 2.91E+02 2.73E+05 1.16E402 3.55E+04 1.45E401 NO DATA NO DATA 1.63 EMS 6.75EMI NO DATA NO DATA 1.66E448 9.57EM5 PR-144 1.19E-53 4.88E-54 6.04E-55 NO DATA 2.80E-54 NO DATA 1.31E-56 ND-147 1.81E402 1.97E+02 1.18E+01 N0' DATA 1.16E+02 NO DATA 7.10 EMS W-187 1.19E+04 9.72E+03 3.41E+03 NO DATA NO DATA NO DATA 2.63E406 l

l NP-239 6.99E+00 6.59E-01 3.66E-01 'NO DATA 2.07E400 NO DATA 1.06E+05 l -I

mrem /yr per pCi/m3 6

- 4.29 x 10 CLINTON-I 3-81 Rev.5-2/89

I TABLE 3.5-20 COW MILK PATHWAY FACTORS - R (ADULT)

(m2 mrem /yr per pCi/sec) '

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI

~

ISOTOPE H-3 NO DATA 7.62E+02* 7.62E+02* 7.62E+02* 7.62E+02* 7.62E+02* 7.62E+02*

C-14 3.63E+05* 7.26E+04* 7.26E+04* 7.26EM4* 7. 26E+04 *- 7.26E+04* 7. 26EM4

NA-24 : 2.46EM 6** 2.46E+06 2.46EM6 2.46E406 2.46E+06 2.46E+06 2.46E+C6

(

I P-32 CR-51 MN-54 1.71E+10 NO DATA 1.06E+09 NO DATA 6.61E+08 2.85E+04 NO DATA 1.70E+04 NO DATA 6.27EM3 NO DATA 3.78E+04 1.92E+09 7.16EM6 NO DATA 8.41E+06 1.60E+06 NO DATA 2.50E+06 NO DATA 2.5CE+07 I MN-56 NO DATA 4.14E-03 7.34E-04 NO DATA 5.26E-03 NO DATA 1.32E-01 FE-55 2.51E+07 1.73E+07 4.04E+06 NO DATA NO DATA 9.68E+06 9.95E+06 FE-59 2.97E+07 6.99EM7 2.68E+07 NO DATA NO DATA 1.95E+07 2.33ER 8 I CO-58 CO-60 NO DATA NO DATA 4.72E+06 1.64E+07 1.06E+07 3.62E+07 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 9.57E+07 3.08E+08 NI-63 6.73EM9 4.67E+08 2.26E408 NO DATA NO DATA NO DATA 9.74E+07 I NI-65 3.70E-01 4.81E-02 2.19E-02 NO DATA NO DATA NO DATA 1.22E+00 I CU-64 ZN-65 NO DATA 1.37E409 2.36E+04 4.37E409 1.11E+04 1.98EM9 NO DATA NO DATA 5.94E+04 2.93EM9 N0 DATA NO DATA 2.01E+06 2.75EM9 I ZN-69 BR-83 BR-84 2.01E-12 NO DATA 3.84E-12 NO DATA 2.67E-13 NO DATA NO DATA NO DATA 2.50E-12 NO DATA NO DATA NO DATA 5.77E-13 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA I BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 I RB-88 NO DATA NO DATA 2.60E+09 2.15E-45 1.21E+09 1.14E-45 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 5.12E+08 2.97E-56 RB-89 NO DATA 4.49E-53 3.16E-53 NO DATA NO DATA NO DATA 2.61E-66 SR-89 1.45E+09 NO DATA 4.16E+07 NO DATA NO DATA NO DATA 2.33E+08 SR-90 4.68E+10 NO DATA 1.15E+10 NO DATA NO DATA NO DATA 1.35E+09 SR-91 2.87E+04 NO DATA 1.16E+03 NO DATA NO DATA NO DATA 1.37E405 g SR-92 4.92E-01 NO DATA 2.13E-02 NO DATA NO DATA NO DATA 9.76E+00 l Y-90 7.10E+01 NO DATA 1.90E+00 NO DATA NO DATA NO DATA 7.53E+05 CLINTON-I 3-82 Rev.5-2/89 1

CPS-0DCM TABLE 3.5-20 (continued)

COW MILK PATHWAY FACTORS - R (ADULT)

(mr mrem /yr peryCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LM GI-LLI ISOTOFE Y-91m 6.42E-20 NO DATA 2.49E-21 NO DATA NO DATA NO DATA 1.89E-19 I Y-91 Y-92 8.60E+03

5.57E-05 NO DATA NO DATA 2.30E+02 1.63E-06 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 4.73E406 9.75E-01 I Y-93 ZR-95 1

2.22E-01 9.45E+02 NO DATA 3.03E+02 6.12E-03 2.05E+02 NO DATA NO DATA NO DATA 4.76E+02 NO DATA NO DATA 7.03E+03 9.61E+05 ZR-97 4.32E-01 8.71E-02 3.98E-02 1.32E-01 2.70EM4 I NO DATA NO DATA NB-95 8.25E+04 4.59E+04 2.47E+04 NO DATA 4.54E+04 NO DATA 2.79E408 I MO-99 TC-99m NO DATA 3.31EMO 2.48E+07 9.35E+00 4.72E+06 1.19E+02 NO DATA NO DATA 5.61E+07 1.42E+02 NO DATA 4.58E+00 5.74E+07 5.53E403 IC-101 2.85E-60 4.11E-60 4.03E-59 NO DATA 7.41E-59 2.10E-60 1.24E-71 RU-103 1.0?.EM3 NO DATA 4.39E+02 NO DATA 3.89E+03 NO DATA 1.19E+05 RU-105 8.52E-04 3.36E-04 I NO DATA NO DATA 1.10E-02 NO DATA 5.21E-01 RU-106 2.04E+04 NO DATA 2.5SE+03 NO DATA 3.94E@4 NO DATA 1.32E@6 I AG-110m TE-125m 5.82E+07 1.63E+07 5.39EM7 5.91E+06 3.20EM7 2.19EM6 NO DATA 4.91EM6 1.06E+08 6.64E+07 NO DATA NO DATA 2.20E+10 6.52E+07 TE-127m 4.58E+07 1.64E+07 5.58E+06 1.17E%7 1.86E+08 NO DATA 1.53E+08 TE .127 6.52E+02 2.34E+02 1.41E+02 4.83E+02 2.65E+03 NO DATA 5.14E+04 i TE-129m 6.01E+07 2.24E+07 9.52E@ 6 I 2.07E407 2.51E+08 NO DATA 3.03E+08 j J

TE-129 2.82E-10 1.06E-10 6.86E-11 2.16E-10 1.18E-09 NO DATA 2.12E-10 I

q TE-131m 3.60E+05 1.76E+05 1.47E+05 2.79E+05 1.78E+06 NO DATA 1.75E+07 i TE-131 3.68E-33 1.54E-33 1.16E-33 3.03E-33 1.61E-32 NO DATA 5.22E-34 i

TE-132 2.41E+06 1.56E406 1.46E+06 1.72E+06 1.50E+07 NO DATA 7.36E407 -

I-130 4.16 EMS 1.23E+06 4.84E+05 1.04E+08 1.91E+06 NO DATA 1.06E+06 l I-131 2.97E68 4.24E+08 2.43E+08 I 1.39E+11 7.27E+0S NO DATA 1.12E@8 {

l I-132 1.65E-01 4.40E-01 1.54E-01 1.54E%1 7.02E-01 NO DATA 8.27E-02 1-133 3.86E+06 6.72EM6 2.05E+06 9.87E+08 1.17E+07 NO DATA 6.04E+06 I-134 1.89E.12 5.13E-12 1.83E-12 8.88E-11 8.15E-12 NO DATA 4.47E-15 I

CLINTON-I 3-83 Rev.5-2/89

CPS-0DCM TABLE 3.5-20 (continued)

COW MILK PATINAY FACTORS - R (ADULT) l (m2 mrem /yr per yCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE I-135 1.29E+04 3.39EM4 1.25EM4 2.23E+06 5.43E+04 NO DATA 3.83E+04 IEg C8-13' CS-136 5.67EM 9 2.64E+08 1.35E+10 1.04EM 9 1.10E+10 7.49EM8 NO DATA NO DATA 4.37E+09 5.79E+08 1.45E+09 7.94E407 2.36E+08 1.18E408 CS-137 7.39EM9 1.01E+10 6.62E+09 NO DATA 3.43E+09 1.14EM9 1.96E+08 l CS-138 8.69E-24 1.72E-23 8.50E-24 NO DATA 1.26E-23 1.24E-24 7.32E-29 BA-139 4.43E-08 3.16E-11 1.30E-09 NO DATA 2.95E-11 1.*/9E-11 7.86E-08

,I BA-140 2.72E+07 3.42E+04 1.78E-06 NO DATA 1.16E+04 1.96E M4 5.60E+07 I BA-141 BA-142 4.33E-46 2.51E-80 3.27E-49 2.58E-83 1.46E-4 7 1.58E-81 NO DATA NO DATA 3.04E-49 2.18E-53 1.86E-49 1.46E-83 2.04E-55 3.54E-98 LA-140 4.53E+00 2.28E+00 6.03E-01 NO DATA NO DATA NO DATA 1.67E+05 LA-142 1.89E-11. 8.61F-12 2.15E-12 NO DATA NO DATA NO DATA 6.29E-08 CE-141 4.84EM3 3.27E+03 3.71E+02 NO DATA 1.52E+03 NO DATA 1.25E+07 CE-143 4.16E+01 3.07EM4 3.40EMO NO DATA 1.35E401 NO DATA 1.15E+06 CE-144 1.58E+05 1.50E+05 1.92E+04 NO DATA 8.87E+04 No DATA 1.21E+08 PR-143 1.MEM2 6.35E+01 7.84E+00 NO DATA 3.66E+01 NO DATA 6.93E+C5

]

l PR-144 6.47E-54 2.69E-54 3.29E-55 NO DATA 1.52E-54 NO DATA 9.31E-61 ND-147 9.44E+01 1.09E+02 6.53E400 NO DATA 6.38E+01 NO DATA 5.24E+05 W-187 6.50E+03 5.43E+03 1.90E403 NO DATA NO DATA NO DATA 1.78E+06 l NP-239 3.67E+00 3.60E-01 1.99E-01 NO DATA 1.12E+00 NO DATA 7.39E+04 J I

mrem /yr per pCi/m3 O* 2.46 x 10 6 ,

I I

I CLINTON-I 3-84 Rev.5-2/89

CPS-ODQ4 1'

TABLE 3.5-21 C

GOAT MILK PATHSAY FACTORS - R ..(INFANT) 4 a13 (m2 mrem /yr per pCi/see?

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 4.86E+03* 4.86EM3* 4.86E403

4.86E+03* 4.86E+03* 4.86E+03*

I C-14 NA-24 :

3.23E406

6.89E+05* 6.89E+05* 6.89E+05* 6.89E+05* 6.89E+05*

1.87E406** 1.87E+06 1.87EM6 1.87E+06 1.87E+C6 1.87E406 6.89E+05*

1.87E406 I

P-32 1.90E+11 1.12E+10 7.46E409 NO DATA NO DATA 30 DATA 2.58E+O9 CR-51 NO DATA NO DATA 1.93E+04 1.26E404 2.75E+03 2.45E+04 5.63 EMS MN-54 NO DATA 4.68EM6 1.06E+06 NO DATA 1.04E+06 NO DATA 1.72E+06 MN-56 N0 c.WA 3.75E-03 6.46E-04 NO DATA 3.22E-03 NO DATA 3.40E-01 l FE-55 1. 75'i+06 1.13E+06 3.02E+05 NO DATA NO DATA 5.53E+05 1.44E+05 E FE-59 2.91E+06 5.08E+06 2.00E+06 NO DATA NO DATA 1.50E+06 2.43E+06 1

l CO-58 NO DATA 2.90E+06 7.24E+06 NO DATA NO DATA NO DATA 7. 23E406 CO-60 NO DATA 1.06E407 2.49E+07 NO DATA NO DATA NO DATA 2.51E+07 NI-63 4.1.9E409 2.59E+08 1.45E+08 NO DATA NO DATA NO DATA 1.29E+07 NI-65 4.20E-01 4.76E-02 2.16E-02 NO DATA NO DATA NO DATA 3.62E400 l

l CD-64 NO DATA 2.04EM4 9.45EM 3 NO DATA 3.45E+04 NO DATA 4.19EM5 m ZN-65 6.64E+08 2.28E409 1.05E+09 NO DATA 1.10E+09 NO DATA 1.92E+09 ZN-69 2.32E-12 4.18E-12 3.11E-13 NO DATA 1.74E-12 NO DATA 3.41E-10 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA

, BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 NO DATA 2.65E409 1.31E409 NO DATA NO DATA NO DATA 6.79E+07 RB-88 NO DATA 2.25E-45 1.23E-45 NO DATA NO DATA NO DATA 2.19E-45 h

g RB-89 NO DATA 4.09E-53 2.82E-53 NO DATA NO DATA NO DATA 1.39E-53 SR-89 2.64E+10 NO DATA 7.56E+08 NO DATA NO DATA NO DATA 5.42E+08 SR-90 2.55E+11 NO DATA 6.50E+10 I

NO DATA NO DATA NO DATA 3.19E+09 SR-91 5.65E+05 NO DATA 2.05E404 NO DATA NO DATA NO DATA 6.69E+05 I SR-92 Y-90 9.83E+00 8.19E401 NO DATA NO DATA 3.65E-01 2.19E400 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 1.06E+02 1.13E+05 CLINTON-1 3-85 Rev.5-2/89 '

I

CPS-0DCM l

) TABLE 3.5-21 (continued)

GOAT MILK PATHWAY FACTORS - R C (INFANT) i (m2 mrem /yr per pCi/sec)

.I ORGAN 1 EONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI IS010?E Y-91m 7.29E-20 NO DATA 2.48E-21 NO DATA NO DATA NO DATA 2.43E-16 I Y-91 Y-92 8.78E+03

6.40E- 05 NO DATA NO DATA 2.34E+02 1.80E-06 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 6.29E+05 1.22EMO i

Y-93 2.55E-01 NO tATA 6.95E-03 NO DATA NO DATA NO DATA 2.02E403 ZR-95 8.16E402 1.99E+02 1.41E+02 NO DATA 2.14E+02 NO DATA 9.90E+04 ZR-97 4.85E-01 8.33E-02 3.80E-02 NO DATA 8.40E-02 NO DATA 5.31E+03 I NB-95 7.12E+04 2.93E+04 1.69E@4 NO DATA 2.10E+04 NO DATA 2.47E447 MO-99 NO DATA 2.48E+07 4.84E+06 NO DATA 3.71E+07 NO DATA 8.18E+06 TC4 9m 3.26E+00 6.73E+00 8.67E+01 NO DATA 7.24E@l 3.52E+00 1.96E+03 TC-101 3.26E-60 4.11E-60 4.06E-59 NO DATA 4.88E-59 2.24E-60 6.98E-58 RU-103 1.04E+03 NO DATA 3.47E+02 NO DATA 2.16E+03 NO DATA 1.26E+04 RU-105 9.60E-04 NO DATA 3.23E-04 NO DATA 7.06E-03 NO DATA 3.82E-01 RU-106 2.28E404 NO DATA 2.84E+03 NO DATA 2.69E404 NO DATA 1.73E+05 AG-110m 4.62E+07 3.37EM7 2.23E407 HO DATA 4.83EM 7 NO DATA 1.75E+09 TE-125m 1.80E+07 6.02E406 2.43E+06 6.06EM 6 NO DATA NO DATA 8.58E+06 TE-127m 5.04EM7 1.67E+07 6.10E+06- 1.46E407 1.24E% 8 NO DATA 2.03EM 7 TE-127 7.57E402 2.54E+02 1.63E+02 6.16E+02 1.85E+03 NO DATA 1.59E+04 TE-129m 6.68E+07 2.29E+07 1.03E+07 2.57E407 1.67E+08 NO DATA 3.99EM 7 TE-129 3.25E-10 1.12E-10 7.59E-11 2.73E-10 8.10E-10 NO DATA 2.60E-08 TE-131m 4.04E+05 1.63E405 1.34E+05 3.30EM5 1.12E+06 NO DATA 2.74E+06 TE-131 4.19E-33 1.55E-33 1.18E-33 3.74E-33 1.07E-32 NO DATA 1.69E-31 TE-132 2.54E+06 1.26E+06 1.17E+06 1.85E+06 7.86E+06 NO DATA 4.65E446 .

1-130 4.22E406 9.28E+06 3.73E+06 1.04E+09 1.02E407 NO DATA 1.99E+06 I-131 3.25E+09 3.83E+09 1.69E+09 1.26E+12 4.48E+09 NO DATA 1.37E+08 1-132 1. 732MO 3.50E+00 1. 25E400 1.64E+02 3.91E400 NO DATA 2.84E+00 I I-133 I-134 4.34E+07 1.97E-11 6.32E+07 4.04E-11 1.85E+07 1.44E-11 1.15E+10 9.42E-10 7.43EM7 4.52E-11 NO DATA NO DATA 1.07E407 4.18E-11 I

CLINTON-1 3-86 Rev.5-2/89 ]

CPS-0DCM I TABLE 3.5-21 (continued)

GOAT MILK PATINAY FACTORS - Rf. (INFANT)

(m2 mrem /yr per pCi/sec) l ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE I-135 1.36E+05 2.70E+05 9.85E% 4 2.42E+07 3.01E+05 NO DATA 9.77EM4 CS-134 1.09E+11 2.04E+11 2.06E+10 NO DATA 5.2SE+10 2.15E+10 5.54E+08 CS-136 i 5.92E+09 1.74E+10 6.50E+O9 NO DATA 6.94E+09 1.42E409 2.64E+08 l

lg % -

g CS-137 1.54E+11 1.80E+11 1.28E+10 NO DATA 4.84E+10 1.96E+10 5.63E+08 CS-138 2.42E-22 3.93E-22 1.90E-22 NO DATA 1.96E-22 3.06E-23 6.28E-22 BA- G 5.14E-08 '3.41E-11 1.49E-09 NO DATA 2.05E-11 2.07E-11 3.26E-06 BA-140 2.87E+07 2.87E+04 1.48E+06 NO DATA 6.82E+03 1.76E+04 7.06E+O6 I BA-141 BA-142 4.97E-46 2.76E-80 3.40E-49 2.30E-83 1.57E-47 1.36E-81 NO DATA NO DATA 2.05E-49 1.32E-83 2.07E-49 1.39E-83 6.07E-45 1.14E-79 LA-140 4.83E+00 1.91E+00 4.90E-01 NO DATA NO DATA NO DATA 2.24E+04 LA-142 2.07E-11. 7.60E-12 1.82E-12 NO DATA WO DATA NO DATA 1.29E-06 CE-141 5.20E+03 3.17E+03 3.73E+02 I NO DATA 9.78E+02 .NO DATA 1.64EM 6 CE-143 4.75E+01 3.15E+04 3.60E+00 NO DATA 9.18E400 NO DATA 1.84E+05 I CE-144 PR-143 2.79E+05 1.78EM 2 1.14E+05 6.66E+01 1.56E+04 8.83E+00 NO DATA NO DATA 4.61E+04 2.47E401 NO DATA NO DATA 1.60E407 9.40E+04 PR-144 7.51E-54 2.90E-54 3.78E-55 NO DATA 1.05E-54 NO DATA 1.35E-49 ND-147 1.06E402 1.08E+02 6.65E+00 NO DATA 4.18E+01 NO DATA 6.88E+04 W-187 7.27E+03 5.06E+03 I 1.75E+03 NO DATA NO DATA NO DATA 2.97E405 NP-239 4.37E400 3.91E-01 2.21E-01 NO DATA 7.80E-01 NO DATA 1.13E+04

mrem /yr per y Ci/m3 -

6

- 1.87 x 10 l

CLINTON-I 3-87 Rev.5-2/89

CPS-0DCM I TABLE 3.5-22 GOAT MILK PATINAY FACTORS - R (CHILD)

(m2 mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY TEYROID KID!!ZY

~

LUNG GI-LLI ISOTOPE H-3 NO DATA 3.20E+03* 3.20E+03* 3.20E+03* 3.20E+03* 3.20E+03* 3.20EM3*

C-14 1.65E+06* 3.29E+05* 3.29E+05* 3.29E%5* 3.29E+05* 3.29E+05* 3.29EM5*

NA-24 , 1.07E+06** 1.07E%6 1.07EM6 1.07E+06 1.07E+06 1.07E+06 1.07E+06 I P-32 CR-51 9.32E+10 NO DATA 4.36E+09 NO DATA 3.59EM9 1.22E+04 NO DATA 6.77E+03 NO DATA 1.85E+03 NO DATA 1.24E+04 2.58E+09 6.47E+05 MN-54 NO DATA 2.51E+06 6.70E+05 NO DATA 7.05E+05 NO DATA 2.11E+06 MN-56 NO DATA 1.53E-03 3.45E-04 NO DATA 1.85E-03 NO DATA 2.21E-01 g FE-55 1.45E+06 7.65E+05 2.38E+05 NO DATA NO DATA 4.35E+05 1.42EH)5 l3 FE-59 1.55E+06 2.52E+06 1.25E+06 NO DATA NO DATA 7.29E+05 2.62E+06 CO-58 NO DATA 1.46E+06 4.46E+06 NO DATA NO DATA NO DATA 8.49E+06 CO-60 NO DATA 5.16E+06 1.52E+07 NO DATA NO DATA NO DATA 2.86E+07 NI-63 3.55E+09 1.90E+08 1.21E+08 NO DATA NO DATA NO DATA 1.28E+07 NI-65 1.99E-01 1.87E-02 1.09E-02 NO DATA NO DATA NO DATA 2.29E+00 I CD-64 ZN-65 NO DATA 4.96E+08 8.23E+03 1.32E+09 4.97E+03 8.22EM8 NO DATA NO DATA 1.99EM4 8.33E+08 NO DATA NO DATA 3.86E+05 2.32E+08 ZN-69 1.09E-12 1.58E-12 1.46E-13 NO DATA 9.56E-13 NO DATA 9.94E-11 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA i I RB-86 RB-88 NO DATA NO DATA-1.05E+09 8.59E-46 6.47E+08 5.97E-46 NO IATA NO DATA NO DATA NO DATA NO DATA NO DATA 6.77E+07 4.21E-47 RB-89 NO DATA 1.67E-53 1.49E-53 NO DATA NO DATA NO DATA 1.46E-55 .

SR-89 1.39E+10 NO DATA 3.96EM 8 N0 LATA NO DATA NO DATA 5.37E+08

, SR-90 2.35E+11 NO DATA 5.95E+10 NO DATA NO DATA NO DATA 3.16E+09

I SR-91 2.71E+05 NO DATA 1.02E+04 NO DATA NO DATA NO DATA 5.99E+05 l g SR-92 4.61E+00 NO DATA 1.85E-01 NO DATA NO DATA NO DATA 8.74E+01 E Y-90 3.86E+01 NO DATA 1.03E+00 NO DATA NO DATA NO DATA 1.10 EMS i

I CLINTON-I 3-88 Rev.5-2/89 I

CPS-0DCM 1

TABLE 3.5-22 (continued)

C GOAT MILK PATHWAY FACTORS - R aij (CM) .

(m2 mrem /yr per pCi/sec)

I ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI i ISOTOPE Y-91m 3.44E-20 NO DATA 1.25E-21 NO DATA NO DATA NO DATA 6.73E-17 l I Y-91 Y-92 4.67E403 3.02E-05 NO DATA NO DATA 1.25EM2 8.64E-07 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 6.22E+05 8.73E-01

)

j l

I

' s.

Y-93 1.20E-01 NO DATA 3.29E-03 NO DATA NO DATA NO DATA 1.79E+03 ZR-95 4.58E+02 1.01E+02 8.97E+01 NO DATA 1.44EM 2 NO DATA 1.05 EMS ZR-97 2.29E-01 3.31E-02 1.95E-02 NO DATA 4.76E-02 NO DATA 5.02E+03 NB-95 3.81E+04 1.48E+04 1.06E+04 NO DATA 1.39EM4 NO DATA 2. 75 E+07 MO-99 NO DATA 9.74E+06 2.41E+06 NO DATA 2.08E+07 NO DATA 8.05E+06 TC-99m 1.58E+00 3.10E+00 5.13E+01 NO DATA 4.50E+01 1.57E+00 1.76E+03 TC-101 1.54E-60 1.61E-60 2.04E-59 NO DATA 2.74E-59 8.50E-61 5.11E-60 RU-103 5.10E% 2 NO DATA 1.96E+02 NO DATA 1.28E+03 NO DATA 1.32E+04 RU-105 4.53E-04 NO DATA 1.65E-04 NO DATA 3.99E-03 NO DATA 2.96E-01 RU-106 1.11E404 NO DATA 1.38E+03 NO DATA 1.49E+04 NO DATA 1.72E405 I AG-110m TE-125m 2.50E+07 8.84E406 1.69E+07 2.39E+06 1.35EM 7 1.18E+06 NO DATA 2.48E+06 3.15E+07 NO DATA NO DATA NO DATA 2.01E+09 8.53E+06 TE-127m 2.49E+07 6.71E+06 2.96E+06 5.96E+06 7.10E+07 NO DATA 2.02E+07 TE-127 3.57E+02 9.61E+01 7.65E+01 2.47E+02 1.01E+03 NO DATA 1.39E+04 TE-129m 3.24E+07 9.06E+06 5.03E+06 1.05E+07 9.52E+07 NO DATA 3.96EM7 TE-129 1.53E-10 4.28E-11 3.64E-11 1.09E-10 4.49E-10 NO DATA 9.55E-09 I TE-131m TE-131 1.91E+05 1.96E-33 6.60E+04 5.97E-34 7.02EM4 5.83E-34 1.36E+05 1.50E-33 6.39E+05 5.92E-33 NO DATA NO DATA 2.68E+06 1.03E-32 TE-132 1.23E+06 5.45E+05 6.59E45 7.94E405 5.06E+06 NO DATA 5.49E+C6 -

I-130 2.06E+06 4.17E+06 2.15E+06 4.59E+08 6.23E+06 NO DATA 1.95E+06 I-131 1.56E+09 1.57E+09 8.94E+08 5.20E+11 2.58E+09 NO DATA 1.40E+08 I-132 8.32E-01 1.52E+00 7.03E-01 7.09E+01 2.34E+00 NO DATA 1.80E+00 I I-133 ;

2.06E+07 2.55E+07 9.64E+06 4.73E+09 4.25E+07 NO DATA 1.03E+07 '

I-134 9.51E-12 1.77E-11 8.13E-12 4.06E-10 2.70E-11 NO DATA 1.17E-11 l

CLINTON-I 3-89 Rev.5-2/89

I L__----__------_------------~--- - - - - - - - - -

CPS-0DSM t

I TABLE 3.';-22 (continued)

GOAT MILK PATHWAY FACTORS - Raij (CHED)

(m2 mrem /yr per pCi/sec) l .

l ORGAN: BONE LIVER T. BODY THYROID KIDNEY ISOTOPE LUNG GI-LLI I-135 6.53E+06 1.17E+05 5.56E+04 1.04E+07 1.80E+05 NO DATA 8.95EM4 I CS-134 CS-136 ;

6.76E+10 3.03E+09 1.11E+11 8.33E+09 2.34E+10 5.39E+09 NO DATA NO DATA 3.44E+10 4.44E+09 1.23E+10 6.62E+08 5.98E408 2.93E+08 CS-137 9.65E+10 9.23E+10 1.36E+10 NO DATA 3.01E+10 1.08E+10 5.78E+08 CS-138 1.15E-22 1.59E-22 1.10E-22 NO DATA 1.12E-22 1.21E-23 7.34E-23 BA-139 2.42E-08 1.29E-11 7.01E-10 NO DATA 1.13E-11 7.59E-12 1.40E-06 BA-140 1.40E+07 1.22E+04 8.15E405 NO DATA 3.98EM3 7.29E403 7.07E+06 I BA-141 BA-142 2.34E-46 1.31E-80 1.31E-49 9.44E-84 7.62E-48 7.32E-82 RO DATA NO DATA 1.13E-49 7.64E-84 7.7]E-49 5.55E-84 1.33E-46 1.71E-82 LA-140 2.32E+0D 8.12E-01 2.53E-01 NO DATA NO DATA NO DATA 2.26E+04 LA-142 9.85E-12 3.14E-12 9.83E-13 NO DATA NO DATA NO DATA 6.22E-07 CE-141 5.93E+03 1.31E+03 1.94E402 NO DATA 5.73E+02 NO DATA 1.63E+06 CE-143 2.24E401 1.22E+04 1.76E+00 NO DATA 5.10EM O NO DATA 1.78E+05 I CE-144 PR-143 1.94E+05 8.61E+01 6.10E404 2.58E+01 1.04EM 4 4.27E400 NO DATA NO DATA 3.38E+04 1.40E+01 NO DATA NO DATA 1.59E+07 9.29E+04 PR-144 3.53E-34 1.09E-54 1.78E-55 NO DATA 5.78E-55 NO DATA 2.35E-51 ND-147 5.33E+01 4.32E+01 3.34E+00 NO DATA 2.37E+01 NO DATA 6.84E+04 W-187 3.46E403 2.05E+03 9.20E+02 NO DATA NO DATA NO DATA 2.88 EMS NP-239 2.07E+00 1.49E-01 1.04E-01 NO DATA 4.29E-01 NO DATA 1.10E+04

mrem /yr per pCi/m3 .

6

- 1.07 x 10

)I l !

I CLINTON-I 3-90 Rev.5-2/89 ~

I .

l

CPS-ODCM TABLE 3.5-23 GOAT MILK PATHWAY FACTORS - R,C (TEEN)

(m2 mrem /yr per yCi/sec)

I ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 2.02E+03* 2.02E+03* 2.02E+03* 2.02E+03* 2.02E+03* 2.02+03*

l C-14 6.70 EMS

1.34EM5* 1.34E+05* 1.34E+05* 1.34E+05* 1.34E+05* 1 34E405

NA-24 : 5.15 EMS ** 5.15E+05 5.15E405 5.15E+05 5.15E+05 5.15E405 5.15E405 P-32 3.78E+10 2.34E409 1.47E+09 NO DATA NO DATA NO DATA 3.18EM 9 CR-51 NO DATA NO DATA 5.94E+03 3.30E+03 1.30E+03 8.48E+03 9.98E+05 MN-54 NO DATA 1.68E+06 3.32E+05 NO DATA 5.00E+05 NO DATA 3.44E+06 MN-56 NO DATA 8.77E-04 1.56E-04 NO DATA 1.11E-03 NO DATA 5.77E-02 FE-55 5.79E+05 4.11E+05 9.57E+04 NO DATA NO DATA 2.60E+05 1.78E+05 FE-59 6.75E+05 1.58E+06 6.08E+05 NO DATA NO DATA 4.97E+05 3. 73E+06 l CO-58 NO DATA 9.51E+05 2.19E+06 NO DATA NO DATA NO DATA 1.31E+07 CO-60 NO DATA 3.32E+06 7.47E+06 NO DATA NO DATA NO DATA 4.32E+07 i NI-63 1.42EM 9 1.00E+08 4.81E+07 NO DATA' NO DATA NO DATA 1.60E+07 NI-65 8.09E-02 1.03E-02 4.71E-03 NO DATA NO DATA NO DATA 5.61E-01 I CU-64 ZN-65 NO DATA 2.52E+08 4.68E403 8.76E+08 2.20E+03 4.09EM8 NO DATA NO DATA 1.18E+04 5.61E+08 NO DATA NO DATA 3.63E+05 3.71E+08 ZN-69 4.44E-13 8.46E-13 5.92E-14 NO DATA 5.53E-13 NO DATA 1.56E-12 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA !

BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA i BR-85 NO DATA NO DATA- NO DATA NO DATA NO DATA NO DATA NO DATA I RB-86 RB-88 NO DATA NO DATA 5.66E+08 4.66E-46 2.66E+08 2.48E-46 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 8.38EM7 3.99E-53 RB-89 NO DATA 9.52E-54 6.73E-54 NO DATA NO DATA NO DATA 1.46E-62 SR-89 5.59E+09 NO DATA 1.60E408 NO DATA NO DATA NO DATA 6.65E+08 SR-90 1.38E+11 3.40E+10 I

NO DATA NO DATA NO DATA NO DATA 3.87E409 SR-91 1.11E+05 NO DATA 4.40E+03 NO DATA NO DATA NO DATA 5.01E405 i

I SR-92 Y-90 1.89E+00 1.56E+01 NO DATA NO DATA 8.05E-02 4.21E-01 N3 DATA NO DATA NO DATA NO DATA NO DATA NO DATA 4.81E+01 1.29E405 i

l 1

l l

I CLINTON-I 3-91 Rev.5-2/89 '

I

CPS-ODCM i I TABLE 3.5-23 (continued)

GOAT MILK PATINAY FACTORS - R 13(TEEN) '

(m mrem /yr per p Ci/sec) 2 ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE Y-91m 1.41E-20 NO DATA 5.37E-22 NO DATA NO DATA NO DATA Y-91 6.64E-19 1.89E+03 NO DATA 5.07E+01 NO DATA NO DATA NO DATA 7.75EM5 Y-92 1.23E'-05 NO DATA 3.57E-07 NO DATA NO DATA NO DATA 3.39E-01 Y-93 4.86E-02 NO DATA 1.33E-03 NO DATA NO DATA NO DATA 1.49E+03 ZR-95 1.98E+02 6.24E401 4.29E+01 NO DATA 9.17EMI NO DATA 1.44E405 ZR-97 9.43E-02 1.87E-02 8.60E-03 NO DATA 2.83E-02 NO DATA 5.05E+03 J

i NB-95 1.69E+04 9.37EM 3 5.16E+03 NO DATA 9.08E+03 NO DATA 4.01E+07 I MO-99 TC-99m NO DATA 6.87E-01 5.33E+06 1.92E+00 1.02E+06 2.48E+01 NO DATA NO DATA 1.22EM7 2.86E+01 NO DATA 1.06E+00 9.55E+06 1.26E+03 I TC-101 RU-103 6.26E-61 2.17E402 8.91E-61 NO DATA 8.75E-60 9.27E+01 NO DATA NO DATA 1.61E-59 7.64E+02 5.43E-61 NO DATA 1.52E-67 1.81E+04 RU-105 1.86E-04 NO DATA 7.21E-05 NO DATA 2.35E-03 NO DATA 1.50E-01 I RU-106 4.47E+03 NO DATA 5.63E402 NO DATA 8.62E403 NO DATA 2.14E+05 I AG-110m TE-125m 1.15E+07 3.59E+06 1.09E+07 1.29E+06 6.62E+06 4.80E+05 NO DATA 1.00E+C6 2.08E407 NO DATA NO DATA NO DATA 3.06E+09 1.06E+07 I TE-127m TE-127 1.01EM7 1.48EM2 3.57E+06 5.14E+01 1.20E+06 3.18E+01 2.39EM6 1.02E+02 4.08E+07 5.87E+02 NO DATA NO DATA 2.51E+07 1.14E404 TE-129m 1.32E+07 4.89E406 2.08E+06 4.25EM6 5.51E+07 NO DATA 4.94E+07 I TE-129 6.22E-11 2.32E-11 1.51E-11 4.44E-11 2.61E-10 NO DATA 3.40E-10 TE-131m 7.86E+04 3.77E+04 3.14E404 5.67E+04 3.93E+05 NO DATA 3.C2E406 TE-131 8.04E-34 3.31E-34 2.51E-34 6.19E-34 3.51E-33 NO DATA 6.60E-35 TE-132 5.13E+05 3.25E405 3.06E+05 3.43 EMS 3.12E406 NO DATA 1.03E+07 -

I-130 8.82E+05 2.55E406 1.02E+06 2.08E+08 3.93E+06 NO DATA I-131 1.96E+06 6.44E+08 9.01E+08 4.84E+08 2.63E+11 1.55E+09 NO DATA 1.78E+08 I-132 3.52E-01 9.20E-01 3.30E-01 3.10E+01 1.45E400 NO DATA 4.01E-01 I I-133 I-134 8.48E+06 4.03E-12 1.44E+07 1.07E-11 4,39E+06 3.84E-12 2.01E+09 1.78E-10 2.52EM7 1.68E-11 NO DATA NO DATA 1.09E447 1.41E-13 I CLINTON-I 3-92 Rev.5-2/89

CPS-0DCM TABLE 3.5-23 (continued)

GOAT hr.LK PATlWAY FACTORS - R,Cij(TEEN)

(ma mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY ISOTOPE LUNG GI-LLI I-135 2.75E+04 7.08E K4 2.62E+04 4.56EM 6 1.12E%S NO DATA 7.85EM4 CS-134 2.94E+10 6.91E+10 3.21E+10 NO DATA 2.20E+10 8.39E+09 8.60E% 8 CS-136 1.34E+09 5.27E+09 3.54EM9 NO DATA 2.87E+09 4.52E+08 4.24EM8 CS-137 4.01E+10 5.33E+10 1.86E+10 NO DATA 1.82E+10 7.05E+09 7.59EM8 CS-138 4.73E-23 9.08E-23 4.54E-23 NO DATA 6.70E-23 7.80E-24 4.12E-26 BA-139 9.84E-09 6.92E-12 2.87E-10 NO DATA 6.53E-12 4.77E-12 8.78E-08 I BA-140 5.82EM 6 7.13E+03 3.75E+05 NO DATA 2.42E+03 4.80E+03 8.98E446 I BA-141 BA-142 9.53E-47 5.44E-81 7.11E-50 5.44E-84 3.18E-48 3.35E-82 NO DATA NO DATA 6.60E-50 4.60E-84 4.87E-50 3.62E-84 2.03E-52 1.67E-92 i

LA-140 9.67E-01 4. 75 E-01 1.26E-01 NO DATA NO DATA NO DATA 2.73EM4 LA-142 4.08E-12 1.81E-12 4.51E-13 NO DATA NO DATA NO DATA 5.52E-08 CE-141 1.07E+03 7.12E+02 8.17E+01 NO DATA 3.35E+02 NO DATA 2.04E+06 I CE-143 9.14E+00 6.65E+03 7.43E-01 NO DATA 2.98E+00 NO DATA 2.00E+05 CE-144 7.86E+04 3.25E+04 4.23EM3 NO DATA 1.94E+04 NO DATA 1.98EM 7 I PR-143 3.47E+01 1.39E+01 1.73E+00 NO DATA 8.06E+00 NO DATA 1.14EM5 l

l

~ l

\

PR-144 1.42E-54 5.81E-55 7.19E-56 NO DATA 3.33E-55 NO DATA 1.56E-57 ND-147 2.17E+01 2.36E+01 1.41E+00 NO DATA 1.38E+01 NO DATA 8.50E+04 W-187 1.43E+03 1.16E+03 4.08E+02 NO DATA NO DATA NO DATA 3.15 EMS I NP-239 8.38E-01 7.90E-02 4.39E-02 t

NO DATA 2.48E-01 NO DATA 1.27E+04 l

l* mrem /yrperyCi/m3

- 5.15 x 10 5 I l I

I CLINTON-I 3-93 Rev.5-2/89 I -

\

CPS-ODCM i k

l TABLE 3.5-24 j GOAT MILK PATHWAY FACTORS - R (ADULT)

(m2 mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE l H-3 NO DATA 1.55EM3* 1.55E+03* 1.55E+03* 1.55E+03* 1.55EM3* 1.55E+03*

l C-14 3.63E+05* 7.26E404

7.26EM4* 7.26E404

7. 26EM4

7.26E404* 7.26E+04* !

NA-24 , 2.95E405** 2.95E405 2.95E405 2.95E+05 2.95EM5 2.95E+05 2.95E405 !

l P-32 2.05E+10 1.27E409 7.91E408 NO DATA NO DATA NO DATA 2.30E+09 CR-51 NO DATA NO DATA 3.43E+03 2.05E+03 7.56E+02 4.55E+03 8.63E+05 HN-54 NO DATA 1.01E+06 1.92 EMS

)

NO DATA 2.99E+05 3.08EM6 NO DATA I MN-56 NO DATA 4.96E-04 8.79E-05 NO DATA 6.29E-04 NO DATA 1.58E-02 FE-55 3.27E+05 2.26E+05 5.27E+04 NO DATA NO DATA 1.26E+05 1.30E+05 FE-59 3.85 EMS 9.06E+05 3.47E+05 NO DATA NO DATA 2.53 EMS 3.02E+06 I CO-58 CO-60 NI-63 NO DATA NO DATA 8.05E408 5.62E+05 1.96E+06 1.26E406 4.33E+06 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 1.14E407 3.69E+07 4

5.58E407 2.70EM7 NO DATA NO DATA NO DATA 1.16E+07 NI-65 4.43E-02 5.76E-03 2.63E-03 NO DATA NO DATA NO DATA 1.46E-01 CU-64 NO DATA 2.62E+03 1.23E+03 NO DATA 6.62E+03 NO DATA 2.24E405 ZN-65 1.64E+08 5.22E+08 2.36E+08 NO DATA 3.49E+08 NO DATA 3.29E408 ZN-69 2.41E-13 4.61E-13 3.21E-14 NO DATA 3.00E-13 NO DATA 6.93E-14 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA ;

BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA I BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA I RB-86 RB-88 NO DATA NO DATA 3.10E+08 2.57E-46 1.45E+08 1.36E-46 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 6.12E+07 3.55E-57 I RB-89 SR-89 NO DATA 3.04E+09 5.37E-54 NO DATA 3.78E-54 8.73EM7 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 3.12E-67 4.88E408 SR-90 9.78E+10 NO DATA 2.40E+10 NO DATA NO DATA NO DATA 2.83E409 I SR-91 6.01EM4 NO DATA 2.43E+03 NO DATA NO DATA NO DATA 2.86E+05 I SR-92 Y-90 1.03E+00 8.48E400 NO DATA NO DATA 4.45E-02 2.28E-01 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 2.04E+01 9.00E+04 CLINTON-I 3-94 Rev.5-2/89

CPS-0DCM I TABLE 3.5-24 (continued)

GOAT MILK PATHWAY FACTORS - R (ADULT)

(m2 mrem /yr per pCi/sec)

I ORGAN: BONE LIVER 1

T. BODY THYROID KIDNEY LUNG CI-LLI ISOTOPE Y-91m 7.69E-21 NO DATA 2.98E-22 NO DATA NO DATA

~Y-91 NO DATA 2.26E-20 1.03E+03 NO DATA 2.75E401 NO DATA NO DATA NO DATA {

Y-92 6.68E-06 5.66E+05 NO DATA 1.95E-07 NO DATA NO DATA NO DATA 1.17E-01

'm

, Y-93 2.65E-02 NO DATA 7.32E-04 NO DATA NO DATA NO DATA 8.41E+02 ZR-95 1.13E+02 3.63E+01 2.46E+01 NO DATA 5.69E+01 NO DATA 1.15E+05 ZR-97 5.17E-02 1.04E-02 4.77E-03 NO DATA 1.58E-02 l NO DATA 3.23E+03 NB-95 9.90E+03 5.51E+03 2.96E+03 NO DATA 5.45E%3 NO DATA 3.34E+07 I MO-99 TC-99m NO DATA 3.95E-01 2.96E+06 1.12E+00 5.63E+05 1.42E+01 NO DATA NO DATA

6. 71E406 1.70E401 NO DATA 5.47E-01 6.86E+06 6.61E+02 I i

l I TC-101 RU-103 3.43E-61 1.22E+02 4.94E-61 NO DATA 4.84E-60

~5.24E+01 NO DATA NO DATA 8.89E-60 4.64E+02 2.52E-61 NO DATA 1.48E-72 1.42E+04 RU-105 1.02E-04 NO DATA 4.02E-05 NO DATA 1.32E-03 NO DATA 6.23E-02 RU-106 2.44EM3 NO DATA 3.09E+02 NO DATA 4.72E+03 NO DATA 1.58 EMS I

AG-110m 6.96E+06 6.44E+06 3. 82EM6 NO DATA 1.27E+07 NO DATA 2.63E+09 I l TE-125m 1.95E+06 7.07 EMS 2.61EM5 .87E+05 7.94E+06 NO DATA 7.79E+06 l

l TE-127m 5.46E405 1.95E+06 6.66E+05 1.40E+06 2.22E+07 NO DATA 1.83E+07 TE-127 7.82E+01 2.81EMI 1.69E+01 5.80EMI 3.19E+02 NO DATA 6.17E+03 TE-129m 7.21E+06 2.69E+06 1.14EM6 2.48E+06 3.01E+07 I NO DATA 3.63EM 7 '

TE-129 3.83E-11 1.27E-11 8.23E-12 2.59E-11 1.42E-10 NO DATA 2.55E-11 L

I TE-131m TE-131 4.33E+04 4.37E-34 2.12E+04 1.83E-34 1.76E+04-1.38E-34 3.35E+04 3.6CO-34 2.14E+05 1.92E-33 NO DATA NO DATA 2.10E+06 6.19E-35 TE-132 2.87 EMS 1.86E+05 1.74E+05 2.05E+05 I-130 1.79E+06 NO DATA 8.79E+06

! 5.00E+05 1.47E+06 5.82E+05 1.25EM8 2.30E+06 I-131 NO DATA 1.27E+06 i 3.54E+08 5.06Ee 8 2.90E+08 1.66E+11 8.68E+08 NO DATA 1.34E+08 l

I-132 1.98E-01 5.29E-01 1.85E-01 1.85E@l

g I-133 8.43E-01 NO DATA 9.93E-02 4.62E+06 8.03EM 6 2.45E@ 6 1.18E+09 1.40E+07 NO DATA 7.22EM6 i

3 I-134 2.27E-12 6.16E-12 2.20E-12 1.07E -10 9.80E-12 NO DATA 5.37E-15 l

l CLINTON-I 3-95 Rev.5-2/89

CPS-0DCM '

TABLE 3.5-24 (continued)

GOAT MILK PATHWAY FACTORS - R,C 3(ADULT)

(ma mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID i

KIDNEY LUNG CI-LLI i ISOTOPE

{

I-135 1.55EM4 4.06E+04 1.50E+04 2.68E+06 6.51E+04 NO DATA 4.59E%4

Eg CS-134 CS-136 1.69E+10 7.88E+08 4.03E+10 3.29E+10 NO DATA 1.30E+10 4.32E+09 7.04E+08 3.11E409 2.24E+09 NO DATA 1.73E+09 2.37E408 3.53E%8 CS-137 2.21E+10 3.03E+10 1.98E+10 NO DATA 1.02E+10 3.41E409 5.84E408 )

CS-138 2.61E-23 5.15E-23 2.55E-23 NO DATA 3.78E-23 3.73E-24 2.20E-28 BA-139 5.32E-09 3.79E-12 1.56E-10 NO DATA 3.54E-12 2.15E-12 9.44E-09 BA-140 3.23EM 6 4.05EM3 2.11E%5 NO DATA s

1.38E+03 2.32EM3 6.65E+06 I BA-141 BA-142 5.18E-47 3.00E-81 3.92E-50 3.09E-84 1.75E-48 1.89E-82 NO DATA NO DATA 3.64E-50 2.61E-84 2.22E-50 1.75E-84 2.44E-56 4.23E-99 LA-140 5.40E-01 2.72E-01 7.19E-02 NO DATA NO DATA NO DATA 2.00E+04 l LA-142 2.27E-12 1.03E-12 2.57E-13 NO DATA NO DATA NO DATA 7.52E-09 l CE-141 5.80E+02 3.92E42 4.45E401 NO DATA 1.82E402 I CE-143 5.00E+00 NO DATA 1.50E+06 3.70E+03 4.09E-01 NO DATA 1.63E+00 NO DATA 1.38E+05

! I CE-144 PR-143 4.29E+04 1.89E401 1.79E+04 7.56E+00 2.30E+03 9.35E-01 NO DATA NO DATA 1.06E404 4.37E+00 NO DATA NO DATA 1.45E+07 8.26E404 PR-144 7.71E-55 3.20E-55 3.92E-56 NO DATA 1.80E-55 NO DATA 1.11E-61 ND-147 1.13E+01 1.30E+01 7.79E-01 NO DATA 7.64E+00 NO DATA 6.25E+04 W-187 7.78E+02 6.50E+02 2.27E402 NO DATA NO DATA NO DATA 2.13E405 NP-239 4.39E-01 4.32E-02 2.38E-02 NO DATA 1.35E-01 NO DATA 8.86E403 l

mrem /yr per yCi/m3 5

1

- 2.95 x 10 I

I CLINTON-I 3-96 Rev.5-2/89

CPS-ODCM I

TABLE 3.5-25 M

MEAT PATINAY FACTORS - R . . (CHILD) 313 .

(m mrem /yr per yCi/sec) 2 ORGAN: BONE LIVER T.EODY THYROID KIDNEY LUNG GI-LLI ISOTOPE l - H-3 NO DATA 2.33E+02* 2.33E402* 2.33E+02* 2.33EM 2* 2.33E+02* 2.33E402*

l g C-14 5.29E+05* 1.06E405

1.06E+05* 1.06E+05* 1.06E+05* 1.06E+05 1.06E%5*

l 3 NA-24 1.84E-03** 1.84E-03 1.84E-03 1.84E-03 1.84E-03 1.84E-03 1.84E-03 P-32 7.43E+09 3.47E+08 2.86E+08 NO DATA NO DATA NO DATA 2.05E% 8 CR-51 NO DATA NO DATA 8.78E+03 4.88E+03 1.33E+03 8.90E+03 4.66E+05 MN-54 NO DATA 8.03E+06 2.14E406 NO DATA 2.25E406 NO DATA 6.74EM6 MN-56 NO DATA 1.56E-53 3.52E-54 NO DATA 1.89E-53 NO DATA 2.26E-51 I l

I FE-55 FE-59 4.58E+05 3.76E+08 2.43E408 6.09E+08 7.52E+07 3.03E+C8 NO DATA NO DATA NO DATA NO DATA 1.37E+08 1.76E+08 4.50E+07 6.34E% 8 CO-58 NO DATA 1.64E+07 5.03E+07 NO DATA NO DATA NO DATA 9.58E+07 CO-60 NO DATA 6.93E+07 2.04E+08 NO DATA NO DATA NO DATA 3.84E+08 NI-63 2.91E+10 1.56EM9 9.90E+08 NO DATA NO DATA NO DATA 1.05E408 NI-65 3.55E-52 3.34E-53 1.92E-53 NO DATA NO DATA NO DATA 4.10E-51 I CU-64 LN-65 NO DATA 3.75E408 2.77E-07 1.00E+09 1.67E-07 6.22E+08 NO DATA NO DATA 6.69E-07 6.30EM8 NO DATA NO DATA 1.30E-05 1.76E+08 ZN-69 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00

.R-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA Bi-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA I RB-86 RB-88 NO DATA NO DATA 5.76E408 0.00E+00 3.54E+08 0.00E+00 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 3.71E+07 0.00E+00 i 1

I RB-89 NO DATA 0.00E%0 0.00E400 NO DATA NO DATA NO DATA 0.00E+00 -

.SR-89 4.80E+08 NO DATA 1. 37E+07 NO DATA NO DATA NO DATA 1.86E+07 SR-90 1.04E+10 NO DATA 2.64E+09 NO DATA NO DATA NO DATA 1.40E408 SR-91 2.26E-10 NO DATA 8.53E-12 NO DATA NO DATA NO DATA 4.99E-10 I SR-92 Y-90 2.00E-49 1.73E+02 NO DATA NO DATA 8.04E-51 4.62E+00 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 3.80E-48 4.91E+05 I CLINTON-1 3-97 Rev.5-2/89 1

I TABLE 3.5-25 (continued)

MEAT PATHWAY FACTORS - R (CHILD)

(m2 mrem /yr per pCi/sec) 1 ORGAN: BONE LIVER T. BODY THYROID KIDNEY ISOTOPE LUNG GI-LLI Y-91m 0.00E+00 NO DATA 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 Y-91 I Y-92 :

1.80E+06 2.37E-39 NO DATA NO DATA 4.81E+04 6.78E-41 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 2.40E+08 6.84E-35 l

N.

Y-93 6.98E-12 NO DATA 1.92E-13 NO DATA NO DATA NO DATA 1.04E-07 ZR-95 2.67E+06 5.87E+05 5.22E+05 NO DATA 8.40E+05 NO DATA ZR-97 6.12E+08 3.16E-05 4.57E-06 2.69E-06 NO DATA 6.55E-06 NO DATA 6.92E41 I NB-95 3.10E+06 1.21E+06 8.61E+05 NO DATA 1.13E+06 NO DATA 2.23EM9 MO-99 NO DATA 1.14E+05 2.83E+04 NO DATA 2.44E+05 NO DATA 9.45E+04

.I TC-99m 6.01E-21 1.18E-20 1.95E-19 NO DATA 1.71E-19 5.98E-21 6.71E-18 I TC-101 RU-103 0.00E+00 1.55E+08 0.00E+00 NO DATA 0.00E+00 5.96E+07 NO DATA NO DATA 0.00E+00 3.90E+08 0.00E+00 NO DATA 0.00E+00 4.01E+09 RU-105 8.48E-28 NO DATA 3.08E-28 NO DATA 7.45E-27 NO DATA 5.54E-25 I RU-106 4.43E409 NO DATA 5.53E+08 NO DATA 5.99E+09 NO DATA 6.90E+10 AG-110m 8.41E406 5.68E+06 4.54E+46 NO DATA 1.06E+07 NO DATA 6.75E+08 TE-125ta 5.69E+08 1.54E+08 7.58E+07 1.60E+C8 NO DATA NO DATA 5.49E+08 TE-127m 1.77E+09 4.78E+08 2.11E+08 4.24E+08 S.06E+09 NO DATA TE-127 1.44EM9 3.34E-10 9.01E-11 7.17E-11 2.31E-10 9.51E-10 NO DATA 1.31E-08 TE-129m 1.79E+09 4.99E408 2.77E+08 5.76E+C8 5.25E+09 NO DATA 2.18E+09 I TE-129 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 I TE-131m TE-131 6.97E+02 0.00E+00 2.41E+02.

0.00E+00 2.57EM2 0.00E+00 4.96E+02 0.00E+00 2.33E+03 0.00E+00 NO DATA NO DATA 9.78E+03 0.00E+00 TE-132 2.13E+06 9.43E+05 1.14E+06 1.37EM6 8.76EM 6 NO DATA 9.50E+06 -

I-130 2.91E-06 5.89E-06 3.03E-06 6.49E-04 8.80E-06 NO DATA 2.75E-06 I-131 1.65E+07 1.66E407 9.46E+06 5.50E+09 2.73E+07 NO DATA 1.48E+06 I-132 1.05E-58 1.93E-58 8.86E-59 8.93E-57 2.95E-58 NO DATA I-133 2.27E-58 I 1-134 5.75E-01 0.00E+00 7.10E-01 0.00E+00 2.69E-01 0.00E+00 1.32E+02 0.00E+00 1.18E+00 0.00E+00 NO DATA NO DATA 2.86E-01 0.00E+00 I

CLINTON-I i 3-98 Rev.5-2/89 '

I

CPS-0DCM TABLE 3.5-25 (continued)

MEAT PATINAY FACTORS - R g)(CHILD)

(m2 mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI

_ ISOTOPE I-135 6.86E-17 1.23E-16 5.83E-17 1.09E-14 1.89E-16 NO DATA 9.38E-17 CS-134 9.20E+08 1.51E+09 3.18E+08 NO DATA 4.68E+08 1.68E+08 8.14E+06 CS-136 1.62E+07 4.45EM7 2.88E+07 NO DATA 2.37E@7 3.53E+06 1.56E+06 CS-137 1.33E+09 1.27E+09 1.88E@8 NO DATA 4.15E+08 1.49E+08 7.98EM6 CS-138 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00EM O BA-139 0.00EM O- 0.00EMO 0.00E+00 NO DATA 0.00E+00 0.00EMO 0.00E+00 I BA-140 4.38EM 7 3.84E4 4 2.56E+06 NO DATA 1.25EM4 2.29E+04 2.22E+07 BA-141 0.00E+00 0.00E@ 0 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 BA-142 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E% 0 0.00E+00 0.00E+00 LA-140 5.56E-02 1.94E-02 6.05E-03 NO DATA NO DATA NO DATA 5.41E+02 LA-142 6.18E-92 1.97E-92 6.17E-93 NO DATA NO DATA NO DATA 3.91E-87 CE-141 5.01EM4 1.11E+04 1.64E+03 NO DATA 4.85E+03 NO DATA 1.38E%7 CE-143 3.20E-02 1.74E+01 2.51E-03 NO DATA 7.28E-03 NO DATA 2.54E+02 I CE-144 PR-143 2.31E+06 3.34E4 4 7.24 EMS 1.00E+04 1.23E+05 1.66E+03 NO DATA NO DATA 4.01E+05 5.43E+03 NO DATA NO DATA 1.89EM 8 3.60E+07 PR-144 0.00EMO 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00 ND-147 1.17E+04 9.47E+03 7.33E+02 NO DATA 5.20E+03 NO DATA 1.50E@7 W-187 3.21E-02 1.90E-02 8.53E-03 NO DATA NO DATA NO DATA 2.67EMO NP-239 4.23E-01 3.04E-02 2.14E-02 NO DATA 8.79E-02 NO DATA 2.25EM3

mrem /yr.per yCi/m3

- 1.84 x 10-3 I

I CLINTON-I 3-99 Rev.5-2/89

_. _. 1

CPS-ODCM TABLE 3.5-26 MEAT PATHWAY FACTORS - RI g ('.?EEN)

(m2 mrem /yr perp Ci/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 1.93EM2* 1.93E+02* 1.93E+02* 1.93EM2* 1.93E+02* 1.93+02*

I C-14 NA-24 ,

2.81E+05* 5.62EM 4* 5.62EM4* 5.62E+04* 5.62E+04* 5.62E+04*

1.16E-03** 1.16E-03 1.16E-03 1.16E-03 1.16E-03 1.16E-03 5.62E+04*

1.16E-03 b

P-32 3.95E+09 2.45E+08 1.53EM 8 NO DATA NO DATA NO DATA 3.32E+08 CR-51 NO DATA NO DATA 5.65E+03 3.14E+03 1.24E4 3 8.07E+03 9.50EM5 MN-54 NO DATA 7.02E+06 1.39E+06 NO DATA 2.09E+06 NO DATA 1.44E+07 MN-56 NO DATA 1.17E-53 2.09E-54 NO DATA 1.48E-53 NO DATA 7.72E-52 FE-55 2.38E+08 1.69E+08 3.94E+07 NO DATA NO DATA 1.07E+08 7.31E+07 FE-59 2.12E+08 4.95EM 8 1.91EM 8 NO DATA NO DATA 1.56E+08 1.17E+09 CO-58 NO DATA 1.41EM7 3.25E+07 NO DATA NO DATA NO DATA 1.94E+08 CO-60 NO DATA 5.84E+07 1.32E+08 NO DATA NO DATA NO DATA 7.61E+08 NI-63 1.52E+10 1.07EM9 5.15E+08 NO DATA NO DATA NO DATA 1.71E+08 NI-65 1.90E-52 2.43E-53 1.11E-53 NO DATA NO DATA NO DATA 1.32E-51 CU-64 NO DATA 2.06E-07 9.68E-08 NO DATA 5.21E-07 NO DATA 1.60E-05 ZN-65 2.50E+08 8.69E+08 4.05E+08 NO DATA 5.56E4 8 NO DATA 3.68E+08 ZN-69 0.00E+00 0.00EMO 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00EM)0 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 NO DATA 4.05E+08 1.90E+08 NO DATA NO DATA NO DATA 6.00EM7 RB-88 NO DATA 0.00E+00 0.00E%0 NO DATA NO DATA NO DATA 0.00E+00 RB-89 NO DATA 0.00E+00 - 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 -

SR-89 2.54E+08 NO DATA 7.27E+06 NO DATA NO DATA NO DATA 3.02E+07 SR-90 8.04EM 9 NO DATA 1.99E+09 NO DATA NO DATA NO DATA 2.26EW8 SR-91 1.20E-10 NO DATA 4.78E-12 NO DATA NO DATA NO DATA 5.45E-10 I SR-92 Y-90 1.08E-49 9.11E401 NO DATA NO DhTA 4.59E-51 2.45E+00 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 2.74E-48 7.51 EMS I CLINTON-I 3-100 Rev.5-2/89 I

CPS-0DCM I TABLE 3.5-26 (continued)

I MEAT PATHWAY FACTORS - R (TEEN)

(m2 mrem /yr perpCi/sec) .!'

l ORGAN: BONE LIVER T. BODY THYROID KIDNEY ISOTOPE LUNG GI-LLI l

Y-91m 0.00E400 NO DATA 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 I Y-91 Y-92 ,

9.55E+05 1.26E-39 NO DATA NO DATA 2.56E+04 3.64E-41 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 3.91E+08 3.45E-35 q :

Y-93 3.70E-12 NO DATA 1.01E-13 NO DATA NO DATA NO DATA 1.13E-07 l ZR-95 1.50E+06 4.74E+05 3.25E+05 NO DATA 6.93E+05 NO DATA 1.09E+09 l ZR-97 1.70E-05 3.36E-06 1.55E-06 NO DATA 5.10E-06 NO DATA 9.11E-01 NB-95 1.79E406 9.94E+05 5. 47EM5 NO DATA 9.64E+05 NO DATA 4.25E+09 l MO-99 NO DATA 8.20E+04 1.56E+04 NO DATA 1.88E+05 H0 DATA 1.47E+05 l TC-99m 3.42E-21 9.54E-21 1.24E-19 NO DATA 1.42E-19 5.29E-21 6.26E-18 1

TC-101 0.00E400 0.00E400 0.00E+00 NO DATA 0.00E400 0.00E+00 0.00E+00 l RU-103 8.57E+07 NO DATA 3.66E+07 NO DATA 3.02E+08 NO DATA 7.16E+09 RU-105 4.56E-28 NO DATA 1.77E-28 NO DATA 5.75E-27 NO DATA 3.68E-25 RU-106 2.36E+09 NO DATA 2.97E+08 NO DATA 4.54E409 NO DATA 1.13E+11 1 AG-110m 5.04E+06 4.77E+06 2.90EM 6 NO DATA 9.10E+06 NO DATA 1.34EM9 TE-125m 3.03E+08 1.09E+08 4.06E407 8.47E+07 NO DATA NO DATA 8.95E+08 TE-127m 9.40E408 3.33E+08 1.12E+08 2.24E+08 3.81E+09 NO DATA 2.34E409 TE-127 1.78E-10 6.30E-11 3.82E-11 1.23E-10 7.20E-10 NO DATA 1.37E-08 TE-129m 9.49E+08 3.52E+08 1.50E+08 3.06E+08 3.97E+09 NO DATA 3.56EM9 I TE-129 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

l 0.00E+00 NO DATA 0.00EMO lE TE-131m TE-131

3. 73EM2 0.00E+00 1.79E+02 1.49E402 2.69E+02 1.87E+03 NO DATA 1.44E404 l

3 0.00E+00 0.00E400 0.00E400 0.00E+00 NO DATA 0.00E+00

TE-132 1.17E+06 7.38E+05 6.95E+05 7.78E+05 7.08E+06 NO DATA 2.34E407 I-130 1.63E-06 4.71E-06 1.88E-06 3.84E-04 7.25E-06 NO DATA 3.62E-06 I-131 8.89E+06 1.24E+07 6.69E+06 3.63E+09 2.14E+07 NO DATA 2.46E406 I I-132 5.78E-59 1.51E-58 5.42E-59 5.09E-57 2.38E-58 NO DATA 6.58E-59 I-133 I 1-134 3.09E-01 0.00E+00 5.2SE-01 0.00E+00 1.60E-01 0.00E+00 7.32EM I 0.00E+00 9.20E+01 0.00E+00 NO DATA NO DATA 3.97E-01 0.00E+00 I CLINTON-I 3-101 Rev.5-2/89 l I l

CPS-0DCM 1

I TABLE 3.5-26 (continued)

MEAT PATHWAY FACTORS - R (' TEEN)

(m2 mrem /yr per pCi/sec) l.I

~

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE -

I-135 3.79E-17 9.75E-17 3.61E-17 6.27E-15 1.54E-16 NO DATA 1.08E-16 I CS-134 CS-136 ,

5.22EM 8 9.36EM6 1.23E+09 3.68E407 5.70 EMS 2.47EM7 NO DATA NO DATA 3.91E+08 2.01E+07 1.49E+08 3.16EM6 1.53E+07 2.96E+06 CS-137 7.24E+08 9.63E+08 3.35EM 8 NO DATA 3.28E408 1.27E+08 1.37E+07 CS-138 0.00E400 0.00E+00 0.00EMO NO DATA 0.00E400 0.00E400 0.00E400 BA-139 0.00E+00 0.00E+00 0.00EMO NO DATA 0.00E+00 0.00EMO 0.00E+00 I BA-140 2.37E407 2.91E+04 1.53E+06 NO DATA 9.86EM3 1.06E+04 3.66E+07 I BA-141 BA-142 0.00E+00 0.00EMO 0.00E400 0.00EMO 0.00E+00 0.00E+00 NO DATA NO DATA 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 LA-140 3.03E-02 1.49E-02 3.97E-03 NO DATA NO DATA NO DATA 8.56EM 2 LA-142 3.37E-92 .1.49E-92 3.72E-93 NO DATA NO DATA NO DATA 4.55E-88 CE-141 1.17EM4 7.83E+03 9.00E+02 NO DATA 3.69E+03 NO DATA 2.24EM7 CE-143 1.70E-02 1.24E+01 1.38E-03 NO DATA 5.55E- 03 NO DATA 3.72E+02 CE-144 1.23EM 6 5.10E+05 6.62E+04 NO DATA 3.04E+05 NO DATA 3.10E+08 PR-143 1.77E+04 7.06E403 .8.80E+02 NO DATA 4.10E+03 NO DATA 5,82E+07 PR-144 0.00E+00 0.00EMO 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00EMO ND-147 6.22E+03 6.76E+03 4.05E+02 NO DATA 3.97E+03 NO DATA 2.44EM 7 W-187 1.74E-02 1.42E-02 4.96E-03 NO DATA NO DATA NO DATA 3.83E400 NP-239 2.25E-01 2.12E-02 1.18E-02 NO DATA 6.67E-02 NO DATA 3.42E+03 I

mrem /yr per pCi/m3 -

- 1.16 x 10 ' '

I I CLINTON-I 3-102 Rev.5-2/89 I

CPS-0DCM I TABLE 3.5-27 MEAT PATHWAY FACTORS - R (ADULT)

(ma mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY ISOTOPE LUNG GI-LLI H-3 NO DATA 3.24E+02* 3.24E+02* 3.24E+02* 3.24E+02* 3.24EM2* 3.24E+02*

C-14 I NA-24 3.33E+05* 6.66E+04* 6.66E+04* 6.66EM4* 6.66E+04* 6.66E+04*

1.45E-03 ** 1.45E-03 1.45E-03 1.45E-03 1.45E-03 1.45E-03 6,66E+04*

1.45E-03 I P-32 CR-51 MN-54 4.65E+09 NO DATA 2.89EM 8 NO DATA 1.80EM8 7.05E+03 NO DATA 4.21E+03 NO DATA 1.55E+03 NO DATA 9.35E+03 5.23E+08 1.77E+06 NO DATA 9.19E+06 1.75EM 6 NO DATA 2.73E+06 NO DATA 2.81E+07 I MN-56 NO DATA 1.45E-53 2.57E-54 NO DATA 1.84E-53 NO DATA 4.62E-52 I FE-55 FE-59 2.94E+08 2.66E% 8 2.03E+08 6.24Ed 8 4.74E+07 2.39E+08 NO DATA NO DATA NO DATA NO DATA 1.13E+08 1.74E+08 1.17E+08 2.08EM9 CO-58 NO DATA 1.83E+07 4.09E+07 NO DATA NO DATA CO-60 NO DATA 3.70EM8 NO DATA 7.51E+07 1.66E+08 NO DATA NO DATA NO DATA 1.41E+09 NI-63 1.89E+10 1.31E+09 6.32E+08 NO DATA NO DATA NO DATA 2.73EM8 I NI-65 2.27E-52 2.94E-53 1.34E-53 NO DATA NO DATA NO DATA 7.46E-52 I CU-64 ZN-65 NO DATA 3.56E+08 2.52E-07 1.13EM9 1.18E-07 5.12EM8 NO DATA NO DATA 6.36E-07 7.57EM8 NO DATA NO DATA 2.15E-05 7.13E%8 l

1 i

i ZN-69 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA i BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA lI BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA g RB-86 NO DATA 4.87E+08 2.27E+08 NO DATA NO DATA NO DATA 9.61E+07 g RB-88 NO DATA 0.00E%0 0.00E40 NO DATA NO DATA NO DATA 0.00E400 RB-89 NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 -

SR-89 3.01E+08 NO DATA 8.64E+06 NO DATA NO DATA NO DATA 4.83E+07 ;

SR-90 1.24E+10 NO DATA 3.05E+09 NO DATA NO DATA NO DATA 3.59E+08 SR-91 1.43E-10 NO DATA 5.79E-12 NO DATA NO DATA SR-92 NO DATA 6.83E-10 E 1.28E-49 NO DATA 5.54E-51 NO DATA NO DATA NO DATA 2.54E-48 g Y-90 1.09E+02 NO DATA 2.92E+00 NO DATA NO DATA NO DATA 1.15E+06 l

I CLINTON-I 3-103 Rev.5-2/89

CPS-0DCM I TABLE 3.5-27 (continued)

MEAT PATHWAY FACTORS - R (ADULT)

(m2 mrem /yr per pCi/sec) g ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI g ,1SOTOPE I

. Y-91m 0.00EMO NO DATA 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 Y-91 , 1.13t+06 NO DATA 3.03EM4 NO DATA NO DATA NO DATA 6.23E+08 Y-92 1.49E-39 NO DATA 4.36E-41 NO DATA NO DATA l (. NO DATA 2.61E-35 I

Y-93 4.40E-12 NO DATA 1.21E-13 NO DATA NO DATA ZR-95 1.87E+06 NO DATA 1.39E-07 6.00E+05 4.06E+05 NO DATA 9.41E+05 NO DATA 1.90E+09 ZR-97 2.03E-05 4.10E-06 1.88E-06 NO D/.TA 6.17E-06 NO DATA 1.27EMO NB-95 2.30EM6 I MO-99 TC-99m NO DATA 4.32E-21 1.28E+06 9.91E+04 1.22E-20 6.86E405 1.89E+04 1.56E-19 NO DATA NO DATA NO DATA 1.26E+06 2.24E+05 1.86E-19 NO DATA NO DATA 5.99E-21 7.75EM 9 2.30E+05 7.23E-18 l

TC-101 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00' O.00EMO RU-103 1.05E+08 NO DATA 4.53EM 7 NO DATA 4.02E+08 NO DATA 1.23E+10 RU-105 5.42E-28 NO DATA 2.14E-28 NO DATA 7.00E-27 NO DATA 3.32E-25 RU-106 I AG-110m TE-125m 2.81E409 6.67E406 3;.59E+08 NO DATA 6.17EM6 1.30E+08 3.55EM8 3.67E+06 4.81E+07 NO DATA NO DATA 1.08E+08 5.42E+09 1.21EM7 1.46E+09 NO DATA NO DATA NO DATA 1.82E+11 2.52EM9 1.43E+09 TE-127m 1.12EM 9 3.99EM8 1.36E408 2.85E+08 4.54E+09 NO DATA 3.75EM 9 TE-127 2.09E-10 7.52E-11 4.53E-11 1.55E-10 8.53E-10 NO DATA 1.65E-08 TE-129m 1.13E409 4.22E+08 1.79E+08 3.89E+08 4.73EM9 NO DATA 5.70E+09 TE-129 0.00E+00 0.00E+00 0.00EMO 0.00E+00 0.00E+00 NO DATA 0.00EMO ITE-131u TE-131 4.50E+02 0.00E400 2.20E+02 1.83E402 3.48E+02 2.23E403 NO DATA 2.18E+04 0.00E+00 0.00E+00 0.00E400 0.00E400 NO DATA 0.00E+00 I TE -132 1.42EM6 9.21E+05 8.64E+05 1.02E+06 8.87E+06 NO DATA 4.36EM7 I-130 2.03E-06 5.98E-06 2.36E-06 5.07E-04 9.33E-06 NO DATA 5.15E-06 I-131 1.07EM7 1.54E+07 8.80E+06 5.03E+09 2.63E+07 NO DATA 4.05E+06 I-132 7.13E-59 1.91E-58 6.67E-59 6.67E-57 3.04E-58 NO DATA 3.58E-59 II-133 I-134 3.70E-01 0.00E+00 6.43E-01 1.96E-01 9.45E+01 *1.12E+00 NO DATA 5.78E-01 0.00E+00 0.00EMO 0.00E+00 0.00E+00 NO DATA 0.00E+00 I

~

i l

CLINTON-I 3-104 l Rev.5-2/89 I

CPS-ODCM TABLE 3.5-27 (continued)

I MEAT PATHWAY FACTORS - R,41)(A N )

(m2 mrem /yr per pCi/sec)

I ORGAN:

ISOTOPE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I-135 4.65E-17 1.22E-16 4.49E-17 8.03E-15 1.95E-16 NO DATA 1.38E-16 l CS-134 3 6.53E+08 1.55EM9 1.27EM9 NO DATA 5.03E+08 1.67E+08 2.72E+07 CS-136 1.20E+07 4.75E+07 3.42E+07 NO DATA 2.65E+07 3.63E+06 5.40E% 6 1

CS-137 8.69E+08 1.19E+09 7.78E+08 NO DATA 4.03E%8 1.34E+08 2.30E+07 CS-138 0.00E+00 0.00E400 0.00E+00 NO DATA 0.00E+00 0.00EM O 0.00E+00 BA-139 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 ,

I BA-140 BA-141 BA-142 2.88E+07 0.00E+00 0.00E+00 3.62E+04 0.00E+00 0.00E+00 1.89E% 6 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 1.23E+04 0.00E+00 0.00E+00 2.07E+04 0.00E+00 0.00E+00 5.94E% 7 0.00E+00 0.00E60 I LA-140 3.68E-02 1.SSE-02 4.90E-13 NO DATA NO DATA NO DATA 1.36E+03 LA-142 4.07E-92 1.85E-92 4.61E-93 NO DATA NO DATA NO DATA 1.35E-88 CE-141 1.39E+04 9.43E+03 1.07E+03 NO DATA 4.38E403 NO DATA 3.61E+07 CE-143 2.03E-02 1.50E+01 1.66E-03' NO DATA 6.61E-03 NO DATA 5.61E+02 CE-144 1.46E+06 6.10E+05 7.83E+04 NO DATA 3.62E+05 NO DATA 4.93E+08 PR-143 2.09EM4 8.40E+03 1.04E+03 NO DATA 4.85E+03 NO DATA 9.17E+07 PR-144 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00 ND-147 7.04E+03 8.14E+03 4.87EM 2 NO DATA 4.76E+03 NO DATA 3.91E+07 W-187 2.06E-02 1.72E-02 6.02E-03 NO DATA NO DATA NO DATA 5.64E+00 i NP-239 2.57E-01 2.53E-02 1.39E-02 NO DATA 7.88E-02 NO DATA 5.18E+03

.1

mrem /yr peryCi/m3 I

- 1.45 x 10 '

l I i I CLINTON-I 3-105 Rev.5-2/89 l

I .

j CPS-ODCM I TABLE 3.5-28 I VEGETATION PATHWAY FACTORS - R ..(CHILD)

Y at3 (m2 mrem /yr per yCi/sec) t ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I ISO'IOPE H-3 NO DATA 4.01E@3* 4.01EM3* 4.01EM3* 4.01EM3* 4.01EM 3* 4.01E+03*

C-14 I 3.51EM6* 7.01E+05* 7.01E+05* 7.01EM5

7.01E+05* 7.01EM5* '

7.01 EMS

NA-24 , 3.75EM5** 3.75EM5 3.75 EMS 3.75 EMS 3.75 EMS 3.75 EMS 3.75E+05

(

I P-32 CR-51 MN-54 3.37E409 NO DATA 1.57EM8 NO DATA 1.30E+08 1.17E+05 NO DATA 6.49EM 4 NO DATA 1.77E+04 NO DATA 1.18E+05 9.30EM7 6.20EM 6

)

i

?

NO DATA 6.64E+08 1.77E408 NO DATA 1.86E+08 NO DATA 5.58E+08 I MN-56 NO DATA 1.87E+01 4.22E+00 NO DATA 2.26E+01 NO DATA 2.71E+03 I FE-55 FE-59 8.02E+08 3.98E+08 4.25E+08 6.43E+08 1.32E+08 3.21E+08 NO DATA NO DATA NO DATA NO DATA 2.40E+08 1.87E+08 7.88E+07 6.70E+08 I

CO-58 NO DATA 6.44E+07 1.97E+0S NO DATA NO DATA NO DATA 3.76E+08 !

Co-60 NO DATA 3.79E+08 1.12E+09 NO DATA NO DATA NO DATA 2.10E+09 l NI-63 3.95E+10 2.11E+09 1.34E+09 NO DATA NO DATA NO DATA 1.42E+08 I NI-65 1.05EM2 9.89E+00 5.77E+00 NO DATA NO DATA NO DATA 1.21E+03 CU-64 NO DATA 1.09E+04 6.59E+03 NO DATA 2.64E+04 NO DATA 5.12E+05 ZN-65 8.11E+08 2.16E+09 1.34E+09 NO DATA 1.36E+09 NO DATA 3.79E408 ZN-69 9.29E-06 1.34E-05 1.24E-06 NO DATA 8.14E-06 NO DATA 8.4CE-04 BR-83 NO DATA NO DATA 5.40EMO NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA 3.92E-11 NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA I RB-86 RB-88 NO DATA NO DATA 4.53E+08 4.38E-22 2.79E+08 3.04E-22 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 2.91E+07 2.15E-23

}

RB-89 NO DATA 4.69E-26 4.17E-26 NO DATA NO DATA SR-89 NO DATA 4.09E-28 l

3.59E+10 NO DATA 1.03E+09 NO DATA NO DATA NO DATA 1.39E+09 SR-90 1.24E+12 NO DATA 3.14E+11 NO DATA NO DATA NO DATA 1.67E+10 SR-91 5.21E+05 NO DATA 1.97E404 NO DATA NO DATA NO DATA 1.15E+06 I SR-51 7.29E+02 NO DA s 2.92E401 NO DATA NO DATA NO DATA 1.38E404 Y-90 2.31E+04 {

NO DA1. 6.18E%2 NO DATA NO DATA NO DATA 6.58E+07 I CLINTON-1 3-106 Rev.5-2/89 L_ --_____________-?_ - - - - - - - - - -

CPS-0DCM I TABLE 3.5-28 (continued)

VEGETATION PATINAY FACTORS - R 13 (CMI.D)

(m2 mrem /yr per pCi/sec) .

ORGAN: BONE LIVER T. BODY THYROID l

KIDNEY LUNG GI-LLI ISOTOPE l

l Y-91m 9.24E-09 NO DATA 3.36E-10 NO DATA NO DATA Y-91 NO DATA 1.81E-05 1.86E+07 NO DATA 4.97E+05 NO DATA NO DATA NO DATA Y-92 2.48E+09

1.58E+00 NO DATA 4.52E-02 NO DATA NO DATA NO DATA 4.57E+04 i

Y-93 2.92E+02 NO DATA 8.01E+00 NO DATA NO DATA NO DATA 4.35E+O6 ZR-95 3.86E+06 8.49E+05 7.56E+05 NO DATA 1.22E+06 NO DATA 8.86E408 ZR-97 5.66E+02 8.18E+01 4.83E401 NO DATA 1.17E402 NO DATA 1.24E+07 I NB-95 4.10E45 1.60E+05 1.14E+05 NO DATA 1.50 EMS NO DATA 2.95E+08 MO-99 7.67EM6 1

I TC-99m NO DATA 4.70E+00 9.21E%0 1.90E+06 1.53E+02 NO DATA NO DATA 1.64E+07 1.34E+02 NO DATA 4.68E+00 6.35E+06 5.24E+03 TC-101 1.48E-30 1.54E-30 1.96E-29 NO DATA 2.63E-29 8.16E-31 RU-103 4.91E-30 1.54E+07 NO DATA 5.90E+06 NO DATA 3.86E+07 NO DATA 3.97E+08 RU-105 9.16E401 NO DATA 3.32E+01 NO DATA 8.05E+02 NO DATA 5.98EM4

\

RU-106 7.45E+08 NO DATA 9.30E+07 NO DATA 1.01E+09 AG-110m NO DATA 1.16E+10 !

E 3.21E+07 2.17E+07 1.73E+07 NO DATA 4.04E+07 NO DATA 2.58E+09 E TE-125m 3.51E+08 9.52E+07 4.68E407 9.86E+07 NO DATA NO DATA 3.39E+08 I

TE-127m 1.32E+09 3.56E408 1.57E+08 3.16E+08 3.77E+09 NO DATA 1.07E409 TE-127 9.84E+03 2.65E+03 2.11E+03 6.81E+03 2.80E+04 NO DATA 3.84E+05 TE-129m 8.43E+0S 2.35E+08 1.31E+08 2.72E+08 2.47E+09 NO DATA 1.03E+09 TE-129 1.32E-03 3.68E-04 3.13E-04 9.42E-04 3.86E-03 TE-131m NO DATA 8.21E-02 1.54E+06 i

l I TE-131 2.59E-15 5.33E+05 7.89E-16 5.67E+05 7.71E-16 1.10E+06 1.98E-15 5.16E+06 7.83E-15 NO DATA NO DATA 2.16E+07 1.36E-14 I TE-132 I-130 I-131 7.00EM 6 6.10E+05 3.10E+06 1.23E+06 3.74E+06 6.35E+05 4.51E406 1.36E+08 2.88E@ 7 1.84E+06 NO DATA NO DATA 3.12E+07 5.77E+05 1.43E+08 1.44E+08 8.16E+07 4.75E+10 2.36EM8 NO DATA 1.28E+07 I I-132 9.20E+01 1.69EM2 7.77E+01 7.84E+03 2.59E+02 NO DATA 1.99E+02 I-133 3.53E+06 I I-134 1.50E-04 4.36E+06 2.79E-04 1.65E+06 1.28E-04 8.11E+08 6.41E-03 7.27E+06 4.26E-04 NO DATA NO DATA 1.76E+06 1.85E-04 CLINTON-I 3-107 Rev.5-2/89

!I

cro-vuun I TABLE 3.5-28 (continued)

VEGETATION PATHWAY FACTORS - R (CHILD)

(m2 mrem /yr per uCi/sec) l ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE I-135 6.28E+04 1.12E+05 5.34E+04 1.00EM 7 1.73E+05 CS-134 1.60E+10 NO DATA 8.61E%4 l

2.63E+10 5.55E+09 NO DATA 8.15Ed9 2.92E+09 8.23E+07 1.42E+08 CS-136 , 2.26E+08 1.46E408 NO DATA 1.20E408 1.80EM7 7.95EM6 i

I CS-137

2.39E+10 CS-138 BA-139 6.44E-11 4.97E-02 2.29E+10 8.95E-11 2.65E-05 3.38EM9 5.68E-11 NO DATA NO DATA 7.46E+09 6.30E-11 2.68EM 9 6.78E-12 1.43E+08 4.12E-11 1.44E-03 NO DATA 2.32E-05 1.56E-05 2.87EMO I BA-140 2.77E+08 2.42E+05 1.62E+07 NO DATA 7.89EM4 1.45E+05 BA-141 1.40E+08 2.04E-21 1.14E-24 6.64E-23 NO DATA 9.88E-25 6.71E-24 BA-142 1.16E-21 9.70E-39 6.98E-42 5.42E-40 NO DATA 5.65E-42 4.11E-42 1.27E-40 l

LA-140 3.24E+03 1.13E+03 3.53E+02 NO DATA NO DATA

' NO DATA 3.16E+07 i LA-142 3.39E-04 1.0SE-04 3.38E-05 NO DATA NO DATA CE-141 1.48E+06 NO DATA 2.14EMI 3.27E+05 4.85E+04 NO DATA 1.43E+05 NO DATA 4.08E+0S I CE-143 1.71E+03 9.29E+05 1.35E d2 NO DATA 3.90E+02 NO DATA 1.36E+07

! E CE-144 1.27E+08 3.99EM 7 6.79E406 NO DATA 2.21EM7 NO DATA 1.04E+10 E PR-143 1.45E+05 4.37E+04 7.22E+03 NO DATA 2.36E404 NO DATA 1.57E+08 l

l PR-144 5.64E-26 1.74E-26 2.84E-27

' NO DATA 9.22E-27 NO DATA 3.75E-23 {

ND-147 7.16E+04 5.80E444 4.49E+03 WO DATA 3.18E+04 NO DATA 9.18E407 W-187 6.44E+04 3.81E%4 1.71E+04 NO DATA NO DATA l NO DATA 5.36E+06 I NP-239 2.56E+03 1.84E+02 1.29EM2 NO DATA 5.31E+02 NO DATA 1.36E+07 I

l

mrem /yr per pCi/m 3 .

5

- 3.75x10 I l CLINTON-I 3-108 Rev.2-2/89 I

l I TABLE 3.5-29 i

VEGETATION PATHWAY FACTORS - R (TEEN)

(m2 mrem /yr per pCi/sec)

I ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA C-14 2.59E+03* 2.59E+03* 2.59E+03* 2.59EM3* 2.59E+03* 2.59E+03*

NA-24 1.45EM6* 2.91E+05* 2.91E+05* 2.91E+05* 2.91E+05* 2.91E+05* 2.91E+05* 1

, 2.40E405** 2.40E+05 2.40E+05 2.40E405 2.40E+05 2.40E+05 2.40E+05 i

l l P-32 1.61E+09 9.97EM7 6.24EM 7 NO DATA NO DATA NO DATA 1.35E+08 E

CR-51 NO DATA NO DATA 6.12E+04 3.40E+04 1.34E+04 8.74E+04 1.03E%7 MN-54 NO DATA 4.54E+08 9.01E47 NO DATA 1.36E+08 NO DATA 9.32E408 MN-56 NO DATA 1.43E+01 2.54E+00 NO DATA 1.81E+01 NO DATA 9.41E402 FE-55 3.26E+08 2.31E+08 5.39EM 7 KO DATA NO DATA 1.46E+08 1.00E+08 TE-59 1.79E+08 4.18E+08 1.61E+08 KO DATA NO DATA 1.32E+08 9.88E408 i

I CO-58 CO-60 NI-63 NO DATA NO DATA 1.61E+10 4.36E+07 2.49E+08 1.14E+09 1.01E+08 5.60E+0S NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 6.02E+08 3.24E+09 i

5.46E+08 NO DATA NO DATA NO DATA 1.81E408 I NI-65 5.73E%1 7.32E+00 3.34E+00 NO DATA NO DATA NO DATA 3.97E402 CU-64 NO DATA 8.2SE+03 3.90E+03 NO DATA 2.10E+04 NO DATA 6.42E+05 ZN-65 4.23E+08 1.47E+09 6.86E+08 NO DATA 9.41E+08 NO DATA 6.23E408 i

ZN-69 5.04E-06 9.60E-06 6.72E-07 NO DATA 6.28E-06 NO DATA 1.77E-05 BR-83 NO DATA NO DATA 2.93E+00 NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA 2.31E-11 NO DATA NO DATA NO DATA NO DATA I BR-85 NO DATA NO T..TA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 NO DATA 2.72E408 1.28E408 NO DATA NO DATA NO DATA 4.02E+07 I RB-88 NO DATA 3.17E-22 1.69E-22 NO DATA NO DATA NO DATA 2.72E-29 i

I RB-89 SR-89 SR-90 NO DATA 1.51E+10 7.50E+11 3.56E-26 NO DATA NO DATA 2.52E-26 4.32E+08 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 5.45E-35 1.80E+09

.I 1.85E+11 NO DATA NO DATA NO DATA 2.11E+10 I SR-91 2.82E+05 NO DATA 1.12E+04 NO DATA NO DATA NO DATA 1.28E406 SR-92 4.00E+02 NO DATA 1.70E+01 NO DATA NO DATA NO DATA 1.02E404 IY-90 1.25E+04 NO DATA 3.37E402 NO DATA NO DATA NO DATA 1.03E408 l

I~CLINTON-1 3-109 Rev.5-2/89 I '

CPS-ODCM I

TABLE 3.5-29 (continued)

VEGETATION PATHWAY FACTORS - R (TEEN)

(m2 mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY ThTROID KIDNEY LUNG GI-LLI ISOTOPE Y -91m 5.04E-09 NO DATA 1.93E-10 NO DATA NO DATA NO DATA 2.38E-07 Y-91 7.84E+06 NO DATA 2.10E+05 NO DATA NO DATA NO DATA 3.21E+09 Y-92 8.60E-01 NO DATA 2.49E-02 NO DATA NO DATA NO DATA 2.36E404 i"

Y-93 1.58E+02 NO DATA 4.34E+00 NO DATA NO DATA NO DATA 4.83E406 ZR-95 1.73E+06 5.46E+05 3.75EM 5 NO DATA 8.02E+05 NO DATA 1.26E+09 ZR-97 3.10E+02 6.14E+01 2.83E+01 NO DATA 9.31E+01 NO DATA 1.66E+07 I NB-95 1.92E+05 1.07E405 5.86E+04 NO DATA 1.03E+05 NO DATA 4.5.6E408 MD-99 NO DATA 5.64E+06 1.08E+06 NO DATA 1.29E+07 NO DATA 1.01E+07 TC-99m 2.73E+00 7.61E+00 9.86E+01 NO DATA 1.13E+02 4.23E+00 5.00E+03 I TC-101 RU-103 RU-105 8.02E-31 6.81E+06 4.97E+01 1.14E-30 NO DATA 1.12E-29 2.91E+06 NO DATA NO DATA 2.06E-29 2.40E+07 6.95E-31 NO DATA 1.95E-37 5.69E+08 NO DATA 1.93E401 NO DATA 6.27E+02 NO DATA 4.01E+04 RU-106 3.09E+08 NO DATA 3.89EM 7 NO DATA 5.95E+08 NO DATA 1.48E+10 AG-110m 1.51E% 7 1.43E+07 I TE-125m 1.49E408 5.35E+07 8.72E+06 1.99E+07 NO DATA 4.15E+07 2.'73 E+07 NO DATA NO DATA NO DATA 4.03E+09 4.38E408 I TE-127m TE-127 TE-129m 5.52E+08 5.40E+03 3.60E48 1.96E+08 1.92E+03 1.34E+08 6.57EM 7 1.16E+03 1.31E+08 3.73E+03 2.24E+09 2.19E+04 NO DATA NO DATA 1.38E+09 4.17E%5 l

5.70E+07 1.16E+08 1.51E+09 NO DATA 1.35E+09 I TE-129 7.13E-04 2.66E-04 1.73E-04 5.09E-04 2.99E-03 NO DATA 3.90E-03 TE-131m 8.44E+05 I TE-131 1.41E-15 4.05E+05 5.80E-16 3.38E+05 4.39E-16 6.09E+05 1.08E-15 4.22EM 6 6.15E-15 NO DATA NO DATA 3.25E+07 1.15E-16 I TE-132 1-130 I-131 3.91E+06 3.50E+05 7.66E+07 2.48E+06 1.01EM 6 2.33E+06 4.05E+05 2.61E+06 8.26E407 2.37E+07 1.56E+06 NO DATA NO DATA 7.84E+07 7.79E+05

1.07EM8 5.76E+07 3.13E+10 1.85E448 NO DATA 2.12E+07 lI I-132 5.19E+01 1.36E+02 4.87EMI 4.58E+03 2.14E+02 NO DATA 5.91E+01 I-133 I I-134 1.93E+06 8.44E-05 3.28E+06 2.24E-04 1.00E+06 8.03E-05 4.58E+08 3.73E-03 5.75E+06 3.53E-04 NO DATA NO DATA 2.48E+06 2.95E-06

'I CLINTON-1 3-110 Rev.5-2/89 I

CPS-ODCM I

1 TABLE 3.5-29 (continued)

VEGETATION PATHWA'l FACTORS - R (TEEN)

(m2 mrem /yr per yCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI

) ISOTOPE I-135 3.53E+04 9.09E+04 3.37E M4 5.85E+06 1.44E+05 NO DATA 1.01E+05 CS-134 7.10E+09 1.67E+10 7.75E+09 NO DATA 5.31E+09 2.03E+09 2.08E+08 CS-136 . 4.37E+07 1.72E+08 1.16E+08 NO DA2A 9.37E407 1.48E+07 1.38E+07

( .

CS-137 1.01E+10 1.35E+10 4.70E+09 NO DATA 4.59E+09 1.78E+09 1.92E+08 CS-138 3.54E-11 6.80E-11 3.40E-11 NO DATA 5.02E-11 5.84E-12 3.08E-14 BA-139 2.70E 1.90E-05 7.86E-04 NO DATA 1.79E-05 1.31E-05 2.41E-01 I BA-140 1.38EM8 1.69E+05 8.89E+06 NO DATA 5.73E% 4 1.14E+05 2.13E+08 BA-141 1.11E-21 I BA-142 5.35E-39 8.27E-25 5.35E-42 3.70E-23 3.29E-40 NO DATA NO DATA 7.67E-25 4.53E-42 5.66E-25 3.56E-42 2.36E-27 1.64E-50 l LA-140 1.80E+03 8.86E+02 2.36E+02 NO DATA NO DATA NO DATA 5.09E+07

'LA-142 1.88E-04 8.35E-05 2.08E-05 NO DATA NO DATA NO DATA 2.54E+00 CE-141 2.83E+05 1.89E+05 2.17E+04 NO DATA 8.90E+04 NO DATA 5.41E408 I CE-143 9.33E+02 6.79E+05 7.58E+01 NO DATA 3.04E+02 NO DATA 2.04E+07 g CE-144 5.29E+07 2.19EM7 2.84E+06 NO DATA 1.31E+07 NO DATA 1.33E+10 g PR-143 7.00E+04 2.79E+04 3.48E+03 NO DATA 1.62E+04 No DATA 2.30E%8 I PR-144 ND-147 V-187 3.04E-26 3.62E+04 1.24E-26 3.94E+04 1.54E-27 2.36E+03 NO DATA NO DATA 7.14E-27 2.31E+04 NO DATA NO DATA 3.35E-29 1.42E+08 3.53E+04 2.88E+04 1.01E+04 NO DATA NO DATA NO DATA 7.79E+06 I NP-239 1.39E+03 1.31EM2 7.26E+01 NO DATA 4.10E+02 NO DATA 2.10E+07 I

l

mrem /yr per yC1/m3

- ? 40x10 5 I

I CLINTON-1 3-111 Rev.5-2/89 I

CPS-0DCM I TABLE 3.5-30 VEGETATION PATHWAY FACTORS - R (ADULT)

(m2 mrem /yr perp Ci/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE B-3 NO DATA l

g C-14 2.26E+03* 2.26E+03* 2.26E+03* 2.26E+03* 2.26E+03* 2.26E+03*

"A-24 8.97E405* 1.79E+05* 1.79E+05* 1.79 EMS

1.79E+05* 1.79E+05* 1.79E+05*

5 , 2.71E+05** 2.71t+05 2.71E+05 2.71E+05 2.71E+05 2.71E+05 2.71E+05 I P-32 CR-51 MN-54 1.40E+09 NO DATA

8. 70E+07 NO DATA 5.41E407 4.60E+04 NO DATA 2.75E+04 NO DATA 1.01E+04 NO DATA 6.11E+04 1.57E+08 1.16E+07 NO DATA 3.13EM8 5.96E407 NO DATA 9.30E407 I MN-56 NO DATA 1.59E+01 2.82E+00 NO DATA 9.58E+C8 NO DATA 2.01E+01 NO DATA 5.06Ee2 I FE-55 FE-59 2.10E408 1.26E+08 1.45E408 2.96E408 3.38E+07 1.13E408 UO DATA NO DATA NO DATA NO DATA 8.10E+07 8.27E+07 8.33E4 7 9.86E+08 CO-58 NO DATA 3.08E+07 6.90E+07 NO DATA NO DATA NO DATA 6.24E+08 CO-60 NO DATA 1.67E+08 3.69E+08 NO DATA NO DATA NO DATA 3.14E+09 NI-63 1.04E+10 7.21E+08 3.49E+08 NO DATA I NI-65 6.18E %1 8.03E+00 NO DATA NO DATA 1.50E+08 3.66E400 NO DATA NO DATA NO DATA 2.04E% 2 CU-64 NO DATA 9.16E+03 4.30E+03 NO DATA 2.31E% 4 No DATA 7.81E+05 I.

ZN-65 3.18E408 1.01E+09 4.57E+08 NO DATA 6.76Ee 8 NO DATA 6.36E+08 ZN-69 5.39E-06 1.03E-05 7.17E-07 NO DATA ER-83 6.69E-06 NO DATA 1.55E-06 NO DATA NO DATA 3.13E+00 NO DATA NO DATA NO DATA 4.50E400 BR-84 NO DATA NO DATA 2.54E-11 NO DATA NO DATA NO DATA 1.99E-16 iI BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA i g RB-86 NO DATA 2.19E408 1.02E+08 NO DATA NO DATA g RB-88 NO DATA 3.43E-22 1.82E-22 NO DATA NO DATA NO DATA NO DATA 4.33E+07 4.74E-33 RB-89 NO DATA 3.96E-26 2.79E-26 NO DATA NO DATA NO DATA 2.30E-39 -

SR-89 9.95E+09 NO DATA 2.86E+08 NO DATA NO DATA NO DATA 1.60E+09 SR-90 6.04E+11 NO DATA 1.48E+11 NO DATA NO DATA NO DATA 1.75E+10 1

SR-91 3.02E+05 NO DATA 1.22E+04 NO DATA NO DATA NO DATA 1.44E406 I SR-92 Y-90 4.28E+02 1.33E404 NO DATA NO DATA 1.85E+01 3.56E+02 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 8.48E+C3 1.41E+08 l I

I CLINTON-I 3-112 Rev.5-2/89 i

CPS-0DCM TABLE 3.5-30 (continued)

VEGETATION PATHWAY FACTORS - R 13 (AM)

(m2 mrem /yr per pCi/sec) -

I ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE Y-91m 5.42E-09 NO DATA 2.10E-10 NO DATA NO DATA NO DATA 1.59E-08 Y-91 5.12E+06 NO DATA 1.37E+05 NO DATA NO DATA NO DATA 2.82E+09 Y-92 9.13E-01 NO DATA 2.67E-02 NO DATA NO DATA NO DATA 1.60E+04 s

I' Y-93 1.69E+02 NO DATA 4.65E+00 NO DATA NO DATA NO DATA 5.35E406 ZR-95 1.18E+06 3.79E405 2.56E+05 NO DATA 5.94E+05 NO DATA 1.20E+09 ZR-97 3.36E+02 6.78E+01 3.10E+01 NO DATA 1.02E+02 NO DATA 2.10E+07 I NB-95 MO-99 1.42E405 NO DATA 7.91E%4 4.25E+04 NO DATA 7.82E404 NO DATA 4.80E+08 6.12E406 1.16E+06 N DATA 1.39E+07 NO DATA 1.42E+07 TC-99m 3.09E400 8.73E+00 1.11E+02 NO DATA 1.33E+02 4.28E+00 5.16E+03 TC 231 8.62E-31 1.24E-30 I RU-103 RU-105 4.77E+06 5.36E+01 NO DATA NO DATA 1.22E-29 2.06E@ 6 2.12E41 NO DATA NO DATA NO DATA 2.24E-29 1.82E+07 6.93E+02 6.35E-31 NO DATA NO DATA 3.73E-42 5.57E+08 3.28E44 I RU-106 1.93E408 NO LATA 2.44E+07 NO DATA 3.73E+08 NO DATA 1.25E+10 AG-110m 1.05E+07 9.75E+06 5.79E406 NO DATA 1.92E+07 NO DATA 3.98E+09 TE-125m 9.67E+07 3.51E+07 1.30E+07 2.91E+07 3.93E+08 NO DATA 3.86E+08 I TE-127m TE-127 TE-129m 3.49E+08 5.65E+03 2.51E+08 1.25E408 2.03EM3 9.35E@ 7 4.26E+07 1.22E+03 3.97E407 8.93EM 7 4.19E&O3 8.61E+07 1 42E409 2.30EtG' 1.05E+09 NO DATA NO DATA NODA1A 1.17EM9 4.46E445

!.?6E+09 I

I TE-129 TE-131m 7.61E-04 2.86E-04 1.85E-04 5.84E-04 3.20E-03 NO DATA 5.75E-04 1

I 9.12E+05 4.46EM5 3.72E405 7.06E+05 4.52E+06 NO DATA 4.43E+07 TE-131 1.51E-15 6.32E-16 4.78E-16 1.24E-15 6.63E-15 NO DATA 2.14E-16 TE-132 4.31EM6 2.79E+06 2.62E+06 3.08E+06 2.6BE+07 NO DATA 1.32E+08 I-130 3.91E+05 1.15E+06 4.55E+05 9. 77E407 1.80EM6 NO DATA I-131 9.93E+05 8.07E+07 1.15 EMS 6.62EM7 3.785+10 1.98EM8 NO DATA 3.05E+07 I I -132 5.77E+01 1.54E402 5.40E+01 5,40E+03 2.46E+02 NO DATA 2.90EMI I-133 2.09E+06 3.63E+06 1.11E4 9 5.34E+08 6.34E+06 NO DATA I-134 3.26E+06 9.33E-05 2.53E-04 9.06E-05 4.39E-03 4.03E-04 NO DATA 2.21E-07 CLINTON-1 3-113 Rev.5-2/89 I -

Ul'b-UUCM I TABLE 3.5-30 (continued)

VEGETATION PATHWAY FACTORS - R (ADULT)

(mm mrem /yr per pCi/sec)

ORGAN: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE I-135 3.91E+04 1.02E+0) 3.77EM4 6. 75 E+06 1.64E+05 NO DATA 1.16E+05 I CS-134 CS-136 ,

4.67E-K)9 4.26EM7 1.11E+10 1.68E408 P308E+09 1.21E+08 NO DATA NO DATA 3.59EM9 9.35E+07 1.19E+09 1.28E407 1.94E+08 1.91EM 7 i

I CS-137 CS-138 BA-139 6.36EM9 3.84E-11 8.70Z+09 7.58E-11 5.70E+09 3.75E-11 NO DATA NO DATA 2.95EM9 5.57E-11 9.82E+08 5.50E-12 1.68E408 3.23E-16 2.86E-02 2.04E-05 8.38E-04 NO DATA 1.91E-05 1.16E-05 5.07E-02 I BA-140 1.29E+08 1.62E+05 8.43EM6 NO DATA 5.50E404 9,26E404 2.65EM 8 I BA-141 1.18E-21 i 8.90E-25 3.98E-23 NO DATA 8.'28E-25 5.05E-25 5.55E-31 BA-142 5.79E-39 5.96E-42 3.64E-40 NO DATA 5.03E-42 3.37E-42 8.16E-57 LA-140 1.98E+03 9.95E+02 2.63E+02 NO DATA NO DATA NO DATA 7.31E+07 IA-142 2.04E-04 9.25E-05 2.31E-05 NO DATA NO DATA NO DATA 6.76E-01 CE-141 1.97E+05 1.33E+05 1.51E+04 NO DATA 6.19E+04 I CE-143 9.98E+02 NO- DA'. 4 5.09E+08 7.3CE405 8.17EMI NO DATA 3.25EM2 NO DATA 2.76E+07 I CE-144 !

3.28E+07 1.37E+07 1.76EM6 NO DATA 8.14E+06 NO DATA PR-143 1.11E+10 i 6.26EM4 2.51E+04 3.10E+03 NO DATA 1.45E+04 NO DATA 2.74E+08 l PR-144 3.25E-26 1.35E-26 1.65E-27 NO DATA ND-147 7.61E-27 NO DATA 4.68E-33 3.33EM4 3.85E+04 2.31E+03 NO DATA 2.25E+04 NO DATA W-187 1.85E408 l 3.80E+04 3.18E404 1.11E+04 NO DATA NO DATA l

(

I lip-239 1.43E403 1.40E+02 NO DATA 1.40E+07

{

7.74E+01 NO DATA 4.38E+02 NO DATA 2.88E+07 I

h

mrem /yr per pCf./m3 .

- 2.71x10 5

,I l

I CLINTON-I 3-114 Rev.5-2/89

i I

l TABLE 3.5-31 i

GROUND PLANE PATINAY FACTORS - Rf (mr mrem /yr per pCi/sec) -

Total Total Total )

l Isotope Body Skin Isotope Body Skin Isotope Body Skin l H-3 0.00E+00 0.00EMO Y-91 1.07E406 1.21E+06 CS-136 1.51E+08 1.71E+08 f i C-14 0.00EMO 0.00E+00 Y-92 1.80E405 2.14E+05 CS-137 1.30E+10 1.52E+10 NA-24 i l 1.20E+07* 1.39EM 7 Y-93 1.83E+05 2.50E+05 CS-138 3.59E+05 4.10E405 I

P-32 ; 0.00EM O 0.00E+00 ZR-95 2.45E408 2.85EM 8 BA-139 1.06E+05 1.19E+05 "4.65E+06 5.50E+06 I CR-51 MN-54 1.38E+09 1.62E+09 ZR-97 NB-95 2.96E+06 3.44E+06 1.37EM 8 1.61E+08 BA-140 BA-141 2.05E+07 2.35E+07 4.17EM4 4.75EM4 j

1 I

MN-56 9.03E+05 1.07E406 MO-99 3.99E446 4.62E+06 BA-142 4.49E+04 3.11E+04 FE-55 0.00E400 0.00E+00 TC-99m 1.84E+05 2.11EM S LA-140 1.92E+07 2.18E+07 FE-59 2. 73E408 3.20E+08 TC-101 2.03E404 2.26EM4 LA-142 7.60E+05 9.12E+05 I

l CO-58 3.80E408 4.45E+08 RU-103 1.08E+08 1.26E+08 CE-141 1.37E+07 1.54E+07 I Co-60 NI-63 2.32E+10 2.73E+10 0.00E+00 0.00E+00 RU-105 6.36E+05 7.21E+05 RU-106 4.22E+08 5.06E+08 CE-143 CE-144

~

2.31E+06 2.63E406 6.96E+07 8.05E+07 t NI-65 2.97EM5 3.45E+05 AG-110m 3.44E+09 4.01E+09 PR-143 0.00E+00 0.00E400 CU-64 6.05E+05 5 86E+05 TE-125m 1.56E+06 2.13E+06 PR-144 1.84E+03 2.11E+03 '

ZN-65 7.48E% 8 8.60E408 TE-127m 9.16E+04 1.08E+05 ND-147 8.39EM 6 1.01E+07

- (

ZN-69 0.00E+00 0.00E+00 TE-127 2.99EM3 3.29E+03 W-187 2.35E+06 2.73E+06 j I

g BR-83 4.87E+03 7.07E+03 TE-129m 1.98EM 7 2.31E+07 NP-239 1.71EM6 1.98E+06 i g BR-84 2.03 EMS 2.36E+05 TE-129 2.64E404 3.12E+04 I

)

BR-85 0.00E+00 0.00E400 TE-131m 8.02E446 9.46E+06 RB-86 8.98E+06 1.03E+07 TE-131 2.92E+04 3.45E+04 RB-88 3.31E+04 3.78E+04 TE-132 4.24E406 4.99E+06 RB-89 1.23EM5 1.48E+05 I-130 5.50E446 6.68EM6 I SR-89 SR-90 2.16E+04 2.50E404 NO DATA NO DATA I-131 I-132 1.72E+07 2.09E+07 1.25EM6 1.47E+06 i

SR-91 2.14E406 2.51E+06 I-133 2.45EM 6 2.98EM 6 SR-92 7.77E+05 8.64E+05 I-134 4.46E+05 5.30E+05 Y-90 4.50E+03 5.31E+03 1-135 2.53E+06 2.95EM6 Y-91m 1.00E+05 1.16E+05 CS-134 6.87E+09 8.01E+09 *1.20 x 10 ,

CLINTON-I 3-115 Rev.5-2/89 I 1

i 1

ATTACHMENT B I-Solidification vendor Procedure / Document Approval Cover Sheet '

l J

I I

I ;

I I

I

c

4. Affect nuclear safety in a way not previcusly evaluated?
Y
5. Require a change to Technical Specifications or the operating license?
I 1 MAINTENANCE DEPARTMENT .......... A /
Signature Date CHEMISTRY GROUP.................. ).}) mm/ / /-5-f 0 SighattQef Date I TECHNICAL DEPARTMENT ............
Signature
/
Date- '
I NUCLEAR STATION ENGINEERING DEPARTMENT........... OrU signature
/i/w/7'r Date I RADIATION PROTECTION DEPARTMENT . / ///$/
SignatAirer
/ /,7,8 f Da'te
~
I QUALITY ASSURANCE DEPARTMENT .... [hf Signatur p
/ // f/ g
' / Dhte I RADWASTE GROUP...................
Signature
/ / 3-Pf Date FACILITY REVIEW I GROUP............__ Mmd--
Sign,dpute
/ /-4 -J1 RCCL f SB. 120 Total Pages Date
/ v Page 1 of 1 I -- - -- -
-

U-601515, Semiannual Radioactive Effluent Release Rept for Clinton Power Station for Jan-June 1989

Contents

Text

Subject:

Dear Sir:

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

References:

SUMMARY

Navigation menu

U-601515, Semiannual Radioactive Effluent Release Rept for Clinton Power Station for Jan-June 1989

Text

Subject:

Dear Sir:

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

References:

SUMMARY

Navigation menu

Search